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Abstract 
Abstract 
Expression systems (ES) in a wide variety of biological systems are used to provide 
foreign protein. Protein production in mammalian cells is a labour-intensive and expensive 
process and insect cells have been used as cheaper alternatives. Insect ES are based on 
two types of vector; viral- and plasmid-based. The baculovirus ES (BES) offers high-level 
transient production of intracellular proteins. Yields of secreted and membrane-targeted 
proteins have until recently been relatively low, however, the development of a novel 
vector, lacking chitinase, has overcome these limitations. Plasmid-based vectors can be 
used for transient and stable expression in insect cells but most utilise the relatively weak 
Autographa californica multiple nucleopolyhedrovirus (AcMNPV) immediate early-1 (ie-1) 
promoter, producing low-levels of intracellular recombinant protein. More recent vectors 
have used stronger promoters, however, compared with mammalian stable ES these are 
limited in use and most notable is the lack of an efficient inducible ES in insect cells. The 
work in this thesis describes methods, with which intracellular levels of foreign protein may 
be increased, while also developing the grounding work for the development of a fully 
functional insect tetracycline regulatory system. 
To improve stable and regulated expression of heterologous genes in insect cells, work 
was undertaken to compare and characterise the transcriptional activity of a range of 
promoters successfully used in insect and mammalian systems. Of the promoters tested, 
Orgyia pseudotsugata MNPV (Op) ie-2 and Bombyx morl actin 3 (BmA3+E) were found to 
be transcriptionally stronger than AcMNPV ie-1. Drosophila melanogaster metallothionein 
and actin 5.1 did not produce any detectable activity, and the Cytomegalovirus (CMV) ie 
promoter, although active, was weaker than AcMNPV ;e-1. Attempts to develop a new 
inducible ES for use in stable cell lines was based on modifying a mammalian tetracycline-
inducible ES. The original CMVie promoters were replaced by the Bm A3+E and Op ie-2 
promoters that had been shown to be optimal in insect cells. The Bm A3+E promoter was 
successfully used to express the tetracycline transcriptional activator protein. Studies also 
demonstrated that the constitutive transcriptional activity of Op ie-2, used to drive 
expression of a reporter gene, was successfully suppressed in normal medium. However, 
in the presence of the inducer, doxycycline, transcriptional activity of Op ie-2 was not 
activated. Work to elucidate why Op ie-2 remain repressed in the presence of the inducer, 
indicated that other, uncharacterised vector sequences may have interfered with the 
activation process. 
To determine whether stable insect cell lines could be used as an effective alternative to 
the BES for producing large quantities of intracellular foreign proteins, protein production 
from stable cell lines, using the Bm A3+E promoter, were compared to the BES using a 
range of reporter proteins. It was concluded that with vectors currently available, stable 
cell lines would not normally provide an effective alternative to the BES. However, a stable 
insect cell line expressing Discosoma red was used to develop methods for scaling-up 
continuous cultivation of cells in an open fermenter system. This stable cell line was 
successfully maintained without contamination or total loss of cell viability for 4 weeks. 
Improving intracellular expression of foreign genes using the BES, initially focused on 
investigating whether a baculovirus vector (BV) lacking chitinase could produce larger 
yields than normal BV. It was concluded that recombinant BV lackingchitinase could be 
used to improve intracellular levels of foreign protein, but demonstrated the importance of 
optimiSing production conditions for each recombinant protein (e.g., vector and cell line). 
Intracellular levels of foreign protein were further improved from the BES using different 
culturing methodologies (fermentation and shaker flask) and concluded that fermenters 
produced optimal conditions for intracellular protein production, probably due to 
maintaining a constant level of dissolved oxygen concentration during virus infection. 
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1.0 Introduction 
Protein production is a core practice for both academic and industrial-based research. 
Expression systems provide the basis for the development of therapeutics, vaccines, and 
antibodies, and for this they are studied in great detail. The production of heterologous 
proteins also provides material for studies in x-ray crystallography, functional genomics, 
verification of protein identity, structure, function, and localisation. However, this is just 
the tip of the iceberg concerning the importance of protein roles. Obtaining large 
quantities of endogenous proteins from their natural hosts (whole animals I organisms) 
falls short of today's requirements for research and commercialisation. This has 
prompted the development of alternative protein production systems, which mimic those 
of natural hosts and assimilate the complex post-translational modification processes of 
higher eukaryotic cells (Pfeifer, 1998). 
Expression systems are based upon the insertion of a foreign gene, under the control of a 
strong trans-activated promoter (for example, the promoter may have originated from a 
virus or mammalian cell line), which is transcriptionally trans-activated in a heterologous 
host organism I cell line to allow over-expression of a recombinant gene. This in turn 
produces varying amounts of heterologous protein, which can be attributed to promoter 
activity (Pfeifer, 1998; Huynh and Zieler, 1999), choice of cell line used to host expression 
(Farrell et al., 1998; Keith et al.; 1999) and a range of other factors. 
In the early stages of heterologous protein production, the choice of expression system 
was limited. The production of recombinant proteins requiring authentic higher eukaryotic 
glycosylation, phosphorylation, methylation, and acetylation were manufactured using 
surface adherent or suspension rodent cell lines (Chinese Hamster Ovary cells [CHO]; 
Geisse et al., 1996), whilst heterologous proteins that necessitate less complex 
glycosylation could be expressed in yeast (Sacharomyces cerevisiae). A third host utilised 
for the expression of recombinant genes includes Escherichia coli. This system has been 
well documented for producing high-levels of foreign protein (Nolan and Shatzman, 1998). 
However, problems associated with this system limits the types of heterologous protein 
expressed, due to the hosts inability to correctly fold and glycosylate proteins. The 
periplasm of E.coli allows for the formation of disulfide bonds, whereas the cytoplasm is a 
fully reductive environment preventing disulfide bond formation and hence proper protein 
folding to occur (Lorenzo and Fernandes, 2000). Therefore, only the production of small, 
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simple proteins, unmodified post-translationally, or at least active and non-toxic without 
post-translational modifications that were apparent in its native state, could be produced 
using this systems. 
Extensive research and development to generate alternative expression systems has led 
to the choice becoming more diverse and complicated; heterologous expression systems 
currently encompass five kingdoms of organism: bacteria (Jacobs et 8/., 1985; Dietrich et 
8/., 1992; French et 8/., 1995), fungi (Beggs et 8/., 1980; Cregg et 8/., 1993), mammalian 
(Hentschel, 1991; Barr, 1995; Geisse and Kocher, 1999), insect and plant (Miller, 1996; 
Pfeifer, 1998; Geisse and Kocher, 1999; Huynh and Zieler, 1999), as well as viruses 
targeted to their host (Yates et 8/., 1985; Blissard and Rohrmann, 1990; Adams and 
McClintock, 1991; King and Possee, 1992, Xiang et 8/., 1994; Schlesinger and Dubensky, 
1999). 
From a commercial value, bacterial, mammalian and viral expression systems are most 
favoured for the production of recombinant therapeutic proteins. However, no one 
expression system is sufficient for the production of all recombinant proteins (Geisse et 8/., 
1996). Furthermore, the development of alternative protein production systems within 
insect cell lines has become extremely attractive to industries and researchers due to the 
number of advantages they hold over mammalian and bacterial producer organisms. Two 
approaches have been made with regards to recombinant protein production in insect 
cells, both of which are studied in this thesis. First is the reputable baculovirus expression 
system (BES) and second is the more recently developed stable insect cell expression 
system. 
The choice of a suitable expression system depends largely on the biochemical and 
biological properties of the protein of interest, as well as on the nature of the experiment 
and the amount of recombinant protein required. Importantly, the choice of expression 
system now involves consideration of the problem not only from the point of view of the 
molecular biologist, but also from those of specialist niches, such as microbial and cell 
physiologists, fermentation specialist, downstream process engineer, and the clinician 
(Hodgson, 1993). 
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1.1 Mammalian versus insect: Hosts for the expression of heterologous 
proteins 
Authentic processing of proteins from higher organisms often requires eukaryotic cell lines 
in order to retain full biological activity. Mammalian cell lines have in the past, been the 
main choice of heterologous gene expression systems. However, a rival competitor has 
emerged, which makes use of insect cell lines as an alternative for the production of 
recombinant proteins. 
Mammalian expression systems use a plethora of different cell lines, the most common of 
which include CHO, established in 1957 by Puck and is by far the most popular (KCinig at 
a/., 1989; Cockett at a/., 1990; Page and Sydenham, 1991), human embryonic kidney 
(HEK)-293 (Berg at a/., 1993; Dovey at a/., 1993), baby hamster kidney (BHK; Wirth at a/., 
1988), mouse L-cells, and myeloma cell lines like J558L (Traunecker at a/., 1991; Lane at 
a/., 1993) and Sp2/0 (Gillies at a/., 1989; Lo at a/., 1992). However, the type of 
expression and protein required will affect the choice of cell line use. For instance, for 
transient expression, the most common cells used are the HEK-293, COS (Gluzman, 
1981), and BHK; whereas stable gene expression utilises, CHO, myeloma cell lines and 
Sp2/0 (Gillies at a/., 1989; Lo at a/., 1992). 
The advantages of using mammalian cell lines and expression vectors for the production 
of recombinant proteins include: 
• Constitutive and inducible recombinant gene expression; 
• The capacity to produce post-translationally modified and appropriately folded 
heterologous proteins; 
• Long-term continuous culture; 
• The ability to characterise the impact of specific mutations on cell metabolism; 
• The capability to alter cellular phenotype as a function of stable transgene expression. 
The key disadvantages of mammalian cells as hosts for recombinant protein production 
include; slow growth, relatively poor yields, and expensive to maintain. Areas of expense 
include: 
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• Stacked multilayer systems utilized for growth of cells for large-scale recombinant 
protein production (Wurm and Bernard, 1999); 
• . Cells are cultivated at 37°C! 5% (v!v) CO2 in a humidified atmosphere and are sub-
cultured twice a week (Geisse and Kocher, 1999); 
• Complex medias and fetal bovine serum (FBS) requirements that may have to be met 
(Le. tetracycline free); 
• Regulatory issues concerning the used of FBS; 
• Screening cell lines for adventitious agents !Iatent viruses. 
The considerations of all these factors mean researchers working within academia and 
industry welcome alternate expression systems. Studies into the development of 
alternative expression systems, which will compete with the mammalian expression 
systems, include the insect cell expression systems. 
Insect cell lines have provided researches with an alternative tool for the production of 
recombinant proteins. The insect cell lines most commonly used are summarised in 
Table 1.1. The advantages of recombinant protein production in insect cells include those 
described for mammalian cells, in addition to those described below: 
• Lower growth temperature 28°C; 
• Does not require CO2 for' growth; 
• Fast growth; 
• Adaptability to large-scale fermentation; 
• The capability to produce high-levels of recombinant protein; 
• Less complex growth conditions; 
• Often null expression background. 
The main limitations of insect cell lines as hosts for heterologous gene expression 
include a number of those outlined for mammalian cells, plus those listed below: 
• Possess limited N-glycosylation capability for the production of complex-proteins; 
• Poor methods of detection for adventitious agents (mycoplasma); 
• Regulatory issues concerning the used of FBS; 
• Screening cell lines for adventitious agents !Iatent viruses. 
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Table 1.1: Summary of eight insect cell lines used as hosts to produce recombinant 
proteins1• 
Cell line Species 
Bm5 Bombyxmori 
BmN4 Bombyxmori 
High five (T.ni Hi5) Trichoplusia ni 
IPLB-LdFB Lymantria dispar 
IZD-Mb-0503 Mamestra brassicae 
Schneider's line 2 (Om 52) Drosophila me/anogaster 
Sf-21 Spodoptera frugiperda 
Sf-9 Spodoptera frugiperda 
Keith et al (1999) 
Eukaryotic protein processing capabilities in insect cell lines is one of the most appealing 
features of recombinant protein production using insect expression systems as an 
alternative to the mammalian systems. A plethora of eukaryotic gene products have been 
successfully expressed with authentic functional activity, using both the baculovirus and 
stable insect expression systems (Guarino and Summers, 1987; O'Reilly and Miller, 1989; 
Jarvis et al., 1990; King and Possee, 1992; Lu et a/., 1997; Ikonomou et a/., 2003). 
Accordingly, insect expression systems are widely considered to be excellent tools for 
recombinant glycoproteins. However, this perception is inconsistent with the fact that 
there are fundamental differences in the glycoprotein processing pathway in insects and 
higher eukaryotes (Stollar et a/., 1976; Hsieh and Robbins, 1984; Marz et a/., 1995; Jarvis 
and Finn, 1996; Hollister and Jarvis, 2001; Hollister et a/., 2002), in particular the N-
glycosylation pathway. 
The N-glycosylation pathway in higher eukaryotes has been well characterised (Hunt and 
Dayhoff, 1970; Kornfield and Kornfield, 1985; Dorner et a/., 1987). This pathway starts 
with the translocation of a nascent polypeptide across the membrane of the rough 
endoplasmic reticulum (RER) and transfer of a pre-assembled oligosaccharide from a lipid 
carrier to an asparagine residue within a specific recognition sequence (Hunt and Dayhoff, 
1970). Glucosidases within the RER remove terminal glucose residues to create a side 
chain with a distinguishing structure known as high mannose, in which all of the outer-
chain sugars are man nose . residues. A quantity of N-linked oligosaccharides remain in 
this relatively unprocessed form, while others are further processed by other glycosidases 
and glycosyltransferases in the RER and Golgi apparatus (GA), which can remove 
specific mannose residues and append N-acetylglucosamine, galactose, and sialic acid 
residues (Kornfield and Kornfield, 1985; Paulson and Colley, 1989; Moremen et a/., 1994). 
6 
Chapter1 Introduction 
Studies on N-glycan structures produced by mosquito cells provided the earliest view of 
the insect N-glycosylation pathway (Stollar et a/., 1976; Hsieh and Robbins, 1984). These 
studies investigated potential differences in the structure and function of Sindbis viris 
glycoproteins produced during its replication in mammalian cells, compared to insect cells. 
The result indicated that there were striking differences, as the structures of the N-glycans 
on the viral glycoproteins produced in insect cells were less complex than those produced 
in mammalian cells. 
These observations suggested that the insect cell N-glycosylation processing pathway is 
truncated relative to the mammalian pathway. The insect N-glycan processing pathway 
appeared to include all the enzymes involved in N-glycan trimming (e.g. a1,2-glucosidase 
I, a1,3-glucosidase II, a-mannosidase I [RER I GA], a-mannosidase II), but few of the 
enzymes involved in N-glycan elongation in mammalian cells (e.g. N-
acetylglucosaminyltransferase I and II, N-acetylglucosaminidase and fucosyltransferases). 
Contrary to the evidence described above, structural analysis of the recombinant human 
plasminogen provided the first direct evidence that the baculovirus-insect cell system 
might be able to produce complex, terminally sialylated N-glycans (Davidson et a/., 1990, 
Davidson and Castellino, 1991). However, studies by Jarvis and Finn. (1995) confirmed 
significant N-glycan structural differences between Autographa californica multicapsid 
nuclear polyhedrosis virus (AcMNPV) major structural glycoprotein - gp64, produced in 
insect cells (S19, T.ni Hi5, and Estigmene acrea) and mammalian cells (COS-1). gp64 
produced in insect cells lacked detectable galactose and sialic acid; whereas, at least one 
N-linked oligosaccharide side chain on gp64 was converted to a complex form containing 
galactose and sialic acid in mammalian cells. Therefore, indicating that gp64 produced in 
insect cells lack complex side chains like those produced by mammalian cells. It was 
concluded from these data that AcMNPV-infected insect cells cannot process N-linked 
carbohydrates on most glycoproteins to complex forms, unless the glycoprotein is an 
unusually good substrate for the late processing reactions. 
Although post-translational processes in insect cells are more similar to mammalian cells 
than to bacterial and yeast, the limited N-linked carbohydrate processing abilities of insect 
cells (Jarvis and Finn, 1996) may affect protein function. Such as protein half-life within 
blood, and uptake I clearance through the liver. Therefore, correct post-translational 
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modifications of proteins produced for the application of therapeutics are very critical 
(Jarvis and Finn, 1996). 
The problem of foreign protein post-translational processing may also be influences by 
viral and plasmid based vectors. However, improper secretory processing can be 
especially problematic within viral-based expression systems such as the baculovirus-
insect expression system. At several days post-infection with recombinant baculovirus, 
the host cell's post-translational processing machinery beco":,es dramatically 
compromised, producing some protein that may be incorrectly modified and not 
representing native structure or function (Ailor and Betenbaugh, 1999). An innovative 
approach to overcome these limitations in the baculovirus-insect cell system was to 
engineer the secretory pathway of the insect host cells by supplementing secretory 
processing proteins absent or limited in supply in the host insect cell intracellular 
environment. A number of studies were carried out, by which co-expression of 
chaperones (Hsu et a/., 1994), peptidases (Ailor et a/., 1999), foldases (Lenhard and 
Reilander, 1997), and glycosylating enzymes (Wagner, et a/., 1996; Hollister et a/., 1998) 
have proven effective in enhancing secretion, processing, and glycosylation of several 
heterologous proteins expressed in insect cells. 
However, more recently the establishment of genetically transformed lepidopteran insect 
cell lines with constitutively expressible mammalian genes, has yielded transgenic insect 
cell lines with normal growth properties that can support baculovirus infection, have new 
N-glycan processing enzyme activities, and produce humanised heterologous 
glycoproteins (Hollister et a/., 1998; Breitbach and Jarvis, 2001; Hollister and Jarvis, 2001; 
Hollister et a/., 2002). These cells require an extracellular sialoglycoprotein for de novo 
glycoprotein sialylation, which provides the first evidence that these cells have an 
interesting sialic acid salvaging pathway (Nakata et a/., 2000; Lawrence et a/., 2001). 
The advantages of insect cells over mammalian cells as hosts for expressing properly 
processed eukaryotic proteins that do not require complex N-glycosylation, has already 
received much attention by industry and academia. Subsequently, new developments in 
insect cell technology described in this Section further strengthen the establishment of 
insect cells as alternate hosts for heterologous protein production. 
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1.2 Classification of gene expression and expression systems 
Proteins are produced in a number of different expression systems; however, these 
systems are classified into three main classes of gene expression, which include transient, 
inducible, and stable. It is extremely important that novice researchers understand the 
main differences between the types of expression available, consequently they must 
choose the protocol that is most suitable for their needs, as this could effect recombinant 
protein quantities, and authenticity (Hodgson, 1993). 
1.2.1 Classes of gene expression 
1.2.1.1 Transient constitutive gene expression 
The first category of gene expression is referred to as "transient" expression. Transient 
expression can be subdivided into two forms of expression, constitutive and inducible. 
Inducible expression will be discussed in the following Section 1.2.1.2. Constitutive 
expression refers to the continuous transcriptional activity of a promoter constantly 
transcribing a gene. Transient expression of a heterologous gene occurs when the 
production of a foreign protein is temporary. Two types of expression vector operate using 
transient expression; plasmid-based I viral-based vectors (Sections 1.3-1.3.3). The 
temporary nature of this process occurs when a foreign gene is present within the nucleus 
of the host, utilising host cell's DNA replicative enzymes in order to make copies of itself, 
which in turn are transcribed to produce protein. The gene is not integrated into the host 
genome, but remains extra-chromosomal element (episomal) so will be lost I degraded 
within a short time (plasmid-based vectors; 48-72 hours [h)). Viral expression system are 
categorised as transient, due to the completion of viral replication causing death to the 
host, hence the termination of protein production (72-96 h). 
1.2.1.2 Transient inducible gene expression 
The second form of gene expression, "inducible" expression, involves the manipulation of 
inducible elements from prokaryotic or eukaryotic cells into expression vectors containing 
foreign genes. These vectors now produce conditional expression, which is extremely 
advantageous to overcoming the problem of expressing cytotoxic gene products. One 
example of an inducible expression system is the tetracycline-On I tetracycline-Off 
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expression system (Tet-On I Tet-Off, as described in Section 4.1; Gossen and Bujard, 
1992; Saez et a/., 1997). 
1.2.1.3 Stable gene expression 
The third type of gene expression is, "stable" expression. Stable expression can also be 
constitutive or inducible (plasmid-based vectors). The term stable expression comes from 
the stable integration of a heterologous gene into the host's genome, under chronic 
selection (plasmid contains a selectable marker). This is an added advantage because 
the foreign gene is mistaken as part of the host cells make-up and escapes degradation. 
Therefore, the foreign gene is continuously translated to produce heterologous protein 
(McCarroll and King, 1997). When cells undergoing mitosis contain stably integrated 
foreign genes, the genetic information is passed to the daughter cells, therefore, 
producing a continuous cell line that produces exogenous protein. 
If the promoter I enhancer complex can modulate transcription of the recombinant gene, 
the expression can be modified, such that it can be enhanced or decreased by 
environmental factors and components that are added to the growth medium. 
Components that can modulate transcription of the foreign gene include; hormones 
(Ponta at a/., 1985; Israel and Kaufman, 1989; Ko at a/., 1989), metal ions (Hu and 
Davidson, 1990), antibiotics and environmental factors including heat shock (Schweinfest 
at a/., 1988). 
A selectable marker employed within the expression vector facilitates enrichment of cells 
that contain the heterologous gana of interest. A typical plasmid vector used to enrich 
successfully transfected cells will carry a gene essential for the survival of a given cell line 
that is either defective in the gene or void of the gene altogether. Classic selectable 
markers such as the dihydrofolate reductase (DHFR), adenyl phosphoribosyl transferase 
(APRT), and glutamine synthetase (GS) genes can only be used in cell deficient in DHFR, 
APRT or GS, respectively (Ausubel, et aI., 1997). Alternatively, genes that confer 
resistance to cytotoxic drugs are quite effective in situations when the cell line is not 
defective in one of the endogenous genes mentioned earlier. The most common 
selection marker is the aminoglycoside phosphotransferase gene that confers resistance 
to antibiotics such as kanamycin (Kanf), neomycin (Ned) and geneticin (G418f). Genes 
encoding either for hygromycin B phosphotransferase (HygB), xanthine-guanine 
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phosphoribosyl transferase (XG-PRT), Zeocin™ (Zeo), or blasticidin (Bsd) have also been 
effectively used, and to date this is the most commonly used selection method (Fehse at 
a/., 1998). Because each cell line is different in its sensitivity to these compounds, the 
optimal drug concentration must be empirically determined for each cell type. The 
selection typically requires long-term (1 to 5 weeks) in vitro cultivation in the presence of a 
drug (Colosimo at a/., 2000). 
1.2.2 Transient versus stable gene expression 
Both transient and stable expression of heterologous genes have merits and must be 
carefully considered before expressing the gene of choice. The key features of most 
transient expression systems are: 
• Simplicity, in particular in the construction of expression vectors; 
• Extremely short time-frame for the generation of product or if it is important to have 
experimental results within a short time-frame (days); 
• Antibiotic selective pressure not required; 
• Intrinsic genetic stability and consistency due to extremely short time-frame between 
generation of vector and product recovered; 
• Applicability to a wide range of host cell lines; 
• Suitability to multiple processing, allowing study of many genes or mutants at the 
same time. 
However, disadvantages related to this type of expression include: 
• Narrow time-frame for producing recombinant protein; 
• Difficult to scale-up transient plasmid-based expression; 
• Protein production is generated as a single batch; 
• Labour-intensive and expensive process (producing large volumes of high-titre virus 
inoculum, and producing multiple batches of recombinant protein). 
Transient expression studies are predicated on a burst of gene expression between 12 
and 72 h after transfection. This burst of gene expression is followed by a rapid 
deterioration in expression of the transgene because of cell death or loss of the expression 
plasmid (Section 1.2.1.1; Colosimo at a/., 2000). The optimal time to assay expression 
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needs to be determined empirically and will depend on the cell type, the cell doubling time 
and the characteristics of the vector regulatory elements. Transient expression systems 
can be evaluated in terms of the protein products synthesised in the transfected cells, 
such as the activity of a reporter gene that is not endogenously expressed in the cell type 
utilised. The most common reporter gene systems include bacterial chloramphenicol 
acetyltransferase (cat), ~-galactosidase (/aeZ), firefly luciferase (/uc) , ~-glucuronidase 
(gus) and more recently green fluorescent protein (gfp; Alam and Cook, 1990), and 
Oiseosoma red (OsRed; Brooke and Glick, 2002). 
Transient expression is a particularly valuable method for studying initial gene products, 
gene function I characterisation via mutational analyses, and expression regulatory 
mechanisms (Carson at al., 1991). However, transient expression from viral-based 
expression systems, which utilise promoters with high rates of transcriptional activity (as 
described in Section 1.3.2) tend to generate significantly larger quantities of recombinant 
protein than compared to plasmid-based vectors. For this reason transient expression is 
effectively used for producing large quantities of foreign protein (King and Possee, 1992; 
Blasey at al., 1997; Lundstrom, 1997; Possee, 1997; Vlak at al., 1998; Wurn and Bernard, 
1999; Jayakumar at al., 2004). The key disadvantage of transient expression for this 
procedure is that recombinant protein is produced as a single batch, therefore, to 
generate additional protein the experimental procedure must be repeated, which is costly 
and labour-intensive. 
Stable expression prevails this problem, as plasmid-based vectors integrate into the host 
cell genome, therefore, avoiding degradation by host cell mechanisms. Subsequently, 
transformed cell lines are established with either constitutive or inducible transgene 
expression. A number of advantages acknowledged for transient expression also apply to 
stable expression, in addition to those listed below: 
• Development of transformed cell lines producing continuous foreign protein (inducibly 
or constitutively); 
• Simplicity, in particular in the construction of expression vectors; 
• Applicability to a wide range of host cell lines; 
• Transformed cell line is immortal; 
• Established cell lines require low maintenance; 
• Adaptability to large-scale fermentation; 
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• Flexibility to vary the quantities of recombinant protein required. 
In contrast, the disadvantages of stable expression include: 
• Selective pressure required; 
• Initial development of stable cell lines is labour-intensive; 
• Expression of intracellular recombinant proteins is relatively low, due to 
transcriptionally weak promoters (plasmid-based insect expression systems); 
• Transformed cell lines must be routinely screened for adventitious agents. 
Generating stable expression is a time-consuming process, in particular establishing 
clonal cell lines and identifying the highest protein producers. However, this method is 
widely used for producing large quantities of recombinant protein and is perceived as 
more desirable than the labour-intensive transient vial expression system (Fussenegger et 
a/., 1999; Colosimo at a/., 2000; Zahn-Zabal at a/., 2001). 
Transient and stable expression are both important. However, transient expression will 
continue to dominate studies on elements that regulate gene expression or when it is 
important to have experimental results within a short time frame. Stable expression is not 
effective for these preliminary studies, as production of a stable cell line is costly and time 
consuming. 
1.3 Eukaryotlc vector systems 
Mammalian and insect cell expression systems can be divided into two broad categories: 
viral vectors and plasmid vectors. Viral vectors are essentially modified viruses into which 
heterologous genes are cloned. Viral expression systems delivered to mammalian and 
insect cell lines for production of recombinant proteins are summarised in Table 1.2. 
Table 1.2: Summary of mammalian and insect viral based expression systems. 
Mammalian viral based systems Insect viral based systems 
Adeno-X expression system Baculovirus expression system 
Adeno-X Tet-off expression system 
MSCV Retroviral expression system 
PantropiC Retroviral expression system 
Sindbis expression system 
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Plasmid vectors are more complex than viral vectors as their functional components may 
include prokaryotic, eukaryotic and viral sequences. The prokaryotic elements facilitate 
bacterial propagation and maintenance of the vector, while eukaryotic and viral elements 
comprise transcriptional elements and sequences coding for selectable markers. Both 
types of vectors are generally classified with respect to their viral backbone or the 
sequence elements that regulate the expression of the gene to be studied or utilised. 
Promoters and enhancer sequences, whether viral or plasmid b~sed, control the 
regulation of gene expression. The most common promoters I enhancers are of viral 
origin. However, bacteriophage, nuclear, cytoplasmic, cellular-tissue type-specific and 
inducible promoters can also be used (Gossen and Bujard, 1992; Lu at al., 1997; 
Colosimo at al., 2000). 
1.3.1 Viral-based vectors 
Insect cell lines as alternatives to mammalian cell lines have stimulated extensive gene 
expression research and (Friesen and Miller, 1986; Weyer at al., 1990; Weyer and 
Possee, 1991; Bishop and Possee, 1990; King and Possee, 1992; Possee, 1997; 
Grabherr et al., 2001) have produced a vial-based delivery and expression system, which 
is known as the BES. A greater number of mammalian viral-based expression systems 
exist than insect ones, as indicated in Table 1.2. However, my emphasis in this thesis will 
focus on the BES. 
1.3.2 The baculovirus expression system 
Baculovirus expression vectors provide a versatile and dependable expression system. 
Baculoviruses comprise many isolates; however, AcMNPV is most widely used within 
academia and industry (Possee, 1997; Schwartz et a/., 1997; Stewart and Champoux, 
1999; Jayakumar at al., 2004). Frequent use of the baculovirus expression vectors arises 
from the relative ease and speed with which a heterologous protein can be expressed on 
a laboratory scale or industrially scaled-up in bioreactors with a high chance of obtaining a 
biologically active protein. 
Baculoviruses are large double-stranded DNA viruses, compnslng covalently closed 
genomes of 80-133-kb, which are pathogenic to invertebrates. Baculovirus are species 
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specific; however, studies have reported that replication in non-targeted organisms (i.e. 
mammalian cell lines) has been revealed (Miltenburger, 1979). 
Within baculovirus-infected cells, viral proteins are expressed in a cascade fashion; three 
main transcriptional phases are recognised, early, late, and very late (Guarino and 
Summer, 1986; Carson et al., 1988; Kovacs et al., 1991; Mikhailov, 2003). Upon viral 
infection host RNA polymerase II transcribes the viral early genes (Blissard and 
Rohrmann, 1989; Blissard et al., 1992; Lu and Carstens, 1992; Dai et al., 2004). Early 
gene expression may be subdivided into immediate early and delayed early (Guarino and 
Summer, 1986; Carson et al., 1988). The expression levels obtained in each successive 
phase are higher than that of the preceding phase Figure1.1. Viral replication is 
temporally regulated to produce two different types of infectious virion; polyhedra-derived 
virions, which persist outside the insect host and initiate host viral infection, and 
extracellular virus / budded virus, which spreads from cell to cell. The latter of these 
infectious virion forms the basic of the BES, establishing the mean by which recombinant 
viruses are propagated (Figure 1.2). 
% of viral 
protein 
30 
2 
1 
Immediate Early Late 
Hours post infection 
Figure 1.1 Temporal gene expression during baculovirus infection. Baculovirus genes 
are divided into three classes based on their temporal expression, consisting of early, late 
and very late genes. The early gene class may be further subdivided into immediate early 
and delayed early genes. Examples of genes identified in these phases are illustrated 
(immediate early 1 [IE-1]; glycoprotein 64 [gp64]; chitinase [ChiA]; polyhedrin [polh] and 
p10). 
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Figure 1.2: The replication cycle of AcMNPV. 
1. Virus occlusion bodies (polyhedra; A) are ingested by a non-infected 
susceptible larvae. 
2. The polyhedrin matrix of the ingested occluded virus is dissolved in the 
alkaline conditions of the midgut lumen. 
3. Infectious virus particles are released (polyhedra-derived virions). 
4. Midgut cells are infected with polyhedra-derived virions by crossing the 
peritrophic membrane via fusing with membranes of the microvilli of the cell. 
5. Nucleocapsids move to the nucleus where they interact end-on with the 
nuclear pore. 
6. Upon entering the nucleus, viral DNA is released from the nucleocapsid. 
7. Viral DNA is transcribed, replicated, and packaged into nucleocapsids in 
association with the virogenic stroma. 
8. During the late stage of infection, nucleocapsids leave the nucleus and 
migrate to the plasma membrane where they bud from the membrane to 
produce budded virus (8). This form of virus has been effectively exploited 
to form the basis of the baculovirus expression system (BES). Budded virus 
is used to amplify stocks of recombinant baculovirus in insect cell culture (C), 
while also acting as a efficient transfer method of recombinant viral DNA into 
insect cells for the production of recombinant protein. 
9. The budded virus is then able to cause secondary infection of neighbouring 
cells. 
10. During the very late phase of infection, nucleocapsids are enveloped within 
the nucleus. Intra-nuclear virions are then embedded in a polyhedrin (polh) 
matrix to form occlusion bodies (A). The polh gene is non-essential for virus 
replication in insect cell culture, and the polh gene promoter has been 
characterised with extremely high transcriptional activity. For these reasons, 
the poth gene coding-region can be substituted for a foreign gene inserted, . 
which Is subsequently under the control of the polh promoter, therefore 
produce large quantities of recombinant protein. 
11. Polyhedra (A) are released in to the environment (or cell culture) upon cell 
lysis and host cell death. 
16 
Chapter1 
, , 
, , 
, , , , 
, , 
11 
Plasma --. 
membrane 
\ 
\ 
\ 
\ , 
2 
17 
3 
S ' 
8 
... Nuclear 
membrane 
Nuclear 
pore 
Introduction 
, , 
~
\ " , ' , , , , , , 
c 
, , 
I 
9 
, , , , , , 
, , 
, , , , , 
, , , , 
, , 
, , , , 
, , 
, 
, , , , 
Chapter1 Introduction 
The BES is a highly efficient method for producing recombinant proteins. The success of 
this system has promoted its extensive use by biotechnology investigators (King et a/., 
1994; Schwartz et a/., 1997; Stewart and Champoux, 1999; Jayakumar et a/., 2004). The 
very late baculovirus genes encode structural proteins under the control of promoters with 
very high transcriptional activity, and have been determined non-essential for in vitro 
replication. Subsequent removal of these gene-coding regions enables the replacement 
and over-expression of a heterologous gene of choice. Due to the size of the AcMNPV 
genome (133-kb) and the absence of unique restriction sites, it is impos~ible to introduce 
foreign DNA directly into the genome. However, the development of baculovirus transfer 
vectors surmount this problem. The transfer vectors consist of a prokaryotic origin of 
replication for high plasmid copy number, and the promoter I flanking sequence of the 
polyhedrin (polh) , or p10 gene (Possee, 1986; Possee and Howard, 1987; Luckow and 
Summers, 1988; Bishop and Possee, 1990; Weyer and Possee, 1991). However, it is 
possible to use any vial promoter I flanking gene sequence determined non-essential for 
in vitro replication, although the rate of promoter transcriptional activity may be less than 
those characterised for polh and p10. 
Heterologous genes are inserted into the transfer vectors at unique restriction sites within 
a multiple cloning site (MCS) downstream of the strong promoter sequence. 
Recombinant transfer vector and infectious baculovirus DNA are co-transfected into insect 
cells (Section 2.3.2), the foreign gene is inserted into the baculovirus genome by 
homologous recombination involving the identical sequences flanking the native polh 
gene and the heterologous gene in the transfer vector as shown In Figure 1.3. 
Recombinant viruses are selected by rounds of plaque assay, which is a skilled and 
labour-intensive process (Section 2.3.3). A vast number of intracellular, secreted and 
membrane-targeted recombinant proteins have been produced using this method 
(Atkinson et a/., 1992; Neutra et a/., 1992; King et a/., 1992; Scott et a/., 1992; Nguyen et 
a/., 1993; van Lier et a/., 1994; Benincasa et a/., 1996; Lamb et a/., Wu and Chiang, 1996; 
Schwartz et a/., 1997; Ikonomou et a/., 2003). 
The identification of recombinant baculoviruses previously was determined using an 
inverted light microscope to identify polyhedrin negative viruses. This was both a time 
consuming and very difficult technique to carry out. Therefore, to simplify the 
identification of recombinant baculovirus, the polh gene of AcMNPV was replaced with a 
lacZ gene, to derive AcMNPV./acZ (Possee and Howard, 1987). Insect cells were co-
transfected with a recombinant transfer vector and AcMNPV.lacZ DNA and recombinant 
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baculoviruses were selected against parental virus (present as blue plaques) as a 
colourless plaque following application of 2% X-gal, a substrate for lacZ, Figure 1.3. 
An improvement of the BES was developed in which non-infectious, Iinearised 
AcMNPV.lacZ (AcBacPAK6) was co-transfected with a recombinant transfer vector (Kitts 
at a/., 1990; Kitts and Possee, 1993). Homologous recombination must occur between 
the AcMNPV and transfer vectors DNA, in order to produce a viable virus. Following the 
introduction of three Bsu361 sites within the sequence flanking the polh ~xpression locus, 
a recombination frequency approaching 100% may be attained. This is because 
restriction of the viral DNA using Bsu361 removes an essential fragment of the virus 
genome (open reading frame 1629; ORF1629), rendering it non-viable. Rescue with a 
recombinant transfer vector, restores the integrity of the essential gene enabling the 
production of a recombinant viable virus, Figure 1.3. 
The BES has been well documented for producing large quantities of intracellular 
recombinant protein, and is usually favoured over insect plasmid-based expression. 
However, yields of secreted foreign proteins produced by the BES are usually low (Jarvis 
at a/., 1990; Thomas, 1997; Farrell at a/., 1998; Thomas at a/., 1998; Saville at a/., 2002). 
Further developments to the AcBacPAK6 virus, was the removal of the chitinase (chiA) 
gene from the genome (Hawtin at a/., 1997), which subsequently increased the yields of 
secretory proteins (McCarroll, 1997; Possee at a/., 1999). Studies revealed that the chiA 
gene encoded an endoplasmic recticulum (ER) retrieval sequence (KDEL; Thomas at a/., 
1998), which retained chitinase within the ER throughout virus replication (Thomas at a/., 
1998). It was hypothesised that chitinase was blocking further processing of proteins in 
the secretory pathway, therefore, reducing the yield of secreted recombinant proteins and 
localised plasma-membrane proteins. The removal of the chiA gene from the AcMNPV 
genome produced tha AcBacPAK6.~chiA virus (Hawtin at a/., 1997). AcBacPAK6.~chiA 
was used to construct recombinant viruses, which lead to the production of membrane 
secreted proteins. The results indicated that the ER was no longer blocked by chitinase 
and levels of recombinant membrane secreted proteins wera increased (McCarroll, 1997; 
Possee et a/., 1999). 
The BES has also been used to develop multiple expression vectors for simultaneous 
expression of two or more heterologous genes, by the co-infection of two or more 
recombinant viruses (St Angelo at a/., 1987; Belyaev and Roy, 1993). A number of 
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proteins have been co-expressed using this method, including: Cowpea mosaic virus 
capsid proteins (Shanks and Lomonossoff, 2000), human cytochrome P4501A 1 and 
human NADPH-cytochrome P450 reductase (Schwarz et al., 2001), GABAA subunits and 
G-protein coupled 5-HT receptors (Obosi et al., 1996). 
Use of the transient BES does, however, gives rise to several significant problems. These 
include termination of recombinant protein expression with the end of virus infection cycle, 
complex downstream purification due to the release of intracellular proteins by the virus-
lysed host cells, and low secreted protein yield, suggesting the host cell secretory 
pathway is compromised towards the end of infection (Jarvis and Summers, 1989; 
McCarroll and King, 1997; Thomas et al., 1998; Ailor and Betenbaugh, 1999; Keith et aI., 
1999). However, as mentioned above an innovative approach to overcome the latter 
problem of the BES was to engineer AcMNPV genome. 
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Figure 1.3: Schematic representation of the production of recombinant baculovirus. The 
transfer vector contains a polyhedrin promoter and transcription termination sequence 
flanked by AcMNPV sequence (orange). The coding sequence for the gene of interest 
(GO/) within the transfer vector (red) is inserted in place of the deleted polyhedrin 
sequence under control of the polyhedrin promoter. Insect cells are co-transfected with 
the recombinant transfer vector and non-infectious, linearised AcMNPV.lacZ. Homologous 
recombination replaces the lacZ gene (light blue) with the GOI-coding region and progeny 
viruses are screened by plaque assay. Recombinant viruses are identified by the 
production of colourless, lacZ negative plaques (modified from King and Possee, 1992). 
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1.3.3 Plasmid-based vectors 
Plasmid-based expression vectors for mammalian and insect cell lines often utilise 
immediate early viral promoters that are transcriptionally active in the absence of other 
viral promoters (Section 1.5-1.5.4). 
A vast number of mammalian expression systems have been developed to date; however, 
one viral promoter dominates the mammalian expression vectors, due. to its strong 
transcriptional properties within a range of mammalian cell lines (Colosimo at al., 2000). 
The immediate early promoter from the cytomegalovirus (CMV) has been used in over 40 
mammalian expression vectors. Expression systems include the Tet-On I Tet-Off 
(described in Chapter 4, Section 4.1), retroviral, bicistronic, and epitope tagged 
expression systems. Additional promoters include the Drosophila hsp70 and elongation 
factor (EF)-1 (non-viral), retroviral (5'L TR), and a simian virus 40 promoter (SV40). 
More recently non-viral promoters have received strong endorsement, as they appear to 
be as strong or stronger than some viral promoters. A non-viral promoter that has been 
exploited commercially is the Drosophila hsp70 promoter. The hsp70 promoter is used 
within a number of mammalian expression systems, one of which being the ecdysone-
inducible expression system that is based on a unique insect regulatory mechanism (No 
at al., 1996). 
The ecdysone-inducible mammalian expression system, is based on the constitutive 
expression of a human retenoid X receptor and a modified ecdysone receptor from 
Drosophila. These receptor subunits interact to form a functional ecdysone receptor. A 
second plasmid containing the foreign gene downstream of the eCdysone-response 
promoter, which consists of five ecdysone-response element juxtaposed upstream of the 
mOdified Drosophila hsp70 promoter. When both vectors are present in mammalian cells, 
the expressed functional ecdysone receptor bind the ecdysone-response promoter in the 
presence of the induce (ponasterone A or muristerone A) and activates promoter 
transcriptional activity, thus transcribing the heterologous gene (No et al., 1996; Saez et 
al., 1997). 
Even though the promoters used to transcribe heterologous genes in mammalian 
plasmid-based expression vectors are characterised with strong transcriptional activity. 
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The disadvantages of using these vectors for foreign protein production, relates to the 
drawbacks associated with mammalian cells as hosts for expression (Section 1.1). 
The first insect plasmid-based expression vectors comprised early baculovirus promoters 
(Jarvis and Summers, 1989; Jarvis at al., 1990). The main focal pOint of researchers, for 
developing insect plasmid-based expression vectors, was to use the immediate early 
promoter of the ia-1 gene. Those used at the time were ia-1 genes identified and 
characterised in AcMNPV and Orgyia praudotsugata multicapsid nucleopolyhedrovirus 
(OpMNPV; Guarino Summers, 1986a; Carson et aI., 1988; Nissen and Friesen, 1989; 
Theilmann and Stewart, 1991). 
Immediate early genes are trans-activated under the control of host cell's RNA 
polymerase II soon after being transfected, and therefore make good candidates for 
plasmid-based expression. The most common ia-1 promoters used within plasmid 
vectors to drive heterologous gene expression are taken from, AcMNPV (Guarino 
Summers, 1986a; Jarvis and Summers, 1989; Jarvis at al., 1990), Bombyx mori (Bm) 
multicapsid nucleopolyhedrovirus (Lu at al., 1997; Farrell et aI., 1997), and OpMNPV 
(Theilmann and Stewart, 1991; Slack and Blissard, 1997). These vectors provide 
moderate transcriptional rates in most lepidopteran and dipteran cell lines (Pfeifer at al., 
1997). A number of other insect promoters used include the actin 3, Drosophila heat-
shock protein 70 (hsp70), metallothionein (MD, and copia, which function in lepidopteran 
cell lines albeit at much lower levels (Pfeifer at al., 1997; Hegedus at al., 1998). In 
Spodoptara cells, it has been shown that the AcMNPV ie-1 promoter produces 10-fold 
higher levels of gene activity than the hsp70 promoter (McLachlin and Miller, 1997). 
Plasmid-based vectors that utilise the ie-1 promoter of AcMNPV have been a useful tool 
for transient and stable expression studies (Jarvis at al., 1990; Henderson at al., 1995; 
Jarvis at al., 1996; Murges at al., 1997). However, use of the AcMNPV ie-1 promoter for 
stably expressing large quantities of intracellular recombinant protein is usually 
inadequate for industrial application, for example, structural crystallography, and drug 
compound library screening. On the contrary, transformed insect cell lines constitutively 
expressing secreted recombinant proteins from AcMNPV ie-1, have successfully yielded 
quantities equal to or greater than those of the BES (Jarvis at al., 1990). 
It has been possible to elevate ie-1 promoter activity with the use of enhancer sequences 
(Section 1.5.2). The use of baculovirus homologous repeat (hr) sequences in cis to the 
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AcMNPV ie-1 promoter provides up to two-fold enhancement of transcription over the ia-1 
promoter alone {Guarino and Summers, 1986a, b; Pfeifer, 1998}. The effects of hr 
sequences do not appear to be limited to viral promoters as the Bm hr3 sequence can 
function as an enhancer in cis to the Bm cytoplasmic actin 3 gene ( BmA3; Farrell at al., 
1997; Lu at al., 1997). 
Additional factors that have been shown to enhance heterologous gene transcription in 
insect cells, is the presenca of a 70-180bp intron. The 70-180bp intron ha~ been shown 
to increase levels of transcription by fivefold over a non-intron-containing gene in 
Drosophila me/anogaster {Dunkler at al., 1997}. Hypotheses as to why introns boost 
transcription levels range from cis-acting elements to the presence of spliceosomes 
stabilising the mRNA {Pfeifer, 1998}. 
Since the development of the first insect plasmid-based expression vectors, the range of 
promoters available has expanded, offering different types of expression and a broader 
choice of insect cell lines for hosting protein production. However, these choices are still 
limited compared with the plethora of mammalian vector available. Examples of the 
insect plasmid-based expression systems available to date include; Drosophila 
expression system {DES®}, Insectselecf", and Express-insect"" expression systems 
{lnvitrogenT"}. These expression systems permit the choice of either transient I stable, 
and inducible I constitutive expression {Section 1.2.1.1-1.2.1.3}. Stable expression 
Subsequently overcomes the major disadvantage of the BES, which is the cytolytic 
properties of infectious baculovirus that narrow the window for optimal foreign protein 
production. 
The DES is sub-divided into two types of expression, constitutive and inducible. The 
constitutive expression vectors exploit the Drosophila actin 5C promoter, while the 
inducible vectors utilise the Drosophila MT promoter. The inducible MT promoter is 
dependent on metal ions for full activity {Otto at al., 1987; Bunch et al., 1988}. This 
expression system has been used in tissue culture systems and functions efficiently in 
dipteran cell lines {Kovach at al., 1992}. The actin 5C gene is transcriptionally complex, 
containing two promoters from which a variety of stage-specific transcripts are generated 
(Bond and Davidson, 1986; Bond and Davidson, 1988). The actin 5C distal promoter 
appears to be active in early_embryos and in all Drosophila tissue (Burn at al., 1989) and 
is often referred to as the strongest constitutive promoter in dipteran {Chung and Keller, 
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1990; Huynh and Zieler, 1999). The DES® combines the advantages of high-level insect 
expression systems, with the non-lytic stable mammalian expression systems. The DES® 
uses the well-characterised Drosophila Schneider S2 cells and simple expression vectors 
to allow stable or transient expression of recombinant proteins. Transient expression can 
be observed as early as two days post-transfection. Stable polyclonal cell lines can be 
established in 4 weeks with antibiotic selection (HygB). 
InsectSelecC is system designed for continuous, non-lytic insect expression, which 
utilises the constitutive Op ie-2 promoter (Theil mann and Stewart, 1992a), which is 
functional in lepidopteran and dipteran cell lines (Hegedus et al., 1998). Stable 
expression using the InsectSelect™ expression system can be achieved in three steps: 
clone a gene of interest into an InsectSelecf" vector, transfect insect cells, and select 
stable clones (selection based on Zed). This system has been successfully used for the 
production of secreted monoclonal antibodies directed against the type 2 adenovirus 
penton based protein in Sf9 cells (Li et al., 2001). 
Expresslnsecf
M 
is a new non-lytic constitutive expression system. Work described by Lu 
et al. (1997), demonstrated that two baculovirus-specific genetic elements, the hr3 and ie-
1 gene product (IE-1) of BmNPV, are capable of enhancing co-operatively the activity of 
the BmA3 promoter by three orders of magnitude in a virus-free environment. These 
finding lead to the development 'of the Expresslnsect™ expression system. 
The DES®, InsectSelect™, and Expresslnsect™ systems are very successful tools. 
However, the need for new and improved insect expression systems, to increase the 
diversity of expressed recombinant proteins, and to produce competitive intracellular 
protein yields to that of the BES, means that there is a great potential for future research, 
as during the last five to ten years, development has been progressively slow. 
Of the insect plasmid-based expression systems described above only one offers the 
choice of regulated expression (DES®, MT promoter; Om S2 cells). Therefore, it would be 
beneficial to expand the choice of insect cell line used to host regulated expression (e.g 
lepidopteran), while increasing the diversity of regulated expression mechanisms 
available. 
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1.4 Industrial applications: Scale-up of heterologous gene expression 
Mammalian and insect cell culture are two commercially important technologies for the 
production of heterologous proteins. Although neither are routinely carried out at large 
scale, considerable basic information necessary for scale-up of these systems has been 
developed recently. The emphasis from evaluation of different bioreactor configurations 
has shifted of towards understanding what controls protein production in these two 
systems. 
1.4.1 Classification of eukaryotic cell growth requirements 
Mammalian cells of interest to biotechnology are classified either by their requirement for 
anchorage-dependent growth (CHO, BHK, hepatocytes) or by their ability to grow in 
suspension (CHO, BHK, hybridoma, and mouse connective tissue [3T3]). Whereas, 
insect cell lines characterised as excellent hosts for heterologous gene expression can be 
grown using either suspension or adherent cultivation methodologies (Sm, Sf21, T.ni Hi5, 
and Dm S2). Therefore, the choice of cultivation can be reflected by the cell type used, 
which undoubtedly places restricts on mammalian cells. 
1.4.2 Large-scale cultivation of eukaryotic cells 
The stirred tank bioreactor (STR) is one of the simplest and most widely used of all 
fermenter design for culturing mammalian cell suspension cultures. The STR has been 
developed commercially in large-scale mammalian cell culture processing up to a volume 
of at least 10,000 litres (Feder and Tolbert, 1985; Bliem and Katinger, 1988). For 
laboratory use, there are also numerous bench-top STRs (1-5 litres) available 
commercially (Applikon, and New Brunswick). The bench-top models are generally made 
of glass with a stainless steel head-plate, whereas the larger fermenters are made entirely 
of stainless steel. The head-plate of the STR consists of a range ports and pipes, which 
allows for electrodes to be inserted (pH, temperature and dissolved oxygen probes) and 
tubing to be attached for air, oxygen, and media input or sampling (refer to Chapter 5; 
Figure 5.16). This design has been used extensively in all microbial fermentation and 
more recently insect cell fermentation (Agathos at a/., 1990; Caron et a/., 1990; Kuna and 
Papoutsakis, 1990; van Lier.at a/.,1994; Hu and Bentley, 1999). Insect cells can also be 
maintained in suspension culture using less-complex methods, for instance shaker (Sm, 
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T.ni Hi5) and spinner (Sf21) flasks. These system can be used to cultivate insect cells 
from 10ml to 5 litres. An alternate type of bioreactor developed for eukaryotic cell 
suspension cultures includes the airlift (Wood and Thompson, 1987) and wave fermenters 
(Singh, 1999). 
Anchorage-dependent mammalian cell culture has also been successfully scaled-up using 
ceramic (lydersen, 1987), hollow-fibre (Tyo et al., 1988), packed-bed (Whiteside and 
Spier, 1981), and fluidised-bed (Runstadler and Cernek, 1988) bioreactors., 
1.4.3 Optimising growth of eukaryotic cell culture and foreign protein 
production 
The successful scale-up of eukaryotic cell lines expressing large quantities of recombinant 
protein using the systems described previously, is attributed to the vast number of studies 
that have determined factors that limit these processes. These factors include; pH, 
temperature, dissolved oxygen concentrations, and defined nutrient (glucose) and amino 
acid (glutamine) consumption (Maiorella et al., 1988; Scott et al., 1992; lin et al., 1992; 
Borys et al., 1993; Racher et al., 1993; Raghunand and Dale, 1999; Hu and Bentley, 
1999). In particular, oxygen demand of insect cells is higher than that of mammalian cells 
(Tramper et al., 1986; Maiorella et al., 1988), and oxygen uptake increases after infection 
with virus (Streett and Hink, "1978; Maiorella et al., 1988; Hu and Bentley, 1999). 
Therefore, supplementing culture with the required factors can facilitate optimal cell 
growth and conditions for heterologous gene expression. 
1.4.4 Large-scale transient expression in eukaryotic cell for recombinant 
protein production 
Stable expression technologies, based on chromosome-integrated plasmid sequences, 
have delivered large quantities of recombinant proteins from eukaryotic cells (Hill et al., 
2001; Pfeifer et al., 2001; Shin and Cha, 2002). The development of these technologies 
requires considerable investment in time, human resources and bioreactor equipment. 
Due to high demand, the need for faster and cheaper approaches for the production of 
recombinant proteins is evident. The consideration of transient systems for the production 
of milligram to gram quantities of recombinant protein are rather new. With better 
technologies for reliable growth of eukaryotic cells and with better nucleic acid transfer 
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systems, the opportunities to explore scale-up of transient expression in eukaryotic cells 
has become feasible. 
A promising development in transient expression, is the use of elements that provide 
extended maintenance of plasmid-based vectors in cells. A plasmid-based vector has 
been developed, which contains two expression cassettes, the first contains the foreign 
gene of interest and the second, the large T-antigen from SV40 (Geisse et BI., 1997). The 
large T -antigen promotes episomal plasmid replication, which has subsequently improved 
recombinant protein production 3- to 5-fold compare to the same vector minus the large T-
antigen (Geisse et BI., 1997). However, a disadvantage of "naked DNA" systems is the 
requirement for large quantities of highly purified plasmid DNA. 
Viral systems have become easier to use because the methods to create recombinant 
virus vectors have been optimised. The alphavirus and baculovirus expression systems 
have provided the most efficient mammalian and insect expression for scale-up 
(LiljestrOm and Garott, 1991; King et BI., 1992; Berglund et BI., 1993; Nguyen et BI., 1993; 
Paul et BI., 1993; LiljestrOm, 1994; Blasey et BI., 1997; Lundstrom, 1997; Vlak et BI., 1998; 
Yamanaka, 2004). However, a disadvantage of the transient viral systems is the large 
quantity of inoculum requirement to infect scaled-up eukaryotic cell cultures. 
Transformed eukaryotic cell lines expressing high-levels of recombinant protein are 
perceived as more advantageous over the systems described above, due to the relative 
ease with which cultures can be scaled-up without enduring further expenses. 
1.5 Transcriptional activation in eukaryotic cells 
Eukaryotic cells must control their patterns of gene expression in response to physiological 
Signals, generated outside the cell, which are transduced to the nucleus through a series 
of complex biochemical interactions. These transduced signals can either amplify or 
attenuate temporally or spatially regulated gene expression by altering the interactions of 
transcription factors with their cognate targets (De La Brousse and Mcknight, 1993; 
Beckett, 2001; Johnson et BI., 2001; Warren, 2002). It is now generally accepted that 
gene expression is predominantly regulated at the level of transcription (reviewed by 
Latchman, 1995; Naar et B~., 2001), and the majority of data derived from baculovirus-
infected insect cells has shown that this is true. When studying expression systems for 
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the purpose of high-level protein production, it is essential to understand factors governing 
gene regulation. Factors involved in the regulation of eukaryotic gene transcription fall into 
,two categories: promoter I enhancer elements (DNA sequences) and activator elements 
(protein). 
1.5.1 Eukaryotic gene promoters 
The region immediately upstream (25-30 nucleotides) of transcription initiation has been 
the centre of significant study. Evaluating different genes and deleting I mutating 
sequences with significant homology to identified putative regulatory sequences. Many 
gene promoters are found to contain an AT-rich consensus sequence 'TATAA/rAA/T" 
which was determined as the TATA box. The TATA box is situated approximately 30 
nucleotides upstream from the transcriptional start site (Sassone-Corsi and Borrelli, 
1986). This sequence appears to be essential in determining accurate positioning of the 
transcriptional start site. However, not all genes contain the TATA box, in some cases a 
GC or CCAA T box is found in place of the TAT A box, Table 1.3 (Mitchell and Tjian, 1989; 
Gill, 2001; Butler and Kadonaga, 2002; Woychik and Hampsey, 2002). 
Promoters are defined as the region of the gene bracketed by the TAT A box motif and the 
site of transcriptional initiation (the catabolic gene activator protein [CAP] site). However, 
the presence of cis I trans-activiating gene-specific sequences may result in a dramatic 
increase of expression over those demonstrated by the TAT A box alone. The effect of the 
BmNPV hr3 consensus and IE-1 activator element on the BmA3 promoter, and heavy 
metal binding element in MT genes (Glanville et a/., 1981; Carter et a/., 1984; Farrell at a/., 
1997; Lu at a/., 1997; Chen at al., 2004) provida excellent examples of this mechanism 
(enhancer mechanisms are described in Section 1.5.3). Where present, these sequences 
have been shown to have an essential role in the up-regUlation of transcription (Latchman, 
1990, 1995; Farrell at al., 1997; Lu at a/., 1997; Farrell at al., 1999; Chen at al., 2004). 
'\ 
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Table 1.3: Consensus sequences found in the vicinity of eukaryotic RNA polymerase II 
start points 1. 
Element Consensus sequence General transcriptional factor 
BRE G/c G/c GI ACGCC TFIIB 
TATA TATAAIrAA/r TBP 
INR c/rc/rANT/A c/rc/r TFIID 
DPE A/GGAIrCGTG TFIID 
1The name given to each consensus sequence (first column) and the general transcription 
factor (TF) that recognises it are indicated (last column). N indicated any nucleotide, and 
two nucleotides separated by a slash indicate an equal probability of either nucleotide at 
the indicated position (Alberts et al., 2002). 
Baculovirus genes have been shown to contain promoter elements that are important to 
transcription. Transcription by eukaryotic RNA polymerase II is most often initiated by 
recognition of a TAT A box motif. Although not always present, the TAT A box motif is the 
most commonly conserved sequence element associated with RNA polymerase 11-
transcribed promoters. Several baculovirus early genes, including ie-1, ie-2 (ie-N), gp64, 
Pe-38 and pe-39 have been shown to have a consensus TAT A box motif and 
tetranucleotide "CAGT" motif at I near the transcription start site (Blissard and Rohrmann, 
1989; Blissard et al., 1992; Lu and Carstens, 1992). This conserved start site sequence is 
Similar to the consensus (ATCAG/r TCIr) originally described at the mRNA start site of 
Drosophila heat shock protein gene and found a few nucleotides downstream of the 
mRNA start site in a variety of other insect genes (Hunltmark et al., 1986). In p143, 
however, transcription is initiated at an unconventional 'CGTGC' mRNA start site 
consensus. 
Baculovirus late genes (p10 and polh) appear to be transcribed from a consensus late 
promoter element "ATAAG" or "GTAAG," which are also the transcriptional start sites, and 
is the minimal sequence requirement for gene expression (Weyer and Possee, 1989). It 
has been shown that the 5' non-coding leader sequence of the polh gene is very important 
in the regulation of gene expression. The seven nucleotides before the ATG are 
particularly important for maximum promoter activity. Repeating the eight nucleotides 
spanning the 'T AAG' motif with synthetic oligonucleotides results in a 2000-fold reduction 
" of expression. Sequences upstream of the mRNA start site appear to be relatively 
31 
Chapter1 Introduction 
unimportant. Similar results have been obtained with p10, vlf-1 and le(-6 (Weyer and 
Possee, 1989, Yang and Miller, 1998; Yang and Miller, 1999; Lin and Blissard, 2002). 
1.5.2 Enhancers 
The process of transcriptional control in eukaryotic cells is undoubtedly complex, and the 
mechanism of which is not fully understood. Two types of regulatory sequences have 
been described that control transcription initiation by RNA polymerase II:. promoters and 
enhancers (Serfling et al., 1985; Maniatis et al., 1987; MOiler et al., 1988; Blackwood and 
Kadonaga, 1998; Butler and Kadonaga, 2002; Woychik and Hampsey, 2002). Enhancers 
are sequences typically composed of a variety of short sequence motifs (cis-elements). 
Together with the promoter, enhancers can have profound effects on the level of gene 
expression (Atchison, 1988; Butler and Kadonaga, 2002; Chen et al., 2004). The 
definition of an enhancer is based on three criteria: first, an enhancer is capable of 
augmenting the level of foreign gene expression directed by the promoter in a position-
and orientation-independent manner. Second, enhancers are unable to stimulate the 
expression of a promoter in trans. However, work carried out by MOiler and Schaffner, 
(1990) suggest transcriptional enhances can act in trans. Third, increased transgene 
expression from the enhanced promoter is due to significant increases in transcription 
rates (Lu et al., 1997). 
Enhancers were originally identified in the DNA tumor virus simian virus 40 (SV40; Picard, 
1985; Sassone-Corsi et al., 1984; Sassone-Corsi and Borrelli, 1986) as cis-acting DNA 
elements able to dramatically increase transcription from RNA polymerase II-transcribed 
promoters independent of orientation and distance. Studies revealed that when a 200bp-
long DNA fragment of the SV40 was linked to a reporter gene, transcription of the reporter 
gene increased more than 100-fold over. Activation was found to occur over large 
distances of more than 3000bp independent of the enhancer position or orientation. 
Enhancer elements have since been found in many other viruses (Serfling et al., 1985; 
Voss' et al., 1986). However, the initial observations that the SV40 enhancer element 
aUgmented transcription from certain heterologous promoters (~-globin), became apparent 
that the magnitude of the stimulation also depended on the promoter examined. Studies 
carried out on the original SV40-~-globin chimera proved to have been a fortuitous choice 
of construct in terms of revealing an enhancer effect. Subsequent work has shown that as 
far as independence of distance was concerned, the SV40 enhancer had less dramatic 
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effects on other promoters, with both the SV40 early and chicken conalbumin promoters 
exhibiting a biphasic decrease in activity with increased distance between enhancer and 
promoter (Wasylyk et al., 1984). 
Nucleotide sequences exhibiting enhancer function have been identified in baculoviruses. 
AcMNPV consists of primarily unique sequences with the potential capacity to encode 
more than 100 proteins. In addition, eight homologous regions (hrs) of 30- to 800-bp in 
length were identified as potential enhancers of transcription (Guarino at al., 1986; 
Guarino and Summers, 1986; Rodems and Friesen, 1995; Viswanathan et al., 2003; Chen 
at al., 2004). The unique distribution of the largest AcMNPV hrs (hr1 to hr5) and the 
identification of similar DNA elements in the genome of other baculoviruses (Ayers at al., 
1994; Majima at al., 1993; Pearson and Rohrmann, 1995; Acharya and Gopinathan, 2001) 
suggest that the hrs perform an essential function (s) during the multi phase replication 
cycle of these invertebrate viruses. The AcMNPV hrs also function as enhancer elements 
for early viral genes by stimulating transcription from transfected plasmids (Guarino at al., 
1986; Guarino and Summers, 1986; Carson at al., 1991; Chen at al., 2004). Viral 
enhancers differ from other eukaryotic enhancers in that they are interspersed throughout 
the viral genome. hrs were shown to have an average A I T content of 68%, significantly 
higher than the 58% content for the rest of the AcMNPV genome. Similar observations 
have been made for other baculoviruses, such as OpMNPV (Theilmann and Stewart, 
1992a: Theilmann and Stewart,· 1992b), Trichoplusia ni granulosis virus (Hashimoto et al., 
1996) and Choristoneura fuminfarana MNPV (Arif and Doerfler, 1984; Kuzio and Faulkner, 
1984; Qiu at al., 1996). 
The 485-bp hr5 enhancer located immediately downstream from the AcMNPV apoptotic 
suppresser p35, stimulates expression of viral genes in a promoter-specific manner. It 
Consists of six 26- to 30-bp imperfect palindromes each bisected by an EcoRI site. 
Studies have indicated that the central 28-bp repeat (28-mer; 
TTTACGAGTAGAATTCTACTTGTAACGC) represents the smallest functional unit of hr5 
capable of position- and orientation-independent transcriptional activation (Rodems and 
Friesen, 1993). Consistent with a modular organisation of hr5, repetition of the 
palindrome increases enhancement. It has subsequently shown that hr5 stimulates early 
gene expression in the AcMNPV genome but is not required for virus replication. It has 
also been suggested that the hr region may be utilised by the virus as origins of DNA 
"-
replication (Kool at al., 1993). The highly conserved imperfect palindrome of 28-mer has 
been identified in all hrs (Rodems and Friesen, 1995; Olson at al., 2003). 
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Activity of the hr enhances is stimulated by the AcMNPV trans-regulator gene ie-1. The ie-
1 gene product (IE-1) is a 67-kDa multifunctional protein that trans-regulates the 
expression of transfected genes under control of viral and heterologous promoters by hr-
dependent and hr-independent mechanisms. Studies revealed that transcription of ie-1 is 
not affected by cis-activation of the hrS enhancer, whereas expression of the delayed early 
gene 39K was increased up to 1000-fold in the presence of the hrS enhancer (Guarino et 
a/., 1986; Guarino and Dong, 1994). A 1-bp mismatch was found to occur in the same 
location in hr1 to hr4, hrS contained a 2-bp mismatch in the same region. hr1 to hrS have 
varying effects on 39K expression. Out of all the hr enhancer hrS exhibits greater cis-
activation of 39K and hr3 the lowest. However, studies carried out by Lu et a/. (1997) first 
reported that when linked to gene constructs expressing reporter proteins under control of 
the BmA3 gene promoter, a DNA fragment containing the hr3 of BmNPV enhances 
Significantly the in vitro expression of reporter proteins. Secondly it was show that linkage 
of the hr3 enhancer to the ac BmA3 promoter, combined with the presence of the BmNPV 
IE-1 protein in transfected cells resulted in an augmentation in the level of BmA3 promoter 
strength by three orders of magnitude relatively to that of the basic BmA3 gene promoter. 
hr1 has been shown to be important in regulating AcMNPV ie-2, while AcMNPV IE-1 
down-regulates ie-2, both in the presence and absence of hr1 (Carson et a/., 1991). 
1.5.3 The enhancer mechanism 
Numerous models have been proposed to explain the mechanism of gene activation by 
remote enhancers and distal promoter sequences. Some of these models (the 'sequence-
specific gyrase' model) are now considered unlikely (Pion and Wang, 1986). Also, it is 
unlikely that the main action of enhancers is the formation of a specific 'chromatin 
structure', since enhancers can stimulate transcription in vitro in the adsence of chromatin, 
albeit with a more pronounced distance-dependent attenuation than in vivo (MOiler et a/., 
1988; Carey et a/., 1990; Blackwood and Kadonaga, 1998). Although considerable 
progress has been made in understanding the structure and function of transcription 
factors that bind to promoters and enhancers, there is still little known about the way these 
factors interact with the general transcription apparatus. 
Two principle models have been the most often considered for this process: looping and 
scanning (MOiler et a/., 1988; Blackwood and Kadonaga, 1998). In the looping model, 
initiation of transcription is stimulated by the interaction of enhancer I upstream promoter 
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elements with proximal promoter elements through proteins bound to the DNA. The DNA 
between remote sequences and proximal promoter elements is thereby looped out (Picard 
and Schaffner, 1985; Ptashne, 1986). The main problem for communication over large 
distances is low concentration of the DNA regions (such as an enhancer and a promoter) 
in the vicinity of each other (Rippe et al., 1995). Measurements of local concentrations of 
linear DNA ends in the vicinity of each other suggests that it is relatively high only when 
the distance between DNA ends is 100- 900-bp (Shore at al., 1981). When distance 
between the DNA ends is increased to 3-kb, their local concentration is d~creased by an 
order of magnitude (Shore at al., 1981; Liu at al., 2001). Thus, it is remarkable that 
enhancer and promoter regions positioned far away from each other can communicate 
efficiently. 
Several models have been proposed to explain the mechanism of enhancer action over a 
large distance. One class of models suggests that initial communication of an enhancer 
with a promoter leads to the formation of a stable DNA-protein complex in the vicinity of 
the promoter. This stable complex may facilitate subsequent rounds of transcription 
serving as a "memory" of initial enhancer-promoter interaction (Blackwood and Kadonaga, 
1998). Alternatively, the average distance between promoter and enhancer could be 
considerably decreased if the intervening DNA is super-coiled or bent (Shore at al., 1981, 
liu at al., 2001). 
Work to determine the mode of enhancer promoter interaction over large distances in 
prokaryotes, favours the looping model. Work by Liu et al. (2001) has demonstrated that 
short distances of 100- 900-bp between an enhancer and promoter does not necessitate 
DNA super-coiling to result in enhancement of promoter activity. However, when the 
enhancer was placed 2.3- or 2.5-kb upstream of the promoter, DNA super-coiling was 
required to elect equivalent up-regulation of promoter activity, as observed for short 
distances. There are several possible explanations for the effect of DNA super-coiling on 
the rate of enhancer-promoter communication. Local concentration of DNA sites 
separated by 2.5-kb is quite low (~10-8 M; Shore at al., 1981) and could be dramatically 
increased by DNA super-coiling. Metropolis-Monte Carlo simUlations of equilibrium DNA 
conformation suggested that DNA super-coiling increases the probability of juxtaposition of 
two sites (enhancer and promoter) spaced by 3-kb by about two orders of magnitude as 
compared with relaxed DNA (Vologodskii and Cozzarelli, 1996). Understanding the 
'. 
mechanism of action of prokaryotic enhancers could subsequently be important for better 
understanding of the mechanism of eukaryotic enhancer action. 
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The scanning (or entry site) model proposed by Moreau et al. (1981), suggests that 
enhancers I upstream promoter elements are recognised by RNA polymerase II I or 
transcription factors, which binds and then slides in either direction along the DNA, until it 
reaches the proximal promoter elements where it facilitates the formation of a 
transcriptional pre-initiation complex. 
The mechanism of enhancer action has previously been proposed as a cis-activation 
regulatory element. However, a number of studies have demonstrated, that enhancer 
sequences can also stimulate transcription in trans (MOiler et al., 1988; Morris et al., 1999; 
Chen et al., 2002). 
1.5.4 Mechanism of transcriptional activation 
Eukaryotic RNA polymerase II is a large multi-subunit enzyme comprising at least 12 
distinct subunits and possessing a molecular mass in excess of 500 kiladaltons (Woychik, 
1998). Over the last 25 years, biochemical studies aimed at reconstituting promoter-
dependent transcription by RNA polymerase II with pure proteins and elucidating its 
mechanism have bought to light the remarkable complexity of the initiation stage of 
eukaryotic mRNA synthesis. Previous studies (Fire et al., 1984; Brown et al., 1985; 
Reinberg and Roeder, 1987; Ptashne, 1988; Zhang et al., 1990; Bates and Maxwell, 1993; 
Buratowski, 1994; Stargell and "Struhl, 1996; Beckett, 2001; Warren, 2002) revealed that 
transcription initiation by RNA polymerase II is an elaborate multi-step process that 
requires as a minimum five general transcription initiation factors: TFIIB, TFIIE, TFIIF 
(Reinberg and Roeder, 1987), TFIID (Lin, Y-S et al., 1991) or TBP (Carthew et al., 1985), 
TFIIH (Xiao et al., 1994) and an ATP cofactor. Assembly of the above transcription factors 
on a core promoter causes the formation of the pre-initiation complex, Figure 1.4 (Fire et 
al., 1984; Bates and Maxwell, 1993; Buratowski, 1994; Stargell and Struhl, 1996; Dvir et 
al., 2001; Naar at al., 2001; Warren, 2002). 
The basic transcriptional factors essential for transcription by RNA polymerase I I is more 
Complex than that of RNA polymerase I or III. The first step in the assembly of the pre-
Initiation complex is binding of TFIID (TBP and TAFs) sequence-specifically to the TATA 
element (Stringer et al., 1990; Takada et al., 1992; Dvir et al., 2001; Woychik and 
Hampsey, 2002). This results in protection of the -35 to -19 upstream region of the 
transcription start site, Fig~re 1.4, which subsequently establishes a nucleoprotein 
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recognition site for RNA polymerase lion the DNA. This is the earliest step in the 
formation of the stable transcriptional complex (Baldick et al., 1994; Woychik and 
Hampsey, 2002) and is facilitated by TFIIA. TFIIA binds to the promoter-TFIID complex 
(Buratowski et al., 1989), TFIIA is not essential for basal transcription but it does function 
to stabilise the pre-initiation complex under more physiological conditions (Lee et al., 
1992). Several negative regulators of transcription have been discovered (Auble and 
Hahn, 1993; Gill, 2001; Wei et al., 2003). Some of these inhibitors act by displacing TFII D 
from the core promoter, while others block interactions between TFIID and .the other basal 
factors. TFIIA appears to counteract these repressors of transcription, presumably 
through its direct interaction with TBP. This antagonism may represent a mechanism for 
regulation of the pre-initiation complex. 
The second step of pre-initiation complex assembly is the recruitment of TFIIB to the 
TFIID-TFIIA-TAT A-element complex (Lin and Green, 1991; Kimura and Ishihama, 2000). 
TFIIB functions as an adaptor to promote selective binding of RNA polymerase II to TFIID 
at the promoter by binding specifically to both polymerase and the TBP subunit of TFIID to 
from the Dbpol II complex (Johnson and Mcknight, 1989, Misra et al., 1995; Dvir et al., 
2001). The recruitment of RNA polymerase II, brings with it TFIIF. TFIIF performs dual 
roles in assembly of the pre-initiation complex by binding to and strongly stabilising the 
Dbpol II intermediate and by recruiting TFIIE into the complex. TFIIF also has an 
enZymatic activity needed to unwind the DNA helix. TFIIE incorporation into the pre-
initiation complex appears necessary for subsequent recruitment of TFIIH. TFIIE is a 
DNA-dependent ATPase and is probably needed for generating the energy for 
transcription (Bunick et al., 1982; Sawadogo and Roeder, 1984). Evidence that TFIIE 
makes contact with promoter DNA both upstream and downstream of the transcriptional 
start site suggests that this initiation factor accenuate DNA bending, and promotes the 
complete wrapping of promoter DNA around the pre-initiation complex. Leaving DNA 
Upstream and downstream of the transcriptional start site juxtaposed (Robert et al., 1996; 
RObert et al., 1998; Johnson et al., 2001). , 
TFIIH is one of the last additions to the pre-initiation complex. TFIIH is a multi-subunit 
Complex associated with several biochemical activities. TFIIH possesses the serine I 
threonine protein kinase activity that is capable of phosphorylating the carboxyl-termini-
domain of RNA polymerase II (Buratowski, 1994; Kimura and Ishihama, 2000; Butler and 
Kadonaga, 2002). TFIID ca~not bind this heavily phosphorylated region and releases the 
RNA polymerase enabling transcription of DNA. During transcription, TFIIA and TFIID 
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(Takada at al., 1992) remain bound to the promoter region, allowing repeated rounds of 
transcription, (Mastsui at al., 1980; Samuels at al., 1982; Kadonaga, 1990; Wampler at al., 
1990; Latchman, 1995; Gill, 2001; Johnson at al., 2001; Butler and Kadonaga, 2002) 
Figure 1.4. Even though the formation of the transcriptional complex is undoubtedly 
important, it has been demonstrated that DNA binding per se does not initiate transcription 
(Keegan et al., 1986; Gill, 2001; Johnson et al., 2001; Butler and Kadonaga, 2002; 
Woychik and Hampsey, 2002). 
'. 
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Figure 1.4: The formation of the active eukaryotic pre-initiation complex. The diagrams 
represent the complexes formed on the TAT A box by the transcription factors and RNA 
polymerase II. A: The TFIID complex binds to the TATA box through its TBP subunit. B: 
TFIIA binds promoter-TFIID complex and stabilizes TFIID. C: TFIIB is recruited to the 
complex on the TATA box. 0: The recruitment of RNA polymerase II, brings with it TFIIF. 
RNA polymerase II is positioned by TFIIB, and its carboxy-terminal domain (CTD) is bound 
by TFIID. E: TFIIE and TFIIH bind to the complex. F: The CTD is phosphorylated by 
TFIIH and is released by TFIID. The RNA polymerase II is now competent to transcribe 
mRNA from the gene. 
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1.6 TOPO® cloning 
Gateway'" is a universal cloning technology that takes advantage of the site-specific 
recombination properties of bacteriophage lamda (Landy, 1989) to proved a rapid and 
efficient way to transfer heterologous genes of interest into multiple vector systems 
Topoisomerase I from Vaccinia virus binds to duplex DNA at specific sites (CCCTT) and 
cleaves the phosphodiester backbone in one strand (Shuman, 1991). The energy from 
the broken phosphodiester backbone is converted, by the formation of a covalent bond 
between the 3' phosphate of the cleaved strand and a tyrosyl residue (Tyr 274) of 
topoisomerase I. The phospho-tyrosyl bond between the DNA and enzyme can 
Subsequently be attacked by the 5' hydroxyl of the original cleaved strand, reversing the 
reaction and releasing topoisomerase (Shuman, 1994). TOPO® cloning exploits this 
reaction to efficiently clone polymerase chain reaction (PCR) products. 
Directional joining of double-stranded DNA using TOPO®-charged oligonucleotides occurs 
by adding a 3' single-stranded end (overhang) to the incoming DNA (Cheng and Shuman, 
2000). This single-stranded overhang is identical to the 5' end of the TOPO®-charged 
DNA fragment. This idea has been modified (Invitrogen"') by adding a four nucleotide 
overhang sequence (GTGG) to the TOPO®-charged DNA and adapting it to a plasmid-
based vector format. 
In this system, PCR products are directionally cloned by adding four nucleotides to the 
forward primer (CACC). The overhang in the plasmid-based vector (GTGG) invades the 
5' end of the PCR product, anneals to CACC, and stabilises the PCR product in the 
correct orientation. Inserts can be cloned in the correct orientation with efficiencies equal 
to or greater than 90%. 
Directional TOPO® cloning was used in this thesis for the rapid and efficient insertion of 
heterologous genes (Sections 1.7.2, 1.7.4 and 1.7.5) into plasmid-based vectors of the 
Expresslnsect'" expression system (Chapters 3, 4, and 5) . 
..... 
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1.7, . Heterologous genes used in this thesis 
1.7.1 Reporter genes 
Reporter genes are those, which are introduced into cells, which allow the detection or 
visualisation of modified gene expression levels, signal transduction rates and cell 
metabolism activities. The detection of reporter-proteins is generally both quick and easy 
to assay for and give quantitative and qualitative results. Reporter genes used in this 
thesis are all intracellular and include: chloramphenicol acetyl transferase (CAT), green 
fluorescent protein I enhanced green fluorescent protein (GFP I EGFP), Discosoma red 
(OsRed), and dihydroorotate dehydrogenase (OHOOH). 
1.7.2 Chloramphenicol acetyl transferase 
CAT is a commonly used reporter gene when accurate quantitative results are required, 
SUch as promoter comparative assays (Roelvink at al., 1992). For this reason cat will be 
Used in this project to compare the activity of different promoters. Assaying for CAT is 
undertaken in the presents of [14C] chloramphenicol, CAT catalyses the conversion of 
chloramphenicol to the inactive mono- or diacetylated forms, which can the be separated 
by thin layer chromatography (Section 2.8.1). Percentage conversion is calculated by use 
of the software program Image-Quant 5.1. 
1.7.3 Green fluorescent protein I enhanced green fluorescent protein 
The cloning of the gene for green fluorescent protein (GFP) from the jellyfish Aaquorea 
Victoria and its subsequent expression in heterologous systems has established GFP as a 
unique genetic reporter system for use in a variety of organisms (Chalfie at al., 1994; Kain 
et a/., 1995; Tsien, 1998). Unlike other reporters, GFP fluorescence emerges in the 
absence of substrates or cofactors and allows for non-invasive monitoring in living and in 
paraformaldehyde-fixed cells. Enhancement of wild-type GFP by human codon 
optimisation (Yang at al., 1996) and fluorophore mutation (EGFP) resulted in higher 
eXpression levels and brighter fluorescence (Yang at al., 1996; Zhang at al., 1996). 
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1.7.4 Discosoma red fluorescent protein 
Recently a novel red fluorescent protein DsRed, was isolated from reef coral (Discosoma 
sp.). DsRed retains the same advantages as described for GFP and EGFP as a reporter 
gene (Section 1.7.3). DsRed fluorescence is excited optimally at 558 nm, but can also be 
excited by a standard 488 nm laser (Hawley et al., 2001). DsRed has a high quantum 
yield and is photo-stable (Baird et a/., 2000). These characteristics make DsRed an ideal 
candidate for fluorescence imaging. However, problems with DsRed have been 
characterised recently, such that they form tetrameric forms (Rodrigues et a/., 2001; 
Sacchetti et a/., 2002). These tetrameric forms have a tendency to self-associate to form 
higher-order aggregates when over-expressed to very high-levels and on occasion these 
have been shown to be toxic to cells (Baird et a/., 2000; Goss et a/., 2000; Heikal et a/., 
2000; Jakobs et a/., 2000). Despite this possible disadvantage, use of DsRed as a 
reporter gene is widespread and generally its advantages outweigh the disadvantages. 
1.7.5 Dihydroorotate dehydrogenase (Candida albicans) 
Dihydroorotate . dehydrogenases (DHODH) have been identified as f1avoproteins. 
Flavoproteins are enzymes or proteins that have a flavin nucleotide as a coenzyme or 
prosthetic group (Bader et a/., 1998). Eukaryotic DHODH are a protein component 
located in the inner mitochondrial membrane and possess a quinone as its electron 
acceptor (Dietz et a/., 2000; Carrey et a/., 2002). DHODH catalyses the fourth of six 
consecutive enzymatic reactions in the de novo biosynthesis of the pyrimidine, UMP. It 
allows for the oxidation of dihydroorotate, which is not a true pyrimidine, to orotate (Loffler 
et a/., 1997). The reducing equivalents resulting from dihydroorotate may be utilised to 
pUsh ATP synthesis through oxidative phosphorylation (Carrey et a/., 2002). DHODH was 
Used as a reporter gene in this thesis, as it has industrial importance and relevance to 
Pfizer. 
1.8 Aims of the project 
The overall aim of this thesis was to improve intracellular expression and regulation of 
heterologOUS genes in insect cells (lepidopteran). This work was subdivided into more 
specific aims, which are described below: 
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• To characterise a-amanitin-sensitive RNA polymerase promoters with stronger 
transcriptional activity than the AcMNPV ie-1 promoter. 
The use of AcMNPV ie-1 for the stable production of intracellular recombinant proteins in 
insect cells has been well documented as producing low yields (Guarino and Summers, 
1987; Jarvis et 81., 1990; Joyce et 81., 1993). Therefore, comparative expression analyses 
of the AcMNPV ie-1 promoter to a number of promoters demonstrated to be useful in 
other eukaryotic expression systems (Section 1.3.3) was undertaken. These data would 
Subsequently aid the development of further work described in this thesis. 
• To develop a new plasmid-based inducible insect cell expression system. 
Mechanisms that will permit tight regulation of inducible gene expression in insect cell 
lines are very limited (Sections 1.3.3, 4.1), compared to those developed for mammalian 
cells. Therefore, work was undertaken with the aim of developing one of the mammalian 
inducible expression systems to lepidopteran cells. The tetracycline inducible system was 
selected as a good candidate to develop to insect cell lines (Chapter 4). The tetracycline 
inducible expression system offers a number of advantages for adaptation to insect cells, 
these include; extremely tight on I off regulation, no pleiotropic effects, and expression is 
indUced by a well-characterised inducer (tetracycline I doxycycline). 
• To investigate ways of improve transient expression of intracellular recombinant 
proteins, using a novel baculovirus expression vector and determining optimal scale-
up cultivation methodologies. 
The removal of chitinase from AcBacPAK6, to derive AcBacPAK6.~chiA, has 
demonstrated improved yields of secreted and membrane targeted proteins (Section 
1.3.2). Experiments to determine if recombinants derived from AcBacPAK6.~chiA could 
augment intracellular protein production over those observed from AcBacPAK6 were 
Undertaken. In addition, different culturing methodologies (fermenter and shaker) were 
Used to scale-up (1-litre) intracellular protein production using the recombinant viruses 
derived from AcBacPAK6.~chiA and AcBacPAK6 (Chapter 5). 
• To examine ways to improve stable expression of intracellular recombinant proteins, 
Using promoters characterised with stronger transcriptional activity than AcMNPV ie-1. 
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The data derived from the promoter comparison study (Chapter 3) conducted at the 
beginning of this thesis, was used to identify the promoter with the strongest 
transcriptional activity in lepidopteran cells. This promoter was subsequently used to 
stably express intracellular heterologous genes (Sections 1.7.4 and 1.7.5) to address 
whether stable insect cell lines could be used as an alternative to the BES for the 
production of intracellular proteins (Chapter 5). 
• To develop methods for continuous cultivation of transformed insect cell .lines. 
Transformed insect cells generated in this thesis were also used for the development of a 
protocol that would maintain continuous cultivation of scaled-up stable insect cell lines in 
an open fermenter system (Chapter 5). 
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CHAPTER 2: MATERIALS AND METHODS 
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2.1 General information 
This chapter gives a summary of materials and methods used throughout this thesis. 
2.1.1 Chemicals and reagents 
General chemicals, solvents and reagents were purchased from Sigma Chemicals 
Company Ltd., UK, BOH Chemicals Ltd., UK, Invitrogen TM, Life Technologies, Gibco BRL, 
USA., and BO Biosciences, unless otherwise stated. All solutions were made as weight 
per volume (w I v) unless otherwise indicated. Solutions were sterilised, when necessary, 
either by autoclaving (15 pounds per square inch (psi) for 15 mins or 10psi for 20 mins) or 
by filter sterilisation. 
2.1.2 Radioisotopes 
The following radioisotope was obtained from Amersham Pharmacia Biotech, UK Ltd. and 
Used as appropriate: 
1-0eoxY[dichloroacetyl-1-14C] chloramphenicol (0.025J.lCi) 
2.1.3 Enzymes 
Restriction endonucleases were purchased from Promega or New England Biolabs (NEB). 
SpeCific modifying enzymes were obtained from the following: 
ProofsprintelM DNA polymerase: 
GatewalM LR Clonase ™ Enzyme mix: 
Shrimp Alkaline Phosphatase (SAP) 
T 4 DNA ligase 
T 4 polynucleotide kinase 
Klenow DNA polymerase 
Omniscript reverse transcriptase 
Hybaid-AGS 
Invitrogen ™ 
Boehringer Mannheim Ltd. 
Promega I NEB 
Promega I NEB 
Promega I NEB 
QIAGEN 
All enzymes were accompanied with the appropriate buffers and reagents. 
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2.1.4 Oligonucleotides 
All oligonucleotides were custom synthesized by Invitrogen TM. 
2.1.5 Bacterial strains 
The following modified Escherichia coli K12 strains were used for prokaryotic cloning and 
plasmid propagation: 
MAX Efficiency® OH5a. ™ 
DB3.1TM 
2.1.6 Glossary of mutations 
F-~80IacZ~(/acZYA-argF)U 169deoRrecA 1 
endA 1 hsdR 17(rk-,mk-)phoAsupE44thi-
19yrA96re/A1tonA (confers resistance to phage T1) 
(I nvitrogen TM) 
F- gyrA462endA-delta(sr1-recA) mcrB mrr hsdS20 
(ra-,ma-) supE44 ara-14 gaIK2 lacY 1 proA2 
rpsL20(Smf ) xy/5lambda-leu mt/1 (InvitrogenTM) 
F- mcrA ~(mrr-hsdRMS-mcrBC) ~80IacZ~M15 
MacX74 recA1 deoR ara0139 ~(ara-leu)7697 ga/U 
galK rpsL(St~) endA 1 nupG (Invitrogen TM) 
~80 cell carries F80 prophage. 
ara-Ieu 76971ara0139 
ara-14 
argF 
blocks arabinose catabolism and leucine 
biosynthesis. 
blocks arabinose catabolism. 
ornithine carbamoyltransferase mutation blocks the 
ability to use arginine. 
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MacX74 
deoR 
endA1 
ga/KI ga1K2 
ga/U 
gyrA 
gyrA96 
hSdRMS 
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entire deletion of lac operon and varying amounts 
of flanking DNA. 
regulatory mutant for constitutive deoxyribose 
synthesis to allow uptake of large plasmids. 
DNA specific endonuclease. Mutation shown to 
increase quantity of plasmid yields. 
lacks the F' episome. 
galactokinase mutation blocks catabolism of 
galactose. 
glucose-1-phosphate uridylyltransferase mutation 
blocks the ability to use galactose. 
mutation affects DNA gyrase, subunit A, conferring 
resistance to nalidixic acid. 
DNA gyrase mutant produced resistance to 
nalidixic acid. 
mutation in the methylation system that E. coli use 
to recognise foreign DNA. There are two parts to 
this system, methylation and restriction. 
restriction minus (via EcoK1 restriction system 
mutant, so no restriction at unmethylated EcoK 1 
sites), modification minus (no methylation at 
EcoK1 sites. 
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hSdS20(rB., mB') 
lacY 1 
lacz 
lacZ~M15 
leu 
mcrA 
mcrB 
mrr 
mCrBC 
mt/1 
nupG 
PhoA 
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mutation in the site recognition gene for strain B 
restriction endonuclease system. This makes the 
strain deficient for both restriction and modification 
of DNA. 
blocks use of lactose via ~-D-galactosidase 
mutant. 
mutation yields colourless (vs. blue) colonies in the 
presence of X-gal. 
a partial deletion of the NH2-terminal region of ~-D­
galactosidase, permits alpha-complementation 
with certain vectors that encode this region (pUC, 
M13) thus producing blue I white colour selection. 
mutation in the leu operon. 
blocks restriction of DNA methylated at G(m)CGC. 
blocks restriction of DNA methylated at AG(mC)T. 
blocks adenine methylation; prevents cleavage of 
C(m)AG and G(mA)C. 
GmeC or AmeC Hha II, Pst I methylases methylate 
these sequence Gm6AC and Cm6AG respectively. 
blocks catabolism of mannitol. 
a mutation for the transport of nucleosides. 
encodes the periplasmic enzyme alkaline 
phosphatase. 
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proA2 
recAI recA1 
ra/A 
rpsl20(SmR) I rpsl(St~) 
supE44 
thi-1 
tonA 
U169 
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requires proline for growth on minimal media. 
involved in DNA repair and recombination. 
Mutation reduces homologous recombination of 
vector with host DNA giving more stable inserts. 
RNA is synthesized in the absence of protein 
synthesis (relaxed phenotype). 
confers resistance to streptomycin due to a 
mutation in S 12 of 30S ribosome. 
carries a tRNA suppressor gene for amber or 
ochre termination codons. 
requires thiamine for growth on minimal media. 
confers resistance to the lytic bacteriophage T1, 
T5 and Phi 80, via a mutation in an outer 
membrane protein. 
this refers to a deletion in this part of the E. coli 
genome, including the lac Z, Y, and A genes. 
xy/5 blocks catabolism of xylose. 
2.1.7 Non-viral insect expression systems 
COnstitutive I Inducible Drosophila Expression System (version F), Invitrogen™ life 
Technologies, Gibco BRl, USA. 
COnstitutive 
. Inducible 
pAc5.1N5-His A, B, C 
pMTN5-His A, B, C 
EXPRESS INSECT™vector set, Invitrogen™, life Technologies, Gibco BRl, USA: 
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Constitutive 
Constitutive 
Constitutive 
pXINsect-DEST38 
pXINsect-DEST39 
pBmA:neo 
Insect Select™vector set, Invitrogen™, Life Technologies, Gibco BRl, USA: 
Constitutive plZT NS-His 
Constitutive pIZTNS-His/CAT 
2.1.8 Non-viral mammalian expression system 
Tet-on™ Gene Expression System, BD Biosciences Clontech: 
Constitutive pTet-on 
Inducible pTRE2 
Living colours expression vectors, BD Biosciences Clontech: 
Constitutive pEGFP-N1 
Constitutive 
2.1.9 Insect virus transfer vectors 
BacPAK™ transfer vectors, BD Biosciences Clontech: 
PBacPAK8 
PBacPAK9 
2.1.10 Insect viruses 
pDsRED-N1 
Viruses used for the construction of recombinant viruses are: 
BacPAK6™ R.D. Possee, CEH, Oxford 
BacPAK6 (chiA) L.A. King, Oxford Brookes 
University 
BacPAK6.DsRed A. Patmanidi, Oxford Brookes 
University 
BacPAK6.chiA-.DsRed C. Pritchard, Oxford Brookes 
University 
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2.1.11 Insect cell lines 
Insect cell lines: 
Spodoptera frugiperda (Sf21) 
Spodoptera frugiperda (S19) 
Drosophila melanogaster (Om S2) 
Trichoplusia ni (T.ni Hi5) 
2.1.12 Insect cell culture medium 
TC100 
Sf90011 serum-free 
Ex-cell 405 serum-free 
Foetal Calf Serum (FCS) 
Schneider's (DES®Expression Medium 
with L-glutamine containing 10% 
heat-inactivated FCS) 
2.2 Standard cell culture procedures 
2.2.1 Insect cell culture 
Materials and Methods 
R.D. Possee, CEH, Oxford. 
Invitrogen"", Life Technologies, 
Gibco BRL, USA. 
Invitrogen'l1l, Life Technologies, . 
Gibco BRL, USA. 
JRH Biosciences. 
Invitrogen'l1l ,Life Technologies, 
Gibco BRL, USA. 
Invitrogen'l1l, Life Technologies, 
Gibco BRL, USA. 
JRH Biosciences. 
Invitrogen"", Harlan-Seralab , 
Globepharm. 
Invitrogen"", Life Technologies, 
Gibco BRL, USA. 
Spodoptera frugiperda (S121) cells were maintained at a low passage in spinner cultures 
(3S rpm) and in disposable 75cm3 T-f1asks for seed stocks. Cells were maintained at a 
. lOW-density stock (0.2x106 cell I ml) and growth to high-density stocks (2x106 cell I ml) 
before passaging. In both cases the cells were maintained in TC100 medium 
SUpplemented with 10% foetal calf serum (FCS). 
~. 
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Spodoptera frugiperda (SI9) cells, and Trichoplusia ni (T.ni Hi5) cells were maintained at a 
low passage in shaker culture and in disposable 75cm3 T-flasks for seed stocks. Cells 
were maintained at a low-density stock (0.35x106 cell I ml) and growth to high-density 
stocks (6-8x106 cellI ml) before passaging. In both cases the cells were maintained in 
serum-free medium (SI9 cells in 5f90011 and T.ni Hi5 cells in Ex-cell 405). 
Drosophila melanogaster Schneider S2 (Om) cells, were maintained at a low passage in 
complete Drosophila expression system® (DES®) medium, containing L-glutamine and 
10% heat-inactivated FCS within disposable 75cm3 T -flasks. Cells were maintained at a 
low-density stock (1x106 cellI ml) and growth to high-density stocks (6-20x106 cellI ml) 
before passaging. 
S121, SI9, and T.ni Hi5 cell lines were incubated at 28°C whilst Om cells were incubated at 
24°C. SI9 and T.ni Hi5 shaker cultures were grown on Denley orbital shakers (135 rpm). 
S121 spinner cultures were grown on biological stirrers (Techne MCS-104L). Prior to use, 
cell numbers were determined using a Neubauer heamocytometer. Cell viability was 
determined by trypan blue staining (Section 2.2.6). 
2.2.2 Long term storage of cells 
All cell lines were frozen slowiy in liquid nitrogen in the appropriate growth medium 
Containing 10% DMSO (FCS was added if required), for long-term storage. Cells were 
stored in 1ml aliquots in sterile cryovials at a cell density of 1-3x107 cellI ml. Recovery of 
cells involved the rapid thawing of the aliquot at 37°C. In the case of monolayer-forming 
cells, cells were transferred initially into disposable 25cm3 T -flasks, 4ml of fresh medium 
was added, and the cells were allowed to settle. The medium was decanted and fresh 
m~dium added. The cells were expanded as required. In the case of suspension cultures, 
cells were removed from storage medium by gentle centrifugation (1400 xg, 10mins 
Bechman J6B) and resuspended into 10ml fresh medium and incubated at 28°C on an 
orbital shaker or biological stirrers. 
2.2.3 Seeding insect cells 
Cells were seeded in either'35mm tissue culture dishes. Seeding densities used for 
35mm dishes were 1x106 for SI9, Sf21 and T.ni Hi5, or 3x106 for Om. S121, SI9, and T.ni 
55 
,Chapter 2 Materials and Methods 
HiS cells were incubated at 28°C, Om cells at 24°C, for 2-3 h to allow the cells to adhere 
prior to use. 
2.2.4 Transfer of heterologous DNA into insect cells 
Transfer of plasmid DNA into Sf9 or T.ni HiS cells for transient or stable protein production 
Was carried out using Lipofectin™ (Invitrogen™, Life Technologies, Gibco BRL, USA). For 
transfection into 3Smm tissue culture dishes, 1 ml total aliquots containing appropriate 
growth medium, Lipofectin'" and plasmid DNA was added to the cells. Lipofectin™ was 
diluted 1 in 1 00 with growth medium (SJlI:49S,.d) to give a volume of SOOJlI. Plasmid DNA 
Was used at varying concentrations (1-10Jlg per transfection), which was added to growth 
medium to give a volume of SOOJlI. The DNA I growth medium was added to the 
Lipofectin™ I growth medium and gently vortexed to mix. The 1ml transfection mixtures 
were incubated at room temperature for 40 mins to form DNA I lipid complexes. The 
transfection mixtures were applied to 1 x1 06 Sf9 or T.ni HiS cells previously seeded into 
3Smm tissue culture dishes (section 2.2.3). Dishes of cells were incubated at 28°C in a 
mOist box for S h, a further 1 ml of appropriate growth medium was then added. 
Transfer of plasmid DNA into Om cells for transient or stable protein production was 
carried out by calcium phosphate transfection. Om cells were seeded (section 2.2.3) into 
3Smm tissue culture dishes. In a microcentrifuge tube, the following components were 
mixed together to form solution A: 2M CaCI2 (36JlI), plasmid DNA (19Jlg), tissue culture 
sterile water (to a final volume of 300JlI). In a second microcentrifuge tube the following 
Was added to form solution B: 300JlI 2X HEPES-Buffer Saline (HBS) (SOmM HEPES, 
l.SmM Na2HP04, 280mM NaCl, pH 7.1). Solution A was slowly added to solution B in a 
drop wise fashion with continuous gentle vortexing to mix the solutions together. 
Continuous mixing ensured production of a fine white precipitate necessary for efficient 
transfection. The resulting solution was incubated at room temperature for 40 mins. The 
solution was swirled to mix and added drop wise to the seeded Dm cells. The 
transfections were incubated for 16 h at 24°C. The calcium phosphate solution was 
. removed and the cells washed twice with fresh DES complete medium. The cells were 
Washed by re-suspending in DES complete medium and pelleted (100 xg, S mins, 
microfuge). The medium was decanted and fresh medium was added, cells were re-
Plated into the same 3Smm tis~ue culture dishes. Dishes were incubated at 24°C to allow 
protein production. 
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2.2.5 Production of stable insect cell lines 
Cells were seeded (Section 2.2.3) and transfected with DNA as described in Section 2.2.4, 
transfections were incubated at 28°C for 48 h. Medium was removed and replaced with 
complete growth medium containing 700J.l.g I ml for T.ni Hi5 cells or 400J.l.g I ml for Sf9 
cells. Selective pressure was reduced to 300J.l.g I ml for T.ni Hi5 cells and 200J.l.g I ml for 
Sf9 cells following 7-21 days incubation at 28°C. Medium was changed at weekly intervals 
until clones of cells were visible by eye. Individual clones were picked using a blue Gilson 
tip and seeded into 24 well plates. Once monolayers were confluent, cells were screened 
for the presence of the heterologous gene using PCR (Section 2.5.5). 
2.2.6 Trypan blue staining 
Cell samples were removed from the stock culture and an equal volume of 0.2% w I v 
trypan blue added. The cells were examined immediately using phase-contrast 
microscopy. Non-viable (stained) and viable (non-stained) cells were counted. 
2.3 Standard Baculovirus Procedures 
2.3.1 Virus infection of insect cells 
Cells were seeded (Section 2.2.3) and incubated at 28°C for 1-2 h to allow cells to adhere. 
Medium was completely removed from the cell monolayer, 100J.l.I of virus inoculum was 
added and incubated at room temperature for 1 h, with gentle agitation. Virus inoculum 
was removed and replaced with'2ml of fresh medium. 
2.3.2 Production of recombinant baculovlruses 
S121 cells were seeded into 35mm tissue culture dishes (Section 2.2.3) and allowed to 
adhere. Co-transfection mixtures were set-up as described in section 2.2.4. Linear viral 
DNA was added to the plasmid DNA I TC100 minus FCS to give a volume of 500J.l.I. Cell 
mOnolayers were co-transfected with 100ng linearised BacPAK6 or BacPAK6.chiA" and 
200ng of the appropriate recombinant baculovirus transfer vector, or200ng virus and 1 J.l.g 
, \. .'
of transfer vector. Following a 48-h incubation at 28°C, co-transfection mixes were 
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removed and subjected to plaque assay (section 2.3.3). Putative recombinant 
baculoviruses were plaque-picked for further analysis (section 2.3.4). 
2.3.3 Titration of viruses by plaque assay 
Virus stock titres were assessed by plaque assay, as described by King and Possee 
(1992). Sf21 cells were seeded at 1.5x106 cells per 35mm tissue culture dish in 2ml of 
TC100 medium supplement with 10% FCS and allowed to adhere. Virus .inoculum was 
initially diluted (1:10) and subsequently used for serial (log) dilutions in TC100 medium 
supplemented with 10% FCS. . Medium was removed from the cells; 100J.l1 of the 
appropriate virus/medium dilution was added to the cells, infections were incubated at 
room temperature for 45 mins, allowing the virus to enter the cells. Virus inoculum was 
removed completely, 2ml of 2% low gelling temperature (LGT) agarose overlay mixed with 
an equal volume of TC100 medium supplemented with 10% FCS was applied to the cell 
monolayer and incubated at room temperature for 15 mins to set. A 1 ml liquid overlay of 
TC100 medium supplemented with 10% FCS was added to each dish. Dishes were 
incubated at 28°C for 3-4 days. 
Plaques were visualized by staining with Neutral Red (0.5% w/v stock solution, Sigma) for 
a minimum of 2 h at 28°C. In the case of viruses expressing the lacZ gene, 12.5J.l1 of 2% 
X-gal (5-bromo-4-chloro-3-indoyi-~-galactoside) was added to the 1ml liquid overlay, 
dishes were incubated at 28°C for a minimum of 4 h. For both staining methods, after the 
incubation period, the dishes were emptied of their liquid content into 1 % Virkon, dishes 
Were then inverted and stored in the dark until the plaques had cleared. To determine the 
Virus titre plaques were counted from the plate with best countable number. The average 
nUmber of plaques counted was multiplied by the dilution factor and by 10 to give plaque-
forming units per ml (pfu / ml). 
Average number of plaques x dilution factor x 10 = pfu / ml 
2.3.4 Amplification of virus stocks 
All viruses used for comparative studies were amplified to high titre working stocks, in 
order to achieve valid date. Virus stocks were amplified from plaque picks. 
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Screening for recombinant virus against background parental virus in a plaque assay was 
based on blue, white selection: blue plaques represent parental virus expressing lacZ, 
white plaques (colourless) for recombinant viruses with insertional inactivation of lacZ. 
From dishes with minimal background, well-isolated white plaques of recombinant virus 
were picked, using a sterile Pasteur pipette. The plaques were dispersed in 500J.l1 of 
TC100 medium supplemented with 10% FCS by vortexing to assist release of the virus 
particles. This virus suspension was used to establish seed stocks (King and Possee, 
1992). Sf21 cells were seeded in disposable 25cm3 T-flasks at a density of 1x106 per 
flask. Medium was removed from the cell monolayer, 250J.l1 of plaque-picked virus 
sUspension was applied to the cells, the cells were incubated for 45 mins at room 
temperature. The inoculum was removed and replenished with 5ml fresh TC100 plus 10% 
FCS and incubated at 28°C for 4-7 days. At four to seven days post infection, the medium 
Was harvested and cells were removed by centrifugation (2700 xg, 4°C, 10 mins, 
Beckman J6B). The medium containing the recombinant virus was stored at 4°C. This 
first inoculum is referred to as the P1 stock. 
From a P1 stock it was possible to increase amplification stocks to a P2 and P3 stock. 
The production of a P2 stock began with a 50ml spinner culture of Sf21 cells seeded at 
0.5x106 cells I ml in TC100 plus 10% FCS. The spinner culture was inoculated at a low 
multiplicity of infection (moi) of 0.1 pfu I cell. The pfu I cell was determined by plaque 
assay (Section 2.3.3). .The infection was incubated at 28°C for five days. At five days 
post-infection, cells were removed by centrifugation (1900 xg, 4°C, 10 mins Beckman 
J6B). The medium containing the virus was stored at 4°C. P3 stocks were carried out as 
described above, however 100-500ml spinner cultures of Sf21 cells were inoculated. 
2.3.5 Production of high titre recombinant baculovirus Inoculum from 
existing stocks 
A shaker culture (50-1000ml) of Sf9 cells at a density of 2x106 cells I ml was infected with 
.0.1 multiplicity of infection (moi).· At three days post infection, cells were pelleted (1900 xg, 
4°C, 15 mins, Beckman J6B) and discarded. The medium containing the virus was stored 
at 4°C and titrated by plaque assay (Section 2.3.3). 
\. 
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2.3.6.1 Recombinant protein production in insect cell lines 
Cells were seeded at a final density of 2x106 1 ml (S19) or 1x106 1 ml (T.ni Hi5) in shake 
flasks, unless otherwise stated. Cells initially seeded in sterile shake flasks were as a 
concentrated volume, virus inoculum was added using a specific moi (2-10 pfu 1 cell). 
Infections were incubated at 28°C for 1 h on a Denley orbital shaker (135 rpm). 
Appropriate medium was added to adjust the cell density to the correct final cell density, 
and re-incubated at 28°C on a Denley orbital shaker (135 rpm). Infections were harvested 
at specified times post-infection. Proteins were visualised on SDS-PAGE and detected 
USing Western blot analysis (Sections 2.7.5/2.7.6). 
2.3.6.2 Recombinant protein production in insect cell lines using fermenters 
Culturing of insect cells (T.ni Hi5 orS19) in fermenter vessels (Applikon~) was carried out 
in a final volume of 1-litre. Cells were seeded initially into sterile Duran bottles with vessel 
connecters at a density of 0.35x106 cells 1 ml. Fermenter vessels were assembled and 
autoclaved empty (121°C, 10min) prior to use with pH and dissolved oxygen concentration 
(d02) probes attached. The vessels were washed with 100ml sterile medium prior to use 
via a heads pace inlet line. The medium was removed through the vessel harvest line and 
discarded. All connections were made in the presence of 70% ethanol spray in order to 
maintain a sterile environment. The 1-litre cell culture (0.35x106 cells 1 ml) was connected 
to the harvest line and pumped into the sterile fermenter. 
The cells were kept in suspension by stirring the culture with impellers (1x marine at the 
bottom of the vessel, 1x rushton at the culture surface) at 120 rpm. A supply of 
compressed air was introduced into the heads pace using a filtered headspace inlet at a 
rate of 500ml 1 min. The same inlet was used to attach an oxygen supply line to provide 
OXygen to the headspace at a rate of 500ml 1 min (when required). A further oxygen 
SUPply was connected to the sparger intake, which delivered oxygen at a rate of 300ml 1 
min. This supply was only activated when the d02 was lower than could be controlled 
from the oxygen in the headspace, which was set to maintain 60%. The temperature 
probe was inserted into the vessel and the exterior heating jacket connected. Using a bio-
Controller (Applikon~ ADI 1030), the temperature was set to regulate cell growth at 27°C. 
Once 27°C was obtained, the interior cooling-finger was connected. 
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Cells were grown to the correct density, Sf9 2x106 cells I ml and T.ni Hi5 1x106 cells I ml. 
Cell viability and total counts were taken (section 2.2.6) to monitor cell growth. At the 
correct cell density, cells were infected with the appropriate recombinant baculovirus at 
the required moL The virus was added aseptically via a sterile syringe and needle through 
a self-sealing septum at the top of the vessel, in the presence of 70% ethanol spray. 
The fermentation was monitored using BioXpert software to measure changes in 
temperature, pH and d02 during the fermentation. These data were recorded on a graph 
throughout the period of fermentation. 
To monitor virus infection, 1.5ml samples of the virus-infected cells were taken every 24 h. 
Viral-proteins were visualised on SDS-PAGE (Section 2.7.5) and recombinant proteins 
detected using western-blot analysis (Section 2.7.6). Harvesting infections were carried 
out using the vessel harvest line and collected into 4x 250ml disposable centrifuge tubes 
(Corning). Samples were centrifuged (1800 xg, 4°C, 30min, Beckman GS-6R) to pellet 
the infected cells. The medium was removed and discarded into 1 % Virkon. Pellets were 
stored at -80°C prior to further analysis. 
2.4 Standard Bacterial Manipulations 
2.4.1 Culturing and storage of E. coli strains and clones 
Bacterial cultures were grown in L-broth (1% bactotryptone, 0.5% yeast extract, 0.5% 
NaCl, 2mM NaOH) or SOC medium (2% tryptone, 0.5% yeast extract, 10mM NaCl, 2.5mM 
KCI, 10mM MgCI2, 10mM MgS04, 20mM glucose) at 37°C on an orbital shaker rotating at 
150 rpm (Certonat® BS-1) unless otherwise stated. The medium was supplemented with 
antibiotics where appropriate. This was to exert selective pressure on untransformed 
bacteria and to ensure only transformed bacteria expressing the appropriate antibiotic 
resistance gene were able to grow. 
L-agar Was prepared by adding 4.8g technical agar number 3 (Oxoid) to 400ml L-broth 
and autoclaved. Antibiotic L-agar plates were prepared by adding the appropriate filter-
steriliSed antibiotic (ampicillin 100J..1g I ml, kanamycin 50J..1g I ml) to cooled L-agar prior to 
Plate pouring. " 
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2.4.2 Preparation of competent bacterial cells 
A variation to the method described in Sambrook at 81. (1989) was employed to prepare 
competent cells for cloning purposes. Starter cultures of OH5a. bacterial cells were 
propagated and then inoculated into 400ml of L-broth at a 1:100 dilution. The cultures 
were incubated on an orbital shaker (150 rpm) at 37°C for 1-2 h until the Aaoo reached an 
optical density (00) of 0.4-0.5. This was determined using a spectrophotometer 
(Shimadzu). At this stage the cells were incubated on ice in the cold room (4°C) for 30 
mins. The cultures were transferred to chilled universal centrifuge bottles and pelleted 
(1900 xg, 4°C, 15 mins, Beckman J6B centrifuge). The cell pellets were washed in 
reducing volumes of calcium chloride (50mM CaCI2 containing 15% glycerol, 4°C). The 
final pellet was resuspended in 2ml of CaCI2 and the bacteria aliquoted (501l1) into pre-
chilled microfuge tubes and stored at -70°C. The competent cells were then tested for 
transformation efficiency with 1 ng of known plasmid. 
2.4.3 . Transformation of competent cells 
Competent cells were transformed with 1-51l1 of ligation reaction or 10ng of circularised 
plasmid. Transformation procedure was based on either, the method described in 
Sambrook at 81. (1989), or provided by the supplier. Microfuge tubes containing 50111 
(DH5a, TOP10) or 100lli (OB3.1) of competent cells were mixed gently with ligation mix or 
circularised plasmid DNA and incubated on ice for 30 mins. The transformation mix was 
then heat-shocked for 45 seconds (OB3.1), or 30 seconds (OH5a., TOP10) at 42°C. 
Transformations were placed on ice and appropriate growth medium was added (OH5a., 
450111 SOC, TOP10, 250111 SOC, OB3.1, 900111 SOC). Transformations were incubated for 
1 h (DH5a, OB3.1) or 30 mins (TOP10) on an orbital shaker (225 rpm, 200 rpm) at 37°C to 
allow expression of the plasmids antibiotic resistance gene for selection purposes. The 
Culture was then spread onto L-agar plates with the appropriate antibiotic and incubated at 
37°C overnight. For long-term storage, the plates were sealed with parafilm and kept at 
4°C. 
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2.5 Standard DNA Manipulation 
2.5.1· Restriction endonuclease digestion 
For analysis of DNA, up to 1J.1.g of DNA was digested using 5-10 unit (U) of enzyme in the 
bUffer recommended by the enzyme manufacturer. Restriction digests were incubated for 
1-3 h at 37°C unless otherwise stated. For preparative digests, the amount of both DNA 
and enzyme were increased as required. Multiple digests were carried out simultaneously 
in universal buffer (multi-core) unless otherwise stated. Confirmation that DNA was 
digested appropriately was achieved by agarose gel electrophoresis (Section 2.7.1). 
2.5.2 Filling recessed 3' termini 
Recessed 3' ends of double-stranded DNA, generated by restriction enzyme digestion, 
Were repaired to produce blunt ended double-stranded DNA fragment, with the use of 
large fragment DNA polymerase I (Klenow). Following digestion with the appropriate 
restriction enzyme, dNTPs (final concentration 0.25mM each) and Klenow fragment (1 unit 
J.l.g DNA) was added. Samples were incubated at room temperature for 10 mins, reactions 
Were terminated either by heating to 75°C for 10 mins or by extraction with equal volumes 
of phenol chloroform (1:1), follo~ed by precipitation of the DNA with two volumes of 
absolute ethanol and 10% 3M sodium acetate. 
2.5.3 Dephosphorylation of linear plasmid DNA 
FOllowing restriction enzyme digestion of plasmid DNA, shrimp alkaline phosphatase 
(SAP) was added directly to the reaction mix (>1 unit J.l.g DNA) and then re-incubated at 
37°C for 30 mins. Enzymes were inactivated by phenol:chloroform extraction and DNA 
Was concentrated by ethanol precipitation. The dephosphorylated plasmid DNA was 
resuspended in TE buffer (1 OmM TrisHCI pH 8.0, 0.1 mM EDTA) or distilled water (20-
50J.l.I). Recovery of DNA was confirmed by agarose gel electrophoresis (Section 2.7.1 ). 
2.5.4 Ligation of DNA with blunt and cohesive ends 
'\ 
ligation of DNA fragments to ~~ctor DNA was performed using a range of insert to vector 
concentrations (vector to insert 1: 1, 1 :2, 1 :3,·1:4 and 1 :5). Reactions were set up to a final 
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volume of 20J-l1, containing 30mM Tris-HCI (pH 7.8), 10mM MgCb, 10mM DTT and 1mM 
ATP (ligation buffer), vector and insert of known concentration, sterile water and 2.5 units 
ofT4 DNA ligase per reaction. Ligations were incubated at 16°C for 16-18 h or 22°C for 3 
h. A vector only control was included. Ligations were transformed as described in Section 
2.4.3. 
2.5.5. Amplification of DNA sequences using the polymerase chain reaction 
(PCR) 
Amplification of DNA sequences using the polymerase chain reaction (PCR) was carried 
out in a Robocycler® gradient 96 thermo-cycler (Stratagene®). Reactions were carried out 
Using template sequences requiring amplification with an initial concentration of 200ng I J-li 
of DNA. Final reaction volumes of 100J-l1 were routinely used containing 1 x reaction buffer 
(50mM KCI, 10mM Tris-HCI, pH 9.0, 0.1 % Triton X-100, 1.5nM MgCI2), primers (200ng I 
J-l1), dNTP's (final concentration 0.2mM) and 1 unit of ProofsprintelM DNA polymerase. A 
standard program was followed for routine amplifications. The PCR program is detailed in 
Table 2.1. 
Table 2.1: Programme for amplification of DNA using PCR 
Temperature block Temperature °C I duration No. of cycles 
mins 
1 95 for 6 1 
1 95 for 1 30-35 
2 n1 for 1 30-35 
3 72 for n2 30-35 
3 72 for 10 1 - 4 6 for storage 0 
1 
n2 Depends on Tm of primers. 
n depends on the size of DNA fragment wished to be amplified. 
2.5.6 Reverse transcription polymerase chain reaction (RT ·PCR) 
. Synthesis of cDNA was achieved using the Omniscript reverse transcriptase (QIAGEN) is 
a recombinant heterodimeric enzyme expressed in E. coli. For the reverse transcription of 
total insect RNA to single stranded DNA, 2J-lg of RNA was mixed on ice with 2J-l1 10J-lM 
Oligo-dT primers (15mers), 2~1 10x buffer RT, 2J-l1 dNTP mix (5mM each dNTP), 1J-l1 
RNase inhibitor (10 units I J-l1), 1J-l1 Omniscript reverse transcriptase (4 units I J-l1), and RNA 
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free water to a final reaction volume of 20).l1. The reaction was incubated at 37°C for 60 
mins. 
For analysis of cDNAs by PCR (Section 2.5.5), Omniscript reverse transcriptase was 
inactivated by incubating the reaction at 93°C for 5 mins followed by rapid cooling on ice. 
To a fresh, 10).l1 of the reverse transcriptase reaction was added, and subjected to PCR 
(final volume 50).l1) for further analysis. 
2.5.7 Column purification of DNA 
2.5.7.1 From PCR reactions 
Amplified DNA was purified from PCR reactions using QIAGEN QIAquick® Mini columns 
and method. Confirmation of a correct PCR product was confirmed by running 1: 1 0 of the 
PCR reaction on an agarose gel (Section 2.7.1). The remaining PCR reaction was mixed 
. . 
with five volumes of PB buffer (supplied by, QIAGEN) and mixed; the solution was applied 
to a QIAquick column and pulled through by centrifugation (11300 xg, 1 min, microfuge). 
The DNA binds to the column while unwanted impurities pass through. The columns were 
Washed with 750).l1 PE buffer (supplied by, QIAGEN). DNA was eluted in 30-50).l1 of sterile 
distilled water. 
2.5.7.2 From agarose gels 
Restriction digested DNA was visualised using agarose gel electrophoresis (Section 
2.7.1). Specific DNA bands were excised from the agarosegel in order to obtain cloning-
quality DNA. The gel extraction method was based on the QIAquick gel extraction 
protocol (QIAGEN). 
TargetDNA bands were excised from the agarose gel using a scalpel and placed into 
1.5ml microfuge tubes with three times the volume of QG buffer, supplied by, QIAGEN (for 
. example, 300).l1 of QG buffer was added to each 100mg of gel I DNA excised) and 
diSsolved. To assist dissolving the gel, the tubes were incubated at 50°C for 10 mins and 
Vortexed every 2 mins. Once the gel had completely dissolved, one volume of 
Isopropanol was added (only if band size was <0.5kb and >5kb) and the mixture was 
apPlied onto a QIAqiuck column and centrifuged (11300 xg, 1 min, microfuge). For DNA 
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Subsequently used for direct sequencing, in vitro transcription or microinjection, the DNA 
was washed additionally with 500/-11 of QG buffer prior to an ethanol based wash with 
750/-11 of PE buffer. The DNA fragments were eluted in 30-50/-11 of distilled water. Purified 
linear DNA was analysed using agarose gel electrophoresis (Section 2.7.1) to determine 
its concentration. 
2.5.8 DNA sequencing 
Sequencing was performed at the DNA sequencing facility, Department of Biochemistry, 
University of Oxford, using ABI Big Dye terminator chemistry. Reactions used the cycle 
sequencing method (Table 2.2) to generate authentic data. A standard set of cycling 
conditions was used and is listed in Table 2.2. 
Table 2.2: Programme used for sequencing of DNA, at the DNA sequencing facility, 
Department of Biochemistry, Oxford. 
-
BigDye 'M terminator cycling conditions 
"- Pre-denaturation 10 seconds jl96°C 
100. Followed by: 
Denaturation 30 seconds @ 98°C 
Annealing 15 seconds @ 50°C 
Extension 4 mins@60°C 
'- Number of cycles 25 cycles 
2.5.9 Purification of plasmid DNA 
2.5.9.1 Small-scale plasmid DNA purification (mini-prep) 
ISOlated colonies of bacteria transformed with the specified plasmid of choice were 
Inoculated into 5ml of L-broth containing the appropriate antibiotic (starter culture). 
CUltUres were incubated at 37°C for 7-18 h with continuous agitation (150 rpm). From the 
transformed bacterial culture 1.5ml was transferred to a microfuge tube and pelleted (1100 
xg, 4°C, 5 mins, microfuge). The medium fraction was discarded into 1 % Virkon, whereas 
the bacterial pellet was resuspended in 100!-1l of glucose-based solution (50mM glucose, 
25rnM Tris-HCI, pH 8.0, 10mM EDTA). Bacterial lysis was achieved with the addition of 
200/-11 of cell lYSis buffer (200mM NaOH, 1 % SDS and 100/-1g I ml ribonuclease A), which 
Was incubated at room temperature for 5 mins. Cell lysis was terminated by the addition 
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of 150/l1 neutralization buffer (5M KAc, 110ml glacial acetic acid, and distilled water, 4°C) 
and incubation on ice for 10 mins. Cell debris was removed by centrifugation (11300 xg, 
20°C, 10 mins, microfuge). The supernatant fraction containing plasmid DNA was 
transferred to a fresh microfuge tube. 
Protein traces were removed by phenol I chloroform extraction (1:1 v I v) and the DNA 
precipitated with two volumes of absolute ethanol and 10% 3M sodium acetate. The 
ethanol precipitate was incubated at -20°C for 1 h. DNA was pelleted (14100 xg, 20°C, 10 
mins microfuge) and washed twice with 75% ethanol, all traces of ethanol were removed 
and the DNA was left to air-dry for 5 mins. The DNA was resuspended in 20/l1 of sterile 
distilled water and subsequently used for restriction digestion for identification of positive 
clones. Initial cultures were stored at 4°C until their further use in the production of large 
qUantities of DNA. 
2.5.9.2 Large-scale plasmid DNA purification (pure-prep) 
Plasmid DNA was extracted from transformed bacteria using a modification of the method 
of Sambrook at al. (1989). A 1-litre flask containing 400ml L-broth and the appropriate 
antibiotic were inoculated with 1-3ml of the specific starter culture transformed with the 
appropriate plasmid. The 400ml culture was propagated for 14-18 h at 37°C with shaking 
(150 rpm). 
The cells were pelleted (2500 xg, 4°C, 10 mins, BeckmanJ-6B centrifuge) and the 
medium fraction discarded into 1% Virkon, the pellet was resuspended in 7.5ml of sucrose 
bUffer (50mM Tris-HCI, pH 8.0, 25% sucrose). The cell suspension was transferred to two 
chilled Beckman centrifuge tubes before adding 1.5ml lysozyme (1 Omg I ml made up fresh 
in SUcrose buffer) and incubated on ice for 10 mins. RNase A (125/l1; 10mg I ml) and 3ml 
Tris I EDT A solution (250mM Tris-HCI, pH B.O, 250mM EDTA) was added and re-
inCUbated on ice for 5 mins. Triton lysis buffer (12.5ml; 2% v/v Triton X-100, 50mM Tris-
HCI, pH B.O, 10mM EDTA) was added, samples were mixed gently and re-incubated on 
ice for 10 mins. 
CellUlar debris was pelleted (26000 xg, 4°C, 1 h, Beckman Ti-70 rotor, Beckman ultra-
Centrifuge). The supernatant fraction containing plasmid DNA was transferred to a fresh 
SOml polypropylene tube and SDS was added to 1 % (w I v). Protein traces were removed 
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by phenol! chloroform extraction (1:1 v ! v). Equal volumes of phenol! chloroform were 
added to the supernatant (5ml of each), the solution was mixed vigorously by vortexing 
then incubated at room temperature for 10 mins. To separate the aqueous phases the 
solutions were centrifuged (1900 xg, 4°C, 20 mins, Beckman J-6B centrifuge). The top 
clear aqueous phase of the solution was carefully transferred to a fresh polypropylene 
tube. Two volumes of absolute ethanol and 10% 3M sodium acetate were added and 
incubated at -20°C for 1 h, to precipitate the DNA. The DNA was pelleted (1800 xg, 4°C, 
30 mins, Denley BS400 centrifuge), washed in 75% ethanol and re-pelleted.· The ethanol 
Was removed and the pellet was briefly air-dried. 
The pellet was resuspended in 7.5ml TE buffer to which 8g cesium chloride (CsCI) and 
75/-1.1 ethidium bromide (10mg! ml) was added. The solution was loaded into a Beckman 
quick-seal polyallomer tube, filled with liquid paraffin and heat-sealed. Tubes were 
Centrifuged (133042 xg, 20°C, 16-20 h, Beckman Ti-70 rotor, Beckman ultra-centrifuge). 
The plasmid DNA was harvested and ethidium bromide removed by repeated extractions 
with an equal volume of butanol. The DNA! CsCI solution was diluted 1:3 by the addition 
of two volumes of TE and sodium acetate to 300mM, the DNA was ethanol precipitated. 
DNA was pelleted (1800 xg, 4°C, 30 mins, Denley BS400 centrifuge), washed in 75% 
ethanol and re-pelleted. The DNA was resuspended in 1ml TE buffer and SDS to 1%, 
followed by phenol ! chloroform extraction. The DNA was re-precipitated, pelleted (600 
xg, 4°C, 5 mins, microfuge) and washed twice in 75% ethanol. The plasmid DNA pellet 
Was air-dried and resuspended in 500/-1.1 TE and stored at -20°C. The concentration and 
purity of the plasmid was determined using a spectrophotometer (Shimadzu) at 260 ! 
280nm. 
2.5.10 Extraction of DNA from virus-infected cells 
The method described by King and Possee (1992) was employed to extract DNA from 
VirUS-infected cells. Cells were seeded at the required density as described in Section 
2.2.3, the medium was removed and discarded into 1 % Virkon. Cells were infected using 
a moi of 10 pfu ! cell, and incubated at room temperature for 1 h. The inoculum was 
removed and discarded into 1 % Virkon, and 1.5 ml appropriate medium was carefully 
added to the cell monolayer.' Cells were incubated for 18-26 h at 28°C. Cells were 
harvested with a Pasteur pipette and transfer to a 1.5ml microfuge tube, and pelleted (600 
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xg, 10 mins, microfuge). The medium was discarded into 1% Virkon. Pellets were 
washed once with PBS and resuspended in 250J.l1 TE, 250J.l1 of cell lysis buffer (50mM 
Tris-HCI, pH 8.0,5% 2- mercaptoethanol, 0.4% w I v SDS, 10mM EDTA) was added and 
gently mixed. Proteinase K (12.5J.l1; 10mg I ml made up fresh in TE and pre-incubated at 
37°C for 30 mins prior to use) and 2.5J.l1 RNase A (10mg I ml) was added to the sample, 
and incubated at 37°C for 30 mins. 
The cellular lysate was extracted with an equal volume of phenol I chloroform as 
described in Section 2.5.9.1 (violent shaking was avoided as this shears the high 
molecular-weight virus DNA), a second extraction with phenol I chloroform was repeated. 
The top aqueous phase was transferred to a fresh microfuge tube, and 50J.l1 3M sodium 
acetate and two volumes of absolute ethanol were added to precipitate the DNA. The 
DNA was pelleted (14100 xg, 4°C, 10 mins, microfuge) and washed twice with 75% 
ethanol. All traces of ethanol were removed with a drawn-out Pastuer pipette. The pellet 
Was air-dried and resuspended in 100J.l1 TE by socking overnight at 4°C, then incubating at 
37°C for 10 mins, and finally gently resuspended the pellet with a Gilson tip. The DNA 
Was stored at -20°C. 
2.5.11 Extraction of total RNA from insect cells 
Total cytoplasmic RNA was isolated from 1.5x106 Sf9 or T.ni Hi5 cells. RNA extraction 
Was carried out using the Rneasy kit from Qiagen. The kit encompassed the selective 
PUrification of cytoplasmic RNA, which comprises approximately 85% of the total cellular 
RNA content. 
Cells grown in 25cm3 T -flasks were harvested and transferred to 15ml centrifuge tubes. 
The cells were pelleted (200 xg, 10min, Denley BS400 centrifuge), medium was removed 
and discarded into 1 % Virkon. Cell pellets were resuspended into 17SJ.l1 of cold RLN 
bUffer (SOmM Tris-HCI, pH 8.0, 140mM NaCI, 1.SmM MgCb, 0.5% (v I v) Nonidet P-40) 
and incubated on ice for 5 mins to allow complete cell lysis to occur. Cell debris was 
pelleted (11300 xg, 4°C, 10 mins, microfuge) and the supernatant transferred to a fresh 
1.5011 microfuge tube. RNase traces were removed by addition of 600J.l1 of RL T buffer 
(SUPPlied by, QIAGEN) to the cytoplasmic extract, which contained guanidine . \ 
Isothiocyanate supplemented with 10J.l11 ml p-mercaptoethanol. To the homogenate 430J.l1 
of ethanol (100%) was added to create the appropriate conditions for selective binding of 
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RNA onto the silica-gel based membrane of the RNeasy columns. The RNA-containing 
mix was transferred onto the column and RNA bound to the membrane by centrifugation 
(6700 xg, 4°C, 15 sec, microfuge). The flow-through was discarded before 700~1 of RW1 
bUffer (supplied by, OIAGEN) was added to the column. The column was washed by 
centrifugation (6700 xg, 4°C, 15 sec, microfuge), before two final washes with 500~1 RPE 
buffer (supplied by, OIAGEN). The bound RNA was eluted in DEPC-treated water (0.01 % 
of DECP). The recovered RNA was visualised on a formalin-based gel (Section 2.7.2) 
and quantified using a spectrophotometer (Shimadzu) at 260/280nm. Purified RNA was 
stored at -70°C. 
2.5.12 Directional TOPO® cloning 
Directional TOPO~ cloning was performed using two sub-cloning steps. In this system, 
PCR products were directionally cloned into a TOPO~ entry vector by adding four bases to 
the beginning of the forward primer (CACC). DNA of interest was amplified by PCR 
(Section 2.5.5). PCR products were visualised on an agarose gel (Section 2.7.1), and 
Purified (Section 2.5.7.1). Purified PCR product (10-100ng) was added to a standard 
cloning reaction as described in Table 2.3 to generate a TOPO~ entry clone. 
Table 2.3: Standard cloning reaction set up to generate a TOPO~ entry clone. -..... Reagent Volumes added to 1.5ml mlcrofuge tube (Il'> 
Fresh PCR product 0.5 to 4 
~alt solution 1 
..§terile water Add to a final volume of 5 
J'OPO~ entry vector 1 
The cloning reaction was mixed gently and incubated for 5 mins at room temperature (22-
23°C). From the TOPO~ cloning reaction 2~1 was transformed using TOP10 chemically 
competent E. coli (Section 2.4.3). Mini-preps were performed to identify positive clones 
(Section 2.5.9.1). Once positive clones were identified, a pure-prep was performed 
(Section 2.5.9.2). 
Once the TOPO~ entry clone had been constructed, it was then possible to generate an 
eXpression construct by performing a recombination reaction between the entry clone and 
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a linear Gatewal' destination vector of choice (pXINsect-OEST38, pXINsect-OEST39). 
The protocol for producing LR Clonase"" reactions is provided in Table 2.4. 
Table 2.4: Standard LR Clonase'hl reaction to generate a TOPO® expression construct. 
Components Negative control Sample 
LR reaction buffer (5x) 4/-l1 4/-l1 
Entry clone (100-300ng I reaction) -- 1-11lJ:1 
Destination vector (100-300ng I reaction) 1-11/-l1 ,'1-11lJ:1 
TE buffer To 16/-l1 To 16/-l1 
LR Clonase™ Enzyme mix 4/-l1 4/-l1 
The LR Clonase 1M reactions were incubated at 25°C for 60 mins. Proteinase K solution 
(2/-l1; 2mg I ml) was added to the LR Clonase'hl reaction and incubated at 37°C for 10 mins, 
this terminated the LR Clonase
1M 
reaction. From the LR Clonase'hl reaction 1/-l1 was 
transformed using OH5a. chemically competent E. coli (Section 2.4.3). Mini-preps were 
performed to identify positive clones (Section 2.5.9.1). Once positive clones were 
identified, a pure-prep was performed (Section 2.5.9.2). 
2.6 ,Protein Purification 
2.6.1 Purification of 6x-Histidine-tagged recombinant proteins 
Cell pellets containing recombinant protein were retrieved from the -80°C freezer (Section 
2.3.6.1 I 2.3.6.2) and thawed on ice for 30min. Pellets were resuspended in 10ml cell lysis 
bUffer per gram of cell pellet (50mM Tris-HCI, pH8.0, 10% v I v glycerol, 150mM sodium 
chloride, protease inhibitor cocktail EOTA-free tables, Sigma (one tablet per 50ml), O. 1% v 
I v Triton X-100). A 50/-l1 sample of the lysate was taken for SOS-PAGE analysis (Section 
2.7.5). The lysate was passed through a cell disrupter (20 kpsi, 13°C, Constant systems 
ltd, Cell disruption equipment B series) collected in a clean beaker and placed on ice. 
The lysate was centrifuged to pellet cellular debris (36514 xg, 4°C, 45min, SW-34 rotor, Pu 
Pont instruments, Sorvall® RC-5B). The supernatant fraction containing soluble histidine-
. tagged (His) recombinant protein was transferred to a sterile Duran bottle and placed on 
Ice. The pellet was resuspended in 10ml PBS. Samples (50/-l1) of the supernatant and 
Pellet were taken for SOS-PAQE analysis (Section 2.7.5). The pellet was decontaminated 
by autoclaving (1210C, 10min) ~nd discarded into 1% Virkon. 
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A HiTrap chelating sepharose™ high performance 5ml (Amersham Biosciences) protein 
purification column was used to bind 6xHis-tagged recombinant proteins. The column was 
charged with metal ions prior to use. First the column was washed with 15ml de-ionised 
water using a syringe, followed by charging with 7ml 0.1 mM nickel sulphate. A second 
15ml wash with de-ionised water was carried out to remove unbound nickel. The charged 
column was connected to a AKTA explorer chromatography system (Amersham 
Biosciences). The AKTA explorer pumps were washed with 10ml binding buffer pH 8.0 
(50mM Tris-HCI, pH 8.0, 10% v I v glycerol, 150mM sodium chloride, 5mM' p-
mercaptoethanol, 20mM imidazole) and 10ml elution buffer pH 8.0 (50mM Tris-HCI, pH 
8.0, 10% v I v glycerol, 150mM sodium chloride, 5mM p-mercaptoethanol, 500mM 
imidazole) at a rate of 5mll min, before the sample was injected onto the HiTrap chelating 
sepharose™ 5ml column. The sample was injected into a super-loop (Amersham 
Biosciences) using a syringe, and connected to the injection-valve of the AKTA explorer. 
Binding buffer from the AKTA pumps was injected into the super-loop, causing the sample 
to be injected into AKT A explorer. The sample was then passed through the column, 
binding proteins that contained histidine repeats. The column was first equilibrated with 
one column volume (CV) of binding buffer. The sample was then injected into the column 
at a rate of 2mll min. The flow through was collected in 10ml fractions using a Frac-900 
(Amersham Biosciences). The column was then washed with ten CV of binding buffer, 
followed by 5 CV of 92% binding buffer and 8% elution buffer. This was to remove weakly 
bound his-containing proteins and' non-specific binding. 
Samples (50J.l1) of each step were taken for SOS-PAGE analysis (Section 2.7.5). The 
process was paused to attach a Hi-PrepTM G-25 fine desalting-column (Amersham 
Biosciences) to the bottom of the HiTrap chelating sepharose™ column. It was important 
at this step to remove any imidazole present in the eluted sample. This was achieved by 
passing the eluted sample through the desalt column. The desalt-column was washed 
prior to Use with desalt buffer pH 8.0 (50mM Tris-Hel, pH 8.0, 10% v I v glycerol, 50mM 
Sodium chloride) at a rate of 5mll min for 20mins. 
,Protein bound to the HiTrap chelating sepharose™ column was eluted with 20 CV of 100% 
elution buffer. The eluted protein sample was desalted and collected in 2ml fractions 
USing a Frac-900. A computer connected to the AKTA explorer chromatography system 
monitored the specific time of protein elution from the column. This identified, which 2ml 
fractions of elution buffer contained eluted protein. The fractions were pooled and 
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analysed using SDS-PAGE 1 western blot analysis (Sections 2.7.5/2.7.6). The remaining 
sample was stored at -20°C in 2ml aliquots prior to further analysis. 
2.7 Electrophoretic techniques 
2.7.1 Agarose gel electrophoresis for DNA 
Horizontal agarose gels were used routinely for DNA analysis, using apparatus supplied 
by Stratagene$. Concentrations of agarose (Invitrogen"', LifeTechnologies, Gibco BRl, 
USA.) between 0.7-2.0% were used, depending on the size of DNA to be analysed. 
SUbmerged gel electrophoresis was performed in 1x TAE buffer (2M Trizma base, 50mM 
EDTA, pH 8.0 using glacial acetic acid, make up to 1 litre with sterile water, makes 50x). 
Samples were mixed with 5x DNA loading dye (0.25% bromophenol blue, 0.25% xylene 
Cyanol FF, 30% glycerol in water) prior to electrophoresis. Gels were resolved at 100 
Volts for 1 h or 20 volts overnight. DNA was visualised by the addition of ethidium bromide 
(5~1 of10mg 1 ml) to the gel prior to casting. Stained gels were placed on a Chromato-vue 
UV tranSilluminator (UVP, Inc, USA) and photographed using a UVP video camera. 
2.7.2 Agarose gel electrophoresis for RNA 
AnalYSis of RNA was carried out in 1.2% formaldehyde-agarose (FA) gels. The gels 
ConSisted of 1.2g of agarose (Sigma-Aldrich, UK), 10xFA gel buffer (200mM 3-[N-
morpholino]propanesulfonic acid (MOPS), 50mM sodium acetate and 10mM EDTA), and 
Were adjusted to 100ml with RNAse-free water. After dissolving the agarose and cooling 
to 65°C, 1.8ml of 37°C (12.3M) formaldehyde and 1~1 ethidium bromide from a 10mg 1 ml 
stOck were added. Prior to electrophoresis, the gels were submerged in 1xFA buffer for 
30mins. Gels were resolved at 100 volts for 1 h or 20 volts overnight. RNA was 
Visualised using a Chromato-vue UV transilluminator (UVP, Inc, USA) and photographed 
USing a UVP video camera. 
2.7.3 Extraction of protein from insect cells for analysis by SOS· 
Polyacrylamide Gel Electrophoresis (SOS-PAGE) 
Cells were harvested from 35mm tissue culture dishes by removing the medium and 
adding 500~1 cell lysis buffer (10% 1M Tris-HCI, pH 8.0, 0.1% Triton$ X-100, 89.9% sterile 
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water), cells were resuspended into the cell lysis buffer and transferred to a 1.5ml 
eppendorf tube and vortexed. Cell nucleus and membranes were pelleted (11300 xg, 
2mins, microfuge). The supernatant fraction containing the intracellular proteins was 
transferred to fresh 2ml microfuge tubes. The cell pellet was resuspended in 1 OO~I cell 
lysis buffer. Samples at this stage were either stored at -70°C or 4x SOS-PAGE sample 
buffer (50% 0.5M Tris-HCI, pH 6.8, 40% glycerol, 8% p-mercaptoethanol, O.04g 
Bromophenol Blue, 0.8g SOS) was added, 125~1 to the supernatant fraction, and 25~1 to 
the pellet fraction. All samples were incubated at 100°C in a boiling incubator for 5 mins 
prior to electrophoresis. 
2.7.4 Protein estimation using the Bio-Rad protein assay 
The protein content of all samples was determined using the Bio-Rad protein assay (Bio-
Rad). This method of protein quantification is based on the observation that the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 
465 nm to 595 nm, when binding to protein occurs (Bradford, 1976). Protein estimation 
Was carried out according to the manufactures instructions. Samples optical density (00) 
was read (595nm) using a biowave S2100 Diode Array spectrophotometer (y'JAP Ltd). 
2.7.5 SOS-PAGE 
Glass plates were assembled according to manufacturers instructions (Invitrogen"', 
LifeTechnologies, Gibco BRL, USA.). Acrylamide gels at a concentration of 12% w I v 
Were de-gassed and cast (32.6% sterile water, 40% protoGel [30% acrylamide, 0.8% Bis-
acrylamide] 25.3% Tris-HCI, pH 8.8, 1% SOS, 1% Ammonium sulfate at 100mg I ml, 
0.04% TEMEO; all v I v) unless otherwise stated. Water-equilibrated butanol was layered 
onto the gel, which was then allowed to set. Once set, the butanol was removed and the 
exposed gel and glass washed three times with sterile water, and all traces of water were 
removed. A stacker gel was cast on top of the resolving gel (70% sterile water, 16.6% 
protoGel [30% acrylamide, 0.8% Bis-acrylamide), 12.5% Tris-Hel, pH 6.8, 1% SOS, 1% 
Ammonium sulfate at 100mg I nil, 0.1% TEMEO; all v I v). Previously denatured (Section 
2.7.3) samples were loaded into preformed sample wells in the stacker gel. Samples 
Were resolved at 150 volts for 2 h. Gels were either stained with Coomassie brilliant blue 
(0.25g Coomassie brilliant blue, 45ml methanol, 45ml sterile water, 10ml glacial acetic 
acid) and destained by washing with destain (45% methanol, 45% sterile water, 10% 
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glacial acetic acid) as detailed in Sambrook at al. (1989), or stained with antibody via the 
procedure of Western blotting (Section 2.7.6). 
2.7.6 Analysis of proteins by Western blot 
Immunological detection of proteins on nitrocellulose membrane was employed as a 
means to visualise the presence of specific polypeptides / proteins. Following SOS-
PAGE, proteins were transferred onto nitrocellulose membranes using a wet-blot 
apparatus (King and Possee, 1992). The nitrocellulose membrane was washed in 
blocking solution (10% w / v non-fat milk, 0.1% v / v Tween 20 in PBS) for 1 h at room 
temperature. Primary antibody specific to the recombinant protein was diluted (1/500-1 / 
10000) in blocking solution and applied to the membrane for 1 h at room temperature. 
The excess antibody was removed and the membrane washed five times for 5 mins at 
room temperature in PBST buffer (0.1% v / v Tween 20 in PBS). Secondary anti-antibody 
(alkaline phosphatase-conjugated antibody) was applied to the membrane and incubated 
for 1 h at room temperature. The excess secondary anti-antibody was removed and the 
membrane washed five times for 5 mins at room temperature in PBST buffer. The 
membrane was developed in an alkaline phosphatase development buffer (20m Is alkaline 
Phosphatase buffer, 100mM Tris-HCI, pH 9.5, 5mM MgCI2, 100mM NaCI,132J.d nitro blue 
tetrazolium chloride, Sigma, 66J..l1 5-bromo-4-chloro-3-indolyl phosphate, Sigma) to detect 
proteins. The membrane was· rinsed in sterile water to terminate the development 
reaction. 
2.8 Enzyme assays 
2.8.1 Chloramphenicol acetyltransferase assay 
A Variation of the method described by Gorman at al. (1982) was employed to assay for 
chloramphenicol acetyltransferase (CAT) production. Cell samples were harvested by 
resuspending the cells into the medium, and transferred to 2ml microfuge tubes. Cells 
Were pelleted (1700 xg, 4°C, 10 mins, microfuge) and washed twice in PBS and re-
pelleted. Cell pellets were resuspended in 100J..l1 250nM Tris-HCI, pH 7.8. Cells were 
lYsed by three freeze-thaw cycles in a dry ice ethanol bath followed by incubation at 37°C 
Until thawed. Samples were subjected to sonication (3 mins) to complete cell lysis. Cell 
debris was pelleted (1700 xg, 4°C, 5 mins, microfuge) and 80J..l1 of the supernatant was 
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transferred to a fresh 1.5ml microfuge tube containing 20J..11 sterile water. To each sample 
5J..11 of 1-Deoxy[dichloroacetyl-1-14Cj chloramphenicol (0.004625Mbqi) was added and 
incubated at 37°C for 10 mins. Acetyl coenzyme A (10J..11; 4mM) was added to each 
reaction and incubated at 37°C for 1 h. Samples were briefly centrifuged, 1-
Deoxy[dichloroacetyl-1-14Cj chloramphenicol was extracted using 1ml of ethyl acetate. 
Reactions were vortexed for 30 seconds and centrifuged (14100 xg, 3 mins, microfuge) to 
separate the aqueous phases. The upper aqueous phase was transferred to a fresh 
1.5ml microfuge tube and dried under heat-vacuum centrifugation for 1 h.' Dry samples 
were resuspended in 20J..11 ethyl acetate (vortex 30 seconds / sample). Reactions were 
dotted onto an aluminum backed silica gel thin layer chromatography (TLC) plate 
(Whatman) in 2J..11 aliquots, allowing spots to dry between applications until all the reaction 
mix was absorbed. 
The TLC plate was then subjected to ascending chromatography in a tank pre-equilibrated 
with a 95:5 mixture of chloroform and methanol (final volume 300ml). Plates were air-
dried and exposed to a blanked storage-phosphor screen for 1 h. The storage-phosphor 
Screen was scanned using a Typhoon 8600 variable mode imager (Molecular dynamics 
subdivision of Amersham Pharmacia Biotech) and results quantified by calculating the 
percentage conversion of 1-Deoxy[ dichloroacetyl-1-14C] chloramphenicol to acetylated 
chloramphenicol using the software program Image-Quant 5.1. 
2.8.2 Dihydroorotate dehydrogenase (DHODH) assay 
A Variation of the method described by LOffie at at., (1997) was used to assay 
dihYdroorotate dehydrogenase (DHODH) functional activity. DHODH produced using the 
baculovirus expression system in insect cells (Sections 2.3.6.1 / 2.3.6.2) was purified 
(Section 2.6.1), and total protein of each purified sample quantified (Section 2.7.4). 
To a fresh 1.5ml microfuge tube on ice, 36J..11 2,6 dichlorophenylindolphenol (1mM 2,6 
dichlorophenylindolphenol [DCIP] / 0.1 mM Tris-HCI, pH 8.0), 50J..11 Co-enzyme Q6 (5mM 
Co-enzyme Q6/ 0.1mM Tris-HCI, pH 8.0), 20J..11 L-dihydroorotate (1mM L-dihydroorotate / 
0.1 mM Tris-HCI, pH 8.0) was added. The volume of Tris-HCI (0.1 mM Tri-HCI, pH 8.0) 
varied according to the sample volume that was added. The final volume totalled 1 ml. 
'\ 
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Samples were immediately read using a Cary 300 scan UV visible spectrophotometer at 
595nm over a period of 2mins. The specific activity of DHODH was calculated using the 
fOllowing equations. 
M I min = mM conversion of DCIP I min 
E 
Where IlA = slope of absorbance over linear range (1min). 
E = millimolar extinction coefficient of DCIP (21 mM-1'cm-1 at 595nm). 
To convert mM conversion of DCIP I min to nmoles conversion of DCIP I min the following 
equation was used: 
M x V = nmoles conversion of DCIP I min 
Where M = molarity and V = volume (litre) 
To convert nmoles conversion of DCIP I min to J-lmoles conversion of DCIP I min I mg of 
total protein the following equation was used: 
.Q.moles conversion of DCIP I min = J-lmoles conversion of DCIP I min I mg 
mg of total protein 
2.9 Fluorimetric assays 
2.9.1 OsRed fluorescent assay 
One ml cell samples were harvested into 1.5ml microfuge tubes and pelleted (600 xg, 10 
Olins, microfuge). The growth medium was removed and transferred to fresh 1.5ml 
Olicrofuge tubes. The cell pellets and growth medium was assayed immediately or stored 
at -80°C pending further analysis. 
Cell pellets were washed in 1ml PBS and re-pelleted (600 xg, 10 mins, microfuge). PBS 
Was removed and discarded into 1 % Virkon. Cell pellets were resuspended into 100J-l1 cell 
lYsis bUffer (10% 1M Tris-HCI, pH 8.0, 0.1% Triton$ X-100, 89.9% sterile water). The 
samples were centrifuged (14100 xg, 5 mins, microfuge) to pellet cellular debris. The 
intracellular supernatant fractions (100J-l1) were transferred to individual wells of a black 
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96-well, flat bottom microplate and the OD read using a LAMBDA FLUORO-320 
microplate fluorescent reader (MWG-Biotech) at 530 I 590nm. The growth medium 
(100J..l1) was assayed as described above. 
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CHAPTER 3: ANALYSIS OF TRANSIENT PROMOTER 
ACTIVITY IN INSECT CELLS 
'\ 
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3.1 Introduction 
The ability to produce high-levels of authentic recombinant proteins relies on the 
successful interaction between an expression system and the host in which it functions. 
Insect cells have been used as successful hosts for the production of recombinant 
proteins, since they are generally able to perform the post-translational modifications often 
necessary for proteins to be functionally active (O'Reilly and Miller, 1989; King and 
Possee, 1992; Altmann et al., 1999). One of the first insect expression systems to be 
exploited for the production of high-level recombinant proteins was the baculovirus 
expression system, in which a foreign gene is placed under the control of the promoter for 
the non-essential viral polyhedrin (polh) gene, (Smith et al., 1983a,b; Pennock et al., 
1984). The most significant advantage of this expression system is the strength of the 
polh promoter, compared to others used in eukaryotic expression vectors. Although yields 
of recombinant protein produced are generally high, the disadvantage is expression can 
only be sustained for up to 96 hpi due to the lytic nature of the virus infection. Also, the 
level of expression is not entirely reproducible and depends on the degree of infection of 
the cells (Broeck et al., 1995). 
One way to overcome the limitations of the baculovirus expression system would be to 
develop a baculovirus vector with only those viral genes required to initiate optimal 
transcription from the p10 or polh promoters. Unfortunately, the size and complexity of the 
baculovirus genome makes this approach difficult. 
A Simpler strategy has been adopted, which takes advantage of the same principles used 
to develop mammalian plasmid-based expression systems (Wigler et al., 1980; Southern 
and Berg, 1982; Bebbington et al., 1992). Foreign gene products are expressed under the 
Control of a viral or cellular promoter, which is transcriptionally controlled by an a-amanitin-
sensitive RNA polymerase (Fuchs at al., 1983; Glocker at al., 1992). The characterisation 
of ie-1, an immediate early gene of the baculovirus AcMNPV, was found to contain such a 
promoter (Guarino and Summers, 1986; 1987). Since the AcMNPV ie-1 promoter requires 
only host cell RNA polymerase II to be transcribed, it was initially used for the 
development of a plasmid-based expression system, which has been shown to work in 
insect cells (Jarvis and Summers, 1989; Jarvis et al., 1990). 
'\ 
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Insect cells are transformed by co-transfecting a mixture of two plasmids, one containing a 
dominant selectable marker e.g. neomycin-resistant gene, the second a foreign gene, both 
under the control of the AcMNPV ie-1 promoter. Transformed cells were found to be 
stable, expressed foreign genes continuously, and were able to process complex 
glycoproteins, such as tissue plasminogen activator (Jarvis et al., 1990). 
A plethora of recombinant cell lines have been produced using this method (Johansen et 
al., 1989a,b; Joyce et al., 1993; Broeck et al., 1995; Henderson et a/., 1995; McCarroll and 
King, 1997; Hegedus et al., 1998). The main advantage of the plasmid-based system over 
the baculovirus system is its non-lytic nature; therefore, expression of a foreign gene is 
continuous, allowing long-term expression without the detrimental effects of virus infection. 
However the disadvantage of this system is the weak transcriptional activity of the 
AcMNPV ie-1 promoter; expression levels are very low and do not compare favourably to 
other expression systems (Guarino and Summers, 1988; Jarvis et al., 1990; Joyce et a/., 
1993). 
Levels of protein production equal to those observed using the baculovirus expression 
system have been reported using the BmNPV ie-1 promoter in Drosophila cells (Broeck et 
a/., 1995). It was also reported that over-expression of the secreted glycoprotein, juvenile 
hormone esterase, yielded 47 -fold more active protein in stable Bm5 cells, under the 
Control of the BmA3 gene promoter I enhancers, compared to levels achieved using the 
P10 promoter of AcMNPV in infected Sf21 cells (Farrell et al., 1998). 
TechnOlogical advances in stable insect expression systems, has been inherently slow 
Over the last 10 years, and only a few new systems have been developed. The discovery 
of new promoters for mammalian based expression over the last decade has led to the 
development of numerous plasmid-based expression systems, offering control of 
expression and enhanced transcriptional activity. The common factor between current 
Plasmid-based expression systems is the large percentage of promoters that constitutively 
express foreign genes. A range of inducible promoters are available for use in mammalian 
cell lines, whilst the choice of inducible promoter for use in insect cells is very limited. The 
only inducible insect expression system available commercially, is the inducible Drosophila 
system (InvitrogenTM). 
.\ 
.Inducible expression offers the choice to produce cytotoxic proteins, which can be 
detrimental to the cells viability if expressed under the control of a constitutive promoter. 
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The Drosophila melanogaster (Dm) metallothionein (MD promoter (Maroni et al., 1986; 
Otto et al., 1987; Bunch et al., 1988) has been characterised as an inducible promoter. 
The Dm MT gene promoter has been used to express foreign genes upon induction with 
COpper sulphate (Otto et al., 1987; Hu and Davidson, 1990) and is currently employed in 
the inducible Drosophila system. 
In order to further the use of plasmid-based expression systems, it was necessary to 
attempt to identify promoters that significantly improved foreign gene expression above the 
eXisting AcMNPV ie-1 promoter in Sf9 and T.ni Hi5 cell lines. The identification of such 
promoters would subsequently lead to the attempt to generate a novel inducible plasmid-
based expression system for use in Sf9 and T.ni Hi5 cell lines. 
The gene promoter used in this system need not be of baculovirus in origin providing 
transcription can be initiated by insect cell transcription factors. Eukaryotic gene 
promoters and viral immediate early promoters, identified as having been shown to induce 
high levels of expression in other cell lines, were tested to see if they were functional in 
Sf9 and T.ni Hi5 cell lines. These included the human cytomegalovirus immediate early 
(CMVie; Chan et al., 1996), Bm A3 and enhancers BmNPV ie-1 and hr3, (Mounier and 
PrUdhomme, 1986; Johnson et al., 1992; Lu et al., 1996, 1997), Orgyia pseudotsugata 
MNPV ie-2 (Theilmann and Stewart, 1992; Pfeifer et al., 1997; Hegedus et al., 1998), Dm 
MT (Maroni et al., 1986; Otto et al., 1987; Bunch et al., 1988), and the Dm actin 5.1 gene 
promoter (Bond and Davidson, 1986; Vigoreaux and Tobin, 1987; Bond-Matthews and 
Davidson, 1988). 
This Chapter first describes attempts to identify transcriptional activity of the CMVie 
promoter in Sf9 and T.ni Hi5 cell lines. Expression of the green fluorescent protein and 
enhanced green fluorescent protein (GFP I EGFP) were used because of their ease of 
detection. Secondly, attempts to identify increased levels of expression in Sf9 and T.ni 
Hi5 cell lines, by comparing transient expression of CAT from a number of baculovirus and 
eukaryotic gene promoters would be investigated. The cat gene was selected for use as a 
reporter gene because of the ease of detection of the gene product and the ability to 
. accurately quantify the levels of expression. The identification of transcriptionally strong 
promoters active in insect cells would enable further progress for the development of a 
nOvel stable inducible expressi,on system for use in insect cells, as described in Chapter 4. 
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3.2 Functional analysis of the human cytomegalovirus immediate early 
(CMVie) gene promoter in insect cells. 
3.2.1 Human CMVie gene promoter 
The human CMVie promoter was chosen because it has been characterised as a very 
strong promoter in mammalian cell lines (Furth et al., 1991; Furth et al., 1994) and is 
transcriptionally active early after infection in vivo I in vitro suggesting that iUs dependent 
on eukaryotic host cell transcription factors. In this respect it is similar to the AcMNPV ie-1 
promoter. A plasmid (pEGFP.N1) containing the CMVie promoter, with the egfp gene in-
frame was obtained (SO Siosciences, Clontech) for the purpose of this work. This 
construct was used in transient experiments to determine the functional activity of the 
CMVie promoter in insect cells. The detection of EGFP from CMVie was used to analyse 
promoter function. A genetic map of pEGFP.N1 is shown in Figure 3.1 
,----~) y 
Kad gene 
SV40 early 
poly-A 
r'l 
~~\.. 
~--~y -,,- ~--~v~--~ 
CMVie MCS egfp gene Not I I Xba I 
promoter coding region 
Figure 3.1: Genetic map of pEGFP.N1 (SO Siosciences, Clontech), shows the CMVie 
promoter, a multiple cloning site (MCS), egfp gene-coding region, SV40 early poly-
~enylation (poly-A), and kanamycin (Kan') resistance gene. 
3.2.2 OpMNPV ie-1 gene promoter 
Plasmid pIZTN5-His (InvitrogenTM) contains the Orgyia pseudotsugata multicapsid nuclear 
Polyhedrosis virus (OpMNPV) immediate early (OpMNPV ie-1 I ie-2) promoters. 
Downstream of the OpMNPV ie-1 promoter is the coding region of a fused GFP-Zeocin 
resistance gene. The OpMNPV ie-1 promoter has been characterised previously 
(Theil mann and Stewart, 1991; Pfeifer et al., 1997). This construct was used as a positive 
Control in transient experiments to determine functionally active promoters in insect cell 
lines. pIZTN5-His provided basal levels of GFP production. A genetic map of pIZTN5-
His is shown in Figure 3.2. 
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Figure 3.2: Genetic map of pIZTN5-His (InvitrogenTM), shows the pUC origin of replication 
(pUC ori) and two expression cassettes, the first contains the coding region of the gfp-
zeocin chimeric gene in-frame with the OpMNPV ie-1 and EM? promoter and SV40 early 
polY-A coding region; the second, OpMNPV ie-2 promoter with a downstream MCS, and 
QpMNPV ie-2 poly-A coding region. 
3.2.3 Analysis of CMVie promoter activity in insect cells 
Having obtained the expression vectors outlined in Section 3.2.1 / 3.2.2, they were tested 
to determine their transient activity in Sf9 and T.ni H5 cells. Expression using the 
OpMNPV ie-1 promoter was used as a standard because foreign gene expression under 
Control of this promoter had been previously characterised (Theilmann and Stewart, 1991; 
Pfeifer et al., 1997). 
8m and T.ni H5 cells were seeded (Section 2.2.3) into 8 well chamber slides, and left to 
adhere for 1 h. The cell mono-layers were transfected (Section 2.2.4) using 2f..lg of 
plasmid DNA (pIZTN5-His, pEGFP.N1). Transfections were carried out in triplicate. Cells 
Were visualised for the production of EGFP and GFP on a Carl Zeiss Axiovert 510 CLSM 
microscope, using a standard Argon 488nm laser, and 534nm Helium/Neon laser, after 48 
h incubation at 28°C. 
Figure 3.3 shows results obtained for promoter activity in Sf9 (panel A) and T.ni Hi5 
(panel B) cells. Expression of gfp from the OpMNPV ie-1 promoter was shown to be 
detectable by visualisation of green fluorescence. The fluorescence observed from the 
level of GFP produced by OpMNPV ie-1 served as a positive control. The detection of 
EGFP production from the CMVie promoter was also shown, as fluorescence was 
detected. The levels of EGFP produced by the CMVie promoter were visibly much lower 
than the levels of GFP produced by the OpMNPV ie-1 promoter. Mock-transfected Sf9 
cells after 48 h did not show any detectible level of background auto-fluorescence. 
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A 
B 
Figure 3.3: Transient GFP / EGPF production after 48 hpt in Sf9 (panel A) and T.ni Hi5 
(panel B) cells. Transient GFP production shown under control of the OpMNPV ie-1 
promoter (a), EGFP under the CMVie promoter (b) and mock-transfected cells showing no 
~ctable levels of background auto-fluorescence (c). 
The results show that the CMVie promoter is transcriptionally active in Sf9 and T.ni Hi5 
cells. However, the intensity of EGFP produced by the CMVie promoter was much lower 
in comparison to the intensity of GFP produced by the OpMNPV ie-1 promoter, suggesting 
that the CMVie promoter is a weaker promoter than the OpMNPV ie-1 promoter. These 
findings correlate with reports suggesting that the activity of the CMVie promoter is weak 
in insect cells (Walker, 1989; Pfeifer et al., 1997). The activity of the OpMNPV ie-1 
promoter has been characterised as moderate in insect cells (Shotkoski et al., 1996; 
Pfeifer et al., 1997), whilst AcMNPV ie-1 has been determined as weak. The CMVie was 
shOwn to function in insect cells, however it was not possible to quantify the strength of 
this promoter, or compare promoter activity directly with AcMNPV ie-1. Therefore the 
CMVie promoter was used in the following investigation to determine its transcriptional 
activity in insect cells. This involved comparing the expression of CAT to the commonly 
used weak AcMNPV ie-1 promoter and a number of other baculovirus and eukaryotic gene 
85 
Chapter 3 Promoter analysis 
promoters. This investigation was an attempt to identify promoters with significantly higher 
transcriptional activity than the AcMNPV ie-1 promoter. 
3.3 Use of alternate baculovirus and eukaryotic gene promoters 
With the identification and characterisation of new mammalian, insect and viral promoters, 
it was decided to test a range of these promoters against the weak AcMNPV ie-1 promoter 
in Sf9 and T.ni Hi5 cells. Baculovirus and eukaryotic gene promoters shown to work well 
in other expression systems in the absence of specific factors were chosen. 
3.3.1 AcMNPV ie-1 gene promoter 
The AcMNPV ie-1 promoter is commonly used for transient and stable production of 
recombinant proteins. The AcMNPV ie-1 has been characterised as a weak promoter 
(Guarino and Summers, 1987; Jarvis et al., 1990; Joyce et al. , 1993) in insect cells and so 
the levels of protein produced from this promoter will be used as basal levels in 
comparison with other promoter activity tested. The plasmid p1E-1 (Joyce, 1993) contains 
the AcMNPV ie-1 promoter, gene-coding region and transcription termination sequence. 
This construct was used in transient experiments as a negative control, because there 
Were no foreign genes present within it. A restriction enzyme map of p1E-1 is shown in 
Figure 3.4A. 
Amp' gene AcMNPV ie-1 AcMNPV IE-1 AcMNPV ie-1 
promoter gene coding termination 
region region 
Figure 3.4A: Restriction map of p1E-1 (Joyce, 1993), shows the AcMNPV ie-1 promoter, 
~e-coding region and termination region, and Amp' gene. 
Plasmid plEK1.cat is similar to pIE-1 , except the AcMNPV ie-1 coding region was removed 
and replaced with the cat gene downstream of the AcMNPV ie-1 promoter (Joyce, 1993). 
Since the AcMNPV ie-1 promoter has been characterised previously (Jarvis and 
Summers, 1989; Joyce, 1993; Atkinson et al. , 1996), plEK1.cat was used in all transient 
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experiments in order to obtain basal levels of expression. A restriction enzyme map of 
plEK1 .cat is shown in Figure 3.4B. 
~ 
Ampr gene AcMNPV ie-1 cat gene AcMNPV ie-1 
promoter coding region termination 
region 
F~gure 3.4B: Restriction map of plEK1.cat (Joyce, 1993) is similar to plE1 described in 
!2gure 3.4A, except the ie-1 gene coding region has been replaced with that of cat. 
3.3.2 Human CMVie gene promoter 
The human CMVie promoter has been shown in Section 3.2.3 to be transcriptionally active 
in S19 and T.ni Hi5 cells, albeit at relatively low levels. To analyse the strength of the 
CMVie promoter in comparison to the AcMNPV ie-1 promoter, the cat gene (Joyce, 1993) 
Was inserted into pEGFP.N1. pEGFP.N1 was digested using Bg/li and Bam HI (Section 
2.5.1), and treated with shrimp alkaline phosphatase (Section 2.5.3). The cat gene from 
PIEK1.cat (Joyce, 1993) was removed using Bam HI and cloned into pEGFP.N1. Digestion 
Using EcoRI and Notl identified the correct orientation of the cat gene, to derive plasmid 
PEGFP.N1 .cat (Figure 3.5). 
egfp gene SV40 early 
Bg/li MCS coding region poly-A 
I I r __ - ----A ----...." ,-1, 
~~ ~ 
I "---------v".-----) I 
Kad gene CMVie MCS cat gene BamH I Not I / Xba I 
promoter coding region 
F~gure 3.5: Genetic map of pEGFP.N1.cat. pEGFP.N1 .cat is similar to pEGFP.N1 (SO 
~osciences, Clontech) described in Figure 3.1, except the cat gene has been cloned into 
~g/ll and BamHI cloning sites of the MCS. 
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3.3.3 BmA3 gene promoter and BmNPV enhancers 
The 8m A3 gene promoter (Mounier and Prudhomme, 1986; 1991) has been reported to 
be functionally active in Lepidopteran cell lines (Johnson et al., 1992). Work to develop an 
in vitro expression system that employed the 8m A3 promoter to drive expression of 
foreign genes identified two cis-acting enhancers (Lu et al., 1996; Farrell et al., 1998; 
1999; Keith et al., 1999). The presences of both cis-acting enhancers in transfected cells, 
has been shown to increase level of the 8m A3 promoter strength by three orders of 
magnitude, relative to that of the basic 8m A3 promoter (Lu et al., 1996; Farrell et al., 
1998, 1999; Keith et al., 1999). From this evidence, the 8m A3 promoter and enhancers 
(8m A3+E) were chosen to analyse in this expression study. 
The cat gene from pEGFP.N1.cat was amplified using PCR (Section 2.5.5), and inserted 
into the entry vector pENTRD.TOPO (InvitrogenTM) using directional TOPO® cloning 
(Section 2.5.12). The correct sequence of cat was confirmed by sequencing (as describe 
in Section 2.5.8). A genetic map of pENTRD.TOPO.cat is shown in Figure 3.6. 
LY 
Kad gene T1 
TTC ACC cat AAG GGT 
AAG TGG gene TTC CCA 
~~~--~y~----) 
a ttL 1 cat gene 
'-y-I 
attL2 
Figure 3.6: Genetic map of pENTRD.TOPO.cat, shows the Kad gene, pUC ori, 
tr~nscriptional termination sequences (T1 / 72), phage A recombination sites (attL 1 / attL2) 
~ cat inserted amidst. 
FOllowing the construction of pENTRD.TOPO.cat, this entry vector was used to transfer 
cat into the expression vector (Section 2.5.12) pXINsect.DEST38 (InvitrogenTM ), 
downstream of the 8m A3 promoter. Plasmid pXINsect.DEST38.cat was derived. A 
genetic map of pXINsect.DEST38.cat is shown in Figure 3.7. 
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BmNPV ie-1 Ec04 7 I CCC TTC ACC cat AAG GGT 
Sma I 
Xbal 
Not I BamH I Not GGG AAG TGG gene TTC CCA Asc I 
~ / L'-----:====r--' 
Y "-y---J "-y---l '-'--~y~-~) '----y---J '----y---J 
Ampr gene BmNPV hr3 Bm A3 attL 1 
Coding promoter 
region 
cat gene attL2 Bm Actin 
coding region poly-A 
Figure 3.7: Genetic map of pXINsect.DEST38.cat shows the Amp' gene, BmNPV ie-1 
promoter / gene, BmNPV hr3 coding region, Bm A3 promoter with cat inserted 
~ownstream, a ttL 1 / attL2 recombination sites, and the Bm actin poly-A. 
3.3.4 OpMNPV;e-2 gene promoter 
The OpMNPV ie-2 promoter was chosen because it has been shown to be functionally 
active in Lepidopteran cell lines (Pfeifer et al., 1997, Hegedus et al., 1998; InvitrogenTM). It 
has also been reported that the OpMNPV ie-2 promoter provides relatively high levels of 
constitutive expression, and has been shown to be about 5-10-fold stronger than the 
OpMNPV ie-1 promoter (Pfeifer et al., 1997, Hegedus et al., 1998). The plasmid pIZTN5-
His (Invitrogen), described in Section 3.2.2 was used for the purpose of this experiment. 
The cat gene was excised from pXINsect.DEST38.cat (Section 3.3.3) on a BamHI and 
Notl fragment and cloned into complementary restriction enzyme sites of pIZTN5-His, 
downstream of the OpMNPV ie-2 promoter. Plasmid pIZTN5-His.cat was subsequently 
generated. A genetic map of pIZTN5-His.cat is shown in Figure 3.8. 
0pMNPV ie-1 
promoter 
~ 
~ 
gfp / zeocin 
gene coding region 
r---~A~------..,\ 
pUC ori 
r'I 
EM7 promoter SV40 early OpMNPV ie-2 BamHI cat gene Notl OpMNPV 
poly-A promoter coding ie-2 
region poly-A 
F:~ure 3.8: Genetic map of pIZTN5-His.cat (InvitrogenTM). pIZTN5-His.cat is similar to 6 TN5-His described in Figure 3.2, except that cat has been cloned downstream of the 
M~MNPV ie-2 promoter using the restriction enzyme sites BamHI and Notl present in the 
~ --------------------------------------------------------------
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3.3.5 Om Ac5.1 gene promoter 
The Om Ac5.1 promoter has previously been used in transient and stable Drosophila cell 
line work (Chung and Keller, 1990), and was chosen because of its functional activity in 
Sf21 cells (Han et al., 1989; Chung and Keller, 1990). It was of interest to determine if the 
Om Ac5.1 promoter was functionally active in alternative insect cell lines. The plasmid 
PAc5.1N5-His was obtained from InvitrogenTM. pAc5.1N5-His was digested using Notl 
(Section 2.5.1). The cat gene was excised from pXINsect.DEST38.cat using Notl and 
inserted into pAc5.1N5-His. Digestion, using Xbal and Xhol, identified the correct 
orientation of cat, to derive plasmid pAc5.1N5-His.cat. A genetic map of pAc5.1N5-
His.cat is shown in Figure 3.9. 
Ampr gene 
Notl MCS 
SV40 early 
poly-A 
!_----.I ~ 
~--~y~--~/
Om Ac5.1 MCS cat gene Notl Xbal / Xhol 
promoter coding region 
Figure 3.9: Genetic map of pAc5.1N5-His.cat, shows the Amp' gene, Om Ac5.1 promoter, 
cat gene inserted downstream of the Om Ac5.1 promoter using the restriction site Notl 
present in the MCS, Xbal and Xhol restriction sites to identify correct orientation of cat, 
~ SV40 poly-A. 
3.3.6 Om MT gene promoter 
The Om MT promoter was chosen because it is an inducible promoter and shows 
fUnctional activity in Drosophila cells (Bunch et al., 1988). It was of interest to determine if 
this promoter was functionally active in alternative insect cell lines. The Om MT promoter 
has been shown to be induced by low levels of heavy metals (Stuart et al., 1984; Bunch et 
al., 1988; Kovach et al., 1992). Plasmid pMTN5-His was obtained from InvitrogenTM. The 
Cat gene from pXINsect.DEST38.cat was inserted into the Notl cloning site downstream of 
the promoter. Section 3.3.5 described how the correct orientation of cat was identified. A 
restriction enzyme map of pMTN5-His.cat is shown in Figure 3.10. 
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SV40 early 
Notl MCS poly-A 
~ __ --,I ~ 
'---~yr----) ~ 
Ampr gene Om MT MCS cat gene Notl Xbal / Xhol 
promoter coding region 
Figure 3.10: Genetic map of pMTN5-His.cat, shows an Amp' gene, Om MT promoter, cat 
gene inserted downstream of the promoter using the restriction site Notl present in the 
~CS, Xbal and Xhol restriction sites to identify correct orientation of cat, and SV40 poly-A. 
3.4 Analysis of promoter activity in insect cells 
FOllowing construction of the expression vectors, as described in Section 3.3, the 
constructs were tested for their ability to produce CAT in insect cell lines. The expression 
of CAT from the AcMNPV ie-1 promoter was used as the standard because foreign gene 
eXpression had been previously characterised using this promoter in insect cells (Guarino 
and Summers, 1986b; Jarvis et al., 1990; Henderson et al., 1995). As the promoters 
tested were from a variety of expression systems, their ability to function to produce CAT 
Was tested in two different insect cell lines (Sf9 and T.ni Hi5 cells). 
Cells were seeded as described in Section 2.2.3, and monolayers transfected (Section 
2.2.4) using 5Jlg of each construct (pIE-1, pIEK1.cat, pEGFP.N1.cat, 
PXINsect.DEST38.cat, pIZTN5-His.cat, pAc5.1N5-His.cat, pMTN5-His.cat) . 
Transfections were carried out in triplicate. After 24 h incubation at 28°C, cells transfected 
With pMTN5-His.cat were treated with 500JlM CUS04 to induce transcription. Cells were 
harvested every 24 h, over a period of 120 h, and CAT activity quantified. The assays 
Were carried out in triplicate as described in Section 2.8.1. 
FOllowing phosphor-imaging, the percentage conversion from non-modified to the 3-
acetylated form of chloramphenicol by each cellular extract was calculated using the 
SOftware program Image-Quant 5.1 (Section 2.8.1). CAT activity was expressed as a total 
percentage conversion per 106 cells. Since the AcMNPV ie-1 promoter has been used 
previously in stable insect cell lines and is known to give low levels of expression in these 
Circumstances, expression using this promoter in Sf9 and T.ni Hi5 cells was considered as 
the basal level, and all data was compared to this (Figure 3.11A-B). Mock-transfected 
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Sf9 and T.ni HiS cells were used as a negative control to determine non-specific 
background expression levels, and commercially purified CAT (Sigma) was used to 
determine 100% chloramphenicol conversion (positive control). Statistical analyses were 
carried out using the unpaired 2 sample T-test at a 9S% confidence level. In experiments 
the level of CAT activity detected was assumed to be directly proportional to the level of 
CAT produced under control of the promoters used. 
In both cell lines tested, CAT activity observed from the negative control, CMVie, Dm 
AcS.1 and Dm MT promoters (induced/non-induced) was significantly lower than that 
observed from using AcMNPV ie-1 (Figure 3.11A-B; p<O.OS in all cases). These gene 
promoters would not be appropriate for high level continuous or inducible protein 
production in Sf9 or T.ni HiS cells. 
Figure 3.11A shows results obtained from the promoter activity assays in Sf9 cells. The 
production of CAT at 0 hpt from all promoters tested yielded no detectable CAT activity 
(P>O.OS in all cases) above background levels. Expression of cat using AcMNPV ie-1, 
produced CAT activity at 24 hpt of 1.4 %. At 48 hpt the level of activity increased to 3.9%, 
and by 72 hpt levels had augmented to S.3%. The levels of CAT produced were low, 
Which is characteristic of this weak promoter. At 96 hpt levels of CAT activity decreased 
by 0.78-fold (4.1%), and by 120 hpt, activity was not observed above background levels. 
These data, demonstrating CAT activity produced from the AcMNPV ie-1 promoter, are 
used as basal levels in the cell lines tested to which other promoters are compared in this 
assay. 
The production of CAT from 8m A3+E resulted in a significant increase compared with 
AcMNPV ie-1 at 24 hpt (CAT activity, 20.2%; p<0.0001), which corresponds to a 14-fold 
increase in expression. At 48 hpt CAT activity from Bm A3+E increased to 39.8%, a 10-
fold increase compared to AcMNPV ie-1 at this time-point (p<0.0001). At 72 hpt CAT 
activity from 8m A3+E remained significantly higher (38.1 %; p<0.0001) than that detected 
from AcMNPV ie-1 at this time-point (7-fold increase). At 96 hpt the levels of CAT activity 
from 8m A3+E were similar (4.S%) to those produced by AcMNPV ie-1 (p=0.607). No 
. significant CAT activity (0.8%) was detected above background levels at 120 hpt (p=0.197; 
Figure 3.11A). 
'\ 
Cells producing CAT under control of OpMNPV ie-2, showed CAT activity was significantly 
increased by 24-fold in comparison to those observed from AcMNPV ie-1 at 24 hpt (CAT 
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activity, 34%; p<0.0001}. Expression from OpMNPV ie-2 also results in a 1.7-fold increase 
in CAT activity (34%) over those observed from 8m A3+E (20%) at 24 hpt. At 48 hpt CAT 
activity from OpMNPV ie-2 was detected at 28.9%, which corresponds to a 7-fold increase 
in expression compared to AcMNPV ie-1, but a 1.4-fold decrease compared to 8m A3+E 
at this time-point (p<0.0001). The levels of CAT activity at 72-96 hpt from OpMNPV ie-2 
(72hpt, 5.2%; 96hpt, 4.9%) were similar to those observed from AcMNPV ie-1, hence not 
significantly different (p>0.05). However at 72 hpt, 8m A3+E produced a 7.6-fold increase 
in CAT activity compared to OpMNPV ie-2 at this time-point. At 120 hpt CAT activity was 
still detectable from OpMNPV ie-2 and resulted in levels of activity that were significantly 
higher than both AcMNPV ie-1 (p=0.007) and 8m A3+E (p=0.002), though overall levels 
Were low (3.2%). It was concluded, that OpMNPV ie-2 and 8m A3+E would be suitable for 
high level transient or stable expression of foreign genes in Sf9 cells. 
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Figure 3.11 A: Time course of transient CAT activity in Sf9 cells following transfection with 
Plasmids containing different promoters to drive expression of cat (relative to CAT activity 
~uced by the AcMNPV ie-1 promoter). 
Figure 3.11 B shows results obtained from the promoter activity assays in T.ni Hi5 cells. 
At 0 hpt no detectable levels of CAT activity above background levels were observed for 
any of the promoters tested (p>0.05 in all cases). The AcMNPV ie1 promoter appears to 
be only active at 24 hpt, producing CAT activity of 3.1%, which was characteristically low, 
althOugh an increase compared to levels observed using Sf9 cells (Figure 3.11 A). The 
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OpMNPV ie-2 and 8m A3+E produced significantly higher levels of CAT activity (OpMNPV 
ie-2, 51 .3%; 8m A3+E, 41.1 %) than those obtained from AcMNPV ie1 at 24 hpt (OpMNPV 
ie-2, 17-fold increase; 8m A3+E, 13-fold increase; p<0.0001). A comparison of CAT 
activity at 24 hpt from OpMNPV ie-2 and 8m A3+E, showed OpMNPV ie-2 resulted in 1.2-
fold greater expression. Both promoters were shown to have a greater transcriptional 
activity at 24 hpt than in Sf9 cells (Figure 3.11A). At 48 hpt OpMNPV ie-2 shows 
detectable CAT activity of 5%, which was significantly higher than the basal levels from 
AcMNPV ie-1 (p<O.OOO1), but no detectable CAT activity was observed above background 
levels from this promoter at 72-120 hpt (p>0.05). The 8m A3+E produced no detectable 
CAT activity above background levels from 48-120 hpt, which correlates with the same 
expression profile of the AcMNPV ie1 promoter (p>0.05), suggesting no functional 
promoter activity. It was concluded that OpMNPV ie-2 and 8m A3+E would be suitable for 
high level transient and stable expression of foreign genes in T.ni Hi5 cells. T.ni Hi5 cells 
are also shown to produce the highest levels of CAT activity compared to levels observed 
Using Sf9 cells (Figure 3.11A). 
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F~gure 3.11B: Time course of transient CAT activity in T.ni Hi5 cells following transfection 
:It~ plasmids containing different promoters to drive expression of cat (relative to CAT 
~y produced by the AcMNPV ie-1 promoter). 
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It was therefore shown that, OpMNPV ie-2 or 8m A3+E transfected T.ni Hi5 and Sf9 cells 
would appear to be the most useful combination in producing stable cell lines. Both these 
promoters would also be suitable as potential candidates to drive foreign gene expression 
in a developmental inducible expression system (described in Chapter 4), for use in T.ni 
Hi5 or Sf9 cell lines. 
3.5 Discussion 
Early studies on the development of non-lytic expression systems for generating 
continuous insect cell lines have shown that the AcMNPV ie-1 promoter could be used to 
produce heterologous proteins in Lepidopteran (Sf9) cells (Jarvis et al., 1990). Levels of 
foreign protein produced by AcMNPV ie-1 were found to be very low and did not compare 
favourably with other expression systems. Often, demand for high levels of recombinant 
protein is generally required, such as that for screening large compound libraries for drug 
targets, consequently the use of AcMNPV ie-1 would not be appropriate. The work in this 
Chapter was carried out to determine whether strong eukaryotic promoters could be used 
in place of AcMNPV ie-1 in stable insect cell lines for the production of recombinant 
proteins, yielding levels comparable with other expression systems. Those promoters 
matching the above description would be used in the development of a novel inducible 
insect expression system, as described in Chapter 4. 
Endogenous cellular promoter activation is reliant on host cell transcription factors (TF) to 
initiate transcription of endogenous I heterologous genes. Heterologous promoters may 
be Used if the transcriptional machinery recognises complementary DNA-protein binding 
motifs to initiate transcription. Viral immediate early (ie) promoters have been shown to be 
similar in structure to mammalian counterparts (Miller, 1996). It follows that other 
eUkaryotic promoters may be able to function using the same host TF. Studies have 
shown (Morris and Miller, 1992) that promoter choice strongly influences the range of 
insect cells that can efficiently support the production of heterologous proteins. To 
determine if there were host cell differences in the regulation of the promoters tested, 
constructs were transfected into Sf9 and T.ni Hi5 cell lines, and assayed for transient CAT 
activity. 
Results in Section 3.4 show that neither Om Ac5.1, nor Om MT (non-induced I induced) 
promoters were active in the insect cell lines tested. One explanation is likely to be due to 
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the incompatibility of promoter DNA-protein binding sites with TF endogenous to Sf9 and 
T.ni Hi5 cells. If the TF of insect cells used cannot recognise trans-activating domains of 
the promoters to initiate formation of the transcription initiation complex, then promoter 
activation is inherently silent and gene expression will not occur. This work is believed to 
be the first testing of the Om Ac5.1 promoter function in Sf9 cells. The lack of detectable 
transcription from this promoter suggests, it would not be suitable for generating stable Sf9 
or T.ni Hi5 cell lines. The lack of transcription from Om MT was disappointing, as previous 
reports (McCarroll, 1997) have shown this promoter to be active in Lepidopteran cells 
(S121, T.m), albeit at levels that are barely detectable when using CAT assay analysis. In 
a direct comparison with the weak AcMNPV ie-1, it has been shown that Om MT activity 
Was not detectable above background levels. Due to the transcriptionally weak nature of 
Om MT reported in Sf21 and T.ni cells, attempts to augment activity levels in Sf9 and T.ni 
Hi5 cells failed. Given these and previous data, levels of expression as low as those 
reported would not be useful for developing a stable cell line with the view to developing 
an expression system. 
The strong eukaryotic promoter CMVia was found to be functionally active in T.ni Hi5 (as 
described in Section 3.2.3) and Sf9 cells (as described in Section 3.2.3/3.4), albeit at low 
levels. An explanation of why CAT activity from the CMVia promoter was detected in one 
cell line, but not the other (Section 3.4), could also explain why CAT activity from the Om 
promoters was not observed. If the transfection efficiency was low then the number of 
cells transformed may have been inadequate to detect CAT activity. DNA transfer into 
cells was liposome-mediated (Lipofectin, InvitrogenTM), whereas in some previous studies 
the calCium phosphate method was utilised. However, it is generally accepted that 
Lipofectin works more efficiently In Lepidopteran cell lines (Mann and King, 1989). Similar 
stUdies have also shown the CMVia promoter to be active in Om cells (Bello at al., 1998), 
although levels of CAT were only just detectable above background. Similar findings were 
reported in Sf9 cells (Section 3.4). These data characterise the CMVia as a weak 
promoter in insect cell lines, as CAT production was significantly lower than levels 
observed from AcMNPV ie-1. The CMVia promoter would be an inappropriate choice for 
further investigation of constitutive or inducible heterologous gene expression In stable 
Insect cell lines. 
The Bm A3+E and OpMNPV ie-2 promoters were the most successful in transcribing cat in 
transient studies. Both promoters produced significantly higher levels of CAT in 
comparison to AcMNPV ie-1 in both insect cell lines tested. As the promoters were 
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identified as being transcriptionally stronger than AcMNPV ie-1, a comparison of 8m A3+E 
and OpMNPV ie-2 was investigated using the data obtained from Section 3.4. Firstly, a 
comparison of promoter activity was conducted, followed by a comparison to determine if 
there were host cell differences in the regulation of the two promoters. In Sf9 cells the 
overall expression profile of CAT from 8m A3+E produced the most significant result 
compared with OpMNPV ie-2 (Figure 3.11A). Optimal levels of CAT were produced 
between 24-72 hpt from 8m A3+E and 24-48 hpt from OpMNPV ie-2 (Figure 3.11A). 
These data show that the 8m A3+E was the stronger of the two promoters. -However, both 
promoters were sufficiently stronger than AcMNPV ie-1, and are potential candidates for 
increasing yields of recombinant protein in stable Sf9 cells. 
Both OpMNPV ie-2 and 8m A3+E promoters were functional in T.ni Hi5 cells. The 
production of CAT was detectable from both these promoters at 24 hpt, but only OpMNPV 
ie-2 at 48 hpt (Figure 3.11 B). At 24 hpt, expression of cat from OpMNPV ie-2 was 
significantly elevated in comparison to levels observed from 8m A3+E, and in fact the level 
of CAT activity from OpMNPV ie-2 at this time was significantly higher than all other 
promoters tested in both cell lines (Figures 3.11A / 3.11 B). Comparison of optimal cat 
expression from 8m A3+E in Sf9 I T.ni Hi5 cells shows no significant difference apart from 
the time (hpt) CAT was expression. The difference in expression profiles, observed from 
the same promoters in different hosts, indicates that there are differences in host cell 
regulation of heterologous promoters. The characterisation of 8m A3+E and OpMNPV ie-
2 promoter activity in T.ni Hi5 cells has demonstrated that these promoters have a 
Significantly increased transcriptional activity compared to the weak AcMNPV ie-1 and 
should be classified as strong promoters. These promoters are therefore eligible for 
generating high level recombinant protein in stable T.ni Hi5 cell lines. 
These data coincide with findings from earlier studies, that have shown OpMNPV ie-2 to 
be functionally active in Sf9 (Hegedus et a/., 1998; Pfeifer et al., 1997; Theilmann and 
Stewart, 1991) and T.ni Hi5 cells (InvitrogenTM), and 8m A3+E in T.ni Hi5 cells (Keith et al., 
1999). The data presented in this thesis characterising the strong transcriptional activity of 
Bm A3+E in Sf9 cells, is the first acknowledged study to date of its kind. However, 
eVidence supporting 8m A3+E activity in Sf21 cells has been shown previously (Keith et 
a/., 1999; Lu et al., 1997). 
'\. 
The difference in CAT production from the cell lines used in Section 3.4, may be explained 
by a number of hypotheses. Transient expression studies rely on a burst of gene 
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expression between 12-72 hpt. This burst of gene expression is most often followed by a 
rapid deterioration in expression of the heterologous gene because of cell death. Due to 
the episomal nature of expression vectors used for transient expression studies, the vector 
does not integrate into the cell genome, but remains extra-chromosomal in the nucleus as 
multiple copies. Loss of the expression vector (Colosimo at al., 2000) from the cell 
consequently results in decreased expression of the transgene. It is possible that the 
expression vectors housing the 8m A3+E and OpMNPV ie-2 promoters were degraded by 
the cell, or cell viability was compromised by over-expression of cat. This· would explain 
the rapid decrease in cat expression observed from 8m A3+E and OpMNPV ie-2 
promoters in Sf9 cells (Figure 3.11A) at 72-96 hpt, and may account for the loss of CAT 
activity after 24 hpt from 8m A3+E and 48 hpt from OpMNPV ie-2 in T.ni Hi5 cells (Figure 
3.11B). 
The concept of protein degradation may have also contributed to loss of CAT activity in 
Sf9 and T.ni Hi5 cells. Similar constructs (pXINSect.DEST38 or pIZTN5-His) used in 
Section 3.4, were transfected into Sf9 and T.ni Hi5 cells, although cat was replaced with a 
red fluorescent reporter gene called DsRed, as described in Chapter 5 (BD Biosciences, 
Clontech). Both cell lines were shown to produce OsRed from 24 to 120 hpt (data not 
Shown). However, levels of fluorescence were not quantified; fluorescence was clearly 
visible throughout transfection (data not shown). The expression of cat in T.ni Hi5 cells 
may therefore have still been active, but cellular defence mechanisms may have been 
triggered, directing CAT to lysosomal compartments for degradation. Finally CAT may 
have been inactivated by some other cellular mechanism rendering the recombinant 
protein catabOlically ineffective, detection via CAT assay would not have accounted for the 
non-active form of CAT respectively. 
Figure 3.12 shows partial sequence alignment of all promoters tested in this Chapter. The 
promoter may be considered to be central in its role in gene transcription (Latchman, 
1995); without promoter activation, gene expression is essentially silent. Studies of 
promoter regions have identified putative regulatory sequences immediately upstream of 
the transcribed region. These regulatory sequences have shown some level of homology 
across many gene classes (Dynan and Tjian, 1985; Berg and von Hippel, 1988; Latchman, 
1995). A short sequence primarily composed of A and T nucleotides known as the TAT A 
box (consensus TATAA/TAAIr),Js found about 25-30bp upstream of the transcriptional start 
site (+1) of many, but not all g~nes (Section 1.5.1). Analysis of published sequences for 
those promoters used in this thesis showed that all contained a TATA box (Figure 3.12). 
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Interestingly, the baculovirus promoters AcMNPV ie-1 and OpMNPV ie-2 contain identical 
TATA boxes, whilst the two Om promoters retain identical homology to one another, but 
differ from AcMNPV ie-1 and OpMNPV ie-2. The TAT A box sequences of the Bm A3 and 
CMV;e differ from all TATA boxes identified in this study. Notably all promoters tested 
showed a high level of homology (>71%) to the AcMNPV ie-1 TATA box. 
The distance of the TAT A box in relation to the RNA start site was also found to differ 
between promoters (Table 3.1). A comparison of TAT A box homology with AcMNPV ie-1, 
and the distance relationship of the RNA start site showed OpMNPV ie-2 to be highly 
comparable (Figure 3.121 Table 3.1). This may explain its promoter activity in the cell 
lines tested in this thesis. It was disappointing to find the Om Ac5.1 promoter functionally 
inactive given it has 86% homology with the AcMNPV ;e-1 TATA box, and a similar 
distance from the RNA start site. 
The activity of CMV;e was surprising because it resembles the least homology (71%) and 
a closer RNA start site, also the first nucleotide of the CMVie initiator motif is T (Table 
3.1), Whereas AcMNPV ie-1 and OpMNPV ie-2 utilises the nucleotide A (Table 3.1), with 
eXception to OpMNPV ie-2, which can use the nucleotide C as well (Table 3.1; Theilmann 
and Stewart, 1992). It was surprising to see no activity from Om MT considering the 
similarity it possessed with CMVie (Figure 3.121 Table 3.1). This may support a previous 
argument that the transfection efficiency was very low in this study. Unfortunately, the Bm 
A3 RNA start site has not been elucidated, so a comparison could not be made. However, 
this promoter was characterised as transcriptionally active. 
Viral immediate early genes may play a role in host specificity or virulence since the 
promoter of these genes must be able to utilise host transcriptional machinery. Studies 
have identified a conserved putative sequence motif (Blissard and Rohrmann, 1989; 
PUllen and Friesen, 1995a; Theilmann and Stewart, 1992), at the RNA start site of a 
nUmber of genes from both OpMNPV (gp64, ie-2) and AcMNPV (gp67, ie-1, 39K). This 
motif is depicted by the sequence CAGT, and is located at the transcriptional start site 21-
24 nUcleotides downstream of the TAT A box. It is noteworthy that many baculovirus 
. genes lack an obvious CAGT motif at their RNA start sites. For these genes, the TAT A 
box may suffice to position the RNA start site, as is the case for the p35 gene of AcMNPV 
(Dickson and Friesen, 1991)., 
'. 
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AcMNPV ie-l ATATTGTTAT CGTGTTCGCC ATTAGGGCAG T AT .;;.;;.~ TTGA CGTTCATGTT 
OpMNPV ie-2 ACACGAGGCG CCCGTCCCGC TTATCGCGCC TAT.AA~TACA GCCCGCAACG 
BmA3 TGGACGCAAA TAAATTTGTC GTTTACTTAG TATIL~TGTAT GGAATGAGAA 
CMVie GGGCGGTAGG CGTGTACGGT GGGAGGTCTA TATAAGCAGA GCTGGTTTAG 
DmMT GACCCGTGTG AAAGCCGCGT TTCCAAAATG TAT .;;';;'AACCG AGAGCATCTG 
Dm AcS.l GCTGATAAGG TTTTAGCGCT AAGCGGGCTT TAT A.l\.AACGG GCTGCGGGAC 
AcMNPV ie-l 
.1 
GGATATTGT'l' TCAG'l' TGCAA GTTGACACTG GCGGCGACAA GATCGTGAAC 
OpMNPV .1+1 ie-2 ATCTGGTAAA CACAGT TGAA CAGCATCTGT TCGAA 
BmA3 TGTAGTTTGA ATTGTTTTTT TTCTTTTCTT GCAGACTAAT TCAAGAGGTG 
CMVie .1 TGAACCGTCA GATCGCCTGG 
DmMT .1 GCCAATGTGC AT CAGT TGTG GTCAGCAGCA 
Dm AcS.l .1 CAGT TTTCAT ATCACTACCG TTTGAGTTCT TGTGCTGTGT GGATACTCCT 
~igure 3.12: Partial nucleic acid sequence alignment of eukaryotic gene promoter regions. 
he TATA boxes of the published sequences of AcMNPV ie-1 (Guarino and Summers, 
1 ~87), OpMNPV ie-2 (Theilmann and Stewart, 1991) Bm A3 (Invitrogen) CMVie (BD 
blosciences, Clontech) Om MT (Maroni et al., 1986) Om Ac5.1 (Chung and Keller, 1990) 
pro~oters were lined up and are shown in red. The location of other known transcription 
~otlf were also identified from published data: CAGT in blue (Blissard et al.,1992; Lu and 
arstens, 1992, Pullen and Friesen, 1995a; Pullen and Friesen, 1995b), and 
~scriptional initiation sites mark by +1 directly above the essential nucleotide{s). 
Table 3.1: Nucleotide distance of the upstream TAT A box of eukaryotic gene promoters 
rom the transcription initiation site 1. 
r-
Promoters TATA Box distance from Nucleotide at position +1 of 
initiator element the transcriptional initiation 
- site 
~cMNPV ie-1 -32 A 
_ OpMNPV ie-2 -31 1-30 CIA 
- BmA3 Unknown Unknown - CMVie -27 T _ OmMT -27 T 
-r-~mAc5. 1 -30 1 
~rst nucleotide of the RNA start site IS depicted as +1 
A 
Of the promoters studied in this thesis, two contained the CAGT motif surrounding the 
reCOgnised RNA initiation site (AcMNPV ie-1 and OpMNPV ie-2; Figure 3.12) and two 
(Om MT and Om Ac5.1; Figure 3.12) contained the motif close to the vicinity of the 
reCOgnised initiation point. The Bm A3 and CMVie promoter do not have a CAGT motif, 
Suggesting the TAT A box can work independently of the CAGT motif. Although CAGT is 
present in both Om promoters, promoter activation was not identified, suggesting that 
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CAGT does not function to activate these promoters in the cell lines tested. Pullen and 
Friesen (1995b) showed that the CAGT motif could function to initiate gene expression in 
the absence of the TAT A element. Point mutation or complete deletion of CAGT from the 
AcMNPV ie-1 promoter, revealed a significant decrease in promoter activity. It was 
concluded that CAGT is sufficient to direct proper transcription from AcMNPV ie-1, and the 
T AT A box helps to boost basal transcriptional level. 
In all promoters, whether a TATA element is present or not, the innate low activity of the 
promoter itself can be significantly increased by elements located upstream (Latchman, 
1995); these are formally known as upstream promoter elements (UPE). Analyses of 
published sequences for the identification of known higher eukaryotic UPE in promoters 
Used in this thesis, shows a high degree of variation (Table 3.2). 
Table 3.2: Identification of upstream promoter elements from known higher eukaryotic 
PMr~moters in published sequences of AcMNPV ie-1 1, OpMNPV ie-22, 8m A33, CMVie4, Om 
,- and Om Ac5.16. 
-
Promoters GCBox CCAATBox GATABox CREB Box AP1 Box 
Consensus Consensus Consensus Consensus Consensus 
r-- GGGCGG CCAAT c/rTATCA/r TGACGTCA TGACGTCA 
AcMNPV NI GGCATAAT TTATCA NI NI 
-Le-1 
OpMNPV NI NI TTATCT NI NI 
Je-2 
BmA3 GGGCGG NI ITATCA NI NI 
- TTATCT _CMVie GGGCGG CCAAT NI NI TGACGTCA 
,..9mMT NI CCAAT NI NI NI 
DmAc5.1 GGGCGG CCAAT TTATCT TGACGTCA NI 
Gu . ..... . ", anno ~nd Summers, 1987 Theltmann and Stewartl 1991, Invitrogen, SO blosclences, ~Iotntech; Maroni at al., 1986; AChung and Keller, 1990. insect binding consensus. Consensus 
~ Identified (Nt). 
Examination of 8m A3, CMVie, and Om Ac5.1 promoters revealed that all contained at 
least one or more copies of a GC-rich sequence, known as the GC or Sp1-box (Dynan and 
Tjian, 1983a, b; Courey and Tjian, 1988). The GC-box binds Sp1, an essential TF for the 
formation of transcription initiation complexes (Pugh and Tjian, 1990; Sune and Garcia-
Blanco, 1995). Studies to identify the role of Sp1 in the regulation of the retroviral long 
terminal repeat (L TR) have demonstrated a strict requirement for Sp1 involvement for both 
basal transcription and Tat-mediated trans-activation of the human immunodeficiency virus 
type1 L TR (Sune and Garcia-Blanco, 1995). The ability of this protein to activate 
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transcription has been mapped to two glutamine-rich regions. These regions interact with 
transcription activation factors (TAFs) that are associated with the transcriptional binding 
protein in the TFIID complex (Figure 1.4). The absence of Sp1 or TAFs from the cell 
renders the promoter transcriptionally inactive (Sune and Garcia-Blanco, 1995). 
Drosophila cells have been shown to produce endogenous Sp1 (Hoey et al., 1990), but it 
is not clear whether other insect cells produce Sp1. If not, this may explain why Om Ac5.1 
Was not active in the cell lines tested here. 
Both Bm A3 and CMVia promoters contain GC-boxes and were active, suggesting a 
separate transcriptional mechanism may have surpassed Sp1 activation, which employs 
cis or trans-activating enhancers to boost transcription above basal levels. 
The penta nucleotide sequence CCAA T is commonly found 50 to 100 nucleotides 
Upstream from the RNA start site (Gidoni at a/., 1984; Dynan and Tjian, 1985; Johnson 
and McKnight, 1989). Like the GC-box, the CCAA T -box plays an essential role in the 
activity of a wide range of promoters. In contrast to the GC-box, the motif binds a number 
of TFs, some of which are produced in all tissues, whilst others are expressed in a tissue-
SpeCific manner (Johnson and McKnight, 1989). Of the promoters used in this study, 
CMVie, Om MT and Om Ac5.1 contain a CCAAT-box. Guarino and Summers (1987) 
identified a sequence similar to CCAAT in AcMNPV ia-1 (GGCATAAT), located 69 to 77 
nUcleotides upstream of the start site for transcription (Table 3.2). Expression from the 
promoters containing the CCAA T motif in this thesis were all classified as weak or 
functionally inactive. Since the two promoters (Bm A3 and OpMNPV i9-2) , shown to 
produce the strongest transcriptional activity do not contain this motif, a different 
mechanism of transcriptional activation may have been employed. 
The GAT A TF family has been characterised as recognising the hexanucleotide 
A./TGATAT/c motif (Evans and Felsenfeld, 1989). The GATA-motif has been found to be 
recognised not only by vertebrate proteins, but also invertebrate and fungal proteins 
(Evans and Felsenfeld, 1989; Fu and Marzluf, 1990; Skeiky and latrou, 1991, Spieth et a/., 
1991). The best-characterised member of the GATA family is the erythroid-specific GATA-
. 1 factor (Evans et a/., 1988). Studies have shown (Krappa at a/., 1992) the interaction of 
an insect GATA-like protein with the PE38 promoter of AcMNPV, which has been termed 
S. frugiperda nuclear protein ,1 (SfNP-1). The characterisation of an insect GATA-motif 
(consensus cIrTATCAIr) upstr~am of the TATA element (Krappa at a/., 1992) was used to 
analYse the promoters used in this study .. Interestingly all but two (CMVie and Om Mn 
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promoters contain one or more copies of this specific motif (Table 3.2). Furthermore, the 
two strong promoters (Bm A3 and OpMNPV ie-2) are included in these findings. It is 
Possible that insect GATA TF may be involved in the regulation of Bm A3, OpMNPV ie-2 
and AcMNPV ie-1 transcriptional activation in Sf9 cells, although evidence from transient 
expression studies suggests mutations in GAT A sequences do not influence PE38 
promoter activity in insect cell culture (Krappa at a/., 1992). 
A common factor identified among the strong trans-acting Bm A3 and ·OpMNPV ie-2 
promoters is the inherent presence of cis and trans-acting enhancer-like elements (Section 
1.5.2, 1.5.3). The CMVia also contains a strong eukaryotic cis-acting enhancer element 
89 to 495 nucleotidas upstream of the TAT A-box, yet activation of this promoter was only 
jUst detectable in this study. It is possible the enhancer was able to aid transcriptional 
activation of CMVia to levels of activity observed. Both Om promoters used did not 
Contain identifiable enhancer-like sequences, and may be a contributing factor to why 
activity from these promoters was not detected in Sf9 and T.ni Hi5 cells. 
Early studies using deletion analysis experiments to characterise the OpMNPV ie-2 gene 
and its promoter (Theilmann and Stewart, 1991) show that, of the 656 nucleotides that 
comprised the proposed promoter region, only 275 nucleotides upstream of the RNA start 
site were needed to activate full promoter activity in Sf9 and Lymantria dispar (L0652Y) 
cells. The identification of an 18 base pair (bp) sequence (consensus 
CTTATCGGNACAGGACGC), contained among the 275-bp previously identified, was 
almost completely repeated at two other locations in the promoter, and partially repeated 
at six other locations in the promoter (Theilmann and Stewart, 1991). Deletion of one or 
more copies of the 18-bp dramatically decreased promoter activity; deletion of all 8 repeat 
sequences rendered the promoter completely inactive (Theilmann and Stewart, 1991). 
Comparison of the 275-bp OpMNPV ie-2 promoter with the same region of AcMNPV ie-1 
Shows very little homology. From previous work by Theilmann and Stewart (1991), the 
identified sequences in OpMNPV ie-2 are thought to act as cis-acting enhancers. The 
presence of these sequences in their entirety augment promoter activity above levels 
observed from AcMNPV ie-1 generating a strong promoter capable of high level 
. heterOlogous gene expression in Sf9 and T.ni Hi5 cells. 
The strong promoter activity observed in this Chapter from Bm A3+E complements 
findings from a number of pre~ious studies (Lu at a/., 1996; Farrell at a/., 1998; Farrell at 
sl., 1999; Keith at a/., 1999). The effect of trans-acting enhancers on the Bm A3 gene 
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promoter was first described when the BmNPV ie-1 gene was characterised as a co-
activator of the Bm A3 promoter in transfected insect cells and was shown to increase the 
level of transcription from this promoter by two orders of magnitude (Lu et al., 1996). 
FOllowing further work on this system, the hr 3 from BmNPV was identified (Lu et al., 
1997) and characterised as a second enhancer of the Bm A3 promoter. Interestingly, 
comparisons of hr 3 from BmNPV with hr 1 to 5 of AcMNPV show identical homology 
between the highly conserved palindrome consensus TTT ACAAGTAGAA TTCTACT 
(Guarino et al., 1986; Lu et al., 1997). The hrs of AcMNPV are known to increase 
expression of viral genes in Sf and T.ni cells (Rodems and Friesen, 1993); it may be that 
hr 3 from BmNPV would also function to enhance specific promoters in the same cell lines. 
When hr 3 from BmNPV was linked to gene constructs expressing CAT under the control 
of the Bm A3 promoter, hr 3 was found to enhance significantly the in vitro expression of 
CAT in Sf21 and Bm5 cell lines (Lu et al., 1997). Furthermore, when CAT was expressed 
under the Bm A3 promoter in the presence of both cis and trans-acting enhancers in 
transfected cells, the results indicated an augmentation in the level of Bm A3 promoter 
strength by three orders of magnitude relative to that of the basic Bm A3 promoter (Lu et 
al., 1996; Farrell et al., 1998; Farrell et al., 1999; Keith et al., 1999). The apparent 
increased promoter activity from Bm A3+E compared to AcMNPV ie-1 may be explained 
by the presence of enhancers; no enhancer-like elements were identified in the AcMNPV 
ie-1 promoter used in this study. 
Gene expression is a complex process, which is tightly regulated at the transcriptional 
level. Although the interaction of multiple proteins is likely to be important in eukaryotic 
gene expression, the absence or inactivity of a single factor does not necessarily lead to 
termination of a transcription complex (Johnson and McKnight, 1989). Although the data 
in Figure 3.12 and Tables 3.11 3.2 allows interesting comparisons to be made, it is by no 
means conclusive. 
The results presented and discussed in this Chapter give an insight into promoters and 
DNA elements able to stimulate increased transcription activity that may be used in a 
stable insect cell expression system. Transient, in vitro assays were deemed to be the 
Simplest way of indicating likely results in a stable cell system without generating 
reCombinant cell lines for all promoters tested in this study. 
" In Conclusion, SI9 and T.ni Hi5 cells were deemed suitable for generating stable insect cell 
lines with the use of Bm A3+E or OpMNPV ie-2 promoters, as an alternative to AcMNPV 
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ie-1, driving expression of a foreign gene of interest. The 8m A3+E and OpMNPV ie-2 
were also identified as potential candidates for the development of a novel insect 
expression system (described in Chapter 4) for use in Sf9 and T.ni Hi5 cells. 
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CHAPTER 4: CONSTRUCTION OF A TETRACYCLINE 
INDUCIBLE EXPRESSION SYSTEM FOR INSECT CELLS 
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4.1 Introduction 
Stringent regulation of gene expression offers a number of advantages for studying gene 
fUnction or production of recombinant proteins that are either cytotoxic or cytostatic 
(Yarronton, 1992; Rossi and Blau, 1998). Early attempts to develop inducible expression 
vectors for mammalian cells relied upon the use of heat shock promoters (Schweinfest et 
a/., 1988), metallothionein promoters with heavy metal ion control (Hu and Davidson, 
1990) and steroid regulatory promoters (Israel and Kaufman, 1989; Ko et a/., 1989). A 
nUmber of transcriptional control systems have been described (yarronton, 1'992), in which 
the expression of heterologous genes by RNA polymerase II promoters is susceptible to 
outside stimuli. These endogenous systems usually suffer from one, or both, of the 
fOllowing drawbacks. First, inducement treatment (such as heat shock) can invariably lead 
to the co-ordinat~ induction of a variety of cellular genes, which evoke pleiotropic effects 
that render analysis of the resulting phenotype difficult (Lee et a/., 1988). Second, most 
regulated promoters have high basal levels of activity in the non-induced state, which 
prevents the total shut-off of gene expression. The resulting leaky activity of these 
promoters generally precludes them from applications such as gene function studies. 
Even so, when the primary goal is the induction of high level protein synthesis, and 
negative effects that interfere with the physiology of the cell can be tolerated, such 
systems may be employed. 
In an endeavour to overcome some of the problems of utilising endogenous control 
elements, attempts have been made to use regulatory elements distant in evolution from 
eUkaryotic cells. In a number of cases, regulatory elements from E. coli have been used 
sUccessfully to regulate foreign gene expression in eukaryotic cells (Brown et a/., 1987; Hu 
and Davidson, 1987; 1990). Several studies have shown that the lactose (lac) repressor I 
operator I inducer system of E. coli functions in mammalian cells. Three fundamentally 
different approaches have been described: (i) prevention of transcription initiation by 
Properly placed lac operators at promoter sites (Brown et a/., 1987; Hu and Davidson, 
1987; Figge et a/., 1988; Deuschle et al., 1989; Fuerst et a/., 1989); (ii) blockage of 
tranSCribing RNA polymerase II during elongation by a lac repressor I operator complex 
(DeUSchle et al., 1990), and (iii) activation of a promoter responsive to a fusion between 
lac repressor and the activating domain of virion protein 16 (VP16) of herpes simplex virus 
(HSV; lawbow at al., 1990; Baim et a/., 1991). 
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Studies have shown that utility of the lac repressor I operator system in mammalian cells is 
limited since the inducer isopropyl ,8-D-thiogalactopyranoside (IPTG), despite its rapid 
uptake and intracellular stability (Wyborski and Short, 1991), acts rather slowly and 
inefficiently, resulting in only moderate induction. 
The tetracycline-resistance (tet) operon identified as·a set of prokaryotic control elements, 
has also been characterised as functional in higher eukaryotic cells (Gossen and Bujard, 
1992; Gossen et al., 1995), without the interference of phYSiological processes. 
In E. coli, the tetracycline repressor protein (TetR) negatively regulates the genes of the tet 
operon on the Tn10 transposon. The TetR blocks transcription of these genes by binding 
to the tetracycline operator sequences (tetO) in the absence of tetracycline (Tc) (Figure 
4.1A-C). The TetR and tetO provide the basis of the tetracycline-Off (Gossen and Bujard, 
1992) and-On (Gossen et al., 1995) inducible systems developed for use in mammalian 
cell lines, such as CHO and Hela. 
The Tetracycline inducible (Tet) system is comprised of two plasmid-based vectors. The 
first vector (pTet-Off I pTet-On depending on the system of choice) contains the first 
critical component of the Tet system, which is the regulatory protein based on the TetR. In 
the Tet-Off system, this protein is a fusion of amino acids 1-207 of the TetR and the C-
terminal 127 amino acids of the HSV VP16 activation domain (Triezenberg et al., 1988). 
The VP16 domain converts the TetR from a transcriptional repressor to a transcriptional 
activator, the resulting chimeric protein is known as the tetracycline-controlled 
transactivator (tTA; Gossen and Bujard, 1992). The gene encoding tTA has been 
SUbseqUently placed under the control of the human cytomegalovirus immediate early 
(CMVie) promoter, to derive the pTet-Off regulator plasmid. 
The Tet-On system is very similar to Tet-Off. However, the regulatory protein is based on 
a reverse TetR (rTetR), which has been created by 4 amino acid changes in the TetR 
(Hillen and Berens, 1994; Gossen et al., 1995). The rTetR is fused with the VP16 
activation domain to generate the reverse tTA (rtTA). The resulting protein, rtTA is 
enCOded by the pTet-On regulator plasmid (Figure 4.2). Both pTet-On I Off regulator 
Plasmids also include a neomycin-resistance (Ned) gene to permit selection of stably 
transfected cell line. 
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A 
Transcription 
tetR gene tetPR 01 O2 tetPA tetA gene 
promoter v __ -~J promoter 
tet operator 
B 
T etR ---=:::::--_ 
Transcription Transcription 
.... ---X----~ r----X---~ 
tetR gene tetPR 01 O2 tetPA tetA gene 
promoter ' V" J promoter 
tet operator 
C 
, Tetracycline 
~ 
"-
\., . TetA 
•• ~ 
t 
Transcription Transcription 
t 
tetR gene tetPR 01 O2 tetPA tetA gene 
promoter ' 'V" promoter 
tet operator 
Figure 4.1A-C: Schematic of the mechanism of regulation from the Tn10-encoded Tc-
~eSistanc~ operon in E. coli. A I B: In the absence of tetracycline (Tc), expressed TetR 
orms a dlmer and binds to the two tandem tet operators 01 and O2 located between tetA 
~nd te~R. The affinity of TetR to operator O2 is about 2-5 fold higher than it is to operator 
t 1. ThiS causes TetR to bind operator O2 first, which means the tetPR promoter retains 
~ansc.riptional activity and tetR is expressed, whilst the tetPA promoter is repressed and no 
etA IS produced (A). Subsequent binding of both operators renders tetPA and tetPR 
jromoters transcriptionally repressed therefore neither tetA or tetR are expressed (B). C: 
en the p~esence of Tc, Tc binds the TetR-operator complex and triggers a conformational 
f hange In TetR so it can no longer bind to the tet operator, enforcing rapid dissociation 
;om the DNA. The dissociation of TetR from the tet operator, activates tetPA and tetPR 
~ter activity and tetA or tetR expression. 
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The second critical component is the response plasmid (pTRE), which expresses a 
heterologous gene of interest under the control of the tetracycline-response element 
(TRE). The TRE consists of seven tandem repeats of a 42-bp sequence containing the 
teto, and is located just upstream of the of the minimal CMVia promoter (Gossen and 
BUjard, 1992), which lacks the strong enhancer elements normally associated with the 
CMVie. Because these enhancer elements are missing, there is no leaky expression of 
the heterologous gene from the TRE I minimal CMVia promoter in the absence of binding 
tTA or rtTA (Figure 4.2). 
The ultimate goal in setting up a functional Tet system is to create a double-stable Tet cell 
line, which contains both the regulatory and response plasm ids. When cells containing 
both pTet-On (or pTet-Off) and pTRE (includes the heterologous gene of interest), the 
heterologous gene is expressed upon binding of the (r)tTA protein to the TRE (Figure 
4.2). The Tet-Off system operates by tTA binding to the TRE in the absence of Tc or 
doxycycline (Oox), whilst the Tet-On system work by rtTA binding to the TRE in the 
presence of Oox. 
The Tet systems have been shown to modulate gene expression 105-fold (Gossen and 
BUjard, 1992) from the repressed state to the activated state. The very tight control of 
gene expression has earned it increasing popularity since its development (Gatz and 
Quail, 1988; Gossen and Bujard, 1992) and it has been successfully employed in a 
number of studies (Oamke at a/:, 1994; Resnitzky at al., 1994; Yin and Schimke, 1995; 
Gallagher at al., 2003; Martel-Renoir at al., 2003; Modha at al., 2003; Qu at al., 2004). 
The Tet system has also been shown to function as a tetracycline-regulated transcriptional 
system with high induction rates in several other eukaryotic systems, including plant cells 
(Gatz and Quail, 1988; Gatz at al., 1992), transgenic mice I rats (Fishman at al., 1994; 
Efrat at al., 1995; Ewald at al., 1996; Kistner at al., 1996; Mayford at al., 1996; Harding at 
al., 1998), Drosophila spp. (Bello at al., 1998) and a variety of cells infected with virus (Kim 
et al., 1995; Hwang at al., 1996). 
StUdies by Wu at al. (2000) have demonstrated the functional activity of the Tet-Off system 
in' Insect cells. However, levels of tTA were considerably low and the heterologous gene 
. activity observed was exceptionally weak. These studies concluded that the activity of the 
CMVie promoter in insect cells was very weak (these findings correlate with results 
Obtained in Chapter 3, showi~g the CMVia promoter is transcriptionally weak in insect 
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cells, Figures 3.3, 3.11 A I B), and that promoters with stronger transcriptional activity 
were required to drive the Tet system in insect cells . 
To develop a Tet system for use in Sf9 and T.ni HiS cells, it was necessary to replace the 
CMVie promoters of the Tet system with promoters capable of high-level foreign gene 
expression in lepidopteran cells. Work described in chapter 3 has characterised the 
Bombyx mori cytoplasmic actin 3 promoter / enhancers (8m A3+E), and the Orgyia 
pseudotsugata MNPV ie-2 promoter, as functionally strong in lepidopteran cells . These 
promoters were identified as potential candidates for replacing the CMVie promoters of the 
Tet-On system. 
pTet-On 
pTRE2 
CMVie promoter 
Transcription 
r ----X---~ 
TRE P min Gene of 
CMVie interest 
rtTA 
I 
rtetR VP16AD 
I 
Removal of 
dox 
........................ .::::::::=:=-~~.&;;;:. ......... . 
TRE Gene of 
interest 
~igure 4.2: Schematic of gene regulation in the Tet-On System. The Tetracycline 
eSponse element (TRE) is located upstream of the minimal cytomegalovirus immediate 
~arly gene promoter (PminCMVie) , which is silent in the absence of activation. The 
~~erse .tetracycline transcriptional activator (rtTA) is express~d . con~titutively from pTet-
d ' Which binds the TRE (pTRE2) and activates transcription In the presence of 
a oXYCycline (dox). When dox is remove the rtTA no longer has the properties to bind TRE 
nd trans . . 
~cnptlon is silent. 
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This chapter describes the construction of two plasmid-based expression vectors, which 
were used in an attempt to develop an inducible expression system for use in insect cell 
lines. Elements of the "Express Insect''' system", "lnsectSelect''''' (InvitrogenT") and 'Tet-
On™ system" (BD Biosciences Clontech) were used in the construction of this system. The 
gene cat (as described in Sections 1.7.2 and 3.1) was used as a reporter to determine 
functional promoter activity. 
4.2 Construction of the insect Tet regulatory vector 
Construction of the insect Tet regulatory plasmid required placing the regulatory gene rtTA 
from pTet-On (Figure 4.3) under the control of a strong promoter, functional in 
lepidopteran cells. 
~ 
Amp' gene 
Neo' gene 
,-J---.. 
L.,J 
SV40 early 
promoter 
rtetR VP16AD 
coding region coding region 
~,-J---.. 
'" ...... --yr-~) "''--~vr--~~ L.,J 
CMVie 
promoter 
rtTA gene SV40 early 
poly-A 
Figure 4.3: Genetic map of pTet.On (BD Biosciences, Clontech) shows the CMVie 
pro~oter, rtetR / VP16AD, fusion, which encodes the rtTA gene, SV40 early poly-A coding 
~on, SV40 early promoter, neomycin resistance (Ned) gene and Ampr gene. 
Of the promoters tested in this thesis (Chapter 3) the OpMNPV ie-2 and 8m A3+E 
promoters were identified as transcriptionally strong in lepidopteran cells. Comparison of 
eXpression levels from these promoters revealed not a great deal of difference. However, 
for technical reasons the 8m A3+E promoter was used to transcribe rtTA. The main 
technical problem was the removal of rtTA from pTet-On for insertion downstream of the 
°pMNPV ie-2 promoter in pIZTN5-His, as no compatible restriction sites flanked rtTA. 
The vector pXINect.DEST38 containing 8m A3+E utilises the efficient Gateway"M TOPO® 
Cloning technology (Section 1.6). This allows for fast and efficient cloning of foreign 
genes, compared to the conventional ligation dependent method, used to place foreign 
genes downstream of promoters. Due to the nature of TOPO® cloning, the rtTA gene was 
first inserted into an entry plasmid (pENTRlD-TOPO) to produce an entry clone. 
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For insertion of rtTA into pENTRlD-TOPO, primers were designed to amplify the rtTA 
Coding-region from pTet-On. Amplification of rtTA using PCR (Section 2.5.5) was carried 
out. The results shown in Figure 4.4 clearly show, in lanes 2-5, amplified DNA fragments 
of a size relative to the rtTA gene (1010-bp). 
Molecular wt 
marker 
1010-bp 
Figure 4.4: Analysis of the amplification of the rtTA-coding region from pTet-On, using 
PCR (Section 2.5.5). Positive amplified rtTA coding regions produced DNA fragments 
banding at 101 O-bp (rtTA). The above gel shows: 
Track 1: 
Track 2-5· - . 
Smart Ladder (Eurogentec 1 kb) 
Positive amplification of the rtTA coding region 
The rtTA gene was purified (Section 2.5.7.2) and cloned into pENTRlD-TOPO (Section 
2.5.12). Positive clones were identified using the restriction enzymes Xbal and Hind II I 
(Section 2.5.1 ; data not shown). The correct sequence of rtTA was confirmed by 
sequencing (Section 2.5.8). The resulting entry clone pENTRID-TOPO.rtTA was derived 
(Figure 4.5). 
L.y--J 
Kad gene T1 
CCC TTC ACC rtTA AAG GGT 
Not I GGG AAG TGG gene TTC c Ase I 
~ ----.J \.~_~ 
------y- Y 
a ttL 1 rtTA gene 
) "---y---J 
attL2 
Fig~re 4.5: Genetic map of pENTR.D.TOPO.rtTA, shows the Kad gene, pUC origin of 
~ation, T1 / 72 , attL 1 / attL2 recombination sites with tTA inserted. 
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The rtTA gene was subsequently inserted into pXINsect-DEST38 expression vector, using 
TOPO site-specific recombination between the entry clone (pENTR/D-TOPO.rtTA) and the 
linearised destination vector (pXINsect-DEST38; Section 2.5.12). Positive clones were 
identified using the restriction enzyme Xbal (Section 2.5.1; Figure 4.6) and the resulting 
plasmid was named pBmA3+E.rtTA (Figure 4.7). 
Molecular wt 
marker 
10000-bp 
6000-bp 
1000-bp 
11000-bp 
1008-bp 
~igure 4.6: Analysis of plasmid DNA, to positively identify the insertion of the rtTA gene 
Into pXINsect-DEST38 to derive pBmA3+E.rtTA. 
Plasmid DNA was extracted from the E. coli TOP10 bacterial strain by mini-prep 
PUrification (Section 2.5.9.1). Plasmid DNA was cut using the restriction enzyme Xbal 
(Section 2.5.1), and run on a 0.7% agarose gel (Section 2.7.1). 
~Ositive clones with the rtTA coding region produced two DNA fragments banding at 1008-
P (rtTA) and 11000-bp (linear pXINsect-DEST38). The-above gel shows: 
Track 1: 
Track 2-4: 
Track 5· - . 
Smart Ladder (Eurogentec 1 kb) 
pBmA3+E.rtTA I Xbal positive clones 
pBmA3+E.rtTA I uncut 
Sma I 
BmNPV ie-1 Ec047 I eee TTC ACC rtTA AAG GGT Xba I 
Promoter I gene Not IGGG AAG 
~ c..:....:......r---'--' TGG gene TTC .2 AS[ INrtll . _ 
'-y---J "---y--l \. ..... ---.y~-----") 
Ampr gene BmNPV hr3 Bm A3 attL rtTA gene 
Coding promoter 
region 
a ttL BmActin 
poly-A 
Figure 4.7: Genetic map of pBmA3+E.rtTA, shows the Ampr gene, BmNPV ie-1 promoter I 
gene, BmNPV hr3 coding region, Bm A3 promoter with rtTA inserted downstream, a ttL 1 I 
~ecombination sites, and the Bm actin poly-A coding region. 
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4.3 Transient expression of the rtTA gene in insect cells 
Transient expression of rtTA from the BmA3+E promoter in insect cells was evaluated to 
determine, firstly, if the production of rtTA was at suitable levels required for the insect tet 
response vector to work, and secondly, to confirm that the levels of rtTA produced were 
not cytotoxic to the host cells used. This was important as there is evidence to suggest 
over-expression of rtTA can have detrimental effects on host cells, if levels produced are 
above the critical threshold of the cell (Bujard, 1999). A comparison of rtTA expression 
from the CMVie (in pTet-On) and BmA3+E (in pBmA3+E.rtTA) promoters jn insect cells 
Was undertaken to compare level of rtTA produced. 
Sf9 and T.ni HiS cells were seeded (Section 2.2.3) into 3Smm tissue culture dishes, and 
left to adhere for 1 h. The cell mono-layers were transfected (Section 2.2.4) using 1Jlg of 
plasmid DNA (pBmA3+E.rtTA or pTet-On). Transfections were carried out in triplicate. 
Cells were harvested after 24, 48 and 72 h incubation at 28°C. Standard amounts of total 
protein (2SJl9: Section 2.7.4) from each sample were subjected to SDS-PAGE and 
Western blot analysis (Section 2.7.S, 2.7.6). 
Figure 4.8 shows results obtained for rtTA expression from the BmA3+E promoter in Sf9 
(A) and T.ni HiS (B) cells. Qualitative analysis of rtTA production using a polyclonal 
antibody specific to the VP16 domain (BD Biosciences) of rtTA (molecular weight 37 kDa), 
Showed no detectable levels of rtTA in mock-transfected Sf9 or T.ni HiS cells (A I B: lane 
MT). In both cell lines transfected with pBmA3+E.rtTA, production of rtTA was observed at 
24-72 hpt (A I B: lanes 24-72). The levels of rtTA produced from the BmA3+E promoter 
Were Shown to vary between the cell lines used, without detrimental effects to the cells. 
The highest level of rtTA produced was observed in T.ni HiS cells, at 24-48 hpt (visual 
Observation: B: lanes: 24-48): at 72 hpt (B: lane 72) levels were shown to decrease. 
PrOduction of rtTA in Sf9 cells was shown to peak at 48 hpt, while producing relatively 
Similar levels at 24 and 72 hpt (A: lanes 24-72). 
Figure 4.8 also shows results obtained for rtTA expression from CMVie in Sf9 (C) and T.ni 
HiS (0) cells. The production of rtTA was not observed in mock-transfected cells (C I 0: 
lane MT). Expression of rtTA from the BmA3+E promoter at 72 hpt was incorporated as a 
Positive control (C I 0: lane +ve). In both cell lines transfected with pTet-On, no 
detectable levels of rtTA were observed at 24-72 hpt (C I 0: lanes 24-72). 
" 
115 
Chapter 4 Inducible expression system 
The insect Tet regulatory plasmid (pBmA3+E.rtTA) was shown to produce detectable 
levels of rtTA in Sf9 and T.ni HiS cells, without detrimental effects to the cells (cell viability 
studies Section 4.4, data not shown). However, pTet-On produced no detectable levels of 
rtTA. The functional working of the insect Tet regulatory plasmid meant this vector could 
be used to generate stable insect cell lines expressing rtTA, which would be used to test 
the insect Tet response plasmid (Section 4.S). 
A: BmA3+E romoter in St9 cells 
MW MT 24 48 72 
37.4 kOa ~ ~ 37kOa 
B: BmA3+E romoter in T.ni HiS cells 
MW MT 24 48 72 
37.4 kOa ~. ~ 37kOa 
C: CMVie promoter in St9 cells 
MW MT +ve 24 48 72 
37.4 kOa ~ ~ 
0: CMVie promoter in T.ni HiS cells 
MW MT +ve 24 48 72 
37.4 kOa ~ - ~ ....... 
Figure 4.8A-0: Western blot analysis of Sf9 and T.ni HiS cells transfected with 1 Jlg of 
pBmA3+E.rtTA (A I B) or pTet.On (C I 0). In all panels, lane MW shows a protein marker 
(Invitrogen). Lane MT shows intracellular cell extract (2SJlg I lane) from mock-transfected 
Sf9 and T.ni HiS cells (negative control). A I B: Lanes 24-72 shows intracellular cell 
extract (2SJlg I lane) from Sf9 (A) and T.ni HiS (B) cells transfected with 1 Jlg of 
pBmA3+E.rtTA, 24-72 hpt. C I 0 : Lanes +ve shows intracellular cell extract (2SJlg I lane) 
from Sf9 (C) and T.ni HiS (0) cells transfected with 1 Jlg of pBmA3+E.rtTA, 72 hpt (positive 
control). Lanes 24-72 show intracellular cell extract (2SJlg I lane) from Sf9 (C) and T.ni HiS 
(0) cells transfected with 1Jlg of pTet-on, 24-72 hpt. Position of molecular weight (MW) 
size marker is shown in kDa and the position of rtTA is indicated (37kDa). 
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4.4 Production of stable insect cell lines expressing rtTA 
Having constructed and transiently tested the insect Tet regulatory plasmid (Section 4.3), 
the next step was to produce stable Sf9 and T.ni HiS cells expressing rtTA. These cell 
lines provided constitutive expression of rtTA, which was required to activate gene 
expression in the presence of the Tet response plasmid and inducer (Section 4.1). 
Stable Sf9 and T.ni HiS cell lines were produced as described in Section 2.2.5. Co-
transfection of pBmA3+E.rtTA (900ng) with a second plasmid (pBmA:neo, 100ng) carrying 
a dominant selectable marker, Nad, was used for this purpose (Section 3.1; Jarvis at a/., 
1990). Transient transfection of pBmA3+E.rtTAinto Sf9 and T.ni HiS calls was used as a 
Positive control (Section 4.3). Analyses of transient and stable expression of rtTA was 
determined by SOS-PAGE 1 Western blot analysis (Sections 2.7.5/2.7.6). To determine 
cell viabilities at each passage, trypan blue staining (Section 2.2.6) was used. 
Figure 4.9A 18 shows results obtained for passages 1-7 of Sf9 (A) and T.ni HiS (8) cells, 
stably expressing rtT A. The production of rtTA was not observed in mock-transfected cells 
(lane MT). Transient expression of rtTA from the BmA3+E promoter at 24 hpt (lane +ve) 
Was detected (positive control). Stable production of rtTA from passages 1-7 was 
observed in both cell lines used (lanes 1-7). The levels of rtTA produced from passage 1-
7 Were shown to be highly consistent. No apparent visible difference in the levels of rtTA 
could be detected between these cell lines (equal amounts of total protein [25mg] were 
loaded in each lane). 
The stable cell lines generated above were named Sf9.rtTA and T.ni (Hi5).rtTA. The 
viability of these cell lines was determined before each passage, and was shown to vary 
between 88-98% in Sf9.rtTA and 86-92% in T.ni (Hi5).rtTA cells (data not shown). These 
stable cell lines will be used to test the functionality of the insect Tet response plasmid as 
described in Section 4.5. 
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A: Sf9 cells 
passage number 
~-------------~-------------~ 
MW MT +ve 1 2 3 4 S 6 7 
37.4kDa~ ..... 37kDa 
B: Tni. HiS cells 
passage number 
~-------------~-------------~ 
MW MT +ve 1 2 3 4 S 6 7 
37.4kDa~ ..... 37kD 
Figure 4.9A I B: Western blot analysis of Sf9 (A) and T.ni Hi5 (B) cells stably expressing 
rtTA. In panels A I Blane MW shows a protein marker (Invitrogen). Lane MT shows 
intracellular cell extract (25fl9 / lane) from mock-transfected Sf9 and T.ni Hi5 cells 
(negative control). Lane +ve shows intracellular cell extract (25fl9 / lane) from Sf9 and 
T.ni Hi5 cells transfected with 1 fl9 of pBmA3+E.rtTA, 24 hpt (positive control). Lane 1-7 
shows intracellular cell extract (25fl9 / lane) from passages 1-7 of Sf9 (A) and T.ni Hi5 (B) 
cells stably expressing rtTA. Position of molecular weight (MW) size marker is shown in 
kDa and the position of rtTA is indicated (37kDa). 
4.5 Construction of the insect Tet response vector 
The original Tet response plasmid (pTRE; Figure 4.10), designed for the use in 
mammalian cell lines, contains the minimal CMVie promoter (Section 4.1). Whilst this 
vector has been shown to function in insect cells, the levels of expressed protein were 
minimal (Lee et al. , 1998; Wu et al., 2000). To overcome this problem it was suggested 
that by replacing the minimal CMVie promoter of with a strong promoter capable of 
functioning in lepidopteran cells, the inducible system could be adapted for use in insect 
cells. 
The baculovirus OpMNPV ie-2 promoter was chosen to replace the minimal CMVie 
promoter of pTRE, as it has a strong transcriptional activity with a cis-activating enhancer 
sequence integrated into the short promoter sequence (Chapter 3). The BmA3 promoter 
relies on cis and trans-activating enhancers external to the promoter, which would have 
made using this promoter very difficult to engineer into a new vector. Also due to the 
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dependence of the external enhancers boosting the transcriptional activity of the BmA3 
promoter, regulating transcription from this promoter would be very difficult. 
TRE coding PminCMVie 
region promoter 
~
\. y ) '--~ \.~---..., .-------) ----y- v 
Amp' gene Tet-responsive MCS p-globin 
promoter poly-adenylation 
~ 
Col E1 origin 
of replication 
Figure 4.10: Genetic map of pTRE, shows the Amp' gene, tetracycline response element 
(TRE) fused to the PminCMVie promoter (this makes the Tet-responsive promoter), MCS, 
p-globin poly-adenylation coding region, and Col E1 origin of replication. 
The pTRE was used as a backbone plasmid for the development of the insect Tet 
response plasmid. Modifications to pTRE involved removing the minimal CMVie promoter 
followed by the insertion of OpMNPV ie-2 immediately downstream of the TRE (Figure 
4.11A-C). The minimal CMVie promoter is flanked by the restriction enzyme sites Asp71BI 
and these sites were used to excise (Section 2.5.1) the promoter sequence from pTRE 
(Figure 4.11A-B) to derive pTRE~. The OpMNPV ie-2 promoter was amplified (Section 
2.5.5) from pIZTN5-His using peR. The flanking regions of OpMNPV ie-2 were modified 
to incorporate Asp71BI restriction sites for insertion of the promoter into the modified 
promoter-less pTRE~ vector (Figure 4.11B). The Asp71BI-digested pTRE~ vector was 
shrimp alkaline phosphatase-treated to prevent self-ligation (Section 2.5.3), and the 
OpMNPV ie-2 promoter inserted (Section 2.5.4) to derive pTRE~.ie-2 (Figure 4.11C). 
Digestion using Hindlll identified the correct orientation of the OpMNPV ie-2 promoter. 
Subsequently, the OpMNPV ie-2 promoter region was sequenced (Section 2.5.8) to 
confirm sequence integrity. 
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A 
B 
c 
7 
x7 tetO (42-bp repeats) 
TRE coding region 
Pmin CM Vie 
promoter MCS 
--------------------~----------------------
~ __ ~A~ __ ~~ ____ ~A _____ ~ 
"I 
x7 tetO (42-bp repeats) 
TRE coding region 
1319 
Asp71BI (304) 
--------------------~----------------------
,~~I~~i~~i~~~~~~1 1 
91 133 175 217 
438 
Asp71BI (462) 
MCS 
r,.--~A---.., 
Asp71BI 
x7 tetO (42-bp repeats) 
TRE coding region 
OpMNPV ie-2 
312 promoter MCS 
Xho 1(2) 
I Hind III (869) I Hind 111 1(928) 
Asp71BI (304) Asp71BI (875) 
Figure 4.11A: Genetic map of pTRE (Figure 4.10), shows the restriction sites Asp71BI 
bisecting the PminCMVie promoter, and the tetracycline response element (TRE), which is 
constructed from seven tetracycline operator sequences (x7 tetO) 42-bp in length. B: The 
PminCMVie promoter was excised from pTRE on an Asp71BI fragment to generate a 
linear promoter-less pTRE~ vector, which was used for the insertion of the OpMNPV ie-2 
promoter. C: Genetic map of pTRE~.ie-2 ; pTRE~ .ie-2 is similar to pTRE except the 
OpMNPV ie-2 promoter has been cloned in place of the PminCMVie promoter. 
4.6 Problems encountered during the construction of the insect Tet 
response vector 
Having produced the expression vector pTRE~.ie-2 , the reporter gene cat was chosen to 
analyse expression from the insect Tet-responsive promoter (TRE I OpMNPV ie-2 
promoter). In order to do this cat was cloned into pTRE~.ie-2 . The cat gene was excised 
from p1ZTN5-His (Section 2.5.1) on a 8amHI and Notl fragment and cloned into 
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complementary restriction enzyme sites of pTREi\.ie-2, downstream of the insect Tet-
responsive promoter, to derive pTREi\.ie-2.cat (Figure 4.12). pTREi\.ie-2.cat was used to 
transfect (Section 4.7) normal Sf9 and T.ni HiS cells, as well as the stably transformed cell 
lines expressing rtTA (Sf9.rtTA and T.ni (HiS).rtTA; Section 4.4). All cell lines transfected 
with pTREi\.ie-2.cat were analysed for CAT expression in an induced and non-induced 
state. 
TRE coding OpMNPV ie-2 
------------Amp'gene 
region promoter BamH I Not I 
'----,y,.------.Iy' Y ) Ly-J 
cat MCS J3-globin Col E1 origin 
gene poly-adenylation of replication 
Figure 4.12: Genetic map of pTREi\.ie-2.cat, pTREi\.ie-2.cat is similar to pTREi\.ie-2 
described in Figure 4.11 C, except the cat gene has been cloned into the BamHI and Notl 
restriction sites. 
During analyses to confirm the identity of pTREi\.ie-2.cat, it became apparent that a 
contaminant plasmid was present at high levels in the stocks of purified pTREi\.ie-2.cat 
(Figure 4.13). Repeated attempts to isolate pTREi\.ie-2.cat from the contaminating 
plasmid failed. Experiments to determine where the contaminant came from failed to 
produce a definitive answer, although the original stock of pTRE bought from BD 
Biosciences was suspected. Therefore, the initial pTREi\.ie-2.cat ligation stock, which 
yielded the original pTREi\.ie-2.cat was re-transformed (Section 2.4.3), and a new stock of 
pTREi\.ie-2.cat, without the contaminating DNA was eventually derived (Figure 4.14), 
called pTREi\.ie-2.cat2. However, a second problem was then identified; enzymatic digest 
profiles revealed an estimated 210-bp had been deleted from pTREi\.ie-2.cat2 (Figure 
4.14). To confirm this plasmid was pTREi\.ie-2.cat2, primers were designed to amplify the 
OpMNPV ie-2 promoter and cat coding-region. The OpMNPV ie-2 promoter and cat 
coding-region were amplified from both pTREi\.ie-2.cat and pTREi\.ie-2.cat2 using PCR 
(Section 2.S.S; Figure 4.15). The results shown in Figure 4.15 clearly show in lane 3 an 
amplified DNA fragment of a size relative to the OpMNPV ie-2 I cat coding-region 
amplified from pTREi\.ie-2.cat (lane2; 1297-bp). Sequencing of these regions were also 
confirmed as authentic. However, this does not confirm the whereabouts of the deletion in 
the pTREi\.ie-2.cat2 vector. 
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Molecular wt 
marker 
6000-bp (C) 
4140-bp 
1000-bp 
Inducible expression system 
UC+C 
726-bp 
Figure 4.13: Analysis of plasmid DNA, to positively identify pTREil.ie-2.cat. 
Plasmid DNA was extracted from the E. coli TOP1 0 bacterial strain by large scale plasmid 
DNA purification (Section 2.5.9.2). Plasmid DNA was cut using the restriction enzymes 
BamHI and Notl (Section 2.5.1), and run on a 0.7% agarose gel (Section 2.7.1). 
Positive identification of pTREil.ie-2.cat produced two DNA fragments banding at 726-bp 
(cat) and 4140-bp (linear pTREil.ie-2). The above gel shows: 
Track 1: 
Track 2: 
Track 3: 
Smart Ladder (Eurogentec 1 kb) 
pTREil.ie-2.cat / BamHI / Notl (4140 / 726-bp) + contaminant (C) DNA 
(6000-bp) 
pTREil.ie-2.cat / uncut (UC) + contaminant DNA (6000-bp) 
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marker 
5000-bp 4656-bp 
4000-bp 39831 3899-bp 
3226-bp 
2000-bp 
1500-bp 1430-bp 
1000-bp 
800-bp 757-bp 
600-bp 
673-bp 
Figure 4.14: Restriction enzyme digest analysis of pTRE~.ie-2.cat2. 
Plasmid DNA was cut using the restriction enzymes BamHI, Xholl BamHI, BamH11 Xbal, 
and Xholl Xbal (Section 2.5.1), and run on a 0.7% agarose gel (Section 2.7.1). 
The pTRE~.ie-2.cat2 plasmid is 4856-bp (linear), although the restriction profiles shown in 
tracks 2-5 revealed an estimated 200-bp decrease in size. The above gel shows: 
Track 1: 
Track 2: 
Track 3: 
Track 4: 
Track 5: 
Smart Ladder (Eurogentec 1 kb) 
pTRE~.ie-2.cat21 BamHI (predicted size 4886-bp, actual size 4656-bp) 
pTRE~.ie-2.cat2 I Xholl BamHI (predicted size 3983 I 883-bp, actual size 
3983 I 673-bp) 
pTRE~.;e-2.cat2 I BamH11 Xbal (predicted size 4109 I 757-bp, actual size 
3899 I 757-bp) 
pTRE~.ie-2.cat2 I Xhol I Xbal (predicted size 3226 I 1640-bp, actual size 
3226 I 1430-bp) 
The next region of the pTRE~.ie-2.cat2 vector to be checked for authenticity was the TRE 
cOding-region. Primers were designed to amplify the TRE 15' OpMNPV ;e-2 coding-region 
from pTRE~.ie-2.cat2 and pTRE~.ie-2 .cat vector (positive control). Amplification of TRE I 
5' OpMNPV ie-2 coding-region using peR (Section 2.5.5) was carried out. The results 
shown in Figure 4.16 show, in lane 2, the positive amplification of the TRE 15' OpMNPV 
ie-2 coding region (611-bp) from the positive control. Whilst, in lane 3, a DNA fragment of 
401-bp was amplified from the pTRE~.ie-2.cat2 vector, which does not correlate with the 
size of the TRE I 5' OpMNPV ie-2 coding region, but reveals a difference in size of 21 O-bp. 
123 
Chapter 4 Inducible expression system 
As the OpMNPV ie-2 promoter has been shown previously in this chapter to be present in 
this vector, it was suggested that the deletion had occurred within the TRE coding-region. 
Subsequently the TRE and OpMNPV ie-2 coding-regions of the pTREL'de-2.cat2 plasmid 
were sequenced to confirm sequence integrity (Section 2.5.8). The correct sequence of 
the OpMNPV ie-2 coding-region was confirmed, but the sequencing data revealed that five 
of the seven tetO coding-regions had been deleted. The five tetD coding-regions deleted 
were internal repeats 2-6 (Figure 4.17A I B). 
Molecular 
marker 
1500-bp 
1000-bp 1297-bp 
Figure 4.15: Analysis of the amplification of OpMNPV ie-2 / cat coding-region from 
pTRE~.ie-2 . cat2 , using PCR (Section 2.5.5). A positive control was included, which 
involved amplifying the OpMNPV ie-2 / cat coding-region from pTRE~.ie-2 . cat. Positive 
amplification of OpMNPV ie-2 ! cat coding-region produced a DNA fragment banding at 
1297-bp. The above gel shows: 
Track 1: 
Track 2: 
Track 3: 
Smart Ladder (Eurogentec 1 kb) 
Positive amplification of the OpMNPV ie-2! cat from pTRE~.ie-2.cat 
Positive amplification of the OpMNPV ie-2 ! cat from pTRE~.ie-2.cat2 
Molecular wt 
marker 
800-bp 
600-bp 
400-bp 
611-bp 
Figure 4.16: Analysis of TRE amplification from pTRE~.ie-2.cat2, using PCR (Section 
2.5.5). A positive control was included, which involved amplifying the TRE coding-region 
from pTRE~.ie-2 . cat. Positive amplification of TRE produced a DNA fragment banding at 
611-bp. The above gel shows: 
Track 1: Smart Ladder (Eurogentec 1 kb) 
Track 2: Positive amplification of the TRE (611-bp) from pTRE~.ie-2.cat 
Track 3: Amplification of an unidentified DNA fragment (401-bp) from pTRE~.ie-2.cat2 
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A ' 
Amp' gene 
TRE coding region 
x7 tetO (42bp repeats) 
............ 
9l/// 
............. 
....... 
Inducible expression system 
OpMNPV ie-2 j3-globin 
312 promoter MCS poly-adenylation 
~ 
MCS Col E1 origin 
gene of replication 
~~----~~----~; '----------------v---------------~ 
x2 tetO 
(42bp repeats 1 and 7) 
S' OpMNPV ie-2 
promoter reoion 
Figure 4.17A I B: Analysis of the TRE / S' OpMNPV ie-2 coding-region form pTRE~je-
2,cat (A; as described in Figure 4.11) and pTRE~je-2.cat2 (B), after identification of a 
mutation, which caused 210-bp to be deleted from pTRE~je-2.cat2 . Sequencing 
identified S of the 7 tetO coding-regions (coding-regions 2-6) had been deleted from 
pTRE~je-2.cat2 leaving the remaining 2 tetO coding-regions (coding-regions 1 and 7) 
intact (B). 
Earlier studies had shown that the Tet system can work effectively with as little as one or 
two tetO cOding-regions to. suppress / activate promoter activity (Gossen and Bujard, 
1992). In light of this evidence the pTRE~je-2 . cat2 vector was established as the insect 
Tet response plasmid. 
4.7 TRE suppression of the OpMNPV ie-2 promoter in insect cells 
The construction of the insect regulatory and response plasmids (Section 4.2, 4.S), and 
subsequent generation of stable insect cell lines expressing the regulatory protein rtTA 
(Section 4.4), completed the initial development of the inducible insect expression system. 
To test the functionality of this system in illsect cells it was essential to first confirm that 
the TRE of pTRE~je-2.cat2 would repress the transcriptional activity of the OpMNPV ie-2 
promoter. In order to test this Sf9 and T.ni HiS cells were transfected with either 
pTRE~je-2.cat2 or pIZTNS-His.cat, the latter being a positive control in which OpMNPV 
ie-2 expresses cat constitutively. In addition, pTRE~je-2.cat2 and pIZTNS-His.cat 
(positive control) were transfected into the stable cell lines Sf9.rtTA and T.ni (HiS).rtTA to 
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show that in the absence of any inducer, expression of rtTA does not affect expression of 
cat. 
Sf9 or Sf9.rtTA and T.ni HiS or T.ni (HiS).rtTA cells were seeded (Section 2.2.3) into 3Smm 
tissue culture dishes, and left to adhere for 1 h. The cell mono-layers were transfected 
(Section 2.2.4) using 1Jlg of plasmid DNA (pTRE~.ie-2.cat2 or pIZTNS-His.cat). 
Transfections were carried out in triplicate. Cells were harvested after 24 h incubation at 
28°C, and CAT activity assayed. The assays were carried out in triplicate (Section 2.8.1). 
FOllowing phosphor-imaging, the percentage conversion from non-modified to the 3-
acetylated form of chloramphenicol by each cellular extract was calculated using the 
software program Image-Quant S.1 (Section 2.8.1). CAT activity was expressed as a total 
percentage conversion per 106 cells. Since the constitutive activity of the OpMNPV ie-2 
promoter has been characterised previously in S19 and T.ni HiS cells (Chapter 3; Section 
3.4) expression from this promoter was considered the basal level, and all data was 
COmpared to this (Figure 4.18A-B). Mock-transfected S19 and T.ni HiS cells were used as 
a negative control to determine non-specific background expression levels, and 
commercially purified CAT (Sigma) was used to determine 100% chloramphenicol 
Conversion (positive contrOl). Statistical analyses were carried out using the unpaired 2 
sample T -test at a 9S% confidence level. 
In all cell lines tested, no dete~table levels of CAT activity above background levels was 
observed from mock- transfected cells, or cells transfected at 0 h (Figure 4.18A-B; p>O.OS 
in all cases). 
Figure 4.18A shows results obtained from pTRE~.ie-2.cat2 (TRE I OpMNPV ie-2) and 
PIZTNS-His.cat (OpMNPV ie-2 without TRE, control) promoter activity assays in S19 and 
Sf9.rtTA cells. Expression of cat from pIZTNS-His.cat produced CAT activity levels at 24 
hpt of 35% in both S19 and S19.rtTA cells. At 24 hpt, very low levels of CAT were 
Observed from pTRE~.ie-2.cat2, which were significantly lower (S19, 1.2%; S19.rtTA, 1.3%) 
than those observed from pIZTNS-His.cat (S19, p<0.0001; S19.rtTA, p<0.0001). 
FigUre 4.18B shows results obtained from pTRE~.ie-2.cat2 (TRE I OpMNPV ie-2) and 
PIZTNS-His.cat (OpMNPV ie-2 without TRE, control) promoter activity assays in T.ni HiS 
and T.ni (HiS).rtTA cells. At 24 hpt, the levels of CAT activity detected from pIZTNS-
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His.cat was S1% in T.ni HiS and SO% in T.ni (HiS).rtTA cells. At 24 hpt, expression of cat 
from pTREilJe-2.cat2 was detected at an activity level of 3.9% in T.ni HiS and 4.2% in T.ni 
(HiS).rtTA cells. A significantly reduced level of CAT activity from pTREilJe-2.cat2 was 
observed compared with that of pIZTNS-His.cat (T.ni HiS, p<0.0001; T.ni HiS.rtTA, p<O. 
0001 ). 
These data show that the transcriptional activity of the OpMNPV ie-2 promoter was 
successfully reduced when placed downstream of the TRE (pTREilJe-2.cat2). Therefore, 
this evidence suggested that the TRE was actively suppressing the OpMNPV ie-2 
promoter. 
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Figure 4.18A: Transient CAT activity in Sf9 and Sf9.rtTA cells following, transfection with 
plasmids containing a TRE I OpMNPV ie-2 promoter (pTREilJe-2.cat2) or OpMNPV ;e-2 
promoter (pIZTNS-His.cat) to drive expression of cat in the absence of the inducer 
doxycycline. 
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Figure 4.188: Transient CAT activity in T.ni Hi5 and T.ni (Hi5).rtTA cells, following 
transfection with plasmids containing a TRE I OpMNPV ie-2 promoter (pTRE~.ie-2.cat2) or 
OpMNPV ie-2 promoter (pIZTN5-His.cat) to drive expression of cat in the absence of the 
inducer doxycycline. 
4.8 Induction of the TRE I OpMNPV ie-2 promoter in insect cells 
To determine the induction of transcriptional activity of the TRE I OpMNPV ie-2 promoter 
from pTRE~.ie-2 . cat2 by doxycycline (dox), pTRE~.ie-2.cat2 was transfected into Sf9 I 
T.ni Hi5 cells and Sf9.rtTA I T.ni (Hi5).rtTA stable cell lines (as describe in Section 4.7). 
The plasmid pIZTN5-His.cat (contains OpMNPV ie-2 without TRE, control) was 
transfected in parallel, and used as a control to determine if the inducer affected 
constitutive activity of the non-modified OpMNPV ie-2 promoter. After 5 hpt, all 
transfected cell lines were treated with 1)..Lg I ml of dox, to induce promoter activity, and 
subsequently cat expression. Cells were harvested after 24 h inCUbation at 28°C, and 
CAT activity assayed for. 
Following phosphor-imaging, the percentage conversion from non-modified to the 3-
acetylated form of chloramphenicol by each cellular extract was calculated using the 
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software program Image-Quant S.1 (Section 2.8.1). CAT activity was expressed as a total 
percentage conversion per 106 cells. Since the constitutive activity of the OpMNPV ie-2 
promoter has been characterised previously in S19 and T.ni HiS cells (Chapter 3; Section 
3.4) expression from this promoter was considered the basal level, and all data was 
compared to this (Figure 4.19A-B). Mock-transfected S19 and T.ni HiS cells were used as 
a negative control to determine non-specific background expression levels, and 
commercially purified CAT (Sigma) was used to determine 100% chloramphenicol 
Conversion (positive control). Statistical analyses were carried out using the unpaired 2 
sample T-test at a 9S% confidence level. 
In all cell lines tested, no detectable levels of CAT activity above background levels was 
observed from mock- transfected cells, or cells transfected at 0 h (Figure 4.19A-B; p>O.OS 
in all cases). 
Figure 4.19A shows results obtained from pTREAJe-2.cat2 (TRE I OpMNPV ie-2) and 
pIZTNS-His.cat (OpMNPV ie-2 without TRE, control) promoter activity assays in S19 and 
S19.rtTA cells, in the presence of dox. Expression of cat from pIZTNS-His.cat was 
observed at 24 hpt, and produced CAT activity levels of 36% in S19 and 39% in S19.rtTA 
cells. A comparison of induced vs. non-induced pIZTNS-His.cat (Figure 4.18A) OpMNPV 
ie-2 activity showed, that there was no Significant difference (S19, p=0.74S; S19.rtTA, 
P=0.264) in the levels of CAT activity detected. Consequently, the presence of the inducer 
did not interfere with the constitutive activity of this promoter. At 24 hpt, levels of CAT 
activity detected from pTREA.ie-2.cat2 was 1.3% in Sf9 and 1.8% in S19.rtTA cells. The 
levels detected were significantly lower than those observed from the pIZTNS-His.cat 
(S19, P<0.0001; S19.rtTA, p<0.0001). Comparison of CAT activity from the induced 
PTREAJe-2.cat2 with the non-induced (Figure 4.18A) showed, that there was no 
significant difference (S19, p=0.897; S19.rtTA, p=0.13S). 
FigUre 4.19B shows results obtained from pTREA.ie-2.cat2 (TRE I OpMNPV ie-2) and 
PIZTNS-His.cat (OpMNPV ie-2 without TRE, control) promoter activity assays in T.ni HiS 
and T.ni (HiS).rtTA cells, in the presence of dox. At 24 hpt, the levels of CAT activity 
detected from pIZTNS-His.cat was S6% in T.ni HiS and S2% in T.ni (HiS).rtTA cells. No 
Significant difference (T.ni HiS, p=0.340; T.ni (HiS).rtTA, p=0.609) was observed between 
the levels of CAT activity detected from pIZTNS-His.cat non-induced (Figure 4.18B) and 
the induced OpMNPV ie-2 '·promoter. The levels of CAT activity detected from the 
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pTRE~.ie-2.cat2 at 24 hpt, were shown to be 3.3% in T.ni HiS and 3.6% in T.ni (HiS).rtTA 
cells. The levels detected from pTRE~.ie-2.cat2 were Significantly lower than those 
observed from pIZTNS-His.cat (T.ni HiS, p<O.0001; T.ni (HiS).rtTA, p<O.0001). These 
data were compared with the non-induced pTRE~.ie-2.cat2 results (Figure 4.18B), which 
identified no significant difference (T.ni HiS, p=O.694; T.ni (HiS).rtTA, p=O.736) in the 
production of CAT. 
It was therefore shown that in the presence of the inducer dox, the transcriptional activity 
of the TRE I OpMNPV ie-2 promoter from pTRE~.ie-2.cat2 could not be restored to the 
levels observed from OpMNPV ie-2 of pIZTNS-His.cat. Attempts were made to activate 
the suppressed TRE I OpMNPV ie-2 promoter, by varying the concentration of dox needed 
to induce promoter activity. However, no significant effect was observed (data not shown), 
compared with the data shown in Figures 4.18 I 19 A, B. To identify if any other 
sequence element in pTRE~.ie-2.cat2 besides TRE was suppressing OpMNPV ie-2 
activity, a rescue plasmid was generated to try and restore the transcriptional activity of 
OpMNPV ie-2 in pTRE~.ie-2 . cat2. 
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Figure 4.19A: Transient CAT activity in Sf9 and Sf9.rtTA cells, following transfection with 
plasmids containing the TRE I OpMNPV ie-2 promoter (pTRE~.ie-2.cat2) or OpMNPV ie-2 
promoter (pIZTNS-His.cat) to drive expression of cat in the presence of the inducer 
doxycycline. 
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Figure 4.19B: Transient CAT activity in T.ni HiS and T.ni (HiS).rtTA cells, following 
transfection with plasmids containing the TRE I OpMNPV ie-2 promoter (pTRE~.ie-2.cat2) 
or OpMNPV ie-2 promoter (pIZTNS-His.cat) to drive expression of cat in the presence of 
the inducer doxycycline. 
4.9 Construction of the OpMNPV ie-2promoter rescue plasmid 
In the absence of the inducer, the TRE (Section 4.7) was shown to successfully suppress 
the transcriptionar activity of the OpMNPV ie-2 promoter in pTRE~.ie-2.cat2 by 99% in 
Sf9.rtTA and 98% in T.ni HiS.rtTA cells respectively. However, partial or full transcriptional 
activation of TRE I OpMNPV ie-2 was not observed in the presence of the inducer, as 
expected. By removing the TRE from pTRE~.ie-2.cat2, it was hypothesised that the 
transcriptional activity of OpMNPV ie-2 could be reconstituted. Restoration of OpMNPV 
ie-2 transcriptional activity would subsequently localise the problems observed in Section 
4.7 to the TRE coding-region. 
The TRE coding-region was removed from pTRE~.ie-2.cat2 on a Xhol I Sacl fragment 
(Section 2.S.1), and a Xhol I Sacl linker was inserted to religate the linear vector (Section 
2.S.4). The resulting plasmid pRescue.cat1 was derived (Figure 4.20). 
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Figure 4.20: Genetic map of pRescue.cat1; pRescue.cat1 is similar to pTRE~.ie-2.cat2 
described in Figure 4.12, except the TRE coding-region has been removed using the Xhol 
and Sacl restriction sites. A Xholl Sacl linker was used to relegate this v~ctor. 
Sf9 I Sf9.rtTA and T.ni HiS I T.ni (HiS).rtTA cells were seeded (Section 2.2.3) into 3Smm 
tissue culture dishes. The cell mono-layers were transfected (Section 2.2.4) using 1j..Lg of 
plasmid DNA (pTRE~.ie-2.cat2, pRescue.cat1, pIZTNS-His.cat). Cells were harvested 
after 24 h incubation at 28°C, and CAT activity quantified. 
In all cell lines tested, no detectable levels of CAT activity above background levels were 
observed from mock-transfected cells, or cells transfected at 0 h (Figure 4.21A I B; 
p>O.OS in all cases). 
Figure 4.21A shows results obtained from the non-induced pTRE~.ie-2.cat2 (TRE I 
OpMNPV ie-2), pRescue.cat1 (OpMNPV ie-2.~ TRE) and pIZTNS-His.cat (OpMNPV ie-2, 
control) promoter activity assays in Sf9 and Sf9.rtTA cells. Expression of CAT from 
pIZTNS-His.cat was observed at 24 hpt, producing CAT activity levels of 37% in Sf9 and 
36% in Sf9.rtTA cells. The levels of CAT activity detected from pRescue.cat1 (Sf9, 1.9%; 
Sf9.rtTA, 1.6%) and pTRE~.ie-2.cat2 (Sf9, 1.7%; Sf9.rtTA, 1.6%) at 24 hpt, were not 
significantly different (p>O.OS in all cases). However, the basal levels produced by 
pIZTNS-His.cat were significantly higher than those from pRescue.cat1 (Sf9, p<O.0001; 
Sf9.rtTA, p=O.003). These data show that no increase in OpMNPV ie-2 promoter activity 
was observed with the removal of the TRE from pTRE~.ie-2.cat2. 
Figure 4.21B shows results obtained from the non-induced pTRE~.ie-2.cat2 (TRE I 
OpMNPV ie-2), pRescue.cat1 (OpMNPV ie-2.~ TRE) and pIZTNS-His.cat (OpMNPV ie-2, 
control) promoter activity assays in T.ni HiS and T.ni (HiS).rtTA cells. The levels of CAT 
activity detected from pIZTNS-His.cat at 24 hpt, were 47% in T.ni HiS and 46% in T.ni 
(HiS).rtTA cells. Like the results shown in Figure 4.21A, the levels of CAT activity 
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detected from pRescue.cat1 (T.ni Hi5, 4.7%; T.ni (Hi5).rtTA, 4.6%) and pTRE~.ie-2 .cat2 
(T.ni Hi5, 4.1 %; T.ni (Hi5).rtTA, 4.4%) at 24 hpt, did not differ significantly (p>O.05 in all 
cases). A comparison of CAT activity from pRescue.cat1 and pIZTN5-His.cat shows that 
pIZTN5-His.cat produced significant more CAT activity than that observed from 
pRescue.cat1 (T.ni Hi5, p<O.0001; T.ni (Hi5).rtTA, p<O.0001). 
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Figure 4.21A: Transient CAT activity in Sf9 and Sf9.rtTA cells, following transfection with 
plasmids containing the TRE / OpMNPV ie-2 (pTRE~.ie-2.cat2), OpMNPV ie-2.~ TRE 
(pRescue.cat1) or OpMNPV ie-2 promoter (pIZTN5-His.cat) to drive expression of cat in 
the absence of the inducer doxycycline. 
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Figure 4.218: Transient CAT activity in T.ni HiS and T.ni (HiS).rtTA cells, following 
transfection with plasm ids containing the TRE I OpMNPV ie-2 (pTREd.ie-2.cat2), 
OpMNPV ie-2.d TRE (pRescue.cat1) or OpMNPV ie-2 promoter (pIZTNS-His.cat) to drive 
expression of cat in the absence of the inducer doxycycline. 
These results have shown that the removal of the TRE from pTREd.ie-2.cat2 was not able 
to restore basal transcriptional activity of the OpMNPV ie-2 promoter, as demonstrated by 
the positive control (pIZTNS-His.cat). Therefore, suppression of OpMNPV ie-2 in 
pTREd.ie-2.cat2 was not exclusively attributed to the mechanism of the TRE. Two 
hypotheses were put forward to resolve this problem. Firstly, that pTREd.ie-2.cat2 
contained DNA elements, other than TRE that might inhibit the transcriptional activity of 
OpMNPV ie-2. Secondly, that the published literature used to identify the OpMNPV ie-2 
promoter coding-region from pIZTNS-His.cat may be incorrect, and that a crucial 
sequence, not identified in the literature, was missing from the promoter sequence 
amplified. Therefore, as a consequence cause a dramatic reduction in the transcriptional 
activity of OpMNPV ie-2. This prompted the construction of a second OpMNPV ie-2 
rescue plasmid. 
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4.10 Transcriptional restoration of the OpMNPV ie-2 promoter 
To address the problems encountered in Section 4.8/4.9, a second OpMNPV ie-2 rescue 
plasmid was constructed. This vector would hopefully resolve one of two hypothesises 
proposed in Section 4.9; were there DNA sequences present in pTRE~.ie-2.cat2, other 
than TRE that may inhibit the transcriptional activity of the OpMNPV ie-2 promoter; or was 
the amplified OpMNPV ie-2 promoter from pIZTNS-His.cat missing an essential sequence 
not elucidated in the literature? However, sequencing of OpMNPV ie-2 from pTRE~.ie-
2.cat2 was confirmed with published data (Theilmann and Stewart, 1991; S~ction 4.S). 
Construction of the new rescue vector was based on the excision of the OpMNPV ie-2 
promoter and cat gene coding-region from pRescue.cat1 and insertion into a selected 
expression vector. The vector chosen for this purpose was pBacPAK9 (BD Biosciences; 
Figure 4.22A). This vector is a baculovirus transfer vector, which contains the poth 
promoter. The poth promoter cannot be trans-activated by eukaryotic RNA polymerase II, 
but only works in the presence of late / very late viral transcription factors. However, to 
rule out any possible activation of this promoter, w~ich may cause interference with the 
OpMNPV ie-2, poth was removed by restriction digestion (Section 2.S.1) from pBacPAK9 
Using EcoRV and Sma!. These restriction sites once digested generate blunt S' /3' ends, 
which were ligated together (Section 2.S.4) to derive plasmid pBacPAK9~oth (Figure 
4.228). 
The pBacPAK9~poth vector was digested using Notl (Section 2.S.1) and purified using 
column purification (Section 2.S.7.2). The OpMNPV ie-2 promoter / cat gene coding-
region of pRescue.cat1 was removed using Notl and inserted into pBacPAK9~poth. 
Digestion using BamH11 Xhol and EcoRI identified the correct orientation of the OpMNPV 
ie-2 promoter / cat gene cOding-region. The plasmid pRescue.cat2 was derived (Figure 
4.23). 
St9 / Sf9.rtTA and T.ni HiS / T.ni (HiS).rtTA cells were seeded (Section 2.2.3) into 3Smm 
tiSSue culture dishes, and left to adhere for 1 h. The cell mono-layers were transfected 
(Section'2.2.4) using 1 ~g of plasmid DNA (pTRE~.ie-2.cat2, pRescue.cat1, pRescue.cat2, 
PIZTNS-His.cat). Transfections were carried out in triplicate. Cells were harvested after 
24 h incubation at 28°C, and CAT activity assayed for. The assays were carried out in 
triPlicate (Section 2.8.1). \. 
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Figure 4.22A: Genetic map of pBacPAK9, shows the Ampr gene, AcMNPV up I 
downstream polh flanking sequences, AcMNPV polh promoter, MCS, and poly-adenylation 
coding-region. B: Genetic map of pBacPAK9~polh, which is similar to pBacPAK9 except 
the polh promoter has been removed. 
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Figure 4.23: Genetic map of pRescue.cat2, which is similar to pBacPAK9~polh (Figure 
4.20B), except the OpMNPV ie-2 promoter and cat gene coding-region have been 
inserted. 
In all cell lines tested, no detectable levels of CAT activity above background levels were 
observed from mock-transfected cells, or cells transfected at 0 h (Figure 4.21A I B; 
p>0.05 in all cases). 
Figure 4.24A shows results obtained from the non-induced pTRE~.ie-2 .cat2 (TRE I 
OpMNPV ie-2), pRescue.cat1 (OpMNPV ie-2.~ TRE), pRescue.cat2 (OpMNPV ie-2 
rescue) and pIZTN5-His.cat (OpMNPV ie-2, control) promoter activity assays in Sf9 and 
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S19.rtTA cells. The levels of CAT activity detected from pIZTNS-His.cat at 24 hpt (36% in 
both cell lines used), were determined as the basal transcriptional activity of the OpMNPV 
ie-2 promoter. Expression of cat from pTREilJe-2.cat2 and pRescue.cat1 at 24 hpt, were 
similar to that shown in Figure 4.21A; although CAT activity was detected, the levels were 
significantly lower than those observed from pIZTNS-His.cat (p<O.OS in all cases). The 
production of CAT from pRescue.cat2 was observed at 24 hpt; the levels of CAT activity 
detected (S19, 24%; S19.rtTA, 26%) were shown to be significantly higher than those 
observed from pTREilJe-2.cat2 and pRescue.cat1 (S19, p=0.003; S19.rtTA, p=0.003). 
However, the levels of CAT activity produced from pRescue.cat2 were still significantly 
lower than those observed from pIZTNS-His.cat (S19, p=0.010; S19.rtTA, p=0.018). 
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Figure 4.24A: Transient CAT activity in S19 and S19.rtTA cells, following transfection with 
plasmids containing the TRE I OpMNPV ie-2 (pTREilJe-2.cat2), OpMNPV ie-2.il TRE 
(pRescue.cat1), OpMNPV ie-2 rescue (pRescue.cat2) or OpMNPV ie-2 promoter 
(pIZTNS-His.cat) to drive expression of cat in the absence of the inducer doxycycline. 
Figure 4.248 shows results obtained from the non-induced pTREilJe-2.cat2 (TRE I 
OpMNPV ie-2), pRescue.cat1 (OpMNPV ie-2.il TRE), pRescue.cat2 (OpMNPV ie-2 
rescue) and pIZTNS-His.cat (OpMNPV ie-2, control) promoter activity assays in T.ni HiS 
and T.ni (HiS).rtTA cells. The levels of CAT activity detected from pIZTNS-His.cat at 24 
hpt (56% in both cell lines), were determined as the basal activity of the OpMNPV ie-2 
promoter. The pTREilJe-2.cat2 and pRescue.cat1 produced very low levels of CAT 
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activity at 24 hpt (as seen previously in Figure 4.21B). However, the levels produced did 
not significantly differ between these promoters tested (p>O.OS in all cases); although the 
levels were significantly lower than those detected from pIZTNS-His.cat (p<O.OS in all 
cases). The pRescue.cat2 produced significantly higher levels of CAT activity (T.ni HiS, 
37%; T.ni (HiS).rtTA, 39%) than those observed from the pTRE~.ie-2.cat2 (T.ni HiS, 4%; 
T.ni (HiS).rtTA, S%) and pRescue.cat1 (T.ni HiS, 4%; T.ni (HiS).rtTA, 4%; T.ni HiS, 
p=O.006; T.ni (HiS).rtTA, p=O.004). Conversely, the levels of CAT activity produced from 
pRescue.cat2 were shown to be significantly lower than those observed from pIZTNS-
His.cat (T.ni HiS, p=O.020; T.ni (HiS).rtTA, p=O.002). 
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Figure 4.24B: Transient CAT activity in T.ni HiS and T.ni (HiS).rtTA cells, following 
transfection with plasmids containing the TRE I OpMNPV ie-2 (pTRE~.ie-2.cat2), 
OpMNPV ie-2.~ TRE (pRescue.cat1), OpMNPV ie-2 rescue (pRescue.cat2) or OpMNPV 
ie-2 promoter (pIZTNS-His.cat) to drive expression of cat in the absence of the inducer 
doxycycline. 
It was therefore shown that, even though complete transcriptional activity of OpMNPV ie-2 
rescue was not restored (pRescue.cat2) , compared with the levels observed from 
pTRE~.ie-2.cat2 and pRescue.cat1 , activity was shown to increase 10.9-fold in Sf9; 13.4-
fold in Sf9.rtTA; 7.6-fold in T.ni HiS; and 8-fold in T.ni (HiS).rtTA cells. 
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4.11 Discussion 
The availability of inducible expression systems for use in insect cells is very limited. 
Systems designed to direct inducible gene expression in insect cells are currently based 
on the use of endogenous transcriptional regulatory elements, such as the Drosophila heat 
shock protein 70 (Hsp70; Bunch et al., 1988), and MT (Maroni et al., 1986) promoters. 
The Hsp70 promoter is heat-induced and has been shown to function in Drosophila (Oi 
Nocera and Oawid, 1983; Steller and Pirrotta, 1984), mosquito (Lycett and Crampton, 
1993; Shotkoski et al., 1996), and lepidopteran (Helgen and Fallon, H~90; Morris and 
Miller, 1992) cell lines. However, this promoter is not available commercially. The MT 
promoter (commercially available) depends on metal ions for full activation (Otto et al., 
1987; Bunch et al., 1988; Johansen et al., 1989; van der Straten et al., 1989), and has 
been shown to function in dipteran cell lines (Johansen et al., 1989; Kovach et al., 1992). 
Due to a high level of basal expression from Hsp70 in an non-induced state (Clem and 
Miller, 1994; Prikhod'ko and Miller, 1996), and the relatively low activity of the MT 
promoter in an induced state (Hegedus et al., 1998); combined with the pleiotropic effects 
bought about by inducement, these systems lack the specificity required to regulate 
cytotoxic genes successfully in insect cells. 
More advanced schemes developed for use in mammalian cells have sought to avoid 
these problems by constructing inducible systems, such as the Tet expression system (as 
described in Section 4.1), that rely on non-mammalian elements, or re-engineered 
mammalian proteins, that are incapable of responding to endogenous inducers. The 
fundamental principle of these systems is the existence of an inducer that modifies the 
activity of a synthetic TF, and subsequently acts through a heterologous promoter to 
regulate the expression of a target gene. Increased specificity of these systems has been 
achieved by selecting inducers that do not affect cellular physiology, and by assembling 
chimeric transactivators with minimal homology to natural TF, which consequently do not 
interact with endogenous promoters (Gossen and Bujard, 1992; 1995; No at al., 1996). 
The Work in this chapter was carried out to determine whether the Tet expression system 
(T et-On) could be adapted for use in insect cell lines. For this system to be successfully 
adapted, the CMVie promoters of the Tet-On system were first replaced, due to their 
inherent low activity in insect cells rNu et al., 2000; this thesis Chapter 3). These 
promoters were replaced with eukaryotic I viral promoters, which have been characterised 
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as having strong transcriptional activity in insect cell lines (Theilmann and Stewart, 1991; 
Lu et al., 1996; Farrell et al., 1998; this thesis Chapter 3). The re-engineering of the Tet-
On system was hypothesised to generate a functionally novel inducible insect expression 
system. 
The functionality of the Tet expression system (as describe in Section 4.1) is governed by 
a number of factors, such as the availability of a constitutively expressed transactivator 
protein (rtTA) , the presence of the TRE promoter, and presence I absence of the inducer 
dox (Gossen and Bujard, 1992; Gossen et al., 1995; Baron et al., 1997). the combination 
of these factors was perceived as essential for this system to work efficiently in insect 
cells. Therefore, the first step towards producing this system was developing the insect 
regulatory vector, which would constitutively produce rtTA to detectable levels in insect 
cells. 
The results described in Section 4.2 show the methodology used to construct the insect 
Tet regulatory vector. The BmA3+E promoter was chosen to express the rtTA gene in 
replace of the CMVie promoter. To determine the productivity of rtTA from the BmA3+E 
promoter, compared with that from the CMVie promoter, pXINsect.DEST38.rtTA and pTet-
On were transfected into SI9 and T.ni Hi5 cells, and subjected to Western blot analysis for 
detection of rtT A. 
Early studies (Wu et al., 2000) to try and adapt the Tet system for use in insect cells have 
shown that the strength of promoter used to drive expression of rtTA in insect cells is 
crucial to the functioning of the Tet system. A Tet regulatory vector was developed by Wu 
et al. (2000), which utilised the Dm actin promoter to drive expression of rtTA in insect 
cells. However, the levels detected were extremely low, which subsequently caused 
problems with the inducible expression system they developed. To overcome the problem 
of low rtTA production the rtTA was placed under the control of the late AcMNPV p10 
promoter. Insect cells (Sf21, SI9, TN368) were transfected with a Tet response vector 
(PTRE.Luc) and subsequently infected with the recombinant baculovirus expressing rtTA. 
The result was a transient inducible insect expression system that was shown to function 
With some varying degree of success. The disadvantage of this system is that it can only 
be used for transient expression, and cannot t>e use to generate stable insect cell lines, 
WhiCh is one of the aims of this thesis. 
'\, 
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Results in Section 4.3 show that the production of rtTA was successfully detected at 24-72 
hpt, from the BmA3+E promoter in Sf9 and T.ni HiS cells (Figure 4.8A). Optimal 
production of rtTA was observed between 24-48 hpt, in T.ni HiS cells. At 72 hpt, the levels 
of rtTA produced from BmA3+E were shown to decrease. The reduction in expression 
may be explained by the transient nature of plasmid-based expression, as proposed in 
Chapter 3. Transient expression studies rely on short bursts of gene expression (12-
72hr), these bursts of gene expression are most often followed by a rapid deterioration in 
expression of the heterologous gene because of cell death. A decrease in plasmid copy 
number may also explain the possible decrease observed in rtTA production. The 
Production of rtTA in Sf9 cells was shown to be relatively consistent between 24-72 hpt. 
However, the levels detected were less than those observed in T.ni HiS cells. No 
detectable levels of rtTA were observed from the full length CMVie promoter (Figure 
4.88), or mock transfected Sf9 and T.ni HiS cells. The lack of detectable rtTA from the 
CMVie promoter was undoubtedly due to the weak transcriptional activity of this promoter 
in insect cells f'Nu et al., 2000; this thesis Chapter 3). However, rtTA may have been 
produced, but at levels not detectable by Western blot analyses. Subsequently, levels this 
low could not be used to develop a functional inducible insect expression system. 
The insect Tet regulatory vector was shown to function efficiently in both insect cell lines 
Used. The rtTA detected on the Westerns (Figure 4.8A) suggests that production in these 
cell lines was between moderate to high levels. These data prompted the next stage of 
development, which was to use the insect Tet regulatory vector to generate stable insect 
cell lines expressing rtTA constitutively. 
Results in Section 4.4 show the successful generation of two stable insect cell lines 
expressing rtTA (Sf9.rtTA and T.ni (HiS).rtTA). The results in Figure 4.9A I B show that 
the production of rtTA, from passages 1-7, in both cell lines was detectable; rtTA has also 
been detected from passages 10, 20, 30 and 40, with no Significant decrease in 
eXpression (data not show). The levels of rtTA detected from passages 1-7 in both cell 
lines was shown to be consistent, suggesting that the levels of rtTA produced were stable. 
The level of rtT A produced is one of the crucial factors required for the successful 
functioning of the Tet expression system. If the levels produced are low, the TRE 
promoter from the Tet response vector will remain suppressed in the presence of the 
indUcer. However, if the levels produced are above the host cells critical threshold, then 
rtTA becomes cytotoxic, which subsequently has a detrimental affect to the host cells 
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(Gossen and Bujard, 1992; Baron et al., 1997; Bujard, 1999). The levels of rtTA produced 
in Sf9.rtTA and T.ni (Hi5).rtTA cell lines was considered to be below the crucial level 
proposed to induce cytotoxicity, but high enough for detection using Western blot 
analyses, and subsequent TRE promoter activation. The viability of Sf9.rtTA and T.ni 
(Hi5).rtTA cells was determined at each passage, which indicated greater than 85% of 
cells were viable (data not shown). This suggests that stable production of rtTA from 
BmA3+E is not toxic to the cell lines used. The successful generation of Sf9.rtTA and T.ni 
(Hi5).rtTA cell lines, provides the first critical co~ponents necessary to develop the insect 
inducible expression system. 
Results in Section 4.5 describe the methodology used to construct the insect Tet response 
plasmid (pTREi\.ie-2.cat). The pTREi\.ie-2.cat plasmid is the second critical component 
necessary to complete the development of the insect inducible expression system. The 
OpMNPV ie-2 promoter was chosen to replace the minimal CMVie promoter of the TRE 
promoter, which is used to control expression of a heterologous gene in mammalian cells. 
It was hypothesised that the TRE upstream of the OpMNPV ie-2 promoter would mimic the 
Original TRE promoter by suppressing I activating the OpMNPV ie-2 promoter in insect 
cells, in the absencel presence of the inducer dox. : 
The pTREi\.ie-2.cat vector was originally constructed with seven tetO sequences (each 
teto is 42-bp), upstream of the OpMNPV ie-2 promoter. However, a contaminating DNA 
was isolated with the stock of pTREi\.ie-2.cat. Attempts to isolate pTREi\.ie-2.cat from the 
Contaminant failed. This lead to the original ligation reaction stock of pTREi\.ie-2.cat being 
transformed in E. coli to generate a clean stock of pTREi\.ie-2.cat. A contaminant-free 
stock of pTREi\.ie-2.cat was produced and renamed pTREi\.ie-2.cat2. However, a second 
problem was identified; five of the seven tetO sequences were identified as missing. The 
deleted tetO sequences were identified as sequences 2-6 (Figure 4.17A I B). 
An explanation to account for this mutation may be justified by the occurrence of 
transposition. Transposition is the mechanism used to move transposable elements, such 
as transposons, from one location to another on the genome; for example, from one 
chromosomal site to another, from a chromosome to a plasmid, or from a plasmid to a 
chromosome (Hillen and Berens, 1994). Because transposons occur in plasmids, they 
can also be transmitted from one cell to another. The Tet system is based on regulatory 
elements of the Tn10 transposon-specified tetracycline-resistance operon of E. coli (Hillen 
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and Wissmann, 1989; Gossen and Bujard, 1992). It is possible that when the ligation 
reaction was transformed in E. coli, the five tetO sequence (2-6) of pTRE~.ie-2.cat2 
became mobile and integrated into the bacterial genome. Hence, being lost from the 
plasmid. 
Early studies on the development of the Tet-Off system (Gossen and Bujard, 1992) have 
shown that, one, two, and seven tetO sequences can function to suppress! activate the 
minimal CMVie promoter in the presence! absence of Tc. This evidence suggested that, 
with the mutation identified in pTRE~.ie-2.cat2, control of the OpMNPV ie-2 promoter 
would still be possible. To determine if the TRE could suppress! activate the constitutive 
activity of the OpMNPV ie-2 promoter, pTRE~.ie-2.cat2 was transfected into Sf9! Sf9.rtTA 
and T.ni HiS! T.ni (HiS).rtTA cell lines, and assayed for transient CAT activity. 
Results in Section 4.7 show that, in the absence of dox, the levels of CAT activity 
produced from the pTRE~.ie-2.cat2 (TRE ! OpMNPV ie-2) was significantly lower than 
those observed from the pIZTNS-His.cat (OpMNPV ie-2) in all the cell lines used (Sf9 ! 
Sf9.rtTA, 26.9-fold respectively; T.ni HiS! T.ni (HiS).rtTA, 12.S-fold respectively; Figures 
4.18A ! B). The activity of the TRE! OpMNPV ie-2 promoter compared with those 
observed from the OpMNPV ie-2 promoter, was shown to decrease by 99% in Sf9 ! 
Sf9.rtTA, and 98% in T.ni HiS! T.ni (HiS).rtTA cells respectively. These data suggest that 
the TRE was suppressing the OpMNPV ie-2 promoter; complete suppression was not 
Observed, which may be correlated to the length of the OpMNPV ie-2 promoter used. The 
minimal CMVie promoter of the Tet systems is 120-bp, compared with its full-length 
sequence (S87-bp). Minimal promoters are used because promoters such as the CMVie 
have upstream cis-acting enhancer elements capable of up-regulating the minimal . ~ 
promoter to exceptional levels. These promoters do, however, retain a high transcriptional 
rate with the removal of the enhancer element (Gossen and Bujard, 1992; Yin et al., 
1996). The removal of the strong enhancer element allows the minimal promoter to be 
tightly regulated by the TRE, but still produce high levels of recombinant protein in an 
induced state. 
The full length OpMNPV ie-2 promoter (S48-bp) was used in the development of this 
system. Studies have shown that the minimal OpMNPV ie-2 sequence required for basal 
activity in Sf9 cells is 12S-bp upstream of the RNA start site (Theilmann and Stewart, 
1992). The level of promoter activity observed from the minimal OpMNPV ie-2 are shown 
'. 
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to be weak compared with those observed from the full length OpMNPV ie-2 promoter. If 
the minimal OpMNPV ie-2 promoter had been used in the development of this system, 
complete suppression of the OpMNPV ie-2 promoter may have occurred, but the ability to 
produce high levels of recombinant protein would inevitably be compromised. However as 
described in Chapter 3, to retain full-activity of the· OpMNPV ie-2 promoter, the minimal 
sequence required is 27S-bp upstream of the RNA start site (Theil mann and Stewart, 
1992). By removing the full-length (S48-bp) OpMNPV ie-2 from pTRE~.ie-2.cat2 and 
replacing it with the 27S-bp OpMNPV ie-2 promoter, complete suppression of this 
promoter may be achieved, without compromising transcription activity whe,n induced. 
Analysis of induced transcriptional activity from pTRE~.ie-2.cat2 (TRE I OpMNPV ie-2) in 
the presence of dox was determined to verify the complete functionality of the Tet 
inducible insect expression system in insect cell lines. Production of CAT from pTRE~.ie-
2.cat2 in the presence of dox showed (Section 4.8) that no significant increase of CAT 
activity was observed from the TRE I OpMNPV ie-2 promoter, in all cell lines used, when 
compared with those observed from TRE I OpMNPV ie-2 in the absence of dox (Figure 
4.18A I B). The levels of CAT activity detected from pTRE~.ie-2.cat2 in the presence of 
dox, was shown to be significantly lower than those observed from pIZTNS-His.cat 
(OpMNPV ;e-2) , in all cell lines used (Flgure4.19A I B). The levels of CAT activity 
detected from pIZTNS-His.cat in the presence of dox was not shown to differ Significantly 
from those observed in the absence of dox, in all cell lines used (Figure 4.18 I 19A, B), 
highlighting that the concentrations of dox used did not affect the production of CAT from 
this promoter. Cox concentrations were varied (1ng-10J,.lg/ml) to try and induce pTRE~.ie-
2.cat2 activity, although with little success. However, concentrations above SJ,.lg/ml were 
observed to have cytotoxic affects to the host cells (data not shown). Subsequently these 
COncentrations were not used to test for induction of pTRE~.ie-2.cat2. 
The transient insect Tet inducible expression system, developed by Wu et a/. (2000), 
employs the original TRE promoter and the reporter gene Iuc, to detect changes in 
promoter regulation. The drawbacks of this system are, firstly, it uses the minimal CMVie 
promoter to drive foreign gene expression in insect cell lines. The full length CMVie 
Promoter has already been characterised as functionally weak in insect cells, thus removal 
of the strong enhancer may potentially reduce transcriptional activity of this promoter in 
insect cells further. Secondly, the means by which suppression I activation of the minimal 
CMVie promoter was analysed in insect cells was reliant on the production of luciferase. 
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The assays used to detect the production of luciferase are highly sensitive, compared with 
those used in this thesis (CAT), and may explain why Wu et al. (2000), were able to detect 
activation of this promoter. 
The transcriptional activity of a plethora of prokaryotic I eukaryotic promoters have been 
shown to be significantly decreased or silenced by various cellular processes I 
mechanisms. Studies have shown that it is possible to suppress heterologous prokaryotic 
I eukaryotic promoters by flanking sequence elements (Hu and Davidson, 1987; Gossen 
and BUjard, 1992; Schnetz, 1995), such as thebgl operon (Schaefler, 1~67), lac operon 
(Miller and Reznikoff, 1980), and the Tn10-specified tetracycline-resistance operon (as 
describe in this Chapter; Hillen and Wieemann, 1989). However, the lac and Tn10 
operons have been manipulated to re-activate heterologous promoter activity (Hu and 
Davidson, 1987; Gossen and Bujard, 1992). The inability to induce activity of the TRE I 
OpMNPV ie-2 promoter from pTRE~.ie-2.cat2 may be due to the number of tetD 
sequences present. The two tetD sequences upstream of TRE I OpMNPV ie-2 may be 
sUfficient to suppress significant promoter activity as observed, but might not be 
satisfactory to induce TRE I DpMNPV ie-2 promoter activity. With only two tetD 
sequences controlling the TRE I DpMNPV ie-2 promoter, it is possible that the rtTA 
binding to these sequences is insufficient to trans-activate the TRE I OpMNPV ie-2 
promoter. However, the evidence described previously in this Chapter by Gossen and 
Bujard (1992) has shown it is possible to suppress and activate the minimal CMVie 
promoter with two tetD sequences, although Gossen and Bujard used the heptameric 
version of the tetO sequences because enhanced activation of promoter activity was 
observed. 
Promoter activities of prokaryotic I eukaryotic genes may be modulated by their sequence 
COntext. Studies have shown that the deletion of the 5' long terminal repeat (LTR) of the 
aVian leukosis retrovirus activates its 3' LTR promoter (Cullen et al., 1984). Similar 
transcriptional interference was also shown to occur between duplicated alpha-globin gene 
COnstructs (Proudfoot, 1986). This phenomenon was attributed to the mechanism 
id~ntified as promoter occlusion (Adhya and Gottesman, 1982). The mechanism of 
promoter occlusion is likely to be caused by an inhibition of transcriptional initiation from a 
downstream promoter as read-through transcripts from an upstream promoter destabilise 
initiation complexes within the downstream promoter region (Adhya and Gottesman, 1982; 
CUllen et al., 1984; Jansen et al., 1993; Meng et al., 1997; Greger et al., 1998). Promoter 
'- . 
Occlusion has not been found to occur when antisense RNA production transpires from 
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two promoters that are in opposite directions (Brondyk, 1995), which is the case for TRE I 
OpMNPV ia-2 and the upstream EM1 promoter (Figure 4.12) in pTREL\.ia-2.cat2. 
Therefore, the inability to induce TRE I OpMNPV ie-2 could not be explained by the 
mechanism of promoter occlusion. 
A second mechanism discovered, which serves to silence promoter activity is CpG island 
promoter hypermethylation (Greger at a/., 1989). CpG island promoter hypermethylation 
was identified as a common mechanism of inactivating the tumor suppressor gene p16ink4a 
in human cancers (Gonzalez-Zulueta at a/., 1995; Herman at a/., 1995; Merlo at a/., 1995). 
DNA methylation, catalysed by DNA methyltransferase, involves the addition of a methyl 
group to the carbon-5 position of the cytosine ring in the CpG dinucleotide and results in 
the generation of methylcytosine (Singal and Ginder, 1999; Baylin and Herman, 2000; 
Robertson and Wolffe; 2000). Hypermethylation of gene promoters has been shown to 
result in suppression of promoter activity and gene silencing (Garinis at a/., 2002; Kalpana 
at a/., 2002; Kikuchi at a/., 2002; Kin and Shibata, 2002). Work to determine the exact 
mechanism of how promoter methylation leads to gene silencing is still ongoing; there is 
evidence that promoter hypermethylation is associated with histone de-acetylation, change 
in chromatin structure and thus transcriptional i~hibition (Clark and Melki, 2002; Esteller, 
2002; Garinis at a/., 2002; Kikuchi at a/., 2002; Turker, 2002). 
Analysis of the TRE I OpMNPV ia-2 promoter sequence revealed forty eight potential CpG 
islands and four prospective Hpall-methylase sites (CCGG; Figure 4.25). The enzyme, 
Hpall-methylase is endogenous to bacteria and methylates the central C nucleotide of the 
sequence CCGG, to protect bacterial DNA against its own Hpall restriction nuclease 
(Barras and Marinus, 1989; Holliday, 1993). It is possible that the TRE I OpMNPV ie-2 
promoter has been hypermethylated, which subsequently resulted in the repression of this 
promoter, thus explaining why it was not possible to induce transcriptional activity. of the 
TRE I OpMNPV ia-2 promoter. 
DNA methyltransferases have been identified and characterised in bacteria and 
mammalian cell lines, and more recently in insect cells (Drosophila me/anogastar; 
Tweedie at a/., 1999). It is feasible that the CpG islands and methylation sites identified in 
TRE I OpMNPV ia-2 may have been hypermethylated when pTREL\.ia-2.cat2 was 
propagated in E. coli (TOP10 E. coli contains all genomic methyltransferases; 
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InvitrogenTM), or transfected in Sf9 and T.ni HiS cells if, like Drosophila melanogaster cells, 
they contain endogenous methyltransferases. 
Further possible explanations to explain suppression of the activity of TRE! OpMNPV ie-2 
in the presence of dox, are the presence of unidentified flanking element sequences in 
pTRE~.ie-2.cat2 , that may contribute to TRE repression of OpMNPV ie-2. It may also be 
suggested that the OpMNPV ie-2 sequence amplified from pIZTNS-His.cat may be 
missing a critical transcriptional component, which was not elucidated in the literature. To 
resolve this problem a rescue vector was constructed, which was propo~ed to restore the 
promoter activity of the OpMNPV ie-2, by removing TRE from pTRE~.ie-2.cat2. The 
Figure 4.25: Nucleic acid sequence of the TRE! OpMNPV ie-2 promoter. CpG islands 
are indicated as purple CG boxes, and Hpall-methylase sites as yellow! purple! yellow 
CCGG boxes. The TATA box has been underlined and the RNA start site is indicated by 
+1. 
The results in section 4.9 show that, surprisingly the removal of TRE from pTRE~.ie-2.cat2 
did not restore the constitutive activity of pRescue.cat1 (OpMNPV ie-2.~ TRE) in any of the 
cell lines used (Figure 4.21A I B). In fact, the levels of CAT activity detected from 
pRescue.cat1 were shown not to significantly differ from those observed from pTRE~.ie-
2.cat2. These data suggest that either the OpMNPV ie-2.~ TRE promoter was silenced by 
one of the mechanisms describe above, or the promoter sequence amplified from 
pIZTNS-His.cat was incorrect. Further investigation of this enigma lead to the 
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construction of a second rescue plasmid. Attempts to restore the constitutive activity of 
the OpMNPV ie-2.~TRE promoter from pRescue.cat1 were made by removing the 
OpMNPV ie-2.~ TRE promoter from pRescue.cat1 and cloning it into a completely different 
promoter-less vector; the plasmid pRescue.cat2 was derived. 
Results in Section 4.10 show that the constitutive activity of the OpMNPV ie-2 rescued 
promoter was restored in all cell lines used. The ievels of CAT activity produced from 
pRescue.cat2 were shown to be significantly higher than those observed from pTRE~.ie-
2.cat2 and pRescue.cat1. However, compared with the pIZTN5-His.cat, complete 
restoration of transcriptional activity from OpMNPV ie-2 of pRescue.cat2 was not 
achieved. Levels of transcriptional activity were, however, restored to 70% of the 
OpMNPV ;e-2 promoter from pIZTN5-His.cat in Sf9 I Sf9.rtTA cells and 74% in T.ni Hi5 
T.ni (Hi5).rtTA cells respectively. 
Conclusions drawn from these data suggest that the TRE I OpMNPV ie-2 and OpMNPV 
ie-2.~ TRE promoters were not subjected to hypermethylation, as OpMNPV ie2 rescue was 
Shown to function in all insect cell lines used, albeit in a different vector. The second 
Possible explanation eliminated was the authenticity of the OpMNPV ie-2 promoter 
sequence used, as confirmed by the literature. Even though low levels of CAT activity 
were detected from the TRE I OpMNPV ie-2 and OpMNPV ie-2.~ TRE promoters, it was 
hyPothesised that a crucial sequence may be missing, which may be used to augment 
activity of OpMNPV ie-2 in pIZTN5-His.cat. Finally, the explanation most likely to account 
for why activity of TRE I OpMNPV i9-2 was not augmented in the presence of dox, and 
OpMNPV ie-2.~ TRE constitutive activity was not fully restored, focuses on the presence of 
" other flanking element sequences (other than TRE) present in pTR~.ie-2.cat2 capable of 
caUSing repression of the OpMNPV i9-2 promoter. The flanking elements, hypothesised to 
attenuate the transcriptional activity of OpMNPV ie-2 in pTRE~.ie-2.cat2, have yet to be 
identified. 
The results obtained in this chapter address some of the problems associated with 
constructing novel plasmid-based expression vectors. The complexity of adapting the Tet-
On expression system for use in insect cells was acknowledged in the development of the 
insect Tet response vector. The strategy used to construct this vector was found to be 
compromised, due to unforeseen phenomena such as unidentified, repressor-like 
elements attenuating the activity of the OpMNPV ie-2 promoter. The conclusion drawn 
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from these data is that the original Tet response vector cannot be directly re-engineered to 
incorporate the OpMNPV ie-2 promoter in place of the minimal CMVie to generate a 
functional insect Tet response vector. 
The foundation work for adapting the Tet-On expression system for use in insect cells has 
been initiated, with the successful development and use of the insect Tet regulatory vector 
(pXINsect-DEST38.rlTA). It is likely that the problems identified with the insect Tet 
response vector (pTREA.ie-2.cat2) can be overcome with further investigation, to generate 
a fully functional insect Tet inducible expression system that will offer the researcher a 
more diverse choice of expression system and cell lines for recombinant protein 
production. 
149 
~hapter5 Gene expression 
CHAPTER 5: METHODS OF IMPROVING 
INTRACELLULAR PROTEIN PRODUCTION USING INSECT 
EXPRESSION SYSTEMS 
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5.1 Introduction 
Advances in the development of plasmid-based expression systems for the generation of 
stable insect cell lines has progressed slowly over the last fifteen years, and has been 
dominated by the transcriptionally weak activity of the AcMNPV ie-1 promoter (Jarvis and 
Summers, 1989; Jarvis et al., 1990). However, a number of new RNA polymerase II 
transcribed insect and viral promoters (Bm A3+E I OpMNPVie-2) have been shown to 
increase foreign gene expression above those observed from AcMNPV ;e-1 in insect cells 
(Johnson et al., 1992; Jarvis et al., 1996; Lu et al., 1996; 1997; Heged~s et al., 1998). 
Subsequently, new plasmid-based expression vectors have been developed using these 
promoters (Bm A3+E and OpMNPV ie-2). These vectors are currently used for transient 
and stable foreign gene expression in insect cell lines. 
The baculovirus expression system (BES) is widely used as an alternative to stably-
transformed insect cell lines for transient expression of heterologous genes, as levels of 
foreign protein produced are generally high. However, expression levels of secreted and 
membrane-targeted proteins may be considerably lower than those directed to the 
Cytoplasm or nucleus (King and Possee, 1992). Studies have shown that stably 
transformed insect cells, continuously expressing secreted recombinant proteins can 
produce levels comparable to those reported for baculovirus vectors (Farrell et al., 1998; Li 
et al., 2001), although, stably expressed foreign proteins targeted to intracellular 
compartments have been shown to be significantly lower than those observed form the 
BES (Jarvis et al., 1990). In this Chapter attempts were made to compare intracellular 
foreign protein production from an improved stable insect plasmid-based expression 
system (Express Insect"" system; Bm A3+E), to that of the BES. 
The inherent lower levels of secreted recombinant proteins from baculovirus-infected cells 
has been well documented, and has been attributed to the onset of baculovirus infection 
compromising both the cell secretory pathway and viability (Thomas et al., 1998; Saville et 
al., 2002). Baculovirus infected cells have been shown to retain the baculovirus 
expressed enzyme, chitinase (chiA) in the endoplasmic reticulum (ER), which 
SUbsequently causes blockage of the secretory pathway (Thomas et al., 1998; Saville et 
al., 2002), and as a consequence reduces secretion of proteins. Further-more, the 
Cytolytic effect of the baculovirus on insect cells inevitably leads to the release of cellI viral 
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proteases into the culture medium, which inexorably cause proteolytic degradation of 
secreted foreign proteins (Li at a/., 2001). 
Previous work in our laboratory has shown that deletion of chiA from the AcMNPV genome 
improves yields of secreted foreign proteins (urokinase I tissues-plasminogen activator; 
McCarroll, 1997) from infected insect cells. However, no evidence for improved 
intracellular foreign protein production has been attained using this virus. It was for this 
reason, that analyses of intracellular levels of foreign protein produced from the polh 
promoter of AcBacPAK6.~chiA (designated here as Ac.~chiA; Possee at a/., 1999) was 
compared to those of AcBacPAK6 (designated here as Ac; Kitts and Possee, 1993). 
Small-scale protein production in insect cells is commonly carried out in T-flasks (cell 
monolayers) or shaker cultures (suspended culture), and often provides sufficient protein 
for research purposes. However, industrial scale projects demand large quantities of 
foreign protein, which cannot often be obtained from T-flasks. To meet these demands, 
industries have turned to using large shaker flasks (3-litre) or fermenter vessels to scale-
up protein production. The disadvantages associated with using fermenter vessels are 
inevitably the initial setting up costs; also these systems are very time-consuming and 
labour-intensive, compared to the simplicity and relative inexpensive shaker flasks. 
However, the advantages of recombinant protein production in fermenters includes the 
ability to control environmental factors associated with maintaining optimal culturing 
Conditions for maximising protein production. Such factors include dissolved oxygen 
concentration and pH (Scott at a/., 1992; Wong et a/., 1994; Hu and Bentley, 1999). 
These factors can be regulated and monitored throughout fermentation, which· is not 
Possible in shake cultures. 
The work in this Chapter examines these two different scale-up culturing methodologies 
(fermenter versus shaker) for recombinant protein production in insect cell lines. Attempts 
Were made to scale-up (1-litre) recombinant protein production from stably transformed 
insect cells, and from baculovirus-infected (recombinant Ac or Ac.~chiA) insect cell 
Cultures. Subsequently the relative yields of recombinant protein produced from fermenter 
or shaker cultures were determined and compared. 
All studies conducted in this Chapter utilised th~ intracellular fluorescence reporter gene 
Discosoma red (DsRad) because of its ease of detection, and intracellular dihydroorotata 
\, 
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dehydrogenase (Candida albicans, DHODH) , due to its industrial importance and 
relevance to Pfizer, the collaborating institution involved in this project. From these 
studies a comprehensive analysis of insect expression systems and culturing methodology 
was anticipated. 
5.2 Comparison of heterologous protein production from Ac and 
Ac.AchiA in insect cell lines 
To examine and compare the levels of intracellular recombinant protein produced from the 
baculoviruses, Ac and Ac.flchiA, DsRed and DHODH were inserted under control of the 
transcriptionally strong polh promoter, using the methods described in Chapter 1 (Section 
1.3.2) and 2 (Sections 2.3.2, 2.3.3 and 2.3.4; King and Possee, 1992). Subsequently the 
recombinant baculoviruses, Ac.DsRed, Ac.DHODH, AC.!"chiADsRed and 
Ac.!,.chiADHODH were derived. 
An important fundamental consideration for the production of foreign protein is the choice 
of cell type used to host expression. Several studies have shown that this can 
dramatically affect the levels of expression obtained (Lynn and Hink, 1980; King and 
Possee, 1992). Another Significant elemental deliberation for the production of foreign 
protein is the moi used to infect cells. Experiment were carried out in this Chapter to 
determine the most suitable insect cell line and virus moi for the expression of 
recombinant OsRed and OHODH, using the recombinant baculoviruses described above. 
Small (2Sml) shaker cultures of SI9 and T.ni HiS cells were set-up as previously described 
. in Section 2.2.3. Cells were infected (moi 2, Sand 10) at the appropriate density with 
Ac.DsRed, Ac.DHODH, AC.!"chiADsRed or Ac.!"chiADHODH. Mock-infected SI9 and 
T.ni HiS cells were used as a negative control. Samples (1ml) were harvested at 0,24,48, 
and 72 hpi and the intracellular total cell protein content was estimated using the Bradford 
BioRad assay (Section 2.7.4). Standard amounts of total protein (25J.l9) from each sample 
Were run on SOS-PAGE for Western blot analyses (Sections 2.7.S, 2.7.6) to determine the 
levels of intracellular OsRed and OHOOH produced. Separate samples (1ml) were also 
harvested at 0, 12, 24, 36,·48, 60, 72, 84 and 96 hpi and subjected to fluorometric 
analyses (as described in Section 2.9.1), quantifying the levels of intracellular fluorescence 
generated by the production of OsRed. SI9 and T.ni HiS cells infected with AC.DHODH or 
'\. 
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Ac.llchiADHODH were used to detect background auto-fluorescence (negative controls). 
As expected, the production of DHODH was not detected from mock-infected Sf9 cells. 
Figure 5.1 shows results obtained for optimal DHODH expression from AC.DHODH and 
Ac.llchiADHODH in T.ni Hi5 cells. To detect the production of DHODH, six juxtaposed 
histidine residues were inserted in-frame at the N-terminus of the DHODH-coding region. 
An anti-polyhistidine monoclonal antibody (Sigma) was used to detect these residues, 
therefore producing qualitative I semi-quantitative analyses of DHODH (molecular weight 
43 kDa) production. The production of DHODH was not detected from mock-infected or 
Ac.DHODH I AC.llchiADHODH infected T.ni Hi5 cells at 0 hpi (lanes MI, Oa, ~b). 
However, DHODH was detected at varying time-points in AC.DHODH and 
Ac.llchiADHODH using an moi of 2, 5 and 10 (selected data shown). However, an moi of 
5 was shown to produce optimal DHODH production. Expression of DHODH from 
Ac.DHODH (moi of 5) was detected at 48-72 hpi (lanes 48a, 72a), optimal levels were 
detected at 48 hpi. At 72 hpi the production of DHODH was dramatically decreased, and a 
second His-tagged protein (estimated molecular weight 28kDa) was detected, which may 
have been a possible degradation product of DHODH (lane 72a). The production of 
DHODH from AC.llchiADHODH (moi of 5) was observed at 24-72 hpi (lanes 24b-72b). 
Although DHODH was detected at 24 hpi from AC.llchiADHODH none was detectable 
from AC.DHODH at the same time-point (lane 24a). The highest levels of DHODH 
produced from AC.llchiADHODH were observed at 48-72 hpi (lane 48b), and was shown 
to be greater than those observed from AC.DHODH (48-72 hpi). Interestingly, the very 
apparent 28kDa product detected from AC.DHODH at 72 hpi was also observed from 
AC.llchiADHODH at the same time-point (lanes 48b, 72b), but at much lower levels. 
Unexpectedly, the production of DHODH was not detected from AC.DHODH / 
AC.llchiADHODH infected Sf9 cells (data not shown) at 0-72 hpi. 
Figure 5.2A I B shows results obtained for optimal DsRed expression from AC.DsRed and 
AC.llchiA.DsRed in Sf9 (A) and T.ni Hi5 (8) cells. Semi-qualitative analyses of DsRed 
production using a DsRed polyclonal antibody (BD Biosciences; molecular weight 25 
kDa), showed no detectable levels of DsRed in mock-infected or Ac.DsRed I 
AC.llchiADsRed infected Sf9 and T.ni Hi5 cells at 0 hpi (A I B: lane MI, Oa, ~b). In both 
cell lines infected with AC.DsRed or Ac.llchiADsRed, production of DsRed was observed 
from all moi's used at 48-72 hpi (moi 2,5 and 10; selected data shown). However, an moi 
of 2 was shown to produce the highest levels of DsRed in the insect cells used (A I B: 
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lanes 48-72a, 48-72a). The levels of OsRed produced from Ac.DsRed at 48-72 hpi were 
shown to be higher than those detected from AC.l1chiADsRed in both cell lines. Optimal 
production of OsRed from both viruses in Sf9 and T.ni Hi5 cells were observed at 72 hpi. 
Overall production of OsRed from Ac.DsRed and AC.l1chiADsRed in Sf9 and T.ni Hi5 
cells, was shown to be higher in Sf9 cells. 
T.niHi5 
37.4 kDa~ 
26 kDa~ 
MW MI Oa 
AC.DHODH 
24a 48a 72a 
Ac.l1chiA.DHODH 
Ob 24b 48b 72b 
---"'43kDa 
Figure 5.1: Western blot analyses of Ac.DHODH and Ac.l1chiADHODH infected T.ni Hi5 
cells expressing OHOOH. Lane MW (molecular weight), shows protein markers 
(Invitrogen). Lane MI (mock-infected), shows intracellular cell extract (25~g I lane) from 
mock-infected T.ni Hi5 cells (negative control). Lane 0-72a shows intracellular cell extract 
(25~g I lane) from T.ni Hi5 cells infected with Ac.DHODH at 0-72 hpi (moi of 5). Lane 0-
72b shows intracellular cell extract (25~g I lane) from T.ni Hi5 cells infected with 
Ac.l1chiADHODH at 0-72 hpi (moi of 5). Position of molecular weight (MW) size marker is 
shown in kOa and the position of OHOOH is indicated (43kOa). 
A: Sf9 A c.l1chiA.Dsred AC.Dsred 
.------~ ...... ---
MW MI Oa 24a 48a 72a Ob 24b 48b 72b 
26 kDa ~ ......... 1181 ... 25 kDa 
B: T.niHi5 AC.l1chiA.Dsred AC.Dsred 
MW MI Oa 24a 48a 72a Ob 24b 48b 72b 
27.5 kDa~ 
- - "'25kDa -
Figure 5.2A I B: Western blot analysis of Ac.DsRed and AC.l1chiADsRed infected Sf9 
(panel A) and T.ni Hi5 (panel B) cells expressing OsRed. Lanes MW (molecular weight), 
shows protein markers (Invitrogen). Lanes MI (mock-infected), shows intracellular cell 
extract (25~g I lane) from mock-infected Sf9 and T.ni Hi5 cells (negative control). Lanes 
0-72a shows intracellular cell extract (25~g I lane) from Sf9 and T.ni Hi5 cells infected with 
Ac.DsRed at 0-72 hpi (moi of 2). Lane 0-72b shows intracellular cell extract (25~g I lane) 
from Sf9 and T.ni Hi5 cells infected with AC.l1chiADsRed at 0-72 hpi (moi of 2). Position 
of molecular weight (MW) size marker is shown in kOa and the position of OsRed is 
indicated (25kOa). 
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Figure 5.3 A I B shows results obtained for OsRed production from Ac.DsRed and 
AC.l:!.chiADsRed (moi 2) in Sf9 (A) and T.ni Hi5 cells (B). No background levels of 
fluorescence were observed from mock-infected, or Ac.DHODH I Ac.l:!.chiADHODH 
infected Sf9 and T.ni Hi5 cells. The production of OsRed from Ac.DsRed in Sf9 (71 
arbitrary fluorescence units [AFU]) and T.ni Hi5 (16.6 AFU) cells was first observed at 24 
hpi, whilst production from Ac.l:!.chiADsRed was initially detected at 36 hpi (Sf9, 475 AFU; 
T.ni HiS, 231 AFU). The highest levels of OsRed produced from Ac.DsRed and 
AC.l:!.chiADsRed in Sf9 (Ac.DsRed, 124873 AFU; Ac.l:!.chiADsRed, 9853 AFU) and T.ni 
HiS (Ac.DsRed, 14930 AFU; Ac.l:!.chiADsRed, 6357 AFU) cells were observed at 72 hpi 
(these finding correlate with those observed in Figure 5.2A I B). At 84-92 hpi the levels of 
OsRed detected were shown to decrease in all cases. Analyses of the cell viability for 
each infected culture, showed cell viability was severely compromised by virus infection at 
72-96 hpi (data not shown). Therefore, the reduction in the detected levels of OsRed from 
each infection at 84-96 hpi correlates with cell death observed at these same time points. 
A comparison of OsRed production from Ac.DsRed and AC.l:!.chiADsRed in Sf9 and T.ni 
HiS cells, showed Ac.DsRed produced significantly higher levels of OsRed than those 
observed from Ac.l:!.chiADsRed (p<0.001 in all. cases). The levels of OsRed produced 
from Ac.DsRed and AC.l:!.chiADsRed were also shown to be significantly higher in Sf9 
cells compared to those observed in T.ni Hi5 cells (p=0.0001 in all cases). 
It was, therefore, shown that DHODH and DsRed were expressed from Ac and Ac.l:!.chiA 
However, the expression profiles observed from these viruses (producing identical foreign 
protein) were noticeably different. As optimum levels of OHOOH production were 
observed from Ac.l:!.chiA, and optimal OsRed production was observed from Ac. 
Heterologous protein production levels were also shown to vary from Ac and Ac.l:!.chiA 
depending on the choice of insect cell line used to host expression. The production of 
OHOOH from Ac and Ac.l:!.chiA was only detected in T.ni HiS cells, whilst production of 
OsRed was detected in both Sf9 and T.ni HiS cells. Therefore, from these data it was 
COncluded that Ac.l:!.chiA improved the production of specific recombinant proteins, but 
highlights the need to characterise gene expression from these expression vectors, as well 
as determine the cell line required for optimal protein·production. 
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Figure 5.3 A I 8: Fluorescence detected for DsRed production in AcDsRed and 
AC.D.chiA.DsRed infected Sf9 (A) and T.ni HiS (8) cells. Mock-infected and AC.DHODH / 
AC.D.chiA.DHODH infected Sf9 and T.ni HiS cells were tested for background fluorescence 
and used as negative controls. Cell samples (1ml) were harvested at 12 h intervals over a 
period of 96 h. These sample were subjected · to f1uorometric analyse to determine the 
levels of fluorescence produced from DsRed expression. 
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5.3 Construction of plasmid-based expression vectors for comparison 
of foreign protein production in stable insect cell lines 
The advances made over the last decade to improve foreign protein production from 
stable insect cell lines, promoted work in this Chapter to compare relative yields of 
intracellular foreign protein, produced from stable insect cell lines to those from the BES. 
Of the new plasmid-based expression systems developed, the Express Insect™ system 
(Invitrogen""), which utilises the Bm A3+E promoter (Lu et al., 1996; 1997), was chosen to 
generate stably transformed insect cell lines expressing DHODH and DsRed.· The 
Express Insect"" system was chosen because of the excellent transcriptional activity of the 
Bm A3+E promoter used to transcribe foreign genes in insect cell lines (as described in 
Chapter 3). This system also utilises the directional TOPO® cloning technOlogy, for rapid 
and efficient cloning of heterologous genes (as described in Chapter 1.6). Due to the 
nature of TOPO® cloning, the DHODH and DsRed genes were first inserted into an entry 
plasmid (pENTRlD-TOPO) to produce an entry clone. 
For insertion of DHODH or DsRed into pENTRlD-TOPO, primers were designed to amplify 
these gene coding-regions. DHODH was amplified from pET-21b.DHODH (obtained from 
Pfizer), whilst DsRed was amplified from pDsRed.N1 (BD Biosciences). Amplification of 
both DHODH and DsRed was carried out using PCR (Section 2.5.5). The results shown in 
Figure 5.4A I B clearly show, in lane 2 (A I B) amplified DNA fragments of a size relative 
to DHODH (A; 1210-bp) and DSRed (B;677-bp) .. 
DHODH and DsRed were purified (Section :2.5.7.2) and subsequently cloned into 
pENTRlD-TOPO (Section 2.5.12). Positive clones were identified using the restriction 
enzymes Hindlll and BamHI (Section 2.5.1; data not shown). Subsequently both DHODH 
~nd DsRed were sequenced (Section 2.5.8) to confirm sequence integrity. The resulting 
entry clones pENTRlD-TOPO.DHODH and pENTRlD-TOPO.DsRed were derived (Figure 
5.5AI B). 
DHODH and DsRed were then inserted into pXINs~ct-DEST38, using TOPO site-specific 
recombination (Section 2.5.12). Positive clones were identified using the restriction 
enzymes Hindlll and BamHI (Section 2.5.1; Figure 5.6A I B). The plasm ids derived were 
named pBmA3+E.DHODH and pBmA3+E.DsRed (Figure 5.7A I B). 
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Molecular wt 
marker 
A 
1500-bp 
1000-bp 
1 2a 
DHODH 
1210-bp 
B 
Molecular wt 
marker 
800-bp 
600-bp 
1 2b 
Gene expression 
DsRed 
677-bp 
Figure 5.4A I B: Analysis of the amplification of the OHOOH (A) coding region from pET-
21 b.DHOOH and OsRed (B) coding region from pOsRed.N1, using PCR (Section 2.5.5). 
Positive amplified OHOOH and OsRed coding-regions produced DNA fragments banding 
at 1210-bp (OHOOH) and 677-bp (OsRed). The above gels show: 
Track 1: Smart Ladder (Eurogentec 1 kb) 
Track 2a: Positive amplification of the OHOOH coding-region 
Track 2b: Positive amplification of the OsRed coding-region 
A 
'-y----J 
Kad gene T1 12 
B 
'-y----J 
Kad gene T1 12 
CCC TTC ACC DHODH AAG GGT 
AAG TGG gene TTC CCA 
Asci 
~ ~ '"---~ ,.---....,) ---y-- v 
a ttL 1 OHOOHgene 
'--y---J 
attL2 
CCC TTC ACC DsRed AAG GGT 
AAG TGG gene TTC 
'--y-J '" ___ ---...y __ ---.J "-y--' 
attL 1 OsRed gene attL2 
Figure 5.5A I B: Genetic map of pENTR.D.TOPO.DHOOH (A) and 
pENTR.D.TOPO.DsRed (B), showing a Kad gene, pUC origin of replication, T1 I 12 , 
attL 1 I attL2 recombination sites with OHOOH or OsRed inserted amidst. 
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Figure 5.6A: Analysis of plasmid DNA, to positively identify the insertion of the OHOOH 
gene into pXINsect-DEST38. Plasmid DNA was extracted from the E. coli TOP10 
bacterial strain by mini-prep purification (Section 2.5.9.1). Plasmid DNA was cut using the 
restriction enzymes BamHI and Hindlll (Section 2.5.1), and run on a 0.7% agarose gel 
(Section 2.7.1). Positive clones with the OHOOH coding-region produced DNA fragments 
banding at 13613-bp (BamHI), 9619-bp, 2767-bp, 1210-bp and 33-bp (BamH11 Hind II I), 
9619-bp, 2767-bp and 1227-bp (Hindlll) . The above gel shows: 
Track 1: 
Track 2: 
Track 3: 
Track 4: 
Smart Ladder (Eurogentec 1 kb) 
pBmA3+EDHOOH I BamHI positive clone 
pBmA3+EDHOOH I BamHI I Hindlll positive clone (33-bp was to small to 
detect) 
pBmA3+EDHOOH I Hindlll positive clone 
Molecular wt 1 2 3 4 5 6 7 
marker 
10000-bp 
8000-bp _t_ ..... 
3000-bp a :=:1 
2500-bp 
200-bp 
10096-bp 
9652-bp 
222-bp 
Figure 5.6B: Analysis of plasmid DNA, to positively identify the insertion of the OsRed 
gene into pXINsect-DEST38. Plasmid DNA was extracted from the E. coli TOP10 
bacterial strain by mini-prep purification (Section 2.5.9.1). Plasmid DNA was cut using the 
restriction enzyme Hindlll (Section 2.5.1), and run on a 0.7% agarose gel (Section 2.7.1). 
Positive clones with the OsRed coding-region produced DNA fragments banding at 10096-
bp, 2767-bp and 222-bp (Hind III). The above gel shows: 
Track 1: 
Track 2-6: 
Track 7: 
Smart Ladder (Eurogentec 1 kb) 
pBmA3+E.OsRed I Hindlll positive clones 
pBmA3+E I Hindlll (negative control; 9652 I 2767-bp) 
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----....... yr--------
I ~ ~ 
Ampr gene OHOOH attL2 Bm Actin 
B 
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Promoter I gene 
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Figure S.7A I B: Genetic map of pBmA3+E.DHOOH (A) and pBmA3+E.DsRed (B), 
showing a Ampr gene, BmNPV ie-1 promoter I gene, BmNPV hr3 coding region, Bm A3 
promoter with OHOOH or OsRed inserted downstream, a ttL 1 I attL2 recombination sites, 
and the Bm actin poly-A coding region. 
S.4 Transient plasmid-based expression of DHODH and DsRed in St9 
and T.ni HiS cells 
The expression vectors pBmA3+E.DHOOH and pBmA3+E.DsRed generated in Section 
5.3 were transfected into Sf9 and T.ni Hi5 cells to determine transient expression of 
OHOOH and OsRed from the BmA3+E promoter. The detection of OHOOH and OsRed 
production from the BmA3+E promoter in these cell lines subsequently provided data, 
which was use to generate stably transformed insect cell lines expressing these foreign 
genes (Section 5.5). 
Sf9 and T.ni Hi5 cells were seeded (Section 2.2.3) into 35mm tissue culture dishes, and 
left to adhere for 1 h. The cell mono-layers were transfected (Section 2.2.4) using 1,...g of 
plasmid DNA (pBmA3+E.DHOOH or pBmA3+E.OsRed). Cells were harvested after 24, 48 
and 72 h incubation at 28°C. Standard amounts of total protein (25,...g; Section 2.7.4) from 
each sample were run on SOS-PAGE and subjected to Western blot analyses (Section 
2.7.5, 2.7.6). Cells transfected with pBmA3+E.DsRed were also visualised for the 
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production of OsRed using a Carl Zeiss Axiovert 510 Confocal Laser Scanning Microscope 
(CLSM), with a standard Argon 488nm laser, and 534nm Helium 1 Neon laser. 
The results shown in Figure 5.8 show OHOOH expression from the BmA3+E promoter in 
Sf9 and T.ni Hi5 cells. Expression of OHOOH was detected using an anti-polyhistidine 
monoclonal antibody (Sigma). Mock-transfected Sf9 and T.ni Hi5 cells showed no 
detectable levels of OHOOH (lanes MT). Expression of DHODH from the BmA3+E 
promoter in T.ni Hi5 cells were shown to be detected at 24-72 hpt (lanes 24-72a), 
however, no OHOOH was detected in Sf9 cells (lanes 24-72b). The yisual detection of 
OHOOH by Western blot analyses was observed as very low signal intensities, indicating 
that the levels of OHOOH produced from the BmA3+E promoter in T.ni Hi5 cells 
throughout transfection were very low. 
T.niHi5 Sf9 
r----~A-'----~" r----~~-----~" 
MW MT 24a 48a 72a MT 24b 48b 72b 
37.4 kDa~ 
~43kD 
Figure 5.8: Western blot analysis of T.ni Hi5 and Sf9 cells expressing OHOOH. Lane MW 
(molecular weight), shows protein markers (Invitrogen). Lane MT (mock-transfected), 
shows intracellular cell extract (25~g 1 lane) from mock-transfected T.ni Hi5 and Sf9 cells 
(negative control). Lane 24-72a I b shows intracellular cell extract (25~g / lane) from T.ni 
Hi5 (a) and Sf9 (b) cells transfected with 1~g of pBmA3+E.DHODH at 24-72 hpt. Position 
of molecular weight (MW) size marker is shown in kOa and the position of OHOOH is 
indicated (43kOa). 
Figure 5.9 shows results obtained for OsRed expression from the BmA3+E promoter in 
transfected Sf9 and T.ni Hi5 cells. The production of OsRed was detected using a anti-
OsRed polyclonal antibody (SO Siosciences; molecular weight 25 kOa), no detectable 
levels of OsRed were observed from mock-transfected Sf9 or T.ni Hi5 cells (lanes MT). 
OsRed production was not detected in transfected Sf9 cells at 24-72 hpt (lanes 24-72a), 
nor in T.ni Hi5 cells at 24 hpt (lane 24b). At 48-72 hpt, OsRed was detected in T.ni Hi5 
cells (lanes 48-72b). However, the signal intensity produced by Western blot were very 
weak, indicating that the OsRed levels detected were very low. 
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Figure 5.9: Western blot analysis of Sf9 and T.ni HiS cells expressing OsRed. Lane MW 
(molecular weight), shows protein markers (Invitrogen). Lane MT shows intracellular cell 
extract (2SJ.!g I lane) from mock-transfected Sf9 and T.ni HiS cells (negative control). Lane 
24-72a I b shows intracellular cell extract (2SJ.!g I lane) from Sf9 (a) and T.ni HiS (b) cells 
transfected with 1J.!g of pBmA3+E.DsRed at 24-72 hpt. Position of molecular weight (MW) 
size marker is shown in kOa and the position of OsRed is indicated (2SkDa). . 
OsRed expression from the BmA3+E promoter in Sf9 and T.ni HiS cells was also 
monitored by the CLSM (Figure 5.10A-H). OsRed-specific fluorescence was not 
observed in mock-transfected Sf9 or T.ni HiS cells (panels: A I E). At 24-72 hpt, the 
production of OsRed was observed in both Sf9 (panels: B-O) and T.ni HiS (panels: F-H) 
cells. At 24 hpt the intensity of fluorescence observed from these cell lines ranged from 
low to medium (Sf9, low; T.ni HiS, low-medium; visual observations), and only a small 
population of cells were shown to produce detectable levels of OsRed. At 48 hpt, the 
population of both cell lines expressing OsRed were shown to increase, producing low to 
high fluorescence levels (Sf9 , low-medium; T.ni HiS, low-high). At 72 hpt, the population 
of cells producing OsRed was shown to further increase (visual observation), and 
fluorescence levels were shown to range from low to high (Sf9, low-medium; T.ni HiS, low-
high). Overall, fluorescence intensity was higher in T.ni HiS cell throughout transfection , 
and a greater population of cells were shown to express detectable levels of OsRed. 
163 
Chapter 5 Gene expression 
Figure S.10A-H: Transient OsRed production from the BmA3+E promoter 24-72 hpt in Sf9 
(panels B-O) and T.ni Hi5 (panels F-H) cells. Mock-transfected Sf9 (A) and T.ni Hi5 cells 
(E). 
Western blot analyses showed transient expression of OHOOH and OsRed from the 
BmA3+E promoter was only detected in T.ni Hi5 cells (OHOOH, 24-72 hpt; OsRed, 48-72 
hpt). However, fluorescence microscopy showed OsRed production was detected in 
transfected Sf9 cells, and also at an earlier time-point for both cell lines (24-72 hpt). 
Overall, T.ni Hi5 cells were shown to produce higher levels of OsRed, compared to those 
observed in Sf9 cells. As the production of OsRed was not observed in Sf9 cells using 
Western blot analyses, but was observed using other means of detection, it may be that 
OHOOH was also produced in Sf9 cells. However, the levels produced were to low to 
detect using Western blot analyses. 
5.5 Production of stable insect cell lines expressing OHOOH or OsRed 
Having constructed and tested pBmA3+E.DHODH and pBmA3+E.DsRed in transient 
expression assays (Section 5.4), the next step was to produce stable insect cell lines 
expressing these foreign genes. Although the transient results in Section 5.4 show 
variety, it was decided to make both Sf9 and T.ni Hi5 cells stably expressing OHOOH or 
OsRed . The generation of these stable insect cell lines will provided the basis for 
comparing intracellular foreign protein production, against that produced from the BES 
(Ac.DHODH / Ac.DsRed and Ac.l1chiA.DHODH / Ac. chiA.DsRed) . 
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Stable Sf9 and T.ni HiS cell lines were produced as described in Section 2.2.S. Cells were 
co-transfected with pBmA3+E.DHODH or pBmA3+E.DsRed (900ng) and a second 
plasmid (pBmA:neo, 100ng) carrying a dominant selectable marker ned (Section 3.1; 
Jarvis et al., 1990). Analyses of stable DHODH and DsRed expression was determined 
by SDS-PAGE (2S mg of protein sample loaded liane, Section 2.7.4) and Western blot 
analyses (Sections 2.7.S/2.7.6). 
Analyses of DsRed production was also determined using quantification of red 
fluorescence (Section 2.9.1 ). Shaker cultures containing stal:,>ly transformed 
(PBmA3+E.DsRed) Sf9 or T.ni HiS cells were seeded (20ml at 0.Sx106 I ml), and cell 
samples (1ml) harvested after 0, 12,24,36,48,60,72,84 and 96 h incubation at 28°C, 
13Srpm. The cells were subsequently analysed using fluorometric analyses (as described 
in Section 2.9.1). Cell samples were also taken for visualisation of DsRed using a CLSM. 
Analyses of DHODH expression from cells of passage numbers 1-18 of transformed Sf9 
and T.ni HiS cells by Western blot did not detect production of DHODH (data not shown). 
To verify DHODH had been successfully incorporated into the genomic DNA of Sf9 and 
T.ni HiS cells, and remained stably integrated, ~nalyses of whole genomic DNA from the 
transformed cell lines was carried out. 
Genomic DNA was extracted from passage 1, 10 and 18 of Sf9 and T.ni HiS cells stably 
transformed with pBmA3+E.DHODH (Section 2.S.10). Genomic DNA was also extracted 
from non-transformed Sf9 and T.ni HiS cells (negative control). To confirm the presence of 
DHODH, primers utilised in Section S.3 were used to amplify the DHODH coding-region 
from stably transformed Sf9 and T.ni HiS genomic DNA and pBmA3+E.DHODH (positive 
control). Amplification of DHODH was carried out using PCR (Section 2.S.S). The results 
shown in Figure 5.11 clearly show, in lanes 3-5 (stably transformed Sf9 cells) and 6-8 
(stably transformed T.ni HiS cells) amplified DNA fragments of a size relative to the 
DHODH cOding-region amplified from the positive control (lane 2; 1210-bp). Lanes 9 
(Sf9) and 10 (T.ni HiS) show DHODH was not detected from non-transformed Sf9 and T.ni 
HiS genomic DNA (negative control). These results confirm that DHODH was stably 
integrated into Sf9 and T.ni HiS genomic DNA, but expression of this foreign gene was still 
elusive. 
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Figure 5.11: Analysis of the amplification of the DHODH coding-region from genomic DNA 
of Sf9 and T.ni HiS cells stably transformed with pBmA3+E.DHODH (passage 1, 10 and 
18), non-transformed Sf9 and T.ni HiS cells and plasmid DNA pBmA3+E.DHODH, using 
PCR (Section 2.S.S). Positive amplified DHODH coding-region produced a DNA fragment 
banding at 1210-bp (DHODH). The above gels show: 
Track 1: 
Track 2: 
Track 3-S: 
Track 6-8: 
Track 9: 
Track 10: 
2-Log ladder (New England Biolabs) 
Positive amplification of the DHODH coding-region (pBmA3+E.DHODH; 
positive control) 
Positive amplification of the DHODH coding-region (stably transformed Sf9 
cells passage 1, 10 and 18) 
Positive amplification of the DHODH coding-region (stably transformed T.ni 
HiS cells passage 1, 10 and 18) 
Negative control, no amplification of the DHODH coding-region (non-
transformed Sf9 cells) 
Negative control, no amplification of the DHODH coding-region (non-
transformed T.ni HiS cells) 
To confirm DHODH was expressed in stably transformed Sf9 and T.ni HiS cell lines, and 
had not been integrated into a transcriptionally repressed region of the genome, reverse 
transcriptase PCR (RT-PCR) was used to detect DHODH mRNA transcripts. 
Total RNA was extracted (Section 2.S.11) from Sf9 and T.ni HiS cells stably transformed 
with pBmA3+EDHODH (passage 19). Total RNA was also extracted from non-
transformed Sf9 and T.ni HiS cells (negative control), and Sf9 and T.ni HiS cells 
transfected with pBmA3+EDHODH 48hpt (positive control). The RNA extracted from the 
samples specified above was subsequently used to generate cDNA as described in 
Section 2.S.6. To detect the presence of DHODH from the cDNA, cDNA was analysed 
using PCR. Primer used in previous experiments specific for amplification of DHODH 
were used to amplify the DHODH coding-region from cDNA and confirm DHODH was 
produced in stably transformed Sf9 and T.ni HiS cells. 
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The results shown in Figure 5.12A I B illustrate in lanes 4 amplified DNA fragments from 
total genomic cDNA of Sf9 (A) and T.ni HiS (B) cells, transiently transfected with 
pBmA3+E.DHODH (48hpt). The amplified DNA shown in lanes 4 were of a size relative to 
the DHODH coding-region amplified from the positive control (lane 2; 1210-bp). Lanes S 
and 6 also show the same identically sized DNA fragments, amplified from total genomic 
cDNA of Sf9 (A) and T.ni HiS (B) cells stably transformed with pBmA3+EDHODH 
(passage 19; lane Sand 6 are replicated samples). DHODH was not amplified from 
genomic cDNA of non-transformed Sf9 (A) and T.ni HiS (B) cells (lane 3, negative 
control). These results confirm that DHODH was stably expressed ,from the BmA3+E 
promoter in transformed Sf9 and T.ni HiS cells. 
Molecular 
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1200-bp 
1000-bp 
A: 519 
DHODH 
1210-bp 
Molecular wt 1 2 3 4 5 6 
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1210-bp 
Figure 5.12A I B: Analysis of the amplification of the DHODH coding-region from cDNA 
produced by RT-PCR from total RNA extracted from Sf9 and T.ni HiS cells stably 
transformed with pBmA3+EDHODH (passage 19), pBmA3+E.DHODH transfected Sf9 
and T.ni HiS cells 48 hpt and non-transformed Sf9 and T.ni HiS cells, using PCR (Section 
2.S.S). pBmA3+EDHODH was used to amplify the DHODH coding-region as a positive 
control. Positive amplified DHODH coding-region produced a DNA fragment banding at 
1210-bp (DHODH). The above gels show: 
Track 1: 
Track 2: 
Track 3: 
Track 4: 
Track S-6: 
2-Log ladder (New England Biolabs) 
Positive amplification of the DHODH coding-region (pBmA3+E.DHODH; 
positive control) 
Negative control, no amplification of the DHODH coding-region (non-
transformed Sf9 (A) T.ni HiS (B) cells) 
Positive amplification of the DHODH cOding-region (pBmA3+EDHODH, 48 
hpt in Sf9 (A) T.ni HiS (B) cells) 
Positive amplification of the DHODH coding-region (pBmA3+EDHODH 
stably transformed Sf9 (A) T.ni HiS (B) cells passage 19) 
Expression of DsRed was detected by Western blot analyses in T.ni HiS cells stably 
transformed with pBmA3+EDsRed (Figure 5.13), but not Sf9 cells. 
The stable expression of DsRed from T.ni HiS cells, passages 1-8 are shown in Figure 
5.13. The production of DsRed was not observed in mock-transfected T.ni HiS cells (lane 
MT). Transient expression of DsRed from the BmA3+E promoter in T.ni HiS cells was 
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detected at 72 hpt (lane +ve; positive control). Stable production of OsRed from passages 
1-8 was also observed (lanes 1-8). The levels of OsRed produced from passage 1-8 were 
considered low, as the signal intensity produce by Western blot was very weak. No 
apparent difference among the levels of OsRed produced between passages were evident 
from these results. 
27.5 kDa~ 
20.5 kDa~ 
MW MT +ve 
T.ni (Hi5).DsRed passage number 
~-------------~-------------~ 
1 2 3 4 5 7 8 
~ 25 kDa 
Figure 5.13: Western blot analysis of T.ni Hi5 cells stably expressing OsRed. Lane MW 
(molecular weight), shows protein markers (Invitrogen). Lane MT (mock-transfected), 
shows intracellular cell extract (25~g 1 lane) from mock-transfected T.ni Hi5 cells (negative 
control). Lane +ve shows intracellular cell extract (25~g 1 lane) from T.ni Hi5 cells 
transfected with 1 ~g of pBmA3+E.DsRed at 72 hpt (positive control). Lane 1-8 shows 
intracellular cell extract (25~g 1 lane) from passages 1-8 of T.ni Hi5 cells stably expressing 
OsRed. Position of molecular weight (MW) size marker is shown in kOa and the position 
of OsRed is indicated (25kOa). 
The stable production of OsRed from the BmA3+E promoter in transformed Sf9 and T.ni 
Hi5 cells was further analysed using fluorometric analyses (Figure 5.14) and fluorescence 
microscopy (Figure 5.15A-D). Subsequently these cell lines were named Sf9.DsRed and 
T.ni (Hi5).DsRed. 
Figure 5.14 shows results obtained from passage 9 of Sf9.DsRed and T.ni (Hi5).DsRed. 
No detectable levels of background fluorescence were observed from non-transformed Sf9 
or T.ni Hi5 cells (negative control). Fluorescence was detected from both Sf9.0sRed and 
T.ni (Hi5).DsRed, which confirmed production of OsRed in T.ni (Hi5).DsRed (these 
findings correlate with those observations in Figure 5.13), and also established that 
OsRed was produced in Sf9.DsRed albeit at a level that was not possible to detect by 
Western blot analyses. Even though OsRed was shown to be stably expressed in 
Sf9.DsRed (Figure 5.14), the levels produced were too low to detect at 0-12 h (0.5-
0.75x106 cell 1 ml). However, with increased cell density OsRed was detected from 
Sf9.DsRed at 24-96 h, whilst in T.ni (Hi5).DsRed, the levels of OsRed produced were 
sufficient to be detected at 0-96 h. Comparison of OsRed production from these cell lines 
showed that T.ni (Hi5).DsRed produced significantly higher levels of OsRed than those 
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observed from Sf9.DsRed (p=O.0001, in all cases), at all time-points. A decrease in 
OsRed production was observed from T.ni (HiS).DsRed at 96 h, these finding were shown 
to correlate with T.ni (HiS).DsRed cell death, as at 96 h T.ni (HiS).DsRed cells enter the 
decline phase of growth (data not shown; this finding correlates with those observed in 
Section S.6, Figure 5.17/5.19). 
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Figure 5.14: Red fluorescence detected from the production of OsRed in Sf9.DsRed and 
T.ni (HiS).DsRed cell lines. Cell samples (1ml) were harvested at 12 h intervals over a 
period of 96 h, these sample were subjected to f1uorometric analyses to determine the 
levels of OsRed produced. 
The results shown in Figure S.1SA-0, show visual evidence of OsRed production in T.ni 
(HiS).DsRed (8) and Sf9.DsRed (0) cell lines. Expression of OsRed was not detected in 
non-transformed Sf9 (C) or T.ni HiS (A) cells. 
These data show that the production of OHOOH was difficult to express under control of 
the BmA3+E promoter in stably transformed Sf9 and T.ni HiS cell lines. As expression of 
OHOOH was only detectable by analyses of mRNA transcripts it was concluded that the 
levels of OHOOH produced in these stable insect cell lines was too low for further 
comparisons to be made between stable cell lines and production using the BES. 
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Figure 5.15A-0: Stable production of OsRed from the BmA3+E promoter in Tn; HiS (8) 
and Sf9 (0) cells . Mock-transfected Tn; HiS (A) and Sf9 cells (C). 
The production of OsRed from the BmA3+E promoter in Sf9DsRed and Tn; (HiS)DsRed 
cell lines was detected using f1uorometric analyses and fluorescence microscopy. 
However, OsRed production was only detectable in Tn; (HiS).DsRed cells using Western 
blot analyses. Therefore concluding, that higher levels of OsRed were produced in Tn; 
(HiS)DsRed than those observed from Sf9DsRed (these results correlate with 
f1uorometric analyses, (Figure 5.14). The fluorometric data obtained for maximal OsRed 
production from Sf9DsRed (96 h) and Tn; (HiS)DsRed (84 h) cell lines (Figure 5.14), 
was subsequently compared to AcDsRed (moi 2) in Sf9 cells (Section S.2; Figure 5.3 A ), 
which was shown to be the highest expressing OsRed baculovirus. These results showed 
that optimal OsRed production from AcDsRed (moi 2) in Sf9 cells (72 hpi) was S2 .S-fold 
greater than those detected from Tn; (HiS)DsRed cells , and 262.9-fold higher than those 
observed from Sf9DsRed cells. From these data it was concluded that OsRed production 
from Sf9DsRed and Tn; (HiS).DsRed cell lines was not comparable to those observed 
from baculovirus expression . 
However, the Tn; (HiS)DsRed cell line was subsequently used at Pfizer to generate a 
protocol for continuous stable insect cell line cultivation in 1-litre fermenters (Section S.6). 
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5.6 Scale-up of stable insect cell cultivation using a 1-litre open 
fermenter system 
Attempts were made to establish a protocol for scaling-up stable insect cell cultivation, 
using a 3-litre open fermenter system. Development of a standardised procedure would 
provide useful data for future projects involving necessary scale-up of stable insect cell 
cultures for maximizing foreign protein yield. 
An open culturing system allows both the removal and addition of cells and medium to a 
vessel once set-up and running. The aims of this experiment were to inoculate a 3-litre 
fermenter with 1-litre of low density stable insect cells and continuously cultivate a viable 
culture, without contamination or total cell death occurring. 
The T.ni (HiS).DsRed cell line generated in Section S.S was chosen as a model to simulate 
culture dynamics throughout the culturing process. A technique described as the fill and 
draw method (Figure 5.16A-C), which is similar to the fed-batch method, was used to 
inoculate cells into the fermenter vessel and passage them during fermentation, enabling 
Continuous culturing to be achieved. The cell culture was analysed for cell growth, viability 
and stability of foreign gene expression. 
A 1-litre culture of T.ni (HiS).DsRed cells was seeded at a density of 0.Sx106 cells I ml in a 
1.S-litre sterile Duran bottle' with vessel connectors, and used to inoculate a 3-litre 
fermenter vessel as described in Section 2.3.6.2 (Figure 5.16A). A 1ml cell sample was 
drawn-off and re-counted to determine the accuracy of the inoculation process, this count 
Was termed day 1. Cell samples (1 ml) were harvested at intervals of 24 h for analyses of 
cell growth and viability. Cell viability was determined using trypan blue staining (Section 
2.2.6). Confirmation of stable OsRed production was monitored using a fluorescence 
microscope, but no camera facility was available (Pfizer) to record data. However, DsRed 
production was visualised from all cell samples taken over the period of culturing. 
The results shown in Figure 5.17 show T.ni (HiS).DsRed cell growth, from a 1-litre open 
fermenter system, after two passages. Day 1, the fermenter vessel was inoculated with 1-
litre of T.ni (HiS).DsRed cells at a density of 0.5x106 cells I ml. Day 2, T.ni (Hi5).DsRed 
cell density was shown to increase to 0.8x106 cells I ml. Day 3, the cell density of the 
. culture was shown to hav~ doubled (1.6x106 cells I ml), compared to those observed on 
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day 2. Day 4, cell density was shown to have increased to 2.8x106 cells I ml. However on 
day S, the cell density was shown to decrease, and was observed at 2.Sx106 cells I ml. It 
was suggested, that cell growth had shifted from log-phase to decline phase (Figure 
5.18), therefore the cells were passaged to continue growth. The fill and draw technique 
was used to passage these cells and re-establish a 1-litre T.ni (HiS).DsRed cell culture at 
a density of 0.Sx1 06 cells I ml. Continued monitoring of T.ni (HiS).DsRed cell growth from 
days 5-8, showed a similar pattern of growth to the initial observations made from days 1-
4. On day 8 the cell density of the culture was observed at 2.4x1 06 cells I ml, so a second 
passage was performed. The T.ni {HiS).DsRed cell culture was again re,-established as a 
1-litre culture at 0.5x106 cells I ml. Further monitoring of cell growth from day 8-11 showed 
no significant difference (p>0.05 in all cases) in cell density compared to those observed 
from days 1-4 and 5-8. 
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Figure 5.16A·C: A schematic of the fill a'nd draw technique used to continuously cultivate 
stable insect cells in a fermenter vessel. A: A 3-litre fermenter vessel was used to culture 
1-litre of T.ni (Hi5).DsRed cells. The vessel was assembled and sterilized (Section 
2.3.6.2). Filling the vessel with the cell culture, required connecting the sterile Duran bottle 
pre-filled with T.ni (Hi5).DsRed cells and Sf90011 medium at the correct inoculating density 
, (0.5x106 cells I ml). The sterile Duran bottles have one inlet, which was used to pass air 
through a filter into the headspace of the Duran bottle and force the cell culture out of the 
Duran bottle via the fill line, which was connected to the fermenter vessel. The culture 
enters the fermenter via the vessel head-unit and inoculates the fermenter. Subsequently 
the Duran bottle was disconnected from the vessel and the vessel is ready to culture the 
cells (B). C: Passaging the cell culture required removing a defined volume of cells (1 ml) 
and medium from the vessel via the sample line. The sample line was also used to 
sample the culture daily to monitor cell growth and viability. Passaging of cells required a 
second sterile Duran bottle to be connected to the draw line of the vessel. Air was 
pumped into the vessel via a filter, which allows release of respired gases during culturing. 
This caused the culture to leave the vessel under-pressure through the draw line and be 
collected into the sterile Duran bottle. A defined volume of cells was left in the vessel and 
fresh medium was added via the fill line (A) to dilute the culture for continuous culturing. 
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Figure 5.17: Total number of T.ni (HiS).DsRed cells I ml, following inoculation of an open 
fermenter system. A 3-litre open fermenter system was inoculated with 1-litre of T.ni 
(HiS).DsRed cells (day 1). Cell samples (1 ml) were taken daily over a period of 11 day, 
which included passaging the cell culture twice (days Sand 8), the total number of cells 
were counted to determine T.ni (HiS).DsRed cell growth. 
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Figure 5.18: The four phases of cell growth in culture. Lag phase; this is an early phase 
in which there is no apparent increase in cell concentration. Log phase; this phase 
involves an exponential increase in cell number. Stationary phase, occurs when there is 
no further increase in cell concentration. Decline phase; this occurs as a result of cell 
death. 
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Figure 5.19 shows results obtained for T.ni (Hi5).DsRed cell viability. from a 1-litre open 
fermenter system. after two passages. The viability of T.ni (Hi5).DsRed cells inoculated 
into the fermenter on day 1 was 90%. which dropped slightly to 89% day 2 and 88% on 
day 3. On day 4. a significant decrease in T.ni (Hi5).DsRed cell viability. to 74% was 
observed. followed by a drop to 51% on day 5. On day 5. T.ni (Hi5).DsRed cells were 
therefore passaged. and the cell viability re-determined (53%). On day 6. T.ni 
(Hi5).DsRed cell viability had increased to 71 % and on to 76% on day 7. However on day 
8. the viability of the culture decreased again to 70%: As shown previously in Figure 5.17. 
T.ni (Hi5).DsRed cell growth shifts from log phase to decline phase after,4 days. therefore 
these cells were passaged to continue culture growth. After passaging these T.ni 
(Hi5).DsRed cells. cell viability was re-established. 71 %. It was noted that these cell had 
establishing a cyclic pattern of growth I viability. again an increase in viability. to 77% was 
Observed on day 9. followed by a steady decrease to 72% on days 10 and 67% on day 11. 
Due to time constraints. it was not possible to proceed with these experiments. However. 
COlin Robinson and Chris Carter carried-out a further four successful passages before 
terminating these studies. Similar results were obtained to that described above. but it 
was unfortunate that samples could not be taken 24 h intervals. therefore these results 
were not included. 
These data show that it was possible to continuously cultivate 1-litre of T.ni (HiS).DsRed 
cells using an open fermenter system. The successful use of this system was attributed to 
the technique used (fill and draw) to inoculate. harvest and passage the T.ni (Hi5).DsRed 
cells from the fermenter. The 1-litre T.ni (Hi5).DsRed cell culture was successful 
sustained for 27 days (selected data shown). without total cell death. yeast or bacterial 
contamination. This culturing methodology may provide a useful tool for future work at 
Pfizer. 
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Figure 5.19: Viability of T.ni (Hi5).DsRed cells, cultured using an open fermenter system. 
A 3-litre open fermenter system was set-up and inoculated with 1-litre of T.ni (Hi5).DsRed 
cells (day 1). Cell samples (1 ml) were taken daily over a period of 11 day, which included 
passaging the T.ni (Hi5).DsRed cell culture twice (days 5 and 8). Samples were subjected 
to trypan blue staining to determine T.ni (Hi5).DsRed cell viability. 
5.7 Comparison of recombinant protein production from Ac and 
Ac.llchiA using different scale-up culturing methodologies 
The successful production of high-level recombinant protein (mg I litre) from the BES has 
been well documented over the years (King et al., 1992; Schwartz et al., 1997; Stewart 
and Champoux, 1999; Jayakumar et al. , 2004). However, to achieve these quantities, 
protein production often requires scaling-up. Two successful methodologies currently 
used for scaling-up protein production include; shaker culture and fermentation, as 
described in Section 5.1 (Figure 5.20A I B). These culturing methodologies are extremely 
different to one another; shaker cultures are simplistic and easy to set-up, and relatively 
inexpensive (£54, 3-litre disposable flask) to use, compared with the very technical, 
expensive (£15000, 3-litre complete set-up) and laborious, fermenter cultures. One of the 
key differences of fermenter and shaker culturing, focuses on the regulation of dissolved 
oxygen concentration in the culture. The dissolved oxygen concentration can be regulated 
using fermenter culturing, whilst this is not possible for shaker culturing. In this Section, 
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attempts were made to determine whether these different scale-up culturing 
methodologies (shaker vs. fermenter), could affect the yields of baculovirus expressed 
recombinant protein. .J 
Figure 5.20A I B: Two different culturing methods used to scale-up protein production 
using the BES. A: Shaker culture. B: Fermenter culture (Applikon®). 
To investigate the affects described above, the recombinant baculoviruses generated in 
Section 5.2 (Ac.DsRed, Ac.DHODH, AC.t1chiA.DsRed and Ac.t1chiA.DHODH) were used 
to express intracellular foreign protein (DHODH or DsRed) in 1-litre Sf9 and T.ni HiS 
shaker and fermenter cultures. 
One-litre Sf9 and T.ni HiS cell cultures were seeded into 1-litre sterile Duran bottles with 
vessel connectors, or directly into 3-litre shaker flasks (as described in Sections 2.3.6.1 
and 2.3.6.2). Small-scale (25ml) Sf9 and T.ni HiS shaker cultures were also set-up 
(Section 2.2.3) as mock-infected controls (negative control). The pre-filled 1-litre sterile 
Duran bottles were subsequently used to inoculate 3-litre fermenter vessels (as described 
in Section 2.3.6.2). 
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Cells cultured in fermenter vessels were grown to the required density, then infected with 
the appropriate recombinant baculovirus at a specified moi (as determined in Section S.2; 
AC.DsRed I Ac.~chiADsRed, moi 2, AC.DHODH I Ac.~chiADHODH, moi S). Fermenter 
cultures were infected with virus inoculum via a sterile syringe and needle through a self-
sealing septum at the top of the vessel, whilst shaker cultures were infected via pipetting 
virus inoculum directly into the flask. Fermenters were equipped with an external heating 
jacket and internal cooling system to regulated the correct culturing temperature (28°C), 
While shaker cultures were maintained at the correct temperature in an orbital incubator 
(28°C). Cells were kept in suspension by stirring (fermenter cultures; 120 rpm) or orbital 
shaking (shaker cultures; 13S rpm). Samples (1m!) were harvested from AC.DHODH and 
Ac.~chiADHODH infected cultures at 24-48 hpi, and 24-72hpi from AC.DsRed and 
Ac.~chiADsRed infected cultures. The intracellular supernatant of each cell sample was 
Subsequently subjected to protein estimation assays. Standard amounts of total protein 
(2SJ.1g) from each sample were run on SDS-PAGE for Western blot analyses (Sections 
2.7.4, 2.7.S, 2.7.6) to determine the levels of OsRed and DHODH produced (visual 
observation). The remaining sample volume of each infection (Ac.DHODH I 
Ac.~chiADHODH, 48 hpi and Ac.DsRed I Ac.llchiADsRed, 72 hpi) was harvested and 
pelleted. Dry cell pellets were stored at -80°C to await further analyses. 
The results shown in Figure S.21A-D show OsRed expression from AC.DsRed and 
Ac.llchiA.DsRed in 1-litre Sf9 and T.ni HiS fermenter and shaker cultures. The detection 
of OsRed was analysed using a OsRed polyclonal antibody (SO Siosciences; molecular 
Weight 2S kOa). No detectable levels of OsRed were observed in mock-infected Sf9 or 
T.ni HiS cells (A-O: lane MI). Sf9 and T.ni HiS fermenter I shake cultures, infected with 
Ac.DsRed or Ac.~chiADsRed, were all shown to produce detectable levels of OsRed at 
48-72 hpi (A-D: lane 48-72 a, b). However, at 72 hpi, OsRed production was shown to be 
higher than those observed at 48 hpi. Sf9 fermenter cultures infected with AC.DsRed or 
Ac.llchiADsRed, were also shown to produce higher levels of OsRed than those observed 
from the shaker cultures (A I B: lanes 48-72 a, b). However, this was not the case for T.ni 
HiS cells, as the shaker cultures produce higher levels of OsRed than those observed from 
the fermenter cultures (C I D: lanes 48-72 a, b). A comparison of OsRed production from 
Ac.DsRed infected Sf9 and T.ni HiS fermenter I shaker cultures, showed production of 
OSRed was higher in both Sf9 cultures (A I C: lanes 48-72 a, b). Similar observations 
, Were also shown for the comparison of OsRed production from Ac.~chiA.DsRed infected 
Sf9 and T.mHiS fermenter I shaker cultures (B I D: lanes 48-72 a, b). A comparison of 
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OsRed expression from AC.DsRed and AC.AchiADsRed in Sf9 fermenter I shaker cultures, 
showed AC.DsRed produced higher levels of DsRed in both cultures, than those detected 
from Ac.AchiADsRed (A 18: lanes 48-72 a, b). Similar DsRed expression profiles were 
also observed from AC.DsRed and AC.AchiADsRed in T.ni Hi5 fermenter I shaker cultures 
(C I D: lanes 48-72 a, b), however, at much lower levels than those observed in Sf9 
cultures. 
Figure 5.22 A I 8 shows results obtained for DHODH expression from Ac.DHODH and 
Ac.AchiADHODH in 1-litre T.ni Hi5 (A) and Sf9 (8) fermenter I shaker cultures. The 
production of DHODH was detected using an anti-polyhistidine monoclonal antibody (as 
described in Section 5.2). No detectable levels of OHODH were observed in mock-
infected T.ni Hi5 or Sf9 cells (negative control; A I 8: lane MI). Production of DHODH 
from AC.AchiADHODH infected T.ni Hi5 fermenter I shaker cultures was detected at 24-48 
hpi (A: 24-48a), whilst from Ac.DHODH, DHODH was only detected at 48 hpi (A: 48b). 
Optimal DHODH production from all T.ni Hi5 infected cultures was observed at 48 hpi (A: 
48a, b). Expression of DHODH from AC.DHODH and Ac.AchiADHODH infected Sf9 
fermenter I shaker cultures, was only detected at 48 hpi (8: 24-48a, b). The levels 
observed. were also considerably lower (at all time points), than those observed from 
infected (Ac.DHODH or Ac.AchiADHODH) T.ni Hi5 cultures (these findings support 
previous results described in Section 5.2). 
A comparison of DHODH pr~duction from Ac.AchiADHODH infected T.ni Hi5 cultures at 
24-48 hpi, showed the fermenter culture produced higher levels of DHODH than those 
observed from shaker culture, at the same time pOints. Similar results were also observed 
from AC.DHODH infected T.ni Hi5 cultures (48 hpi), and AC.AchiADHODH I AC.DHODH 
infected Sf9 cultures (48 hpi). Furthermore, a comparison of AC.AchiADHODH infected 
T.ni Hi5 (at 24-48 hpi) and Sf9 (at 48 hpi) fermenter I shaker cultures, showed levels of 
DHOOH produced were higher than those observed from AC.DHODH at the same time 
POints. 
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A: Ac.DsRed infected St9 cells 
Fermenter Shaker 
j 
MW MI 24a 48a 72a 24b 48b 72b 
26 kDa ~ 
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B: AC.flchiA.DsRed infected St9 cells 
Fermenter Shaker 
r,----'A-----.., r,--------A-----.., 
MW MI 24a 48a 72a 24b 48b . 72b 
26 kDa ~ 
"'25 kDa 
C: Ac.DsRed infected T.ni Hi5 cells 
Fermenter Shaker 
r , 
MW MI 24a 48a 72a 24b 48b 72b 
26 kDa ~ 
"'25 kDa 
D: AC.flchiA.DsRed infected T.ni Hi5 cells 
Fermenter Shaker 
r,--------A ....... -----.." 
MW MI 24a 48a 72a 24b 48b 72b 
26 kDa~ 
"'25kD 
Figure 5.21A-D: Western blot analysis of AC.DsRed (panel A I C) and AC.flchiADsRed 
(panel B I D) expressing OsRed in Sf9 (panel A-B) and Tni HiS (panel C-D) fermenter 
and shaker cultures. Lanes MW (molecular weight), shows protein markers (Invitrogen). 
Lanes MI (mock-infected), shows intracellular cell extract (2S~g 1 lane) from mock-infected 
Sf9 and T.ni HiS cells (negative control). Lanes 24-72a shows intracellular cell extract 
(2S~g 1 lane) from Sf9 and T.ni HiS fermenter cultures infected with AC.DsRed or 
AC.flchiADsRed at 24-72 hpi (moi of 2). Lane 24-72b shows intracellular cell extract 
(2S~g 1 lane) from Sf9 and T.ni HiS shaker cultures infected with AC.DsRed or 
AC.flchiADsRed at 24-72 hpi (moi of 2). Position of molecular weight (MW) size marker is 
shown in kOa and the position of OsRed is indicated (2SkOa). 
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A: Ac.l1chiA.DHODH and Ac.DHODH infected T.ni HiS cells 
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Figure 5.22A I B: Western blot analysis of AC.l1chiADHODH and AC.DHODH expressing 
DHODH in T.ni Hi5 (panel A) and Sf9 (panel B) fermenter / shaker cultures. Lanes MW 
(molecular weight), shows protein markers (Invitrogen). Lanes MI (mock-infected), shows 
intracellular cell extract (25)..lg / lane) from mock-infected T.ni Hi5 and Sf9 cells (negative 
control). Lanes 24-48a shows intracellular cell extract (25)..lg I lane) from T.ni Hi5 and Sf9 
fermenter / shaker cultures infected with AC.l1chiADHODH at 24-48 hpi (moi of 5). Lanes 
24-48b shows intracellular cell extract (25)..lg / lane) from T.ni Hi5 and Sf9 fermenter / 
shaker cultures infected with AC.DHODH at 24-48 hpi (moi of 5). Position of molecular 
weight (MW) size marker is shown in kDa and the position of DHODH is indicated 
(43kDa). 
Conclusions drawn from these data show that optimal DsRed expression was achieved 
from Ac.DsRed in Sf9 cells (these data correlate with findings shown in Section 5.2) using 
fermentation . However, although DsRed production was visibly lower in T.ni Hi5 cells, 
optimal production was also obtained from Ac.DsRed, but using shaker culture. 
Interestingly optimal DHODH production was obtained from AC.l1chiADHODH in T.ni Hi5 
cells (these data correlate with finding shown in Section 5.2) using fermentation. Similar 
results were also observed in Sf9 cells, although the levels of DHODH detected were 
extremely low. 
These data show only semi-quantitative results, Which cannot be used to determine 
accurately the quantities of foreign protein (DsRed and DHODH) produced. Therefore, in 
order to quantify the amounts of recombinant protein produced, heterologous protein was 
purified and analysed using densitometry. DHODH was chosen for this analysis since the 
sequence of DHODH in the construct used here contained an N-terminal His-tag 
(described in Section 5.2), which was subsequently used to purify the protein. 
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5.8 Purification of His-tagged DHODH from Ac and Ac.AChiA T.ni Hi5 
cultures 
Work carried out by the structural biology group at Pfizer have shown that a plasmid-
based expression vector, expressing DHODH in E. coli using fermentation, yielded 2mg I 
litre of biologically active DHODH (Robert Moore; personal communication). To determine 
Whether the yields of DHOOH produced from fermenter I shaker culturing of AC.DHODH 
and AC.6.chiADHODH in insect cell lines was higher than those observed from E. coli, 
yields of purified OHOOH were quantified. 
The results shown in Figure 5.22 A I B show that production of OHOOH from AC.DHODH 
and AC.6.ChiADHODH in Sf9 fermenter I shaker cultures was extremely low compared to 
those observed from infected T.ni Hi5 cultures. For this reason, quantification of DHOOH 
production was determined from infected T.ni Hi5 cultures. 
The PUrification of His-tagged OHOOH from Ac.DHODH and AC.6.chiADHODH infected 
T.ni Hi5 fermenter I shaker cultures (dry cell pellets stored dry at -80°C, Section 5.7) was 
carried out using HiTrap chelating sepharose™, high performance protein purification 
columns (Amersham Biosciences), as described in Section 2.6.1. Technical problems 
prevented successful purification of OHOOH from AC.DHODH infected T.ni Hi5 shaker 
culture, but protein was readily purified from both Ac.6.chiADHODH T.ni Hi5 fermenter I 
shaker cultures and from the AC.DHODH T.ni Hi5 fermenter culture (Figure 5.22 A). 
Purified DHODH was visualised using SOS-PAGE and Western blot analyses (Sections 
. 2.7.5/2.7.6; selected data shown). Quantification of DHOOH production (mg I litre) was 
determined by densitometry (Section 2.7.4). The percentage of purified DHODH to total 
protein was then estimated optically using a Coomasse stained SOS-PAGE (Figure 5.23). 
From these results and observations an estimation of OHOOH production from each 
Culture was calculated (mg I litre). 
Figure 5.23 shows results obtained for purification of His-tagged OHOOH from 
AC.6.chiADHODH and AC.DHODH in 1-litre T.ni Hi5 fermenter and AC.6.chiADHODH 1-
litre T.ni Hi5 shaker culture. The purification of DHODH from these cultures described 
above, showed that optimal OHOOH production was obtained from AC.6.chiADHODH 
infected T.ni Hi5 fermente!- culture, producing an estimated 7.2mg I litre of OHOOH (lane: 
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1; 18 mg of total purified protein flitre; 40% DHODH). The Ac.DHODH infected T.ni Hi5 
fermenter culture produced an estimated 2mg f litre of DHODH (lane: 2; 4 mg of total 
purified protein f litre; 50% DHODH). The lowest level of DHODH production was 
observed from AC.t1chiADHODH infected T.ni Hi5 shake culture (lane: 3), which was 
shown to produce approximately 1.1 mg flitre of DHODH (7.5 mg of total purified protein f 
litre; 15% DHODH). 
These results correlate with the finding shown and described in Figure 5.22 A (Section 
5.7), DHODH production from Ac.DHODH infected T.ni Hi5 shaker .culture, which had 
been lost, might therefore be predicted to be even lower than those observed from the 
latter culture. 
MW 1 2 3 
41 kDa ~ .. 43kDa 
Figure 5.23: Coomasse stained SDS-PAGE analysis of purified His-tagged DHODH from 
AC.t1chiADHODH and AC.DHODH in 1-litre T.ni Hi5 fermenter cultures and 
AC.t1chiADHODH 1-litre T.ni Hi5 shaker culture. Lane MW (molecular weight), shows 
protein markers (Invitrogen). Lanes 1-3 show total purified cell protein (25J.lg flane) from 
AC.t1chiADHODH (lane 1) and Ac.DHODH (lane 2) 1-litre T.ni Hi5 fermenter cultures and 
AC.t1chiADHODH 1-litre T.ni Hi5 shaker culture (lane 3). Position of molecular weight 
(MW) size marker is shown in kDa and the position of DHODH is indicated (43kDa). 
These data show that the production of DHODH from AC.t1chiADHODH T.ni Hi5 shaker 
culture (1.1mg f litre) yielded 0.5-fold less DHODH than those obtained from plasmid-
.. 
based expression in E. coli using fermentation (2mg flitre). However, the yield of DHODH 
obtained from AC.DHODH T.ni Hi5 fermenter culture (2mg flitre), was comparable to that 
obtained from E. coli. The highest yield of DHODH obtained was observed from 
AC.t1chiADHODH T.ni Hi5 fermenter culture (7.2mg flitre), which produced 3.6-fold more 
DHODH than those obtained from E. coli. 
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5.9 Functional analyses of baculovirus expressed DHODH 
Having expressed (Section 5.7) and purified (Section 5.8) DHODH from AC.DHODH I 
Ac.~chiA.DHODH in T.ni HiS cells, DHODH was tested to verify its authentic biological 
activity. 
DHODH purified from Ac.~chiA.DHODH I AC.DHODH T.ni HiS fermenter cultures and 
Ac.~ChiA.DHODH T.ni HiS shaker culture (Section 5.8), were subjected to DHODH activity 
assays to determine the specific activity (J.lmoles conversion of DCIP I min I· mg) of 
DHODH in each sample (Section 2.8.2). To establish that DHODH was actively 
converting the substrate 2,6 dichlorophenylindolphenol (DCIP) and not any non-specific 
proteins co-purified with DHODH, it was important to have a control for non-specific 
proteins that may have co-purified. To obtain this control, a non His-tagged protein 
(PDE5) expressed using the BES in T.ni HiS cell was passed through a HiTrap chelating 
sepharose™ protein purification column (Section 2.6.1) to purify any non-specific proteins 
that may be also present in DHODH samples. This sample was named PDE5 and used 
as a control for non-specific activity. Purified DHODH from plasmid-based expression in 
E. coli using fermentation (2mg I litre), was used as a positive control (obtained from 
~obert Moore; Pfizer). 
Table 5.1 and Figure 5.24 A·E show results obtained form DHODH activity assays. Non-
Specific proteins purified from baculovirus expressed PDE5 T.ni HiS cell sample, were 
Shown to have no specific activity (A; negative control). However, activity was detected 
from DHODH produced in Ecoli (8; positive control). The specific activity of DHODH from 
this sample was calculated to be 1.2 J.lmoles conversion of DCIP I min I mg. DHODH 
produced from Ac.~chiA.DHODH (C I E) and AC.DHODH (D) T.ni HiS fermenter I shaker 
Cultures, was also shown to be active. DHODH purified from Ac.~chiA.DHODH T.ni HiS 
fermenter produced a specific activity of 0.5 !-e.moles· conversion of DCIP I min I mg, while 
Ac.DHODH T.ni HiS fermenter produced approximately 0.1 J.lmoles conversion of DCIP I 
min I mg, and Ac.~chiA.DHODH T.ni HiS shaker culture produced 0.02 J.lmoles conversion 
of DCIP I min I mg. 
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Table 5.1: A summary of DHODH activity assay results shown in Figure 5.24. 
Sample ABSat 595nm ABSat595nm Estimated DHODH 
Omins 2 mins specific activity 
(~moles 
conversion of DCIP 
I min I mg) 
PDE5 T.ni Hi5 1.0666 1.0607 0 
(negative control) 
'" 
DHODH (E.coli; 1.0112 0.2022 1.2 
positive control) 
Ac.~chiA.DHODH 1.1047 0.9354 0.5 
T.ni Hi5 fermenter 
Ac.DHODH T.ni Hi5 1.0800 0.5762 0.1 
fermenter 
Ac.~chiA.DHODH 1.0950 0.9635 0.02 
T.ni Hi5 shaker 
A: Non-specific protein 
1.2 - PDE5 (negative control) 
E 1.0 
c 
It) 
~ 0.8 -CD 
Co) 0.6 c 
CIS 
.Q ... 0.4 
0 
CI) 
~ 0.2 
0.0 
~~ ~~ 
Time (minutes) 
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B: DHODH produced from plasmid-based expression in E.coli using fermentation 
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0: DHODH produced from AC.DHODH T.nl Hi5 fermenter culture 
- DHODH (Ae I fermenter) 
CD 
U 
c 
m 
.a ... 
o 
fI) 
.a 
<C 0.2 
0.0, ..... --...-----'1 ..... ---.--.... 
~~ 
Time (minutes) 
E: DHODH produced from Ac.!1ChiA.DHODH T.nl Hi5 shaker culture 
1.2 
-E 1.0 
c: 
II) 
m 0.8 -g 0.6 
m .a ... o 
fI) 
.a CC 0.2 
0.0 .... - ..... --..... --.--...... 
()~ 
Time (minutes) 
- DHODH CAe.A ChlA I shaker) 
Figure 5.24 A-E: Functional analyses of recombinant DHODH activity. A: Non-specific 
proteins purified from baculovirus expressed PDE5 in T.ni Hi5 cells, were used as a 
negative control to determine possible background activity levels, no activity was 
observed. B: Purified DHODH produced from plasmid-based expression in E. coli by 
means of fermentation, showed DHODH activity was detected (positive control). C-E: The 
prOduction and purification of DHODH from Ac~!1chiA.DHODH (C) I AC.DHODH (D) T.ni 
Hi5 fermenter cultures and AC.AChiA.DHODHT.ni Hi5 shaker culture (E), were also 
~own to be active. 
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In conclusion these data show that DHODH produced from Ac.!lchiADHODH and 
Ac.DHODH T.ni HiS fermenter cultures and Ac.!lchiADHODH T.ni HiS shaker culture was 
biologically active. As expected, Ac.!lchiADHODH T.ni HiS fermenter culture was shown 
to have a higher specific activity (O.S Jlmoles conversion of DCIP , min , mg) than those 
observed from Ac.DHODH T.ni HiS fermenter culture (0.1 Jlmoles conversion of DCIP , 
min' mg) and AC.!lchiADHODH T.ni HiS shaker culture (0.02 Jlmoles conversion of DCIP 
, min' mg). These results correlate with those shown in Section S.7 and S.8, which show 
DHODH production was optimal from AC.!lchiADHODH T.ni HiS fermenter culture. The 
specific activity of DHODH produced in E.coli was shown to be higher than those obtained 
from baculovirus in T.ni HiS cells, even though the purified yield of DHODH was lower 
(E.coJi; 2mg 'litre) than that obtained from AC.!lchiADHODH T.ni HiS fermenter culture 
(7.2mg 'litre). This was firstly explained by the E.coJi purified DHODH sample being 
passed through an ion-exchange purification column to remove some of the non-specific 
proteins present in the sample, therefore producing a cleaner sample. Secondly, the 
sample was concentrated, to increase the amount of DHODH , JlI (this work was carried 
out by Robert Moore at Pfizer) and as a consequence increase the specific activity of 
DHODH. 
5.10 Discussion 
To date, many heterologous. genes have been expressed successfully using the BES. It 
has been well documented that recombinant baculoviruses usually express high levels of 
intracellular foreign proteins (nuclear and cytoplasmic; King and Possee, 1992; Vlak et al., 
1998; Stewart and Champoux, 1999; Ikonomou et al., 2003; Jayakumar et al., 2004). 
However, virus infection severely compromises the insect cells secretory pathway, which 
inevitably has been shown to effect the expression of recombinant proteins destined for 
the plasma membrane or secretion (Jarvis and Summers, 1989; Jarvis et al., 1990; King 
and Possee, 1992; Thomas, 1997; Saville et al., 2002). As described in Section S.1, work 
carried out in our laboratory has identified a non-essential viral gene in the Ac genome 
called chiA (Hawtin et al., 1995). The expression of chitinase from Ac has been shown to 
accumulate at high levels in the ER late in virus infection (Thomas, 1997; Thomas et al., 
1998; Saville et al., 2002), inadvertently blocking the insect cells secretory pathway. The 
removal of chiA from the Ac genome (Ac.!lchiA) has subsequently been shown to improve 
yields of secreted foreign proteins from infected insect cells (urokinase , tissues-
Plasminogen activator; McCarroll, 1997). 
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The initial work in this Chapter was carried out to determine whether OHOOH and OsRed 
were expressed from the polh promoter of Ac and AC.l1chiA in Sf9 and T.ni HiS cells. 
Subsequently, the intracellular levels of OHOOH and Osred from AC.DHODH I AC.DsRed 
and Ac.l1chiADHODH I AC.l1chiADsRed were quantified and compared. The results 
Shown in Figure 5.1 and 5.2 A I B showed that OHOOH and OsRed were expressed from 
both Ac and AC.l1chiA However, OHOOH was only detectable in T.ni HiS cells, whilst 
OsRed was observed in both Sf9 and T.ni HiS cells. 
This was the first known study of AC.l1chiA expressing intracellular targeted foreign 
proteins (OHOOH and OsRed). From what is currently known about the localisation of 
chitinase (retained in the ER, due to the presence of a KOEL-ER retention motif; Thomas 
et a/., 1998) in Ac infected insect cells, it was hypothesised that the removal of chiA from 
Ac should not significantly increase the levels of expressed OHOOH or OsRed in Sf9 or 
T.ni HiS cells: Noting that OHOOH and OsRed are not produced in the ER or processed 
through the cell secretory pathway. 
However, the results shown in Figure 5.1 indicated that the production of intracellular 
OHOOH from AC.l1chiADHODH was significantly higher than that observed for 
Ac.DHODH in T.ni HiS cells at all time-points (24-72 hpi). Interestingly, the expression of 
DHOOH from AC.l1chiADHODH was observed at an earlier time-point (24 hpi) than that 
detected for AC.DHODH (48 hpi). At 72 hpi, the production of OHOOH from AC.DHODH 
Was barely detectable but a lower molecular weight protein was observed (estimated 
28KOa), which was postulated to be a degraded form of OHOOH. This protein was also 
observed at 72 hpi in Ac.l1chiADHODH-infected cells; however, the levels were drastically 
lower than that detected in Ac.DHODH-infected cells, and the levels of OHOOH were 
Significantly higher than those observed from Ac.DHODH. 
Conversely, expression of intracellular OsReci was observed in both AC.DsRed-and 
AC.L\chiADsRed-infected Sf91 T.ni HiS cells (Figure 5.2 A I B t S.3A I B). However, of the 
two recombinant viruses expressing OsRed, AC.DsRed produced higher levels in both 
insect cell lines used. Fluorometric analyses revealed AC.DsRed produced OsRed earlier 
in infection (24 hpi) than AC.l1chiADsRed (36 hpi). The choice of insect cell line used to 
produce OsRed from AC.DsRed and AC.l1chiADsRed also showed a considerable 
Variation in the levels produced, as optimal OsRed production from both recombinant 
Viruses was observed in Sf9 cells. 
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For reasons unclear at this time, it was difficult to address the reasons why the removal of 
chiA from the Ac genome increased the production of intracellular OHOOH. However, this 
was not the case for the production of intracellular OsRed, as the removal of chiA from the 
Ac genome reduced the levels of OsRed produced. Therefore, it is difficult to generalise 
which viral expression vector (Ac or Ac.b.chiA) would be most suited for optimal 
intracellular protein production in insect cells. This study does show that Ac.b.chiA can be 
used to produce improved yields of intracellular foreign protein, although it seems to be 
dependent on the nature of the protein produced. This work also stresses the importance 
of optimising foreign protein production from different expression vectors and insect cell 
lines. 
Studies have shown that promoter choice strongly influences the range of insect cells that 
can effectively support the production of heterologous genes (Morris and Miller, 1992). 
However, in this study OHOOH and Osred were expressed from identical promoters (polh 
promoter of Ac and Ac.b.chiA) in both SI9 and T.ni HiS cells. Subsequently, optimal 
OHOOH production was observed in T.ni HiS cells, while optimum OsRed production was 
detected in SI9 cells. From these data, it was concluded that promoter choice was 
essential for the production of foreign proteins, but the nature of the foreign protein under 
control of the polh promoter may also determine the range of insect cells used to host 
optimal expression. 
As described above, AC.DsRed was shown to produce higher levels of OsRed than 
AC.b.chiA.DsRed in both insect cell lines used. A proposed hypothesis, to explain these 
results, addresses the involvement of chiA, ER-associated degradation (ERAO) pathway 
and the ubiquitin-mediated proteolytic pathway. Eukaryotic cells have several intracellular 
proteolytic pathways for degrading misfolded (cytosol! ER proteins), viral, aggregated or 
denatured proteins (Laney and Hochstrasser, 1999). The ubiquitin-mediated proteolytic 
pathway is the main mechanism for degrading cytosolic proteins (Kirschner, 1999; 
Kornitzer and Ciechanover, 2000), and proteins that become misfolded in the course of 
their synthesis in the ER (Hiller et al., 1996; Lord et al., 2000; Jarosch et al., 2003; 
Kostova and Wolf, 2003). Proteins that are misfolded in the ER are transported back to 
the cytosol by the ERAO pathway via the sec61 :translocon (Hiller et al., 1996; Plemper et 
al., 1998) and subsequently degraded by the ubiquitin-mediated proteolytic pathway. The 
process of protein degradation occurs due to the chemical modification of a target protein 
lYSine side chain with the addition of ubiquitin molecule, a 76-residue polypeptide. 
'. 
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Subsequently, further ubiquitin molecules are added to the preceding one, resulting in a 
Polyubiquitin chain that is recognised by the 26S proteosome (Ciechanover, 1998). The 
26S proteosome then cleaves the protein into numerous small peptide fragments. 
OsRed is known to exist in the cytosol of both prokaryotic and eukaryotic cells as 
monomeric and tetrameric forms (Rodrigues et al., 2001; Sacchetti et al., 2002). However, 
only the tetrameric form emits red fluorescence (Sacchetti et al., 2002). OsRed tetramers 
also have a strong tendency to self-associate to form higher-order aggregates, which has 
Subsequently been shown to be toxic in both prokaryotic and eukaryotic. cells (Baird et a/., 
2000; Goss et a/., 2000; Heikal et al., 2000; Jakobs et al., 2000). 
It was hypothesised that OsRed expression from Ac.DsRed and Ac.tJ.chiA.DsRed formed 
aggregates in the cytosol of Sf9 and T.ni Hi5 cells, which were then targeted for ubiquitin-
mediated proteolytic degradation. However, it is thought that the production of chitinase 
from Ac.DsRed compromised the functional role of the ER I insect cell secretory pathway, 
inadvertently causing an increase in misfolded host cell ER proteins. This possible 
increase in ER misfolded proteins may have increased the activity of the ubiquitin-
mediated proteolytic pathway, and as a consequence over-worked the proteosome 
machinery. The stressed proteosomes may have, therefore, only degraded a small 
proportion of the aggregated intracellular OsRed present. In contrast, as chiA was 
removed from Ac.tJ.chiA.DsRed the insect cell secretory pathway was free of chitinase, 
thus the levels of misfolded host cell ER proteins may have been lower, allowing the 
Ubiquitin-mediated proteolytic pathway to degrade higher levels of aggregated intracellular 
OSRed. 
Attempts to overcome these detrimental affects of the BES (lytic system) has led to the 
development of stable (non-lytic system), plasmid-based expression systems (Bourouis 
and Jarry, 1983; Jarvis et al., 1990; Joyce et al., 1993; Jarvis and Finn, 1996; Lu et al., 
1996; Farrell et al., 1998, 1999), capable of continuous protein production in insect cell 
lines (Henderson et al., 1995; McCarroll and King, 1997). A variety of recombinant 
proteins targeted for secretion (serine protease inhibitor neurosepin, juvenile hormone 
esterase) or the plasma membrane (maize ABP1, chick nicotinic acetylchOline receptor a-
Subunit) have been effectively produced using stable insect cell lines (Henderson et al., 
1995; Atkinson et al., 1996; Farrell et al., 1998; Hill ~t al., 2001). In a number of reported 
cases, the expression of .~ecreted foreign proteins from stable insect cell lines has been 
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equal to or greater than those observed from the BES (Jarvis at al. 1990; Farrell at al., 
1998; Jarvis at al., 1996). However, the expression of intracellular foreign proteins in 
stable insect cell lines (plasmid-based expression systems) are usually very low compared 
to those detected from the BES. 
Work demonstrated by Jarvis at al. (1990),· showed that stable expression of p-
galactosidease from the AcMNPV ia-1 promoter in Sf9 cells (48 h growth), ranged from 
100 to 5000-fold less than that detected from the polh promoter of recombinant AcMNPV 
infected Sf9 cells (48 hpi). As previously described in Chapter 3, the AcMNPV ia-1 
promoter has been characterised as a transcriptionally weak promoter. However, work in 
Chapter 3 characterised two RNA polymerase II transcribed insect 1 viral promoters 
(OpMNPV ie-21 BmA3+E) with significantly stronger transcriptional activity than AcMNPV 
ia-1 in Sf9 and T.ni Hi5 cells. Therefore, work in this Chapter was carried out to compare 
the intracellular levels of expressed OsRed and OHOOH from the BmA3+E promoter to 
those produced from the polh promoter of Ac and AC.AchiA in Sf9 and T.ni Hi5 cells. This 
comparison addresses whether it is feasible to use stable insect cell lines to produced 
intracellular foreign protein as an alternative to the BES. 
Western blot analyses showed transient OHOOH and OsRed expression from the 
BmA3+E promoter was only detected in T.ni Hi5 cells (Figures 5.8 I 5.9). However, 
visualisation of red fluorescence using a CLSM microscope, showed OsRed was 
detectable in both Sf9 and· T.ni Hi5 cells (Figure 510 A-H), although the levels of red 
fluorescence observed were lower in Sf9 cells compared to those detected in T.ni Hi5 
cells. No assays were available for the detection of low level OHOOH production, it was 
however, postulated that OHOOH may have been expressed in SI9 cells, but at very low 
levels. Therefore, the production of stable insect cell lines (819 and T.ni Hi5 cells) 
expressing OHOOH or OsRed from the BmA3+E promoter were generated (Section 5.5). 
Stably transformed Sf9 and T.ni Hi5 cells expressing OHOOH were analysed for DHODH 
production using Western blot analyses, although OHOOH was not detected. Possible 
eXplanations why DHODH was not detected include: firstly, the BmA3+E promoter 1 
DHODH coding-region may not be integrated into the genome of transformed SI9 and T.ni 
Hi5 cells, due to a low transfection efficiency (as described in Chapter 3 Section 3.5). 
Secondly, the BmA3+E promoter I DHODH coding-region may have been integrated into a 
Silent region of the geno~e (O'Gorman at al., 1991), inadvertently repressing the BmA3+E 
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promoter of its transcriptional activity. Finally, it is possible that the levels of DHODH 
produced were extremely low, due to the nature of this protein. 
To identify if the DHODH coding-region was stably integrated into the genomic DNA of 
transformed Sf9 and T.ni Hi5 cells, total genomic DNA was isolated from these cell lines 
and screened for the DHODH coding-region using peR. The results in Figure 5.11 show 
that the DHODH coding-region was amplified successfully from total genomic DNAs 
tested. Therefore, the DHODH coding-region was integrated into the genomic DNA of 
stably transformed Sf9 and T.ni Hi5 cells. 
If the BmA3+E promoter I DHODH cOding-region was integrated into a silent region of 
these genomes then the BmA3+E promoter would not transcribe DHODH. Consequently, 
no DHODH mRNA transcripts would be detected. Analyses of total RNA isolated from 
these insect cell lines revealed that DHODH was expressed as mRNA transcripts (Figure 
5.12 A I B). These data conclude that the BmA3+E promoter I DHODH coding-region was 
not integrated into a silent region of the Sf9 or T.ni Hi5 genome, but was expressed from 
the BmA3+E promoter at very low levels. The production of DHODH from the polh 
promoter of Ac and AC.AchiA in Sf9 fermenter I shaker cultures was also shown to be 
extremely low (Section 5.7), suggesting that DHODH was difficult to express under the 
Control of certain promoters and insect cell lines (BmA3+E, Sf9 I T.ni Hi5 cells; polh 
promoter, Sf9 cells). Therefore, DHODH was not used to compare expression levels from 
the BmA3+E promoter in stably transformed Sf9 and T.ni Hi5 cells with levels produced 
from the polh promoter of Ac and AC.AChiA. 
The production of intracellular DsRed from the BmA3+E promoter in passage 1-8 of stably 
transformed Sf9 and T.ni Hi5 cells {Sf9.DsRed and T.ni (Hi5).DsRed) was initially only 
detected in T.ni {Hi5).DsRed cells (Figure 5.13). The levels were barely detectable; 
however, the levels observed were consistently low from each passage. Fluorometric 
analyses detected the production of intracellular DsRed in both Sf9.DsRed and T.ni 
(Hi5).DsRed cell lines. However, the T.ni {Hi5).DsRed cell line produced significantly 
higher levels of intracellular OsRed than those observed from Sf9.DsRad cell (p=O.0001 in 
all cases). Therefore, it was concluded that the transcriptional activity of the BmA3+E 
promoter was stronger in T.ni Hi5 cells compared to that in Sf9 cells (these findings 
COrrelate with those of Farrell at 81., 1998). 
\, 
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A comparison of optimal intracellular OsRed production from Sf9.DsRed (Figure 5.14, 94 
h growth [estimated 7x106 cells I ml, data not shown)) and T.ni (Hi5).DsRed (Figure 5.14, 
84 h growth [2.8x106 cells I ml, data not shown)) cell lines to those detected from the BES 
revealed (as described above optimal OsRed expression was detected in AC.DsRed 
infected Sf9 cells at 72 hpi; Section 5.2) that Ac.DsRed infected Sf9 cells produced 
significantly higher levels of OsRed than those observed from both stable insect cell lines 
(p=0.0001 in all cases). An estimated intracellular OsRed productivity difference of 262.9-
fold greater than Sf9.DsRed cells and 52.5-fold greater than T.ni (Hi5).DsRed cells was 
observed from AC.DsRed infected Sf9 cells at 72 hpi. 
From these findings it was estimated that to produce an equivalent amount of OsRed from 
the T.ni (Hi5).DsRed cell line to that obtained from a 1-litre AC.DsRed infected Sf9 culture 
at 72 hpi (estimated medium requirements 500ml = £17.5), T.ni (Hi5).DsRed cells would 
have to be amplified to 52.8 litres (estimated medium requirements 42L = £1470) at a cell 
density of 2.8x106 cellsl ml. The implications for producing these volumes, described 
above, increases the scope for experimental error (contamination of culture), and would 
not be cost-effective due to the cost of medium (£35 I litre) required to cultivate these 
VOlumes of cells. Additionally, downstream processing of large volumes may also be 
problematiC, costly and labour-intensive. Therefore, it was concluded that the BES was 
likely to remain the most effective method for producing large amounts of intracellular 
foreign protein in insect cell lines, using current promoters studied for cell lines. 
However, with reports of stable insect cell lines producing secreted foreign proteins equal 
to or greater than those observed from the BES (Jarvis et al. 1990; Farrell et al., 1998; 
Jarvis et al., 1996), a method for scaling-up stable insect cell cultivation was investigated 
using T.ni (Hi5).DsRed cells as a model for culture dynamics (Section 5.6). 
The protocol developed in this Chapter for maintaining large volumes (1-litre) of stable 
insect cells in an open fermenter system, was successfully piloted using the fill and draw 
technique (previously described in Section 5.6). T.ni (Hi5).DsRed cells were seeded in a 
3-lItre fermenter vessel at a density of 0.5x106 cells I ml (90% viable). Subsequently, the 
culture was monitored at 24 h intervals for cell groWth (Figure 5.17) and viability (Figure 
5.19). 
Over a period of 4 days T.ni (Hi5).DsRed cells were shown to proliferate to a density of 
" 2.8x106 cells I ml (74% viable). However, on day 5, cell density decreased (2.5x106 cells I 
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ml), which correlates with the dramatic decrease in cell viability observed (S1%). 
Subsequently, T.ni (HiS).DsRed cells were passaged using the fill and draw technique, 
and re-established at a density of 0.Sx106 cells I ml. T.ni (HiS).DsRed cell growth from 
days S-8 were shown to replicate the data obtained from days 1-4, with no significant 
difference (p>O.OS in all cases), as did the data observed from days 8-11. However, the 
viability of the T.ni (HiS).DsRed cells increase from S1% on day S, to 76% on day 7, before 
decreasing in day 8 to 70%. This apparent cyclic pattern of increased viability followed by 
a decrease was observed throughout the course of culturing (further S passages, data only 
shown for 1 [days 8-11]). From the results shown in Figure 5.19, it was proposed that if 
T.ni (HiS).DsRed cells were passaged on day 4, then the cyclic pattern of cell viability 
observed throughout cultivation may have been slightly higher, inevitably maintaining a 
healthier culture. 
The evident increase in cell viability after passaging was attributed to nutrient metabolic 
consumption kinetics. Maintaining healthy insect cells in a culture is reliant on growth 
medium (Grace, 1962) supplying essential nutrients, carbon sources (glucose, fructose 
and sucrose), organic acids (fumarate, malate, succinate and a-ketoglutarate) and amino 
acids (L-glutamine). As insect cells proliferate from a low-high cell density numbers, 
certain components of the growth medium become depleted or limited (e.g. glucose and L-
glutamine) and waste metabolic products accumulate (ammonia, uric acid and lactate; 
Bedard et a/., 1993), which shifts insect cell growth from log phase to stationary or decline 
phase of cell growth (Raghunand and Dale, 1999). At this critical point cells are passaged 
into fresh growth medium, replenishing essential compounds required for efficient viable 
growth. 
In our laboratory, non-transformed T.ni HiS cells are routinely passaged at 6-8x106 cells I 
ml (S days growth from 0.5x106 cells I ml). Contrary to this, the highest density of T.ni 
(HiS).DsRed cells obtained in this study was between 2.5-8x106 cells I ml, at 4-5 days. 
This, dramatic shift of cell growth may be partly due to maintaining T.ni (HiS).DsRed cells 
in medium (Ex-ceIl40S, JRH Biosciences) containing the antibiotic G418 (concentration of 
G418 per ml of medium, 300~g I ml), inadvertently stressing the cells and changing their 
growth dynamics. Work by Keith at a/. (1999), has shown that growth dynamics of an 
established stably transformed T.ni Hi5 cell line (expressing granulocyte-macrophage 
COlony-stimulating factor) maintained in growth medium containing a selective antibiotic 
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(HygB) was also significantly affected. The highest cell density obtained from their culture 
was 2.8x1 06 cells I ml after 9 days. 
A second contributing factor of altering the growth dynamics of T.ni (HiS).DsRed cells may 
be explained by the stable production of OsRed. As described previously, the expression 
of OsRed has been shown to be toxic to eukaryotic cells due to the formation of 
aggregates (Baird et al., 2000; Goss et al., 2000; Heikal et al., 2000; Jakobs et al., 2000). 
Therefore, it is proposed that in proliferating T.ni (HiS).DsRed cell culture producing 
constitutively low levels of OsRed, as levels increase over time (e.g .. 1-5 days) OsRed 
Surpasses the cells critical threshold (not known), consequently having detrimental affect 
on cell viability. 
Further possible conclusions for the substantially long T.ni (HiS).DsRed population 
doubling-time, with respect to non-transformed T.ni HiS cells include: (i) transformed cells 
redirected energy from cell proliferation towards recombinant protein production, (ii) the 
enhancing transcription factor IE-1, produced to increase the transcriptional activity of the 
BmA3 promoter (Section 3.3.3), may also affect cellular metabolism, or other unknown 
factors may be responsible. 
The fill and draw technique applied to maintaining a Viable, contaminant free stable insect 
cell line in an open fermenter system may prove to be a useful tool in the future. This 
method of cultivating large volumes of stable insect cells can essentially be applied to 
increasing yields of secreted foreign proteins. By increasing the culture volume of stably 
transformed insect cells expressing a foreign gene, the amount of recombinant protein 
produced should also effectively increase. However, from the data obtained for T.ni 
(HiS).DsRed cell growth dynamic, it is postulated that growth dynamics of different stable 
insect cell lines may vary depending on the foreign protein produced. Therefore, growth 
curves of individual stable insect cell lines should be determined before using this method 
of culturing. 
The final Section of this Chapter, investigates the process of scaling-up intracellular 
recombinant protein production (OsRed and DHODH) from the BES (Ac and Ac.AchiA) in 
insect cells (Sf9 and T.ni HiS cells), using two different culturing methodologies (fermenter 
verses shaker). A number of reported studies have shown that fermentation and shaker 
culturing can be successfully applied to scaling-up heterologous protein production from 
" 
Ac in insect cells {King etal., 1992; Neutra et al., 1992; Scott et al., 1992; Nguyen et al., 
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1993; van Lier at al., 1994; Schwartz at al., 1997; Ikonomou et al., 2003). However, these 
are the first reported studies comparing scale-up of intracellular foreign protein production 
(OsRed and OHOOH) from Ac.~chiA in 1-litre Sf9 and T.ni HiS fermenter I shaker cultures. 
Comparison of intracellular OsRed production from AC.DsRed and Ac.~chiADsRed in 1-
litre Sf9 and T.ni HiS fermenter I shaker cultures, using Western blot analyses revealed 
that optimal intracellular OsRed expression was produced from AC.DsRed in Sf9 cells 
using fermentation (Figure 5.21 A). Production of intracellular OsRed from 
Ac.~chiADsRed in Sf9 fermenter I shaker cultures also showed· ·that fermentation 
produced higher levels than those observed from the shaker cultures (Figure 5.21 B). 
However, these levels were lower than those detected from Ac.DsRed. The production of 
intracellular OsRed from AC.DsRed and Ac.~chiADsRed in T.ni HiS fermenter I shaker 
cultures was extremely low. Interestingly the highest levels observed were also from 
Ac.DsRed, but in shaker cultures (Figure 5.21· C). Similar results were also observed 
from Ac.~chiADsRed producing intracellular OsRed in T.ni HiS fermenter I shaker culture, 
but at considerably lower levels (Figure 5.21 D). 
The levels of intracellular OHOOH produced from AC.DHODH and Ac.~chiADHODH in 1-
litre Sf9 and T.ni HiS fermenter I shaker cultures were initially semi-quantified using 
Western blot analyses. However, intracellular OHOOH was subsequently purified from the 
highest producing cultures to accurately determine the amount produced (mg I litre). The 
overall levels of intracellular OHOOH produced from AC.DHODH and Ac.~chiADHODH in 
T.ni HiS fermenter I shaker cultures were significantly higher than in Sf9 cultures (barely 
detectable; Figure 5.22 A I B). Therefore, intracellular OHOOH produced from infected 
Sf9 cultures was not purified. However, infected Sf9 fermenter cultures produced higher 
levels of intracellular OHOOH than those observed from shaker cultures. Optimal 
intracellular OHOOH production from both AC.DHODH and Ac.~chiADHODH in T.ni HiS 
cells was observed from fermenter cultures. Maximal production of intracellular OHOOH 
Was observed from AC.AchiADHODH in T.ni HiS cells using fermentation, producing an 
estimated 7.2mg I litre. The AC.DHODH infected T.ni HiS fermenter culture produced 2mg 
I litre, and Ac.~chiADHODH in T.ni HiS shaker culture was estimated to produce 1.1 mg I 
litre, which was higher than those detected from AC.DHODH in T.ni HiS shaker culture (mg 
I litre was not determined due to technical problems). Subsequently, recombinant 
intracellular OHOOH produced using these recombinant viruses was shown to have 
authentic biological activity. 
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From these results it was concluded that foreign protein production using fermentation 
supports optimal production from recombinant baculoviruses in insect cells. Even though 
the production of intracellular OsRed from AC.llchiA.DsRed in T.ni Hi5 shaker culture was 
higher than those observed from the fermenter culture, OsRed production was not optimal. 
These studies yet again stress the importance of optimising the expression vector and 
insect cell line used to host expression. The results obtained from small-scale OsRed and 
OHOOH production (Section 5.2; 25ml shaker culture) provided a good indicator of which 
recombinant virus I insect cell line would provide optimal expression when scaled-up. 
A number of proposed explanations have been previously described in this Section, 
explaining why higher levels of intracellular OsRed may be observed from AC.DsRed 
compared to AC.llchiA.DsRed in small shaker culture. The increased levels of intracellular 
foreign proteins observed in fermenter culture may be attributed to maintaining a 
consistent d02 concentration (minimum of 60% was used in these studies; Colin 
Robinson; personal communication) throughout infection. Similar properties may be 
effective in explaining OHOOH product levels. 
Studies by Scott et al. (1992) has shown the importance of oxygen demand in baculovirus 
infected insect cell cultures producing heterologous protein. Their results show oxygen 
consumption of insect cells rapidly increases after baculovirus infection (Streett and Hink, 
1978; Maiorella et al., 1988). The high oxygen demand of baculovirus infected insect cells 
has been attributed to maintaining cellular activities such as oxidative phosphorylation, 
COordinate synthesis of adenosine triphosphate, viral DNA synthesis and recombinant 
protein production (Maiorella et al., 1988). Therefore, the effect of maintaining an 
adequate oxygen supply to the culture can prolong infected insect cell viability and as a 
consequence increase recombinant protein production (Lindsay and Betenbaugh, 1992; 
Scott et al., 1992; Malinowski and Oaugulis, 1993; Wang et al., 1996; Taticek and Shuler, 
1997; Hu and Bentley, 1999). 
The major variable distinguishing between fermenter and shaker culturing of infected 
insect cells is essentially the level of d02 concentration maintained in the culture 
throughout infection. Shaker flasks are simplistic vessels and do not have the means of 
ensuring the d02 concentration of an infected insect culture is maintained. . As a 
consequence, oxygen from the headspace and. culture Is rapidly depleted, which 
Subsequently affects foreign protein production. However, fermentation offers the , 
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advantage of aerating infected insect cultures by supplying oxygen and air to the 
headspace of the vessel and culture via gentle sparging. It is also possible to control the 
d02 concentration of a culture maintained in a fermenter, as different cell lines respond to 
different d02 concentrations, e.g. mammalian cell require less O2 than insect cells 
(Maiorella et al., 1988). 
The flavoenzyme DHODH is a mitochondrial protein that performs the fourth enzymatic 
step of the de novo pyrimidine biosynthesis, the ubiquinone-mediated oxidation of 
dihydroorotate to orotate (Jone, 1980; Section 1.7.5). This enzyme links the biosynthesis 
of pyrimidine nucleotides to functional mitochondria and the aerobic metabolism of cells 
(lilffier et al., 1997). Because it connects two essential pathways of a living cell, this 
enzyme has received attention from numerous clinical researchers in different fields 
investigating mitochondrial diseases (Naviaux, 2000). 
Therefore, producing high yields of biologically active recombinant DHODH has been an 
aim at Pfizer, for in-house studies. Their initial attempts using Ecoli to host expression 
Were successful, producing 2mg I litre of biologically active enzyme. However, a 
Significant draw-backs of using Ecoli is that many expressed proteins accumulate 
intracellularly in the form of insoluble, inactive inclusion bodies, from which biologically 
active recombinant proteins must be recovered using complicated and costly denaturation 
and refolding processes (Jeong and lee, 1999: 2001). These processes can inevitably 
lead to the loss or biological inactivation of recombinant protein. However, an alternative 
method of producing DHODH was determined, as studies in this thesis show intracellular 
biologically active DHODH was produced effectively from the BES (Ac.~chiA.DHODH) in 
insect cells (St9 cells). The yields produced were equivalent to or greater than (7.2mg I 
litre; 3.6-fold increase) those observed from Ecoli (2mg I litre), and purification of 
intracellular DHODH from infected insect cells did not require costly denaturation and 
refolding processes. 
Finally the conclusions drawn from work in this Chapter show that Ac.~chiA, originally 
Shown to improve yields of secreted foreign proteins, can effectively be used to produce 
high level intracellular recombinant protein. However, the levels produced may be 
dependent on the nature of the protein expressed. Therefore, Ac.~chiA may be 
Considered as a novel expression vector, when optimising intracellular heterologous 
protein production in inse~t cells. Further investigations for improving heterologous gene 
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expression in insect cells, addressed different culturing methodologies (fermenter versus 
shaker) used to scale-up production of recombinant proteins. Fermentation was 
determined as the pre-eminent method for obtaining optimal yields of foreign protein from 
scaled-up BES infected insect cells. This method is expensive and can be justified for use 
in industry, but the balance of cost versus yield will lie at the users discretion. Cheaper 
alternatives (shaker culture) are available, but levels of foreign protein may be 
compromised. 
Intracellular foreign protein production was also analysed from an imp~oved stable insect 
expression system to determine if the levels produced were sufficient enough to use as an 
alterative to the BES, if scaled-up. However, the levels produced from the stable insect 
cell lines were insufficient for obtaining cost-effective yields of recombinant protein, 
therefore strengthening the cost effectiveness of the BES for producing large amounts of 
intracellular foreign protein. 
Subsequently, the stable insect cell line T.ni {Hi5).DsRed was used to develop a protocol 
for large-scale, long-term cultivation of stable insect cell lines. The success of this work 
will provide researchers with an alternative tool for scaling-up stable insect cells 
expressing heterologous protein, with the aim of improving yields (e.g. secreted 
recombinant proteins). 
'\ 
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The work in this thesis was undertaken to address and improve various problems allied 
with the production of intracellular recombinant proteins in insect cells, in particular with a 
focus on the industrial sector. The production of heterologous proteins is an elemental 
facilitator in drug discovery programmes for the identification of new therapeutics. The 
cost of producing therapeutics is an expensive process, which is reflected by "on the shelf' 
sale prices. Therefore, developing methods to reduce the cost of producing therapeutics 
would subsequently impact their economic value. 
One of the key problems pharmaceutical companies are facing is the need to increase 
compound testing in vitro, due to high throughput programs in place producing vast 
numbers of compound libraries. The cost of producing heterologous proteins for in vitro 
testing using mammalian and viral systems, is both expensive and labour-intensive. 
Therefore, cheaper alternatives for producing high-levels of recombinant protein, 
especially those requiring post-translational modifications, are in high demand (e.g. for 
structural genomics I drug screening in vitro). 
Work previous to this thesis has demonstrated that insect cell lines (e.g. lepidopteran) can 
be used successfully for foreign protein production. Insect cells possess the capability to 
perform most post-translational modifications performed by mammalian cells. Compared 
to mammalian cells, insect cells also have a faster growth rate and require less complex 
growth conditions, which inevitably can reduce the cost of foreign protein production. 
Overall, these properties make insect cells strong candidates as alternative hosts for the 
production of recombinant proteins. 
The most widely used expression system using insect cells is the BES (Section 1.3.2). 
However, the BES encompasses a number of limitations (lytic system, transient 
expression) that limits its use for foreign protein production (e.g. producing high-levels of 
secreted proteins; Jarvis at al., 1990). An alternate expression system, stably transformed 
insect cell lines, was subsequently developed to overcome the limitation of the BES (Jarvis 
and Summers, 1989). This system has shown particular promise for the production of 
secreted foreign proteins (Jarvis at al., 1990, 1996). However, very low levels of 
intracellular recombinant protein were recorded (Jarvis and Summers, 1989; Jarvis at al., 
1990). 
Since these studies, an "increased number of RNA polymerase " transcribing promoters 
have been identified and characterised for transient I stable foreign gene expression in 
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eukaryotic cells. The initial aim of this project was to characterise the transcriptional 
activity of a number of these promoters (eukaryotic 1 viral) in lepidopteran cell lines (SI9I 
T.ni Hi5 cells; Chapter 3). The developed aim led to production of a comprehensive 
promoter analysis, which identified promoters with strong transcriptional activity that may 
be used to generate stably transformed SI9 1 T.ni Hi5 cell lines, or alternatively for the 
development of new plasmid-based expression cassettes (as described in Chapter 4). 
The continuous insect cell expression system developed by Jarvis a~d Summers (1989) 
utilises the AcMNPV ia-1 promoter to transcribe foreign genes. However, previous studies 
have characterised this immediate early baculovirus promoter as transcriptionally weak in 
insect cell lines (Jarvis at al., 1990; Joyce at al., 1993; McCarroll, 1997). Therefore, in 
terms of high-level intracellular heterologous gene expression, it was determined that the 
AcMNPV ie-1 promoter would be of limited use. However, expression levels from the 
AcMNPV ia-1 promoter were used throughout this study as basal levels for comparison. 
Work in this thesis to examine the transcriptional activity of alternative eukaryotic and viral 
promoters in SI9 1 T.ni Hi5 cells has focused on gene promoters that have previously 
demonstrated moderate to high levels of foreign protein production in insect (dipterans I 
lepidopteran) and other expression systems (mammalian [Sections 3.3, 3.4]). It was 
anticipated that if these promoters were functional in SI9 or T.ni Hi5 cells, high levels of 
expression would be obtained. In order to rapidly test the chosen promoters to give an 
indication of how well each functioned, the cat gene was placed under control of each 
promoter (Section 3.3) and the expression cassettes tested in transient assays (Section 
3.4). 
The CMVie promoter has been previously characterised as a strong promoter in 
mammalian cell lines and therefore functions well in mammalian expression systems 
(Chan at al., 1996). However, the CMVia promoter did not result in significantly improved 
gene expression over that exhibited by using AcMNPV ie-1 in both SI9 or T.ni Hi5 cells. 
Two Om gene promoters Ac5.1 (constitutive) and MT (inducible), were also tested in SI9 
and T.ni Hi5 cells, but no detectable levels of CAT activity were observed from these 
promoters (Om MT non-induced 1 induced). These results demonstrated that the 
transcriptional activities of CMVia, Om Ac5.1 and MT gene promoters were extremely low 
in the lepidopteran cell lines used, suggesting that these promoters are not amenable to 
" generating stably transformed lepidopteran cell lines for the efficient production of 
intracellular foreign proteins. 
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Since the characterisation of insect cell TF (e.g. host RNA polymerase II) transcribing 
foreign genes from the AcMNPV ie-1 promoter (Jarvis and Summers, 1989; Jarvis at al., 
1990), a number of other baculovirus gene promoters (AcMNPV ia-n; OpMNPV ie-1; 
OpMNPV ie-2; BmNPV ie-1) have been shown to function via the same cellular 
mechanism (Theilmann and Stewart, 1991, 1992a; Vulsteke at al., 1993; Lu at al., 1996, 
1997). Studies by other research groups have shown that the OpMNPV ie-2 gene 
promoter is transcriptionally active in Sf9 and T.ni Hi5 cells. A promoter isolated from the 
BmA3 gene, has also been characterised as transcriptionally active i.n lepidopteran and 
dipteran cells, but as a weak promoter (Johnson at al., 1992). However, studies by Lu at 
al. (1996, 1997) have shown that the transcriptional activity of Bm A3 in lepidopteran cells 
is enhanced by the presence of BmNPV TF, IE and hr3. These finding prompted the 
testing of both the OpMNPV ie-2 and BmA3+E promoters in this study. The levels of 
transcriptional activity detected from these promoters were shown to significantly improve 
gene expression over that demonstrated by AcMNPV ie-1 in Sf9 and T.ni Hi5 cells. 
Relative to AcMNPV ie-1, these results clearly show both OpMNPV ie-2 and BmA3+E as 
stronger promoters in lepidopteran cells, which subsequently could be used to generate 
stable Sf9 and T.ni Hi5 cells for the production of intracellular foreign protein. 
For future studies, work to improve foreign gene expression levels from plasmid-based 
cassettes in insect cell lines may focus on identifying new baculovirus immediate early I 
delayed early and insect cellular promoters that are transcribed by insect RNA polymerase 
II, as well as enhancers that may up-regulate new and existing promoters. Subsequent 
identification of new promoters I enhancers may be characterised for transcriptional 
activity across a range of insect cell lines to optimise promoter specificity for host RNA 
polymerase II I TF. In contrast, the late and very late baculovirus gene promoters are 
known to be particularly strong. Approximately 50% of the total cell protein in an in vitro 
infection is the product of the late and very late promoters (p10 and polh). Baculovirus 
gene expression is regulated as a cascade system; each phase depends upon the 
presence of viral gene products of the proceeding phase (Section 1.3.2). Therefore, 
identifying all the essential genes involved in the trans-activation of the p 1 0 and polh 
promoters, and discarding the non-essential genes may provide a method for harnessing 
the strong activity of these promoters in a plasmid-based vector. 
Through intense research, Lois K. Miller and collaborators recognised the potential for 
" developing such a vector, and to date have identified nineteen baculovirus open reading 
frames that support late gene expression within plasmid-based vectors (U at al., 1993; 
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Passarelli and Miller, 1993a, b, c; Lu and Miller, 1994; Morris et a/., 1994; Passarelli and 
Miller, 1994; Passarelli et a/., 1994; Lu and Miller, 1995). The open reading frames 
include ie-1, ie-2, late expression factors 1-12, p143, dnapol, p35, p47, and 39k (Rapp et 
a/., 1998; Li et a/., 1999). Once all known essential genes have been identified and in 
which order they trans-activate one another, to finally trans-activate p10 and polh 
promoters, expression vectors may be designed either on the basis of expressing 
constitutively or by induction (chemically I physical stimulus). 
The second aim of this project was to endeavour to develop a novel stable insect inducible 
expression system (Chapter 4). The problems associated with existing insect inducible 
expression systems is the lack of complete promoter suppression. Both the Dm MT and 
Hsp 70 gene promoters have been characterised as inducible promoter, but retain a low to 
. high constitutive activity in a non-induced state (Johansen et a/., 1989; Clem and Miller, 
1994; Prikhod'ko and Miller, 1996; McCarroll, 1997; Hegedus et a/., 1998). Therefore, 
expression systems utilising these promoters lack the specificity required to regulate 
cytotoxic genes successfully in insect (dipteran) cells. 
Work by Wu et a/. (2000) devised a method for the stringent regulation of foreign gene 
expression in insect cells using a modified tetracycline-regulated gene expression system 
(TRES; Section 4.1, 4.11). However, this system utilises the late p10 baculovirus 
promoter to indirectly induce gene expression from the minimal CMVie promoter in insect 
cells (CMVie promoter has been characterised in this thesis as transcriptionally weak in 
insect cells). Due to the lytic-nature of the BES, induction of foreign gene expression can 
only exist transiently. Therefore, this system may have limited use for the production of 
cytotoxic genes that may cause detrimental effects to cells hosting expression, as viral 
infection will inevitably kill the host cell at 72-96 hpl. One could argue the BES is an 
inducible system itself, therefore, as an alternative it may be simpler to express cytotoxic 
genes using the BES. 
On the other hand, the development of a plasmid-based TRES for generating stable insect 
cell lines with inducible expression may appear more attractive economically for the 
production of cytotoxic genes. The main disadvantage of the BES is the transient 
expression of foreign genes. Even though high-levels of recombinant protein can be 
obtained, this system is extremely labour-intensive, compared with having an immortal 
'\ 
stable insect cell line, which may be induced to transcribe foreign genes. The work by Wu 
et a/. (2000) highlights a number of key issues for adapting the TRES for use in insect 
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cells, which were addressed in the current study. The main issue addressed was the 
necessity to substitute the CMVie promoters from the tetracycline regulatory and response 
cassettes, with strong promoters functionally active in insect cells. 
The promoter comparison study previously described (Chapter 3) characterised two 
promoters with strong transcriptional activity in lepidopteran cells; the OpMNPV ie-2 and 
BmA3+E promoters. These promoters were subsequently determined as potential 
candidates for the development of the stable insect TRES. 
The first critical component of this system, the insect tetraCYCline regulatory plasmid, was 
developed using the BmA3+E promoter. The regulatory gene-coding sequence rtTA was 
amplified from pTet-On (mammalian tetracycline regulatory vector) and inserted 
downstream of the BmA3+E promoter, to derive pBmA3+E.rtTA (Section 4.2). Transient 
expression of rtTA from pBmA3+E.rtTA revealed rtTA was successfully transcribed in both 
Sf9 and T.ni Hi5 cells (Section 4.3). Subsequent to these results, stably transformed Sf9 
and T.ni Hi5 cells expressing rtTA were generated and rtTA production analysed (Section 
4.4). The levels of rtTA produced from these cell lines were highly consistent, 
demonstrating the successful establishment of Sf9.rtTA and T.ni (Hi5).rtTA cell lines, 
which represent the first functional components necessary for developing the stable insect 
TRES. 
The second essential constituent constructed to complete the development of the stable 
insect TRES was the insect tetracycline response vector. While constructing this vector a 
number of problems were encountered, which were successfully overcome (as described 
in Section 4.5,4.6). The insect tetracycline response vector was derived by modifying the 
mammalian tetracycline response vector (pTRE), substituting the minimal CMVie promoter 
for the OpMNPV ie-2 promoter (pTREd.ie2). It was hypothesised that the TRE would 
serve to regulate the transcriptional activity of the OpMNPV ie-2 promoter and, therefore, 
adapt this vector for use in insect cells (e.g. Sf9.rtTA and T.ni (Hi5).rtTA cell line). The 
reporter gene cat was placed under control of the TRE I OpMNPV ie-2 promoter and the 
expression cassette tested in transient assays (pTREd.ie2.cBt2; Section 4.7-10). 
Repressing the constitutive activity of the OpMNPV ie-2 promoter using the TRE in Sf9 I 
Sf9.rtTA and T.ni Hi51 T.ni (Hi5).rtTA cells was successful in the absence of the inducer 
\. 
(dox). Complete suppression was not observed, but the TRE was estimated to reduce the 
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transcriptional activity of OpMNPV ie-2 by 99% in Sf9! Sf9.rtTA and 98% in T.ni Hi5! T.ni 
(Hi5).rtTA cell lines, compared with the normal constitutive activity of OpMNPV ie-2 in 
these cell lines (Section 4.7). However, it was not possible to induce the transcriptional 
activity of the TRE! OpMNPV ie-2 promoter in the presence of dox using the cell lines 
described above (Section 4.8). Experimental work carried out to resolve this problem (as 
discussed in Sections 4.9-10), addressed the strong possibility of additional DNA 
sequences present in pTRE~.ia2.cat2, other than TRE, which have the ability to facilitate 
the repression of OpMNPV ie-2 transcriptional activity. However, these DNA sequences 
were not elucidated. 
Further avenues of exploration for the development of a functional insect tetracycline 
response vector involve the removal of TRE (x7 tetO repeats) from pTRE for insertion 
upstream! adjacent the OpMNPV ie-2 promoter in pIZT.V5-His.cat (described in Section 
3.3.4; Invitrogen"') or pRescue.cat2 (constructed to restore OpMNPV ie-2 activity; Section 
4.10). The OpMNPV ie-2 promoter has been characterised as transcriptionally active in 
these vectors, here the problem of additional DNA sequences that suppress the activity of 
OpMNPV ie-2 (as observed in pTRE~.ie2.cat2) is thought not to be an issue. As a result, 
TRE alone should suppress OpMNPV ie-2 in the absence of dox and importantly, activate 
the TRE ! OpMNPV ie-2 promoter in the presence of dox, to overcome the problems 
described in Sections 4.9-10. 
An alternative method for developing a new stable insect inducible expression system, to 
that describe in this thesis, may be accomplished by adapting the mammalian TRES (T-
REx""; Invitrogen"") developed by Yao at a/. (1998). The T-REx"" system works on the 
principle of positioning two juxtaposed tetO sequences between the TATA box and the 
transcriptional start site of the full-length CMVie promoter. The tetO sequences 
themselves have no effect on expression (Yao at a/., 1998). However, when the 
tetracycline repressor protein (tetR) is present, it effectively binds the two tetO sequences 
and blocks transcription initiation. The addition of Tc subsequently changes the 
conformation of the TetR protein, which causes TetR to dissociate from the tatO sites and 
activate transcription from the CMVia promoter (Yao at a/., 1998; Yao and Eriksson, 1999). 
Therefore, it may be possible to use the OpMNPV ie-2 or BmA3+E promoters to adapt this 
system for use in insect cells. 
\ 
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A recent publication by Swevers at al. (2004), describes briefly the development of a new 
inducible plasmid-based expression cassette for use in Bm5 cells, which was designed for 
a cell-based high-throughput screening (HTS) system for detecting ecdysteroid agonists 
and antagonists in plant axtracts and libraries of synthetic compounds. The inducible 
expression cassette was developed using a basal actin promoter (BmbA) derived from the 
silkmoth actin gene. Seven juxtaposed eCdysone-responsive elements (ERE) were 
subsequently cloned upstream of the BmbA promoter, which transformed it into an 
inducible promoter (Luc Swevers; personal communication). The inducible expression 
vector derived, pBmbAIERE.cat, was transiently tested in Bm5 cells for the induction of the 
BmbA promoter with the addition of the inducer, active moulting hormone 20-hydroxy-
ecdysone (20E). Following transfection of pBmbAIERE.cat into Bm5 cells, the addition of 
20E resulted in a dose-dependent stimulation of cat reporter gene activity. Maximal levels 
of inducibility were - 1 BOO-fold; the effective concentration (EC50) of 20E for the ERE-
dependent reporter was between 75 and 100nM (Swevers at al., 2004). 
It may be possible to broaden the applications of the 20E-inducible expression cassette, 
such as generating stable insect cell lines, from which the production of foreign proteins 
are regulated for therapeutic use (e.g. cytotoxic genes). A particular merit of this inducible 
system is its simplicity, which entails the generation of single-stable insect cell lines, 
compared with the tetracycline-regulated expression system, which requires the 
generation of double-stable insect cell lines for the production of recombinant protein 
(Section 4.1). However, this system does have one main disadvantage, which focuses 
primarily on the promoter used to express foreign genes (BmbA promoter). The BmbA 
promoter is functionally active in insect cells (Johnson at al., 1992; Swevers at al., 2004); 
but the overall transcriptional activity from this promoter compared with that of the 
BmA3+E promoter (characterised as a strong promoter in lepidopteran cells, Section 3.4) 
is three orders of magnitude lower (Lu at al., 1997). Therefore, in order to utilise the 20E-
inducible expression system for the production of foreign proteins in insect cells, it may be 
necessary to substitute the BmbA promoter with either the stronger BmA3+E or OpMNPV 
ia-2 promoter (OpMNPV ie-2 has been characterised as possessing comparative 
transcriptional activity to that of BmA3+E lepidopteran cells; Section 3.4). As a result, 
these promoters may be transformed by the ERE into inducible promoters, which retain 
their stronger transcriptional activity. 
, 
The final aim of the work in this thesis was to investigate methods of improving 
intracellular protein production using insect expression systems. Initial work in Chapter 5 
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focuses on using the BES to achieve this. It has been well documented that the 
baculovirus expression vector Ac (Section 5.1) can produce high-levels of intracellular 
recombinant protein (nuclear and cytoplasmic; Vlak et al., 1998; Stewart and Champoux, 
1999; Ikonomou et al., 2003; Jayakumar et al., 2004). However, the levels of secreted 
and membrane targeted foreign proteins produced from Ac are usually low (Jarvis and 
Summers, 1989; Jarvis et al., 1990; Thomas, 1997; Saville et al., 2002). The deletion of a 
non-essential viral gene (chiA) from Ac (Ac.~chiA; Hawtin et al., 1995), which is not 
required for virus replication in insect cell culture, has subsequently im~roved the yields of 
secreted and membrane targeted recombinant proteins produced (Section 5.1; McCarroll, 
1997). However, no published data exists to address whether Ac.~chiA improves the 
yields of intracellular foreign protein; therefore, a study to address this was carried out. 
In order to compare the levels of intracellular protein produced from both Ac and Ac.~chiA, 
DHODH or DsRed gene coding-regions were inserted under control of the polh promoters. 
The data presented in this thesis for this comparison, is the first acknowledged study of its 
kind (Sections 5.2, 5.7). 
The infection of Sf9 and T.ni Hi5 cells with the resulting recombinant viruses (Ac.DsRed, 
Ac.DHODH, Ac.~chiADsRed and Ac.~chiADHODH) demonstrated improved levels of 
intracellular DHODH from Ac.~chiADHODH infected T.ni Hi5 cells, compared to levels 
detected in AC.DHODH infected T.ni Hi5 cells. DHODH was not detected from either 
recombinant virus in Sf9 cells. Detection of DHODH from these viruses in T.ni Hi5 cells 
also demonstrated that AC.DHODH produced significantly higher levels of degrading 
DHODH than Ac.~chiADHODH. Therefore, it may be suggested that the removal of chiA 
from Ac indirectly reduced proteolysis of DHODH. On the contrary, the levels of 
intracellular OsRed in AC.DsRed infected Sf9 and T.ni Hi5 cells was higher than that 
detected in Ac.llchiADsRed infected insect cell lines. 
These results demonstrate that Ac.~chiA may be used as a new baculovirus expression 
vector for improving yields of intracellular protein. However, the use of this vector may be 
dependent on the nature of the protein produced and the cell line used to host expression. 
Therefore, these results verify the importance of optimising conditions for the expression 
of each recombinant gene. The potential for improved foreign protein production, following 
deletion of viral genes that have been found to be non-essential for virus replication in cell 
culture, has been confirmed and opens the possibilities for similar studies in the future. 
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A number of studies by other laboratories have demonstrated improved quality and yields 
of intracellular I secreted foreign proteins from the BES, by the addition of protease 
inhibitors to culture medium to prevent proteolysis (Grosch, 1998; Naggie and Bentley, 
1998; Hu and Bentley, 1999; Martensen and Justesen, 2001). However, the identification 
and characterisation of baculovirus cathepsin (v-cath), a cysteine protease and a non-
essential gene for virus replication in cell culture (Slack et al., 1995), has lead to the 
development of a baculovirus expression vector (BacVector-3000; Novagen) from which v-
cath, chiA, and five other viral genes have been removed. He~erologous . proteins 
produced using this virus are cited as exhibiting improved stability at 4°C. However, 
improved recombinant protein secretion confirmed by McCarroll (1997) and intracellular 
protein production demonstrated in this thesis as a result of the absence of chiA has not 
yet been reported for BacVector-3000. 
To meet the needs of industrial requirements for the production of recombinant protein for 
the post-genomic era, simple, rapid and efficient expression systems are required. Both 
mammalian and viral expression systems fall short of these objectives. Recombinant 
protein production from mammalian systems is a labour-intensive process, although these 
systems are a necessity for producing complex foreign proteins. The downfall of both the 
mammalian and viral systems is their complexity, which makes them not amenable to high 
through-put applications. Stable Insect cell lines are an attractive alternative, possessing 
fast growth, simple generation, and adaptability for high throughput applications, which 
include generating thousands of clones that can be screened to determine cells 
expressing high-levels of recombinant protein. However, the main disadvantage of using 
stable insect cell lines (lepidopteran) for the production of intracellular recombinant protein, 
is the inherently low levels they produce, which subsequently has been contributed to the 
weak promoters used to express foreign genes (AcMNPV ie-1). 
The characterisation of insect I viral promoters (BmA3+E I OpMNPV ie-2) with stronger 
transcriptional activity, than the weak AcMNPV ie-1 promoter (Chapter 3), lead to the 
development of stable insect cell lines (Sf9 and T.ni Hi5) expressing intracellular foreign 
genes (intracellular DHODH or OsRed) from the BmA3+E promoter (sections 5.5). The 
levels of recombinant protein produced were determined and subsequently compared to 
levels from the BES, thereby, determining whether the developments over the last decade, 
to improve intracellular foreign protein production from stable insect cell lines, are , 
sufficient to use as an alternative to the BES. 
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Stably transformed Sf9 and T.ni Hi5 cells expressing intracellular OsRed were initially 
identified by Western blot and f1uorometric analyses (Section 5.5). The production of 
intracellular OsRed in T.ni (Hi5).DsRed cells was observed by both methods of analyses. 
Intracellular OsRed detected by Western blotting produced a very weak Signal intensity, 
indicating that the levels produced were significantly low. However, intracellular OsRed 
produced in Sf9.DsRed cells was only detected by fluorometric analyses. The data 
obtained from fluorometric testing indicated that OsRed expression was significantly higher 
in T.ni (Hi5).DsRed cells compared to that observed in Sf9.DsRed cells (p=0.0001, in all 
cases). 
A comparison of intracellular OsRed production from both Sf9.DsRed and T.ni 
(Hi5).DsRed cell lines with that from the BES (optimised conditions; AC.DsRed infected 
Sf9 cells, 72hpi), showed that OsRed expression from AC.DsRed in Sf9 cells was 52.5-fold 
greater than those detected from T.ni (Hi5).DsRed cells, and 262.9-fold higher than those 
observed from Sf9.DsRed cells. From these data it was concluded that OsRed production 
from Sf9.DsRed and T.ni (Hi5).DsRed cell lines was not comparable to those observed 
from baculovirus expression. 
Stable insect cell lines (Sf9 and T.ni Hi5) expressing intracellular OHOOH were also 
generated and analysed using Western blot analyses. However, OHOOH was not 
detected from either cell line (Section 5.5). Subsequent analyses of total cellular RNA 
from both cell lines indicated that OHOOH mRNA was produced, therefore demonstrating 
that OHOOH was expressed from the BmA3+E promoter, but at extremely low levels. The 
results presented in this thesis indicate that, at present, stably-transformed insect cells 
expressing intracellular foreign proteins are not a viable alternative to baculovirus 
expression using the conditions and heterologous genes described. 
As previously stated (Sections 5.1, 5.10) yields of secreted recombinant proteins 
expressed from stable insect cell lines have been reported to be equal to or greater than 
those produced from the BES. Therefore, to maximise the production of secreted 
recombinant protein from stable insect cell lines, cultures should be continuously cultivated 
at scaled-up volumes. Subsequently, a method to successfully scale-up the continuous 
cultivation of stable insect cell lines was investigated. This work was based on using the 
T.ni (Hi5).DsRed cell line (Section 5.5) as a model for culture dynamics (cell growth I .. 
viability; Section 5.6). T.ni (Hi5).DsRed cells were expanded to generate a 1-litre culture, 
Which was inoculated into a 3-litre fermenter vessel at a low cell density (0.5x106/ml) using 
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the fill and draw technique described in Section 5.6 (Figure 5.16A.C). The T.ni 
(Hi5).DsRed cell culture was successfully maintained (requiring a total of six passages) as 
a viable 1-litre open fermenter culture for four weeks. Continuous intracellular OsRed 
production was also observed (data not shown). The development of this protocol may 
provide useful data for future work involving the scale-up of continuous stable insect cell 
line cultivation. To develop this work, it would be of interest to repeat the work described 
above using stable insect cell lines constitutively expressing secreted foreign proteins. 
This process would address the levels of secreted foreign proteins produced using the 
open fermenter system in comparison to those produced from the BES (fermenter culture), 
and to what order of magnitude expression can be elevated that being the case. 
In order to maintain the importance of baculoviruses as expression vectors, it was 
essential to investigate means by which baculovirus-mediated foreign gene expression 
could be improved. Previous studies have demonstrated the importance of optimising 
conditions for each recombinant gene expressed (Section 5.2; Lynn and Hink, 1980). It 
has been demonstrated that yields of many recombinant proteins can be significantly 
increased by maintaining the d02 concentration of baculovirus infected insect cultures 
(Lindsay and Betenbaugh, 1992; Scott et a/., 1992; Malinowski and Oaugulis, 1993; Wang 
et a/., 1996; Taticek and Shuler, 1997; Hu and Bentley, 1999). Therefore, two different 
insect cell cultivation methods (shake cultures and fermentation, as described in Sections 
5.1, 5.7, 5.10), used to maintain recombinant baculovirus infections, were subsequently 
investigated to determine their effects on foreign protein productivity (Sections 5.7-5.9). 
The recombinant baculoviruses used to infect Sf9 and T.ni Hi5 cells included; Ac.DsRed, 
Ac.DHODH, AC.AchiADsRed and AC.AchiADHODH. 
The expression profiles of intracellular OHOOH I OsRed from infected insect fermenter I 
shaker cultures were shown to correlate with the data described in Section 5.2 
(Ac.AchiADHODH infected T.ni Hi5 cells produced optimal levels of intracellular OHOOH; 
Ac.DsRed infected Sf9 cells produced optimal levels of intracellular OsRed). However, the 
levels of intracellular OHOOH I OsRed produced by fermenter and shaker culturing were 
shown to significantly differ. The highest levels of intracellular OHOOH I OsRed produced 
were detected from infections maintained as fermenter cultures. These infected cultures 
were sustained at a minimum d02 concentration of 60%, as opposed to the infected 
shaker cultures, which did not possess the ability to control the culture d02 concentration. , 
Therefore, the d02 concentration of the shaker culture was rapidly depleted, which 
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inevitably was shown to effect the overall yields of DHODH I OsRed produced. 
Quantitative analyses of DHODH production (Section 5.8) demonstrated that 
Ac.~chiA.DHODH infected T.ni Hi5 fermenter culture produced 7.2-fold more DHODH than 
that produced by Ac.~chiA.DHODH infected T.ni Hi5 shaker culture, and 1.8-fold more 
DHODH than that generated by AC.DHODH infected T.ni Hi5 fermenter culture. 
The results of this study correlate with published reports, which demonstrate that the d02 
concentration of recombinant virus infected insect cell culture is an important factor for 
maintaining high-level foreign protein production (Scott at a/., 1992; Taticek and Shuler, 
1997; Hu and Bentley, 1999). Other factors also found to affect baculovirus recombinant 
protein production include; availability of specific medium constituents ([glucose] 
Raghunand and Dale, 1999; [glutamine] Hu and Bentley, 1999) and the addition of specific 
protease inhibitors to infected cultures (Grosch, 1998; Naggie and Bentley, 1998; Hu and 
Bentley, 1999; Martensen and Justesen, 2001). 
It is clear from the data presented in this thesis that the BES is still a very powerful tool for 
producing intracellular recombinant proteins. The method used to generate the 
recombinant viruses (BacPAK6) for the work in this thesis is not amenable to high 
throughput applications due to its complexity, which ideally is what industry aspire to use. 
However, a new baculovirus expression system based on Ac.~chiA has been recently 
developed in our laboratory in collaboration with Professor Robert Possee (Centre for 
Ecology and Hydrology Oxford), which meets the requirements of industry in the post 
genomic era. This system (f1ashBAC; Oxford Expression Technologies) is simple to use, 
generating recombinant viruses in a one step process; insect cells are co-transfected with 
f1ashBAC DNA and transfer vector, incubate at 28°C for 5 days and harvested. There is 
no need to isolate recombinants virus from parental virus via skilled and tedious methods 
such as plaque assays, as this system generates 100% recombinants. Production of high-
titre recombinant virus stocks is rapid, reducing the time from 17-20 days using traditional 
methods (BakPAK6) to 7-10 days using flashBAC. flashBAC also retains the advantages 
of Ac.~chiA, which increases yields of secreted and membrane targeted proteins as well 
as specific intracellular proteins. 
This system is also importantly amenable to high throughput applications. Work in our 
laboratory has automated the production of recombinant viruses in a 24-well plate and is 
'. 
currently evaluating automated trials to produce recombinants using a 96-well format. It is 
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possible to produce multiple copies of a single recombinant virus or different recombinants 
using the automated technology. 
The limitation of the BES to produce humanised recombinant proteins is also another 
disadvantage of this system. However, work by Donald Jarvis and collaborators have 
recently addressed this problem by developing new lepidopteran insect cell lines, which 
constitutively express mammalian glycosyltransferase genes. Subsequently this has 
yielded transgenic insect cell lines with normal growth properties that can support 
., 
baculovirus infection, have new N-glycan processing enzyme activities, and can produce 
humanised recombinant glycoproteins (Section 1.1). 
These new developments in insect expression technology may be used to expand the 
range of recombinant protein produced, therefore reducing the dependence on 
mammalian expression systems to express complex foreign proteins; and, in turn, reduce 
the overall costs of producing recombinant protein. 
In conclusion, this thesis has demonstrated advances made over the last decade, to 
improve stable insect expression systems following the identification and characterisation 
of novel promoters, has enhanced intracellular recombinant protein production. Secondly, 
these advancements have aided the groundwork for development of a new stable insect 
inducible expression system. Finally, the development of stably-transformed insect cell 
lines, utilising promoters with stronger transcriptional activity than conventional insect 
expression systems, still have limited potential for producing intracellular foreign proteins 
at present, when compared to the BES. However, the inherent advantages continuous 
and inducible insect expression systems possess over transient systems (BES), is 
expected to drive continued development of these systems; thereby, further elevating 
yields of intracellular recombinant protein produced. At the present time it is improbable 
that continuous expression will supplant the efficient use of the BES. A plethora of 
intracellular recombinant proteins have been expressed successfully using the BES and 
with developments and improvements in foreign protein production described recently, this 
system will undoubtedly lead to further popularity for the expression of foreign genes in the 
post genomic era. 
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